,index,0,Source,Name,P-value,P-adjust,VIP_scaled
0,R-HSA-5683826,3.5851960591181773,Proteomics,Surfactant metabolism,0.0021,0.8777425373134329,4.515197495276588
1,R-HSA-380994,3.0371670544169667,Transcriptomics,ATF4 activates genes in response to endoplasmic reticulum  stress,0.0136,0.8777425373134329,4.506929742772937
2,R-HSA-8849473,3.007995371346346,Transcriptomics,PTK6 Expression,0.0122,0.8777425373134329,4.431217604735863
3,R-HSA-166665,3.5307940275661847,Proteomics,Terminal pathway of complement,0.0057,0.8777425373134329,4.396509153461494
4,R-HSA-200425,12.123272387714835,Metabolomics,Carnitine metabolism,0.0031,0.8777425373134329,4.1121694987483774
5,R-HSA-70221,2.850220504495726,Transcriptomics,Glycogen breakdown (glycogenolysis),0.0113,0.8777425373134329,4.021728976025048
6,R-HSA-70171,11.773112159598726,Metabolomics,Glycolysis,0.0002,0.35,3.94300382025699
7,R-HSA-70326,11.773112159598726,Metabolomics,Glucose metabolism,0.0002,0.35,3.94300382025699
8,R-HSA-8857538,2.7935240909666663,Transcriptomics,PTK6 promotes HIF1A stabilization,0.0079,0.8777425373134329,3.8745791980390707
9,R-HSA-8948216,3.2571045204418265,Proteomics,Collagen chain trimerization,0.012,0.8777425373134329,3.799403625486213
10,R-HSA-162791,2.7628673964424064,Transcriptomics,Attachment of GPI anchor to uPAR,0.027,0.8777425373134329,3.7950128637291125
11,R-HSA-5357609,2.735737379823283,Transcriptomics,Glycogen storage disease type II (GAA),0.0265,0.8777425373134329,3.7245996634265266
12,R-HSA-844615,2.7095904933209445,Transcriptomics,The AIM2 inflammasome,0.0454,0.8777425373134329,3.6567380774044826
13,R-HSA-381340,3.150663803751618,Proteomics,Transcriptional regulation of white adipocyte differentiation,0.0048,0.8777425373134329,3.5671830299465537
14,R-HSA-9637628,3.1436915591761014,Proteomics,Modulation by Mtb of host immune system,0.0095,0.8777425373134329,3.5519717570622595
15,R-HSA-5638302,3.123094240863839,Proteomics,Signaling by Overexpressed Wild-Type EGFR in Cancer,0.0034,0.8777425373134329,3.5070348036695598
16,R-HSA-179812,3.123094240863839,Proteomics,GRB2 events in EGFR signaling,0.0034,0.8777425373134329,3.5070348036695598
17,R-HSA-5638303,3.123094240863839,Proteomics,Inhibition of Signaling by Overexpressed EGFR,0.0034,0.8777425373134329,3.5070348036695598
18,R-HSA-4419969,2.6431019053023275,Transcriptomics,Depolymerisation of the Nuclear Lamina,0.091,0.8777425373134329,3.4841737059292752
19,R-HSA-8964058,3.080700036525508,Proteomics,HDL remodeling,0.01,0.8777425373134329,3.4145438125807814
20,R-HSA-6799990,2.601207466911563,Transcriptomics,Metal sequestration by antimicrobial proteins,0.0782,0.8777425373134329,3.3754409497578726
21,R-HSA-5660668,2.5913081572148378,Transcriptomics,CLEC7A/inflammasome pathway,0.0323,0.8777425373134329,3.3497482977289943
22,R-HSA-5668599,2.5618536358264334,Transcriptomics,RHO GTPases Activate NADPH Oxidases,0.0081,0.8777425373134329,3.2733020815893186
23,R-HSA-5603041,2.5422949207813152,Transcriptomics,IRAK4 deficiency (TLR2/4),0.1225,0.8777425373134329,3.222539424880795
24,R-HSA-5602498,2.5422949207813152,Transcriptomics,MyD88 deficiency (TLR2/4),0.1225,0.8777425373134329,3.222539424880795
25,R-HSA-5621480,2.5361108519203284,Transcriptomics,Dectin-2 family,0.0821,0.8777425373134329,3.2064893027777837
26,R-HSA-5686938,2.53252878810655,Transcriptomics,Regulation of TLR by endogenous ligand,0.1477,0.8777425373134329,3.197192420274644
27,R-HSA-212718,2.9772263226977502,Proteomics,EGFR interacts with phospholipase C-gamma,0.0056,0.8777425373134329,3.1887962960762013
28,R-HSA-5686938,2.9652564360498928,Proteomics,Regulation of TLR by endogenous ligand,0.0114,0.8777425373134329,3.162681719884482
29,R-HSA-8964011,2.9484866095071567,Proteomics,HDL clearance,0.0157,0.8777425373134329,3.126095165152939
30,R-HSA-2562578,2.492748846441807,Transcriptomics,TRIF-mediated programmed cell death,0.0795,0.8777425373134329,3.0939476254118823
31,R-HSA-202131,2.4871068184613936,Transcriptomics,Metabolism of nitric oxide: NOS3 activation and regulation,0.0099,0.8777425373134329,3.079304315314622
32,R-HSA-8978868,9.899584698584379,Metabolomics,Fatty acid metabolism,0.0026,0.8777425373134329,3.0378851955065866
33,R-HSA-75109,2.4704778206805083,Transcriptomics,Triglyceride biosynthesis,0.0171,0.8777425373134329,3.0361454419525105
34,R-HSA-75105,9.88748886660321,Metabolomics,Fatty acyl-CoA biosynthesis,0.0048,0.8777425373134329,3.032041586039512
35,R-HSA-917937,9.884834727931743,Metabolomics,Iron uptake and transport,0.0083,0.8777425373134329,3.0307593468440883
36,R-HSA-9032845,2.466784997418187,Transcriptomics,Activated NTRK2 signals through CDK5,0.042,0.8777425373134329,3.026561094559645
37,R-HSA-6803157,2.8813049228300796,Proteomics,Antimicrobial peptides,0.029,0.8777425373134329,2.979525583750029
38,R-HSA-9026357,2.863085638795575,Proteomics,NTF4 activates NTRK2 (TRKB) signaling,0.0167,0.8777425373134329,2.9397767628066984
39,R-HSA-1474151,2.4203535335713373,Transcriptomics,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",0.0123,0.8777425373134329,2.9060529500166763
40,R-HSA-70263,9.593484139911373,Metabolomics,Gluconeogenesis,0.0068,0.8777425373134329,2.890005155065952
41,R-HSA-1236973,2.411089192595309,Transcriptomics,Cross-presentation of particulate exogenous antigens (phagosomes),0.0249,0.8777425373134329,2.8820082947562478
42,R-HSA-71336,2.4051632757450894,Transcriptomics,Pentose phosphate pathway,0.0071,0.8777425373134329,2.866628179955401
43,R-HSA-2142670,2.3989053830716145,Transcriptomics,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),0.0624,0.8777425373134329,2.850386455651448
44,R-HSA-5357769,2.387415673241932,Transcriptomics,Caspase activation via extrinsic apoptotic signalling pathway,0.1355,0.8777425373134329,2.82056608174553
45,R-HSA-9664420,2.385214317791474,Transcriptomics,Killing mechanisms,0.079,0.8777425373134329,2.8148526874470163
46,R-HSA-9673324,2.385214317791474,Transcriptomics,WNT5:FZD7-mediated leishmania damping,0.079,0.8777425373134329,2.8148526874470163
47,R-HSA-197264,2.3846891469399654,Transcriptomics,Nicotinamide salvaging,0.0365,0.8777425373134329,2.8134896598868235
48,R-HSA-187024,2.7837998343766066,Proteomics,NGF-independant TRKA activation,0.0176,0.8777425373134329,2.766799754641669
49,R-HSA-5602358,2.357624800473348,Transcriptomics,Diseases associated with the TLR signaling cascade,0.1042,0.8777425373134329,2.7432468997895363
50,R-HSA-5260271,2.357624800473348,Transcriptomics,Diseases of Immune System,0.1042,0.8777425373134329,2.7432468997895363
51,R-HSA-9634815,2.356456769431537,Transcriptomics,Transcriptional Regulation by NPAS4,0.2217,0.8777425373134329,2.740215393953719
52,R-HSA-450520,2.3538050486847033,Transcriptomics,HuR (ELAVL1) binds and stabilizes mRNA,0.0552,0.8777425373134329,2.7333331223091935
53,R-HSA-1482922,2.3347506519943653,Transcriptomics,Acyl chain remodelling of PI,0.122,0.8777425373134329,2.683879372625311
54,R-HSA-71403,9.125014829363119,Metabolomics,Citric acid cycle (TCA cycle),0.0147,0.8777425373134329,2.6636832532393107
55,R-HSA-140534,2.3242097643251824,Transcriptomics,Caspase activation via Death Receptors in the presence of ligand,0.1755,0.8777425373134329,2.656521570186884
56,R-HSA-381042,2.323987544694136,Transcriptomics,PERK regulates gene expression,0.0261,0.8777425373134329,2.65594482172367
57,R-HSA-9033658,2.732071992709458,Proteomics,Blood group systems biosynthesis,0.0354,0.8777425373134329,2.653945664858643
58,R-HSA-9037629,2.732071992709458,Proteomics,Lewis blood group biosynthesis,0.0354,0.8777425373134329,2.653945664858643
59,R-HSA-9768919,2.3209226238305267,Transcriptomics,NPAS4 regulates expression of target genes,0.0632,0.8777425373134329,2.6479901311788523
60,R-HSA-164938,2.7288773287254324,Proteomics,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.0327,0.8777425373134329,2.64697589994172
61,R-HSA-8964043,2.714919964998736,Proteomics,Plasma lipoprotein clearance,0.0191,0.8777425373134329,2.616525265846401
62,R-HSA-380972,2.30086823755035,Transcriptomics,Energy dependent regulation of mTOR by LKB1-AMPK,0.2236,0.8777425373134329,2.595941010165924
63,R-HSA-8866910,2.285484770092884,Transcriptomics,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,0.0266,0.8777425373134329,2.556014784147053
64,R-HSA-8949613,2.2839585153957596,Transcriptomics,Cristae formation,0.0085,0.8777425373134329,2.552053545228178
65,R-HSA-77289,2.2702094656089313,Transcriptomics,Mitochondrial Fatty Acid Beta-Oxidation,0.056,0.8777425373134329,2.516369284130905
66,R-HSA-75205,2.257831264512697,Transcriptomics,Dissolution of Fibrin Clot,0.1091,0.8777425373134329,2.484242921459956
67,R-HSA-162594,2.253344688288683,Transcriptomics,Early Phase of HIV Life Cycle,0.0853,0.8777425373134329,2.4725984689419427
68,R-HSA-4641262,2.240339790825358,Transcriptomics,Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.1382,0.8777425373134329,2.438845579555424
69,R-HSA-9754119,2.2395841781731196,Transcriptomics,Drug-mediated inhibition of CDK4/CDK6 activity,0.1654,0.8777425373134329,2.436884463726407
70,R-HSA-1251932,2.628184238425582,Proteomics,PLCG1 events in ERBB2 signaling,0.036,0.8777425373134329,2.4272948406322903
71,R-HSA-5654726,2.6125126121651534,Proteomics,Negative regulation of FGFR1 signaling,0.0098,0.8777425373134329,2.393104217941693
72,R-HSA-8857538,2.6113510747343063,Proteomics,PTK6 promotes HIF1A stabilization,0.0253,0.8777425373134329,2.390570103907888
73,R-HSA-445095,2.5985209017084867,Proteomics,Interaction between L1 and Ankyrins,0.0303,0.8777425373134329,2.3625786499457333
74,R-HSA-5620920,2.2080507185276286,Transcriptomics,Cargo trafficking to the periciliary membrane,0.225,0.8777425373134329,2.3550425746696066
75,R-HSA-8963898,2.5869295671902117,Proteomics,Plasma lipoprotein assembly,0.0283,0.8777425373134329,2.3372899569658894
76,R-HSA-112399,2.583984907753317,Proteomics,IRS-mediated signalling,0.0154,0.8777425373134329,2.3308656243480685
77,R-HSA-109704,2.583984907753317,Proteomics,PI3K Cascade,0.0154,0.8777425373134329,2.3308656243480685
78,R-HSA-9758941,2.198490317100753,Transcriptomics,Gastrulation,0.2575,0.8777425373134329,2.33022952460427
79,R-HSA-9754189,2.198490317100753,Transcriptomics,Germ layer formation at gastrulation,0.2575,0.8777425373134329,2.33022952460427
80,R-HSA-6803157,2.1942539921418343,Transcriptomics,Antimicrobial peptides,0.1621,0.8777425373134329,2.3192345738061593
81,R-HSA-162592,2.1936051993045105,Transcriptomics,Integration of provirus,0.0342,0.8777425373134329,2.31755069794826
82,R-HSA-8874081,2.187343688906068,Transcriptomics,MET activates PTK2 signaling,0.0951,0.8777425373134329,2.301299584206904
83,R-HSA-1482788,2.180278210135614,Transcriptomics,Acyl chain remodelling of PC,0.2644,0.8777425373134329,2.2829618522813377
84,R-HSA-1483115,2.1761158718023896,Transcriptomics,Hydrolysis of LPC,0.1911,0.8777425373134329,2.2721589262492956
85,R-HSA-844623,2.169700111043242,Transcriptomics,The IPAF inflammasome,0.1621,0.8777425373134329,2.2555074713766543
86,R-HSA-877312,2.169051809301755,Transcriptomics,Regulation of IFNG signaling,0.1082,0.8777425373134329,2.2538248701080783
87,R-HSA-1971475,2.1635010558341876,Transcriptomics,A tetrasaccharide linker sequence is required for GAG synthesis,0.0241,0.8777425373134329,2.239418453730633
88,R-HSA-3656532,2.161219397699918,Transcriptomics,TGFBR1 KD Mutants in Cancer,0.2292,0.8777425373134329,2.2334966419792495
89,R-HSA-3304356,2.161219397699918,Transcriptomics,SMAD2/3 Phosphorylation Motif Mutants in Cancer,0.2292,0.8777425373134329,2.2334966419792495
90,R-HSA-3304349,2.161219397699918,Transcriptomics,Loss of Function of SMAD2/3 in Cancer,0.2292,0.8777425373134329,2.2334966419792495
91,R-HSA-977225,2.513081428101549,Proteomics,Amyloid fiber formation,0.0717,0.8777425373134329,2.1761762462364094
92,R-HSA-2980766,2.1389294406491466,Transcriptomics,Nuclear Envelope Breakdown,0.2838,0.8777425373134329,2.175645324282464
93,R-HSA-2142688,2.1321455536331846,Transcriptomics,Synthesis of 5-eicosatetraenoic acids,0.1085,0.8777425373134329,2.1580384351311928
94,R-HSA-1251932,2.12943869470795,Transcriptomics,PLCG1 events in ERBB2 signaling,0.0519,0.8777425373134329,2.151013057949558
95,R-HSA-448706,2.127510655445617,Transcriptomics,Interleukin-1 processing,0.252,0.8777425373134329,2.1460090280340647
96,R-HSA-70895,2.122843312189624,Transcriptomics,Branched-chain amino acid catabolism,0.1286,0.8777425373134329,2.1338954130599586
97,R-HSA-4641263,2.4859992731921388,Proteomics,Regulation of FZD by ubiquitination,0.0337,0.8777425373134329,2.1170913928352006
98,R-HSA-879415,2.4852031597079467,Proteomics,Advanced glycosylation endproduct receptor signaling,0.0134,0.8777425373134329,2.115354520394231
99,R-HSA-6803529,2.1099715930615606,Transcriptomics,FGFR2 alternative splicing,0.1059,0.8777425373134329,2.100488174504709
100,R-HSA-196071,2.099090110933806,Transcriptomics,Metabolism of steroid hormones,0.3157,0.8777425373134329,2.0722463937713163
101,R-HSA-1461973,2.0953137942754525,Transcriptomics,Defensins,0.1792,0.8777425373134329,2.062445347756357
102,R-HSA-5626978,2.4584324694062656,Proteomics,TNFR1-mediated ceramide production,0.0592,0.8777425373134329,2.056949186061904
103,R-HSA-5357786,2.4584324694062656,Proteomics,TNFR1-induced proapoptotic signaling,0.0592,0.8777425373134329,2.056949186061904
104,R-HSA-74752,2.457707768217601,Proteomics,Signaling by Insulin receptor,0.0185,0.8777425373134329,2.0553681130773076
105,R-HSA-74751,2.457707768217601,Proteomics,Insulin receptor signalling cascade,0.0185,0.8777425373134329,2.0553681130773076
106,R-HSA-5676594,2.091671247861654,Transcriptomics,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,0.1178,0.8777425373134329,2.052991488813069
107,R-HSA-203615,2.0843995143240743,Transcriptomics,eNOS activation,0.0894,0.8777425373134329,2.0341184436057276
108,R-HSA-168274,2.0833595922589208,Transcriptomics,Export of Viral Ribonucleoproteins from Nucleus,0.3459,0.8777425373134329,2.0314194315962353
109,R-HSA-199220,2.0827936752324927,Transcriptomics,Vitamin B5 (pantothenate) metabolism,0.2096,0.8777425373134329,2.0299506514809873
110,R-HSA-2151201,2.445138014440357,Proteomics,Transcriptional activation of mitochondrial biogenesis,0.0447,0.8777425373134329,2.027944813059195
111,R-HSA-1296072,2.080325249526962,Transcriptomics,Voltage gated Potassium channels,0.2174,0.8777425373134329,2.0235441034837747
112,R-HSA-2404192,2.441417389262024,Proteomics,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.0285,0.8777425373134329,2.0198275641195154
113,R-HSA-2428928,2.441417389262024,Proteomics,IRS-related events triggered by IGF1R,0.0285,0.8777425373134329,2.0198275641195154
114,R-HSA-2428924,2.441417389262024,Proteomics,IGF1R signaling cascade,0.0285,0.8777425373134329,2.0198275641195154
115,R-HSA-8963901,2.441381571244246,Proteomics,Chylomicron remodeling,0.0373,0.8777425373134329,2.019749420325692
116,R-HSA-111447,2.0758603661613853,Transcriptomics,Activation of BAD and translocation to mitochondria ,0.1146,0.8777425373134329,2.0119559525747026
117,R-HSA-1222556,2.0735064550812674,Transcriptomics,ROS and RNS production in phagocytes,0.0581,0.8777425373134329,2.0058466156470582
118,R-HSA-1296071,2.070400872319686,Transcriptomics,Potassium Channels,0.3001,0.8777425373134329,1.9977863912794351
119,R-HSA-430039,2.0701267996237482,Transcriptomics,mRNA decay by 5' to 3' exoribonuclease,0.0142,0.8777425373134329,1.9970750634572862
120,R-HSA-141405,2.064105859951622,Transcriptomics,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,0.051,0.8777425373134329,1.981448326581483
121,R-HSA-141430,2.064105859951622,Transcriptomics,Inactivation of APC/C via direct inhibition of the APC/C complex,0.051,0.8777425373134329,1.981448326581483
122,R-HSA-196741,2.062902828732047,Transcriptomics,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.2958,0.8777425373134329,1.978325981342133
123,R-HSA-168271,2.05898071513002,Transcriptomics,Transport of Ribonucleoproteins into the Host Nucleus,0.3303,0.8777425373134329,1.968146534180485
124,R-HSA-5620971,2.0584987277436815,Transcriptomics,Pyroptosis,0.1856,0.8777425373134329,1.9668955849144363
125,R-HSA-9630794,2.0571570801592007,Transcriptomics,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.1186,0.8777425373134329,1.963413474990665
126,R-HSA-9632700,2.0571570801592007,Transcriptomics,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.1186,0.8777425373134329,1.963413474990665
127,R-HSA-9630747,2.0571570801592007,Transcriptomics,Diseases of Cellular Senescence,0.1186,0.8777425373134329,1.963413474990665
128,R-HSA-9632693,2.0571570801592007,Transcriptomics,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,0.1186,0.8777425373134329,1.963413474990665
129,R-HSA-9675132,2.0571570801592007,Transcriptomics,Diseases of cellular response to stress,0.1186,0.8777425373134329,1.963413474990665
130,R-HSA-9630750,2.0571570801592007,Transcriptomics,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,0.1186,0.8777425373134329,1.963413474990665
131,R-HSA-9664424,2.0478854244912745,Transcriptomics,Cell recruitment (pro-inflammatory response),0.1548,0.8777425373134329,1.9393498351909715
132,R-HSA-9660826,2.0478854244912745,Transcriptomics,Purinergic signaling in leishmaniasis infection,0.1548,0.8777425373134329,1.9393498351909715
133,R-HSA-111465,2.0475480886017476,Transcriptomics,Apoptotic cleavage of cellular proteins,0.074,0.8777425373134329,1.9384743141807201
134,R-HSA-196807,2.0454180005150353,Transcriptomics,Nicotinate metabolism,0.1166,0.8777425373134329,1.932945887080307
135,R-HSA-9006115,2.044137323143616,Transcriptomics,Signaling by NTRK2 (TRKB),0.0244,0.8777425373134329,1.929622019146766
136,R-HSA-6783783,2.0401427694307097,Transcriptomics,Interleukin-10 signaling,0.0721,0.8777425373134329,1.9192545610410439
137,R-HSA-9657688,2.3834393950835433,Proteomics,Defective factor XII causes hereditary angioedema,0.0641,0.8777425373134329,1.8933375821372709
138,R-HSA-180910,2.028888191393372,Transcriptomics,Vpr-mediated nuclear import of PICs,0.3209,0.8777425373134329,1.890044447800437
139,R-HSA-196791,2.027581995053095,Transcriptomics,Vitamin D (calciferol) metabolism,0.2063,0.8777425373134329,1.8866543479772915
140,R-HSA-2022090,2.0270435030581964,Transcriptomics,Assembly of collagen fibrils and other multimeric structures,0.2846,0.8777425373134329,1.8852567467435564
141,R-HSA-400042,2.0249026498563802,Transcriptomics,"Adrenaline,noradrenaline inhibits insulin secretion",0.1056,0.8777425373134329,1.8797003798811913
142,R-HSA-1474290,2.0236532549076625,Transcriptomics,Collagen formation,0.2458,0.8777425373134329,1.8764577022958375
143,R-HSA-433692,2.0211268814373304,Transcriptomics,Proton-coupled monocarboxylate transport,0.1428,0.8777425373134329,1.869900756765615
144,R-HSA-75158,2.0154571514879547,Transcriptomics,TRAIL  signaling,0.191,0.8777425373134329,1.855185549023886
145,R-HSA-1839126,2.014591962426893,Transcriptomics,FGFR2 mutant receptor activation,0.0568,0.8777425373134329,1.8529400387644785
146,R-HSA-8851708,2.014591962426893,Transcriptomics,Signaling by FGFR2 IIIa TM,0.0568,0.8777425373134329,1.8529400387644785
147,R-HSA-1482883,2.0128135027682292,Transcriptomics,Acyl chain remodeling of DAG and TAG,0.0845,0.8777425373134329,1.8483242275051777
148,R-HSA-180336,2.358413108595876,Proteomics,SHC1 events in EGFR signaling,0.0394,0.8777425373134329,1.8387379953153715
149,R-HSA-4655427,2.008286201831188,Transcriptomics,SUMOylation of DNA methylation proteins,0.212,0.8777425373134329,1.8365740781342672
150,R-HSA-5654736,2.356201607985497,Proteomics,Signaling by FGFR1,0.0238,0.8777425373134329,1.833913187621966
151,R-HSA-1679131,2.006395126500761,Transcriptomics,Trafficking and processing of endosomal TLR,0.2882,0.8777425373134329,1.8316659843465632
152,R-HSA-4085377,2.004088726952084,Transcriptomics,SUMOylation of SUMOylation proteins,0.374,0.8777425373134329,1.8256799587691115
153,R-HSA-5340588,2.003560268559002,Transcriptomics,Signaling by RNF43 mutants,0.1112,0.8777425373134329,1.8243083987289508
154,R-HSA-110056,2.350562182997477,Proteomics,MAPK3 (ERK1) activation,0.0518,0.8777425373134329,1.8216097132566937
155,R-HSA-6799198,2.001904399020566,Transcriptomics,Complex I biogenesis,0.0247,0.8777425373134329,1.8200107576651172
156,R-HSA-1483206,7.324759798138144,Metabolomics,Glycerophospholipid biosynthesis,0.0384,0.8777425373134329,1.7939632240596235
157,R-HSA-164843,1.9915314838470972,Transcriptomics,2-LTR circle formation,0.1679,0.8777425373134329,1.7930889107645018
158,R-HSA-8939256,2.3358603737868973,Proteomics,RUNX1 regulates transcription of genes involved in WNT signaling,0.06,0.8777425373134329,1.7895349302549235
159,R-HSA-163125,1.98819512424248,Transcriptomics,Post-translational modification: synthesis of GPI-anchored proteins,0.1358,0.8777425373134329,1.7844297285598079
160,R-HSA-163210,1.9845963282374173,Transcriptomics,Formation of ATP by chemiosmotic coupling,0.0658,0.8777425373134329,1.7750894193550575
161,R-HSA-77286,1.9839588333834715,Transcriptomics,mitochondrial fatty acid beta-oxidation of saturated fatty acids,0.1172,0.8777425373134329,1.7734348662645476
162,R-HSA-9651496,2.322257014195381,Proteomics,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),0.0705,0.8777425373134329,1.7598566232694854
163,R-HSA-9671793,2.322257014195381,Proteomics,Diseases of hemostasis,0.0705,0.8777425373134329,1.7598566232694854
164,R-HSA-6803205,1.9710215251363907,Transcriptomics,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.236,0.8777425373134329,1.7398573978181822
165,R-HSA-9025046,2.310251155401221,Proteomics,NTF3 activates NTRK2 (TRKB) signaling,0.0706,0.8777425373134329,1.7336635670233564
166,R-HSA-8963684,1.968532896496153,Transcriptomics,Tyrosine catabolism,0.1217,0.8777425373134329,1.7333984151576154
167,R-HSA-5654733,2.306977624068531,Proteomics,Negative regulation of FGFR4 signaling,0.0292,0.8777425373134329,1.726521738038801
168,R-HSA-8963888,2.3058926826270323,Proteomics,Chylomicron assembly,0.0495,0.8777425373134329,1.7241547326718254
169,R-HSA-381426,2.3044671438354976,Proteomics,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.0857,0.8777425373134329,1.721044649637543
170,R-HSA-1482839,1.9606238867084846,Transcriptomics,Acyl chain remodelling of PE,0.3572,0.8777425373134329,1.712871384223854
171,R-HSA-2644605,2.2999219482166415,Proteomics,FBXW7 Mutants and NOTCH1 in Cancer,0.041,0.8777425373134329,1.7111284440136465
172,R-HSA-2644607,2.2999219482166415,Proteomics,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,0.041,0.8777425373134329,1.7111284440136465
173,R-HSA-171319,1.958667716733023,Transcriptomics,Telomere Extension By Telomerase,0.0718,0.8777425373134329,1.707794343901992
174,R-HSA-420092,1.9564752448163631,Transcriptomics,Glucagon-type ligand receptors,0.2566,0.8777425373134329,1.702104005912418
175,R-HSA-1236977,2.292698079641586,Proteomics,Endosomal/Vacuolar pathway,0.094,0.8777425373134329,1.6953682056879122
176,R-HSA-8866910,2.2925063115580935,Proteomics,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,0.0744,0.8777425373134329,1.6949498272709038
177,R-HSA-5603041,2.2915389870610743,Proteomics,IRAK4 deficiency (TLR2/4),0.0486,0.8777425373134329,1.6928394255584494
178,R-HSA-5602498,2.2915389870610743,Proteomics,MyD88 deficiency (TLR2/4),0.0486,0.8777425373134329,1.6928394255584494
179,R-HSA-5602358,2.2915389870610743,Proteomics,Diseases associated with the TLR signaling cascade,0.0486,0.8777425373134329,1.6928394255584494
180,R-HSA-5260271,2.2915389870610743,Proteomics,Diseases of Immune System,0.0486,0.8777425373134329,1.6928394255584494
181,R-HSA-8941856,2.2865527446823806,Proteomics,RUNX3 regulates NOTCH signaling,0.0451,0.8777425373134329,1.681960992843125
182,R-HSA-156581,1.9437483374984064,Transcriptomics,Methylation,0.2756,0.8777425373134329,1.6690726116898262
183,R-HSA-73928,7.06583868950018,Metabolomics,Depyrimidination,0.0766,0.8777425373134329,1.6688760168284242
184,R-HSA-110329,7.06583868950018,Metabolomics,Cleavage of the damaged pyrimidine ,0.0766,0.8777425373134329,1.6688760168284242
185,R-HSA-383280,2.279261354546705,Proteomics,Nuclear Receptor transcription pathway,0.0619,0.8777425373134329,1.66605344343657
186,R-HSA-163200,1.9425505555186802,Transcriptomics,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.0313,0.8777425373134329,1.665963890318906
187,R-HSA-156590,1.9423197860226258,Transcriptomics,Glutathione conjugation,0.2796,0.8777425373134329,1.665364951550179
188,R-HSA-1614558,1.941367939921203,Transcriptomics,Degradation of cysteine and homocysteine,0.1618,0.8777425373134329,1.6628945317514134
189,R-HSA-2219528,2.2737493566587723,Proteomics,PI3K/AKT Signaling in Cancer,0.0454,0.8777425373134329,1.654027975439446
190,R-HSA-391906,1.9370210933174745,Transcriptomics,Leukotriene receptors,0.2315,0.8777425373134329,1.6516127332589938
191,R-HSA-74182,7.024973872560077,Metabolomics,Ketone body metabolism,0.09,0.8777425373134329,1.649133841878142
192,R-HSA-77111,7.024973872560077,Metabolomics,Synthesis of Ketone Bodies,0.09,0.8777425373134329,1.649133841878142
193,R-HSA-8939245,1.935239178160023,Transcriptomics,RUNX1 regulates transcription of genes involved in BCR signaling,0.1804,0.8777425373134329,1.6469879536038499
194,R-HSA-8849470,1.9347706879041322,Transcriptomics,PTK6 Regulates Cell Cycle,0.1333,0.8777425373134329,1.645772034767862
195,R-HSA-173623,2.2639868014153754,Proteomics,Classical antibody-mediated complement activation,0.0714,0.8777425373134329,1.6327291110282953
196,R-HSA-2565942,2.2623784153353323,Proteomics,Regulation of PLK1 Activity at G2/M Transition,0.0299,0.8777425373134329,1.6292201119818839
197,R-HSA-4755510,1.9276553572267716,Transcriptomics,SUMOylation of immune response proteins,0.3621,0.8777425373134329,1.6273049172854877
198,R-HSA-5654727,2.261121154445575,Proteomics,Negative regulation of FGFR2 signaling,0.0351,0.8777425373134329,1.6264771590814644
199,R-HSA-8943724,1.925014279281063,Transcriptomics,Regulation of PTEN gene transcription,0.1137,0.8777425373134329,1.6204502679494146
200,R-HSA-176033,1.9226257664868203,Transcriptomics,Interactions of Vpr with host cellular proteins,0.3355,0.8777425373134329,1.6142511257901078
201,R-HSA-77352,1.921359010916238,Transcriptomics,Beta oxidation of butanoyl-CoA to acetyl-CoA,0.128,0.8777425373134329,1.6109633904754543
202,R-HSA-198933,1.921124925605113,Transcriptomics,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.1271,0.8777425373134329,1.6103558458457723
203,R-HSA-187687,1.9182367775427167,Transcriptomics,Signalling to ERKs,0.0454,0.8777425373134329,1.6028599511371164
204,R-HSA-416550,1.9181378239942515,Transcriptomics,Sema4D mediated inhibition of cell attachment and migration,0.1263,0.8777425373134329,1.6026031272609444
205,R-HSA-69273,1.9177877077319727,Transcriptomics,Cyclin A/B1/B2 associated events during G2/M transition,0.2976,0.8777425373134329,1.6016944360923717
206,R-HSA-3296197,1.915981789859767,Transcriptomics,Hydroxycarboxylic acid-binding receptors,0.145,0.8777425373134329,1.5970073598310177
207,R-HSA-6791465,1.9135222628402546,Transcriptomics,Pentose phosphate pathway disease,0.1971,0.8777425373134329,1.5906239074687925
208,R-HSA-2032785,2.242041569713871,Proteomics,YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.079,0.8777425373134329,1.584851429127569
209,R-HSA-8964026,2.24131525646201,Proteomics,Chylomicron clearance,0.0551,0.8777425373134329,1.5832668391215996
210,R-HSA-611105,1.9082038209884622,Transcriptomics,Respiratory electron transport,0.0313,0.8777425373134329,1.5768204322750492
211,R-HSA-196299,1.904001150682184,Transcriptomics,Beta-catenin phosphorylation cascade,0.2371,0.8777425373134329,1.5659128287067892
212,R-HSA-203754,1.9000485898129649,Transcriptomics,NOSIP mediated eNOS trafficking,0.133,0.8777425373134329,1.5556543587581824
213,R-HSA-622312,1.8998255662152717,Transcriptomics,Inflammasomes,0.1155,0.8777425373134329,1.5550755236812621
214,R-HSA-9634638,1.8969134907598983,Transcriptomics,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.1201,0.8777425373134329,1.5475175278564122
215,R-HSA-6799990,2.2245276755469496,Proteomics,Metal sequestration by antimicrobial proteins,0.108,0.8777425373134329,1.5466415498621169
216,R-HSA-9682385,2.2238787627747736,Proteomics,FLT3 signaling in disease,0.0399,0.8777425373134329,1.5452258236711087
217,R-HSA-196108,1.8953306884870225,Transcriptomics,Pregnenolone biosynthesis,0.2876,0.8777425373134329,1.5434095254528737
218,R-HSA-1428517,1.8938082318583047,Transcriptomics,The citric acid (TCA) cycle and respiratory electron transport,0.0268,0.8777425373134329,1.539458144034466
219,R-HSA-4085001,1.8923383639493683,Transcriptomics,Sialic acid metabolism,0.2348,0.8777425373134329,1.5356432512924787
220,R-HSA-379726,1.8919102575475752,Transcriptomics,Mitochondrial tRNA aminoacylation,0.1717,0.8777425373134329,1.5345321446446847
221,R-HSA-399997,1.8881996141151771,Transcriptomics,Acetylcholine regulates insulin secretion,0.2072,0.8777425373134329,1.5249015468118492
222,R-HSA-9604323,1.8874938182879109,Transcriptomics,Negative regulation of NOTCH4 signaling,0.0223,0.8777425373134329,1.5230697254880465
223,R-HSA-9652817,1.8855441381275242,Transcriptomics,Signaling by MAPK mutants,0.1808,0.8777425373134329,1.5180095288215059
224,R-HSA-373080,1.8838903024704987,Transcriptomics,Class B/2 (Secretin family receptors),0.2098,0.8777425373134329,1.5137171664901239
225,R-HSA-3108214,1.8824474084907024,Transcriptomics,SUMOylation of DNA damage response and repair proteins,0.4316,0.8777425373134329,1.509972281839254
226,R-HSA-8849474,1.87502991894758,Transcriptomics,PTK6 Activates STAT3,0.0601,0.8777425373134329,1.4907209417359808
227,R-HSA-9758890,1.8689824632990395,Transcriptomics,Transport of RCbl within the body,0.3147,0.8777425373134329,1.4750253853388078
228,R-HSA-3928664,1.8676961281346467,Transcriptomics,Ephrin signaling,0.05,0.8777425373134329,1.4716868331787327
229,R-HSA-5099900,1.8665752993239144,Transcriptomics,WNT5A-dependent internalization of FZD4,0.4019,0.8777425373134329,1.4687778359354589
230,R-HSA-1236977,1.866245528863717,Transcriptomics,Endosomal/Vacuolar pathway,0.3652,0.8777425373134329,1.4679219502279879
231,R-HSA-399955,1.8637842207051099,Transcriptomics,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,0.04,0.8777425373134329,1.4615338751002995
232,R-HSA-5358508,1.8599854629402337,Transcriptomics,Mismatch Repair,0.0674,0.8777425373134329,1.451674585474554
233,R-HSA-5358565,1.8599854629402337,Transcriptomics,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),0.0674,0.8777425373134329,1.451674585474554
234,R-HSA-5358606,1.8599854629402337,Transcriptomics,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),0.0674,0.8777425373134329,1.451674585474554
235,R-HSA-3928662,1.859914933726734,Transcriptomics,EPHB-mediated forward signaling,0.0301,0.8777425373134329,1.4514915340703822
236,R-HSA-112409,1.8585621571991486,Transcriptomics,RAF-independent MAPK1/3 activation,0.2194,0.8777425373134329,1.4479805401060672
237,R-HSA-201451,2.1789706449090014,Proteomics,Signaling by BMP,0.0735,0.8777425373134329,1.447250253798662
238,R-HSA-5654743,2.1787951064240634,Proteomics,Signaling by FGFR4,0.0522,0.8777425373134329,1.4468672833266472
239,R-HSA-165054,1.858032771986471,Transcriptomics,Rev-mediated nuclear export of HIV RNA,0.4304,0.8777425373134329,1.4466065745998606
240,R-HSA-159230,1.858032771986471,Transcriptomics,Transport of the SLBP Dependant Mature mRNA,0.4304,0.8777425373134329,1.4466065745998606
241,R-HSA-5619107,1.858032771986471,Transcriptomics,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),0.4304,0.8777425373134329,1.4466065745998606
242,R-HSA-168333,1.858032771986471,Transcriptomics,NEP/NS2 Interacts with the Cellular Export Machinery,0.4304,0.8777425373134329,1.4466065745998606
243,R-HSA-170822,1.858032771986471,Transcriptomics,Regulation of Glucokinase by Glucokinase Regulatory Protein,0.4304,0.8777425373134329,1.4466065745998606
244,R-HSA-159227,1.858032771986471,Transcriptomics,Transport of the SLBP independent Mature mRNA,0.4304,0.8777425373134329,1.4466065745998606
245,R-HSA-983170,2.1770211383606513,Proteomics,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.0902,0.8777425373134329,1.442997035803297
246,R-HSA-5654712,2.176609034850354,Proteomics,FRS-mediated FGFR4 signaling,0.0702,0.8777425373134329,1.4420979538959129
247,R-HSA-5654720,2.176609034850354,Proteomics,PI-3K cascade:FGFR4,0.0702,0.8777425373134329,1.4420979538959129
248,R-HSA-4608870,1.8562936650053141,Transcriptomics,Asymmetric localization of PCP proteins,0.0296,0.8777425373134329,1.4420928992147333
249,R-HSA-166208,1.854071765855585,Transcriptomics,mTORC1-mediated signalling,0.126,0.8777425373134329,1.4363261858330783
250,R-HSA-5601884,1.8537852277181348,Transcriptomics,PIWI-interacting RNA (piRNA) biogenesis,0.0333,0.8777425373134329,1.435582505224627
251,R-HSA-5654693,2.172902664662642,Proteomics,FRS-mediated FGFR1 signaling,0.0795,0.8777425373134329,1.4340118049198025
252,R-HSA-5654689,2.172902664662642,Proteomics,PI-3K cascade:FGFR1,0.0795,0.8777425373134329,1.4340118049198025
253,R-HSA-5687613,1.850119197175951,Transcriptomics,Diseases associated with surfactant metabolism,0.2054,0.8777425373134329,1.4260676956133334
254,R-HSA-8854050,1.8491312038010708,Transcriptomics,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,0.0267,0.8777425373134329,1.4235034592407676
255,R-HSA-9619229,1.8491080487433373,Transcriptomics,Activation of RAC1 downstream of NMDARs,0.1705,0.8777425373134329,1.4234433626421887
256,R-HSA-9609523,1.8478668552043753,Transcriptomics,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,0.134,0.8777425373134329,1.4202219709821629
257,R-HSA-1502540,1.8462371247776408,Transcriptomics,Signaling by Activin,0.2204,0.8777425373134329,1.4159921713256456
258,R-HSA-9018678,1.8460465007123605,Transcriptomics,Biosynthesis of specialized proresolving mediators (SPMs),0.126,0.8777425373134329,1.4154974259416118
259,R-HSA-69416,1.8459657655850588,Transcriptomics,Dimerization of procaspase-8,0.315,0.8777425373134329,1.4152878861256226
260,R-HSA-3371378,1.8459657655850585,Transcriptomics,Regulation by c-FLIP,0.315,0.8777425373134329,1.415287886125622
261,R-HSA-5218900,1.8459657655850585,Transcriptomics,CASP8 activity is inhibited,0.315,0.8777425373134329,1.415287886125622
262,R-HSA-9031628,1.84269575435474,Transcriptomics,NGF-stimulated transcription,0.1454,0.8777425373134329,1.406800904381946
263,R-HSA-3560783,1.8426419762047992,Transcriptomics,"Defective B4GALT7 causes EDS, progeroid type",0.0649,0.8777425373134329,1.4066613286604548
264,R-HSA-5654719,2.1565456945141634,Proteomics,SHC-mediated cascade:FGFR4,0.071,0.8777425373134329,1.3983259746546863
265,R-HSA-190322,2.1565456945141634,Proteomics,FGFR4 ligand binding and activation,0.071,0.8777425373134329,1.3983259746546863
266,R-HSA-5576893,1.8372066220402283,Transcriptomics,Phase 2 - plateau phase,0.2807,0.8777425373134329,1.3925544194433168
267,R-HSA-194306,2.1530604890501746,Proteomics,Neurophilin interactions with VEGF and VEGFR,0.0888,0.8777425373134329,1.3907223384373437
268,R-HSA-1614635,1.835195478579958,Transcriptomics,Sulfur amino acid metabolism,0.1246,0.8777425373134329,1.3873347010298223
269,R-HSA-73817,1.8350652644147891,Transcriptomics,Purine ribonucleoside monophosphate biosynthesis,0.2452,0.8777425373134329,1.3869967434007138
270,R-HSA-5620922,1.833292399354383,Transcriptomics,BBSome-mediated cargo-targeting to cilium,0.2076,0.8777425373134329,1.3823954523524866
271,R-HSA-110357,1.8289703188324564,Transcriptomics,Displacement of DNA glycosylase by APEX1,0.1296,0.8777425373134329,1.371177931707851
272,R-HSA-1839124,2.1437183351789906,Proteomics,FGFR1 mutant receptor activation,0.0773,0.8777425373134329,1.3703406592919134
273,R-HSA-187577,1.8265058908328138,Transcriptomics,SCF(Skp2)-mediated degradation of p27/p21,0.0262,0.8777425373134329,1.3647817593498945
274,R-HSA-73614,1.8258463333108155,Transcriptomics,Pyrimidine salvage,0.2967,0.8777425373134329,1.3630699448471786
275,R-HSA-5654738,2.140097347583823,Proteomics,Signaling by FGFR2,0.0594,0.8777425373134329,1.3624407886226952
276,R-HSA-1428517,6.423479499848538,Metabolomics,The citric acid (TCA) cycle and respiratory electron transport,0.0788,0.8777425373134329,1.358546289385574
277,R-HSA-1169091,1.8192362645699736,Transcriptomics,Activation of NF-kappaB in B cells,0.0268,0.8777425373134329,1.3459141833599302
278,R-HSA-6798695,1.8189206288185853,Transcriptomics,Neutrophil degranulation,0.0351,0.8777425373134329,1.345094982852346
279,R-HSA-8864260,2.1306917331075956,Proteomics,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,0.0875,0.8777425373134329,1.3419206581406458
280,R-HSA-1483191,2.130248299291428,Proteomics,Synthesis of PC,0.0816,0.8777425373134329,1.3409532232334516
281,R-HSA-2022377,1.8172698543423136,Transcriptomics,Metabolism of Angiotensinogen to Angiotensins,0.1642,0.8777425373134329,1.3408105655044338
282,R-HSA-166665,1.8086386911657946,Transcriptomics,Terminal pathway of complement,0.1155,0.8777425373134329,1.3184092588585636
283,R-HSA-198725,1.8074467253568338,Transcriptomics,Nuclear Events (kinase and transcription factor activation),0.1452,0.8777425373134329,1.3153156327676374
284,R-HSA-8934593,1.8052209196945375,Transcriptomics,Regulation of RUNX1 Expression and Activity,0.5067,0.8777425373134329,1.3095387804297207
285,R-HSA-170660,1.8051816547115818,Transcriptomics,Adenylate cyclase activating pathway,0.1608,0.8777425373134329,1.3094368721578404
286,R-HSA-8956320,1.8047631709218004,Transcriptomics,Nucleotide biosynthesis,0.2192,0.8777425373134329,1.3083507400213605
287,R-HSA-174184,1.804089636936666,Transcriptomics,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,0.0229,0.8777425373134329,1.306602651029316
288,R-HSA-179419,1.804089636936666,Transcriptomics,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,0.0229,0.8777425373134329,1.306602651029316
289,R-HSA-69541,1.8037296319497902,Transcriptomics,Stabilization of p53,0.0237,0.8777425373134329,1.305668294681265
290,R-HSA-1461957,1.8035067645070983,Transcriptomics,Beta defensins,0.2755,0.8777425373134329,1.3050898648887774
291,R-HSA-73933,1.8019631878539966,Transcriptomics,Resolution of Abasic Sites (AP sites),0.0695,0.8777425373134329,1.3010836685939826
292,R-HSA-9762114,1.8013757657535294,Transcriptomics,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,0.0275,0.8777425373134329,1.2995590742451093
293,R-HSA-1236978,1.8011159429552523,Transcriptomics,Cross-presentation of soluble exogenous antigens (endosomes),0.0596,0.8777425373134329,1.2988847305838023
294,R-HSA-1170546,2.108688374260905,Proteomics,Prolactin receptor signaling,0.0929,0.8777425373134329,1.2939161608567469
295,R-HSA-9706019,1.7990694297354195,Transcriptomics,RHOBTB3 ATPase cycle,0.1548,0.8777425373134329,1.2935732135547855
296,R-HSA-9694548,1.7979522741995306,Transcriptomics,Maturation of spike protein,0.3316,0.8777425373134329,1.2906737499229706
297,R-HSA-9672391,2.105064724081609,Proteomics,Defective F8 cleavage by thrombin,0.0972,0.8777425373134329,1.286010481255654
298,R-HSA-189483,1.7956693749818369,Transcriptomics,Heme degradation,0.4429,0.8777425373134329,1.284748717065719
299,R-HSA-4086398,1.7956463873791755,Transcriptomics,Ca2+ pathway,0.4641,0.8777425373134329,1.2846890550797572
300,R-HSA-2179392,1.795280488976662,Transcriptomics,EGFR Transactivation by Gastrin,0.1991,0.8777425373134329,1.2837394029704985
301,R-HSA-68949,1.79520656471342,Transcriptomics,Orc1 removal from chromatin,0.0315,0.8777425373134329,1.2835475400598357
302,R-HSA-5654732,2.103054641985898,Proteomics,Negative regulation of FGFR3 signaling,0.0641,0.8777425373134329,1.2816251062237651
303,R-HSA-9683673,1.79154044559046,Transcriptomics,Maturation of protein 3a,0.0842,0.8777425373134329,1.2740325005461417
304,R-HSA-9694719,1.79154044559046,Transcriptomics,Maturation of protein 3a,0.0842,0.8777425373134329,1.2740325005461417
305,R-HSA-977068,1.79154044559046,Transcriptomics,Termination of O-glycan biosynthesis,0.0842,0.8777425373134329,1.2740325005461417
306,R-HSA-1257604,2.0987167163113023,Proteomics,PIP3 activates AKT signaling,0.0791,0.8777425373134329,1.2721610992639731
307,R-HSA-168325,1.7900802902005646,Transcriptomics,Viral Messenger RNA Synthesis,0.3317,0.8777425373134329,1.2702428156600245
308,R-HSA-8941858,1.7842215969647373,Transcriptomics,Regulation of RUNX3 expression and activity,0.0406,0.8777425373134329,1.2550371729168892
309,R-HSA-2514856,1.783024104602756,Transcriptomics,The phototransduction cascade,0.2267,0.8777425373134329,1.2519292032193856
310,R-HSA-390522,2.0887202645849543,Proteomics,Striated Muscle Contraction,0.1141,0.8777425373134329,1.250351945348444
311,R-HSA-5632681,2.0886227589623387,Proteomics,Ligand-receptor interactions,0.1101,0.8777425373134329,1.2501392183539597
312,R-HSA-1566977,1.781418524694991,Transcriptomics,Fibronectin matrix formation,0.17,0.8777425373134329,1.2477620837798946
313,R-HSA-442982,1.7797444420766417,Transcriptomics,Ras activation upon Ca2+ influx through NMDA receptor,0.1352,0.8777425373134329,1.2434171725185497
314,R-HSA-8963899,2.08480799814225,Proteomics,Plasma lipoprotein remodeling,0.0704,0.8777425373134329,1.2418165946717021
315,R-HSA-9017802,1.7782022591709266,Transcriptomics,Noncanonical activation of NOTCH3,0.4702,0.8777425373134329,1.239414593553419
316,R-HSA-140837,2.083265869001454,Proteomics,Intrinsic Pathway of Fibrin Clot Formation,0.1037,0.8777425373134329,1.2384521476949217
317,R-HSA-6802953,1.7777748033400667,Transcriptomics,RAS signaling downstream of NF1 loss-of-function variants,0.163,0.8777425373134329,1.2383051753963499
318,R-HSA-196849,1.7770655579427974,Transcriptomics,Metabolism of water-soluble vitamins and cofactors,0.1533,0.8777425373134329,1.2364644010642618
319,R-HSA-77108,1.777006969347989,Transcriptomics,Utilization of Ketone Bodies,0.2085,0.8777425373134329,1.2363123403221103
320,R-HSA-110381,1.7739304694304185,Transcriptomics,Resolution of AP sites via the single-nucleotide replacement pathway,0.2439,0.8777425373134329,1.228327597519775
321,R-HSA-9615017,1.7738012933530185,Transcriptomics,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.2959,0.8777425373134329,1.2279923341419465
322,R-HSA-556833,6.150224413873925,Metabolomics,Metabolism of lipids,0.051,0.8777425373134329,1.2265342037503366
323,R-HSA-5669034,1.773128131638085,Transcriptomics,TNFs bind their physiological receptors,0.1316,0.8777425373134329,1.2262452113393663
324,R-HSA-447115,2.075015846937897,Proteomics,Interleukin-12 family signaling,0.0886,0.8777425373134329,1.220453161062857
325,R-HSA-1660662,1.7704949033553332,Transcriptomics,Glycosphingolipid metabolism,0.1983,0.8777425373134329,1.2194109350055606
326,R-HSA-1650814,2.07409546295672,Proteomics,Collagen biosynthesis and modifying enzymes,0.1104,0.8777425373134329,1.2184451689816291
327,R-HSA-9696264,1.7699759092279757,Transcriptomics,RND3 GTPase cycle,0.1225,0.8777425373134329,1.2180639385050227
328,R-HSA-176814,1.769717434825811,Transcriptomics,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.0255,0.8777425373134329,1.2173930944687574
329,R-HSA-176409,1.769717434825811,Transcriptomics,APC/C:Cdc20 mediated degradation of mitotic proteins,0.0255,0.8777425373134329,1.2173930944687574
330,R-HSA-199418,2.073099639411541,Proteomics,Negative regulation of the PI3K/AKT network,0.1103,0.8777425373134329,1.2162725911946262
331,R-HSA-3232142,1.7691122145894669,Transcriptomics,SUMOylation of ubiquitinylation proteins,0.438,0.8777425373134329,1.2158223068674394
332,R-HSA-4090294,1.7686531564865957,Transcriptomics,SUMOylation of intracellular receptors,0.097,0.8777425373134329,1.214630868225813
333,R-HSA-69052,1.768111702111002,Transcriptomics,Switching of origins to a post-replicative state,0.0269,0.8777425373134329,1.2132255784341173
334,R-HSA-444209,1.7675269354416128,Transcriptomics,Free fatty acid receptors,0.1974,0.8777425373134329,1.2117078759866755
335,R-HSA-389513,1.7665470485945314,Transcriptomics,CTLA4 inhibitory signaling,0.1705,0.8777425373134329,1.2091646792829633
336,R-HSA-420499,1.7657157422618388,Transcriptomics,Class C/3 (Metabotropic glutamate/pheromone receptors),0.4267,0.8777425373134329,1.2070071082007756
337,R-HSA-428542,2.068777638847723,Proteomics,Regulation of commissural axon pathfinding by SLIT and ROBO,0.1404,0.8777425373134329,1.2068433278820379
338,R-HSA-1650814,1.7655067380852334,Transcriptomics,Collagen biosynthesis and modifying enzymes,0.2141,0.8777425373134329,1.2064646591061805
339,R-HSA-2046104,6.10806018140836,Metabolomics,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.0718,0.8777425373134329,1.2061642690165133
340,R-HSA-2046105,6.10806018140836,Metabolomics,Linoleic acid (LA) metabolism,0.0718,0.8777425373134329,1.2061642690165133
341,R-HSA-2022923,2.067680951505832,Proteomics,Dermatan sulfate biosynthesis,0.1082,0.8777425373134329,1.2044506966073356
342,R-HSA-3595172,2.067680951505832,Proteomics,Defective CHST3 causes SEDCJD,0.1082,0.8777425373134329,1.2044506966073356
343,R-HSA-3595174,2.067680951505832,Proteomics,"Defective CHST14 causes EDS, musculocontractural type",0.1082,0.8777425373134329,1.2044506966073356
344,R-HSA-3595177,2.067680951505832,Proteomics,Defective CHSY1 causes TPBS,0.1082,0.8777425373134329,1.2044506966073356
345,R-HSA-9006931,6.101861475724506,Metabolomics,Signaling by Nuclear Receptors,0.0558,0.8777425373134329,1.2031696163730101
346,R-HSA-1483255,6.101817885761319,Metabolomics,PI Metabolism,0.1115,0.8777425373134329,1.203148557654441
347,R-HSA-6814848,6.101817885761319,Metabolomics,Glycerophospholipid catabolism,0.1115,0.8777425373134329,1.203148557654441
348,R-HSA-193697,2.0670787509049897,Proteomics,p75NTR regulates axonogenesis,0.1212,0.8777425373134329,1.2031368818707346
349,R-HSA-5362768,1.7640949784614905,Transcriptomics,Hh mutants are degraded by ERAD,0.0516,0.8777425373134329,1.2028005805115645
350,R-HSA-2219530,2.066055787443191,Proteomics,Constitutive Signaling by Aberrant PI3K in Cancer,0.1024,0.8777425373134329,1.2009050932122125
351,R-HSA-9717189,1.762960501638304,Transcriptomics,Sensory perception of taste,0.4681,0.8777425373134329,1.1998561612393197
352,R-HSA-1475029,1.7625106306944287,Transcriptomics,Reversible hydration of carbon dioxide,0.2701,0.8777425373134329,1.1986885669349696
353,R-HSA-190373,2.0628636469907926,Proteomics,FGFR1c ligand binding and activation,0.1002,0.8777425373134329,1.1939408338577806
354,R-HSA-174430,1.7605723375351578,Transcriptomics,Telomere C-strand synthesis initiation,0.2397,0.8777425373134329,1.1936579240723084
355,R-HSA-5654695,2.0617704427190704,Proteomics,PI-3K cascade:FGFR2,0.098,0.8777425373134329,1.1915558015607444
356,R-HSA-5654700,2.0617704427190704,Proteomics,FRS-mediated FGFR2 signaling,0.098,0.8777425373134329,1.1915558015607444
357,R-HSA-174154,1.7592100471317087,Transcriptomics,APC/C:Cdc20 mediated degradation of Securin,0.032,0.8777425373134329,1.1901222378102978
358,R-HSA-110362,1.757591986319543,Transcriptomics,POLB-Dependent Long Patch Base Excision Repair,0.2338,0.8777425373134329,1.1859227254521494
359,R-HSA-69601,1.7563518676461776,Transcriptomics,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,0.0527,0.8777425373134329,1.1827041234965165
360,R-HSA-69610,1.7563518676461776,Transcriptomics,p53-Independent DNA Damage Response,0.0527,0.8777425373134329,1.1827041234965165
361,R-HSA-69613,1.7563518676461776,Transcriptomics,p53-Independent G1/S DNA damage checkpoint,0.0527,0.8777425373134329,1.1827041234965165
362,R-HSA-9020591,2.057007610177028,Proteomics,Interleukin-12 signaling,0.1005,0.8777425373134329,1.181164779743522
363,R-HSA-180585,1.7548519346338547,Transcriptomics,Vif-mediated degradation of APOBEC3G,0.0493,0.8777425373134329,1.178811199834881
364,R-HSA-9717207,1.7547120946324641,Transcriptomics,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.4543,0.8777425373134329,1.178448259326349
365,R-HSA-174084,1.75470214224214,Transcriptomics,Autodegradation of Cdh1 by Cdh1:APC/C,0.0432,0.8777425373134329,1.1784224289089476
366,R-HSA-8939902,1.7540386916165054,Transcriptomics,Regulation of RUNX2 expression and activity,0.0438,0.8777425373134329,1.1767005102514867
367,R-HSA-1483148,6.039952443344173,Metabolomics,Synthesis of PG,0.1078,0.8777425373134329,1.1732607842828857
368,R-HSA-1810476,1.7511198984498557,Transcriptomics,RIP-mediated NFkB activation via ZBP1,0.1075,0.8777425373134329,1.1691250792898908
369,R-HSA-450341,1.7510599859292433,Transcriptomics,Activation of the AP-1 family of transcription factors,0.2025,0.8777425373134329,1.168969582432895
370,R-HSA-9614657,2.050652785111499,Proteomics,FOXO-mediated transcription of cell death genes,0.1144,0.8777425373134329,1.1673005245303354
371,R-HSA-445989,2.0502750077618965,Proteomics,TAK1-dependent IKK and NF-kappa-B activation  ,0.1889,0.8777425373134329,1.1664763316478188
372,R-HSA-1989781,2.0492261783713763,Proteomics,PPARA activates gene expression,0.1237,0.8777425373134329,1.1641881115638169
373,R-HSA-400206,2.0492261783713763,Proteomics,Regulation of lipid metabolism by PPARalpha,0.1237,0.8777425373134329,1.1641881115638169
374,R-HSA-180534,1.748855940880171,Transcriptomics,Vpu mediated degradation of CD4,0.0624,0.8777425373134329,1.163249207554582
375,R-HSA-5654228,2.045959300129092,Proteomics,Phospholipase C-mediated cascade; FGFR4,0.0948,0.8777425373134329,1.1570607975568397
376,R-HSA-936964,2.0454532108924544,Proteomics,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,0.1445,0.8777425373134329,1.1559566679757671
377,R-HSA-5654716,2.0451079872143176,Proteomics,Downstream signaling of activated FGFR4,0.0981,0.8777425373134329,1.1552034970969518
378,R-HSA-5655302,2.0445618376922545,Proteomics,Signaling by FGFR1 in disease,0.1136,0.8777425373134329,1.154011968411211
379,R-HSA-5610780,1.7446970939121547,Transcriptomics,Degradation of GLI1 by the proteasome,0.0427,0.8777425373134329,1.1524553430060318
380,R-HSA-190236,2.042641169638641,Proteomics,Signaling by FGFR,0.0869,0.8777425373134329,1.1498216670574326
381,R-HSA-9707616,2.0421511718131327,Proteomics,Heme signaling,0.094,0.8777425373134329,1.1487526439392974
382,R-HSA-2980736,1.743262935570829,Transcriptomics,Peptide hormone metabolism,0.149,0.8777425373134329,1.1487331308168136
383,R-HSA-8978934,1.7424482967039174,Transcriptomics,Metabolism of cofactors,0.0702,0.8777425373134329,1.1466188184477721
384,R-HSA-5607761,1.7412855580911506,Transcriptomics,Dectin-1 mediated noncanonical NF-kB signaling,0.0544,0.8777425373134329,1.1436010485735515
385,R-HSA-5676590,1.7412855580911506,Transcriptomics,NIK-->noncanonical NF-kB signaling,0.0544,0.8777425373134329,1.1436010485735515
386,R-HSA-140877,2.0391925338014563,Proteomics,Formation of Fibrin Clot (Clotting Cascade),0.111,0.8777425373134329,1.1422978144114448
387,R-HSA-174414,1.740564784771279,Transcriptomics,Processive synthesis on the C-strand of the telomere,0.1475,0.8777425373134329,1.1417303546901905
388,R-HSA-5654687,2.037633994732866,Proteomics,Downstream signaling of activated FGFR1,0.0971,0.8777425373134329,1.1388975660672584
389,R-HSA-372708,2.0369896917823263,Proteomics,p130Cas linkage to MAPK signaling for integrins,0.0967,0.8777425373134329,1.137491897075779
390,R-HSA-5654688,2.0368094631012243,Proteomics,SHC-mediated cascade:FGFR1,0.103,0.8777425373134329,1.1370986940519718
391,R-HSA-190242,2.0368094631012243,Proteomics,FGFR1 ligand binding and activation,0.103,0.8777425373134329,1.1370986940519718
392,R-HSA-9013508,2.0362760641901736,Proteomics,NOTCH3 Intracellular Domain Regulates Transcription,0.0833,0.8777425373134329,1.1359349832405825
393,R-HSA-4641257,1.737105044369254,Transcriptomics,Degradation of AXIN,0.0621,0.8777425373134329,1.1327509501677833
394,R-HSA-9013694,1.7345969650789999,Transcriptomics,Signaling by NOTCH4,0.0343,0.8777425373134329,1.1262414853223048
395,R-HSA-6811558,2.031336950347941,Proteomics,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.1165,0.8777425373134329,1.1251593703590979
396,R-HSA-174178,1.731978636364855,Transcriptomics,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,0.0395,0.8777425373134329,1.1194458793042408
397,R-HSA-8979227,1.7318611611142367,Transcriptomics,Triglyceride metabolism,0.0887,0.8777425373134329,1.1191409842329068
398,R-HSA-997272,1.7318579830650795,Transcriptomics,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,0.3005,0.8777425373134329,1.1191327359293757
399,R-HSA-1296065,1.7318579830650787,Transcriptomics,Inwardly rectifying K+ channels,0.3005,0.8777425373134329,1.1191327359293735
400,R-HSA-1296059,1.7318579830650787,Transcriptomics,G protein gated Potassium channels,0.3005,0.8777425373134329,1.1191327359293735
401,R-HSA-1296041,1.7318579830650787,Transcriptomics,Activation of G protein gated Potassium channels,0.3005,0.8777425373134329,1.1191327359293735
402,R-HSA-3299685,1.7316425420668686,Transcriptomics,Detoxification of Reactive Oxygen Species,0.3951,0.8777425373134329,1.1185735807186221
403,R-HSA-4641258,1.7315410406543057,Transcriptomics,Degradation of DVL,0.0625,0.8777425373134329,1.118310144120181
404,R-HSA-2468052,1.730272008711079,Transcriptomics,Establishment of Sister Chromatid Cohesion,0.2908,0.8777425373134329,1.1150165007117279
405,R-HSA-8863678,2.02412280043958,Proteomics,Neurodegenerative Diseases,0.1018,0.8777425373134329,1.1094203351465888
406,R-HSA-8862803,2.02412280043958,Proteomics,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.1018,0.8777425373134329,1.1094203351465888
407,R-HSA-447041,2.02326807132384,Proteomics,CHL1 interactions,0.1048,0.8777425373134329,1.107555581596874
408,R-HSA-1168372,1.7272949852530666,Transcriptomics,Downstream signaling events of B Cell Receptor (BCR),0.0336,0.8777425373134329,1.107289938948151
409,R-HSA-425410,1.726803104375679,Transcriptomics,Metal ion SLC transporters,0.2635,0.8777425373134329,1.1060133121317826
410,R-HSA-3238698,1.7249167715236493,Transcriptomics,WNT ligand biogenesis and trafficking,0.2698,0.8777425373134329,1.1011175269646738
411,R-HSA-5693616,2.0190088528635686,Proteomics,Presynaptic phase of homologous DNA pairing and strand exchange,0.1022,0.8777425373134329,1.098263289341304
412,R-HSA-5693579,2.0190088528635686,Proteomics,Homologous DNA Pairing and Strand Exchange,0.1022,0.8777425373134329,1.098263289341304
413,R-HSA-3560783,2.018921805849013,Proteomics,"Defective B4GALT7 causes EDS, progeroid type",0.1399,0.8777425373134329,1.0980733797823627
414,R-HSA-4420332,2.018921805849013,Proteomics,Defective B3GALT6 causes EDSP2 and SEMDJL1,0.1399,0.8777425373134329,1.0980733797823627
415,R-HSA-1971475,2.018921805849013,Proteomics,A tetrasaccharide linker sequence is required for GAG synthesis,0.1399,0.8777425373134329,1.0980733797823627
416,R-HSA-3560801,2.018921805849013,Proteomics,Defective B3GAT3 causes JDSSDHD,0.1399,0.8777425373134329,1.0980733797823627
417,R-HSA-167242,1.7227848394160796,Transcriptomics,Abortive elongation of HIV-1 transcript in the absence of Tat,0.1731,0.8777425373134329,1.0955843138955743
418,R-HSA-5387390,1.7226200798734135,Transcriptomics,Hh mutants abrogate ligand secretion,0.0795,0.8777425373134329,1.0951566972507936
419,R-HSA-1226099,2.0173385362836367,Proteomics,Signaling by FGFR in disease,0.1179,0.8777425373134329,1.0946191771726452
420,R-HSA-69017,1.722300510814124,Transcriptomics,CDK-mediated phosphorylation and removal of Cdc6,0.0541,0.8777425373134329,1.094327288242382
421,R-HSA-75876,1.7207141697106862,Transcriptomics,Synthesis of very long-chain fatty acyl-CoAs,0.1254,0.8777425373134329,1.090210101163851
422,R-HSA-9709957,1.7206913333211769,Transcriptomics,Sensory Perception,0.4494,0.8777425373134329,1.090150831636254
423,R-HSA-9636569,1.7202233779815475,Transcriptomics,Suppression of autophagy,0.1279,0.8777425373134329,1.0889363011210473
424,R-HSA-388844,2.0142390409097874,Proteomics,Receptor-type tyrosine-protein phosphatases,0.1243,0.8777425373134329,1.0878570406146724
425,R-HSA-75105,1.7137221333809225,Transcriptomics,Fatty acyl-CoA biosynthesis,0.2298,0.8777425373134329,1.072062981627493
426,R-HSA-6806667,5.824155272172035,Metabolomics,Metabolism of fat-soluble vitamins,0.0778,0.8777425373134329,1.0690071542396924
427,R-HSA-5083635,1.7124794627392164,Transcriptomics,Defective B3GALTL causes PpS,0.1778,0.8777425373134329,1.0688377562974458
428,R-HSA-1442490,1.7124559213504706,Transcriptomics,Collagen degradation,0.3084,0.8777425373134329,1.068776657015996
429,R-HSA-6806667,2.0054265010666343,Proteomics,Metabolism of fat-soluble vitamins,0.1212,0.8777425373134329,1.0686308148410324
430,R-HSA-975634,2.0054265010666343,Proteomics,Retinoid metabolism and transport,0.1212,0.8777425373134329,1.0686308148410324
431,R-HSA-9696270,1.7119467298536362,Transcriptomics,RND2 GTPase cycle,0.1528,0.8777425373134329,1.0674551022465195
432,R-HSA-174113,1.7101688692902728,Transcriptomics,SCF-beta-TrCP mediated degradation of Emi1,0.0582,0.8777425373134329,1.0628408458781715
433,R-HSA-190375,2.002288530135221,Proteomics,FGFR2c ligand binding and activation,0.1093,0.8777425373134329,1.0617847365625503
434,R-HSA-176408,1.7065943555086902,Transcriptomics,Regulation of APC/C activators between G1/S and early anaphase,0.0404,0.8777425373134329,1.0535635587161167
435,R-HSA-1839122,1.997963864174826,Proteomics,Signaling by activated point mutants of FGFR1,0.1218,0.8777425373134329,1.0523496581821976
436,R-HSA-9035034,1.7035663625046193,Transcriptomics,RHOF GTPase cycle,0.0511,0.8777425373134329,1.045704710676924
437,R-HSA-350562,1.7035488787599482,Transcriptomics,Regulation of ornithine decarboxylase (ODC),0.0551,0.8777425373134329,1.0456593333948951
438,R-HSA-453276,1.7033403807024365,Transcriptomics,Regulation of mitotic cell cycle,0.0444,0.8777425373134329,1.0451181978809596
439,R-HSA-174143,1.7033403807024365,Transcriptomics,APC/C-mediated degradation of cell cycle proteins,0.0444,0.8777425373134329,1.0451181978809596
440,R-HSA-5628897,1.7027213933410505,Transcriptomics,TP53 Regulates Metabolic Genes,0.0932,0.8777425373134329,1.043511679106057
441,R-HSA-5658442,1.7019170862513793,Transcriptomics,Regulation of RAS by GAPs,0.0701,0.8777425373134329,1.0414241818145924
442,R-HSA-9734009,1.9920581172476333,Proteomics,Defective Intrinsic Pathway for Apoptosis,0.1406,0.8777425373134329,1.0394651520346982
443,R-HSA-196854,5.76251623281843,Metabolomics,Metabolism of vitamins and cofactors,0.1125,0.8777425373134329,1.0392287583038968
444,R-HSA-5173105,1.700970015025592,Transcriptomics,O-linked glycosylation,0.037,0.8777425373134329,1.0389661547201612
445,R-HSA-349425,1.7009174190445717,Transcriptomics,Autodegradation of the E3 ubiquitin ligase COP1,0.0551,0.8777425373134329,1.0388296471979328
446,R-HSA-3700989,1.9906118855168295,Proteomics,Transcriptional Regulation by TP53,0.1377,0.8777425373134329,1.0363099234317845
447,R-HSA-9006925,1.990358723895927,Proteomics,Intracellular signaling by second messengers,0.1672,0.8777425373134329,1.0357576033779383
448,R-HSA-418592,1.6995193342185695,Transcriptomics,ADP signalling through P2Y purinoceptor 1,0.3325,0.8777425373134329,1.035201060150776
449,R-HSA-202430,1.9898562258332662,Proteomics,Translocation of ZAP-70 to Immunological synapse,0.1174,0.8777425373134329,1.0346613086234764
450,R-HSA-168898,1.6983187538316096,Transcriptomics,Toll-like Receptor Cascades,0.1195,0.8777425373134329,1.0320850757983455
451,R-HSA-2682334,1.6968776976681024,Transcriptomics,EPH-Ephrin signaling,0.0433,0.8777425373134329,1.028344961012836
452,R-HSA-69202,1.6960156808389495,Transcriptomics,Cyclin E associated events during G1/S transition ,0.0396,0.8777425373134329,1.0261076839588823
453,R-HSA-9753281,1.6955405616993162,Transcriptomics,Paracetamol ADME,0.177,0.8777425373134329,1.0248745605289833
454,R-HSA-171007,1.6953599244436215,Transcriptomics,p38MAPK events,0.216,0.8777425373134329,1.0244057348940452
455,R-HSA-430116,1.985140324606548,Proteomics,GP1b-IX-V activation signalling,0.1642,0.8777425373134329,1.0243726763648076
456,R-HSA-1638091,1.9835538026858404,Proteomics,Heparan sulfate/heparin (HS-GAG) metabolism,0.1515,0.8777425373134329,1.0209113781255659
457,R-HSA-112308,1.6934764538201577,Transcriptomics,Presynaptic depolarization and calcium channel opening,0.2312,0.8777425373134329,1.019517378350227
458,R-HSA-3928665,1.692720874212311,Transcriptomics,EPH-ephrin mediated repulsion of cells,0.1786,0.8777425373134329,1.0175563482845704
459,R-HSA-190241,1.9797862799636388,Proteomics,FGFR2 ligand binding and activation,0.1147,0.8777425373134329,1.012691813306163
460,R-HSA-5654699,1.9797862799636388,Proteomics,SHC-mediated cascade:FGFR2,0.1147,0.8777425373134329,1.012691813306163
461,R-HSA-8984722,1.689978830851141,Transcriptomics,Interleukin-35 Signalling,0.2392,0.8777425373134329,1.0104396534760482
462,R-HSA-9658195,1.689914120376324,Transcriptomics,Leishmania infection,0.1392,0.8777425373134329,1.0102717040166382
463,R-HSA-5610785,1.688995833481611,Transcriptomics,GLI3 is processed to GLI3R by the proteasome,0.052,0.8777425373134329,1.0078883837275132
464,R-HSA-5610783,1.688995833481611,Transcriptomics,Degradation of GLI2 by the proteasome,0.052,0.8777425373134329,1.0078883837275132
465,R-HSA-5654741,1.9771459586302265,Proteomics,Signaling by FGFR3,0.1044,0.8777425373134329,1.0069314519376318
466,R-HSA-4086400,1.68787881595105,Transcriptomics,PCP/CE pathway,0.0457,0.8777425373134329,1.004989278274498
467,R-HSA-205043,1.9759299044835432,Proteomics,NRIF signals cell death from the nucleus,0.1771,0.8777425373134329,1.0042783993565114
468,R-HSA-69656,1.6875498960408344,Transcriptomics,Cyclin A:Cdk2-associated events at S phase entry,0.0509,0.8777425373134329,1.0041356000830441
469,R-HSA-70171,1.6872867532379776,Transcriptomics,Glycolysis,0.0847,0.8777425373134329,1.0034526396873371
470,R-HSA-203927,1.686961278645939,Transcriptomics,MicroRNA (miRNA) biogenesis,0.0733,0.8777425373134329,1.0026079034689865
471,R-HSA-425366,1.6863755653638113,Transcriptomics,"Transport of bile salts and organic acids, metal ions and amine compounds",0.1683,0.8777425373134329,1.0010877441844077
472,R-HSA-3000157,1.6841929460719245,Transcriptomics,Laminin interactions,0.1863,0.8777425373134329,0.9954229776808893
473,R-HSA-5358346,1.6841927652815372,Transcriptomics,Hedgehog ligand biogenesis,0.094,0.8777425373134329,0.9954225084578168
474,R-HSA-9707587,1.6840944108849323,Transcriptomics,Regulation of HMOX1 expression and activity,0.2031,0.8777425373134329,0.995167239619393
475,R-HSA-1483166,1.6838212865278146,Transcriptomics,Synthesis of PA,0.1693,0.8777425373134329,0.994458373114251
476,R-HSA-5663202,1.967457065163557,Proteomics,Diseases of signal transduction by growth factor receptors and second messengers,0.2118,0.8777425373134329,0.9857932946524012
477,R-HSA-975578,1.6801701655474677,Transcriptomics,Reactions specific to the complex N-glycan synthesis pathway,0.2828,0.8777425373134329,0.984982259755112
478,R-HSA-383280,1.67863618241481,Transcriptomics,Nuclear Receptor transcription pathway,0.171,0.8777425373134329,0.9810009624674251
479,R-HSA-159854,1.9647564973175875,Proteomics,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",0.103,0.8777425373134329,0.9799014940991269
480,R-HSA-159782,1.9647564973175875,Proteomics,Removal of aminoterminal propeptides from gamma-carboxylated proteins,0.103,0.8777425373134329,0.9799014940991269
481,R-HSA-159763,1.9647564973175875,Proteomics,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,0.103,0.8777425373134329,0.9799014940991269
482,R-HSA-159740,1.9647564973175875,Proteomics,Gamma-carboxylation of protein precursors,0.103,0.8777425373134329,0.9799014940991269
483,R-HSA-205025,1.6769459437060839,Transcriptomics,NADE modulates death signalling,0.34,0.8777425373134329,0.976614119715813
484,R-HSA-69615,1.6766440971568084,Transcriptomics,G1/S DNA Damage Checkpoints,0.0522,0.8777425373134329,0.9758307076806064
485,R-HSA-69563,1.6766440971568084,Transcriptomics,p53-Dependent G1 DNA Damage Response,0.0522,0.8777425373134329,0.9758307076806064
486,R-HSA-69580,1.6766440971568084,Transcriptomics,p53-Dependent G1/S DNA damage checkpoint,0.0522,0.8777425373134329,0.9758307076806064
487,R-HSA-1169410,1.9612935788838886,Proteomics,Antiviral mechanism by IFN-stimulated genes,0.1212,0.8777425373134329,0.9723464812620815
488,R-HSA-391160,1.6744685015280767,Transcriptomics,Signal regulatory protein family interactions,0.0649,0.8777425373134329,0.9701841703808345
489,R-HSA-69239,1.6719050410046459,Transcriptomics,Synthesis of DNA,0.0552,0.8777425373134329,0.9635309691742833
490,R-HSA-2995383,1.6711185846350753,Transcriptomics,Initiation of Nuclear Envelope (NE) Reformation,0.2577,0.8777425373134329,0.9614898016122708
491,R-HSA-5649702,1.6695212223691285,Transcriptomics,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,0.3002,0.8777425373134329,0.9573440102267754
492,R-HSA-75815,1.667007259700151,Transcriptomics,Ubiquitin-dependent degradation of Cyclin D,0.0614,0.8777425373134329,0.9508192756698804
493,R-HSA-9607240,1.951414873652622,Proteomics,FLT3 Signaling,0.2106,0.8777425373134329,0.9507942136402636
494,R-HSA-9648002,1.9513938362012588,Proteomics,RAS processing,0.1687,0.8777425373134329,0.9507483164532087
495,R-HSA-9667769,1.6657706540866464,Transcriptomics,Acetylcholine inhibits contraction of outer hair cells,0.1822,0.8777425373134329,0.9476097915040053
496,R-HSA-5654219,1.946498611027977,Proteomics,Phospholipase C-mediated cascade: FGFR1,0.1258,0.8777425373134329,0.9400684550205881
497,R-HSA-71406,5.55412747357601,Metabolomics,Pyruvate metabolism and Citric Acid (TCA) cycle,0.1478,0.8777425373134329,0.9385542012964305
498,R-HSA-5617833,1.9456501599652463,Proteomics,Cilium Assembly,0.238,0.8777425373134329,0.9382173982332966
499,R-HSA-500792,1.6616170462873536,Transcriptomics,GPCR ligand binding,0.1554,0.8777425373134329,0.9368295246853028
500,R-HSA-165159,1.6597569864572823,Transcriptomics,MTOR signalling,0.1376,0.8777425373134329,0.9320019284759704
501,R-HSA-3906995,1.9422714502845262,Proteomics,Diseases associated with O-glycosylation of proteins,0.132,0.8777425373134329,0.930846102749671
502,R-HSA-5576890,1.6588785711912002,Transcriptomics,Phase 3 - rapid repolarisation,0.2548,0.8777425373134329,0.9297220909459082
503,R-HSA-5678895,1.6569903205307634,Transcriptomics,Defective CFTR causes cystic fibrosis,0.0874,0.8777425373134329,0.924821328302029
504,R-HSA-180786,1.6568688624499588,Transcriptomics,Extension of Telomeres,0.0732,0.8777425373134329,0.9245060961998106
505,R-HSA-450282,1.65272945649191,Transcriptomics,MAPK targets/ Nuclear events mediated by MAP kinases,0.282,0.8777425373134329,0.913762688816405
506,R-HSA-977606,1.9310626538438078,Proteomics,Regulation of Complement cascade,0.1085,0.8777425373134329,0.9063919890826039
507,R-HSA-5625970,1.6494452638037511,Transcriptomics,RHO GTPases activate KTN1,0.3155,0.8777425373134329,0.9052389005404844
508,R-HSA-5675482,1.9273399827887108,Proteomics,Regulation of necroptotic cell death,0.1281,0.8777425373134329,0.8982702766750398
509,R-HSA-5213460,1.9273399827887108,Proteomics,RIPK1-mediated regulated necrosis,0.1281,0.8777425373134329,0.8982702766750398
510,R-HSA-9007892,1.9270779139208585,Proteomics,Interleukin-38 signaling,0.1442,0.8777425373134329,0.8976985237739185
511,R-HSA-168249,1.646277549402455,Transcriptomics,Innate Immune System,0.0562,0.8777425373134329,0.8970174198178142
512,R-HSA-8953897,5.460960607386295,Metabolomics,Cellular responses to stimuli,0.2002,0.8777425373134329,0.8935444175848622
513,R-HSA-2262752,5.460960607386295,Metabolomics,Cellular responses to stress,0.2002,0.8777425373134329,0.8935444175848622
514,R-HSA-936440,1.9235275102978835,Proteomics,Negative regulators of DDX58/IFIH1 signaling,0.2534,0.8777425373134329,0.8899526454167384
515,R-HSA-418217,1.6426083803712637,Transcriptomics,G beta:gamma signalling through PLC beta,0.4022,0.8777425373134329,0.8874944645773367
516,R-HSA-500657,1.6426083803712637,Transcriptomics,Presynaptic function of Kainate receptors,0.4022,0.8777425373134329,0.8874944645773367
517,R-HSA-3560782,1.921386264330069,Proteomics,Diseases associated with glycosaminoglycan metabolism,0.1838,0.8777425373134329,0.8852811115403744
518,R-HSA-264876,1.6416414627340379,Transcriptomics,Insulin processing,0.3718,0.8777425373134329,0.884984928139453
519,R-HSA-446193,1.641538731921416,Transcriptomics,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.2334,0.8777425373134329,0.8847183007581307
520,R-HSA-525793,1.6414335631121624,Transcriptomics,Myogenesis,0.1808,0.8777425373134329,0.8844453458043786
521,R-HSA-4641265,1.6412033697613964,Transcriptomics,Repression of WNT target genes,0.2255,0.8777425373134329,0.8838479023621809
522,R-HSA-5668914,1.9205118346205132,Proteomics,Diseases of metabolism,0.2078,0.8777425373134329,0.8833733774116986
523,R-HSA-5685939,1.641002850808637,Transcriptomics,HDR through MMEJ (alt-NHEJ),0.451,0.8777425373134329,0.8833274758035344
524,R-HSA-211733,1.6397661498602125,Transcriptomics,Regulation of activated PAK-2p34 by proteasome mediated degradation,0.0852,0.8777425373134329,0.880117744205566
525,R-HSA-8949275,1.6363845754372337,Transcriptomics,RUNX3 Regulates Immune Response and Cell Migration,0.3512,0.8777425373134329,0.871341211536011
526,R-HSA-8941855,1.9146323993404168,Proteomics,RUNX3 regulates CDKN1A transcription,0.1338,0.8777425373134329,0.870546275108784
527,R-HSA-212676,1.6358433301937572,Transcriptomics,Dopamine Neurotransmitter Release Cycle,0.4124,0.8777425373134329,0.8699364645254666
528,R-HSA-6804757,1.9130601831907268,Proteomics,Regulation of TP53 Degradation,0.2127,0.8777425373134329,0.8671161876201708
529,R-HSA-6806003,1.9130601831907268,Proteomics,Regulation of TP53 Expression and Degradation,0.2127,0.8777425373134329,0.8671161876201708
530,R-HSA-71064,1.634225555663561,Transcriptomics,Lysine catabolism,0.3097,0.8777425373134329,0.8657376951830685
531,R-HSA-74259,1.6341488657427816,Transcriptomics,Purine catabolism,0.1183,0.8777425373134329,0.8655386542894031
532,R-HSA-6803211,1.6340919824363465,Transcriptomics,TP53 Regulates Transcription of Death Receptors and Ligands,0.3852,0.8777425373134329,0.8653910194498775
533,R-HSA-446210,1.6317669102853667,Transcriptomics,Synthesis of UDP-N-acetyl-glucosamine,0.2062,0.8777425373134329,0.8593565310312636
534,R-HSA-70921,1.6300278320363266,Transcriptomics,Histidine catabolism,0.1367,0.8777425373134329,0.8548429302174251
535,R-HSA-1169408,1.907337167808156,Proteomics,ISG15 antiviral mechanism,0.1848,0.8777425373134329,0.8546303449675777
536,R-HSA-169911,1.6297403190370943,Transcriptomics,Regulation of Apoptosis,0.0951,0.8777425373134329,0.854096719454315
537,R-HSA-5654696,1.9064359233628183,Proteomics,Downstream signaling of activated FGFR2,0.1406,0.8777425373134329,0.852664109411007
538,R-HSA-977443,1.6286722854889604,Transcriptomics,GABA receptor activation,0.3906,0.8777425373134329,0.8513247469483481
539,R-HSA-71387,5.362178101830324,Metabolomics,Metabolism of carbohydrates,0.1958,0.8777425373134329,0.8458216660166454
540,R-HSA-422356,1.903208113111435,Proteomics,Regulation of insulin secretion,0.2296,0.8777425373134329,0.8456220296301384
541,R-HSA-447043,1.9029811991616712,Proteomics,Neurofascin interactions,0.1288,0.8777425373134329,0.845126973845201
542,R-HSA-140342,1.9027800803271704,Proteomics,Apoptosis induced DNA fragmentation,0.126,0.8777425373134329,0.8446881949927628
543,R-HSA-69206,1.6254053120606433,Transcriptomics,G1/S Transition,0.0382,0.8777425373134329,0.8428456495109672
544,R-HSA-991365,1.62360728213703,Transcriptomics,Activation of GABAB receptors,0.3654,0.8777425373134329,0.8381790456183552
545,R-HSA-977444,1.6236072821370298,Transcriptomics,GABA B receptor activation,0.3654,0.8777425373134329,0.8381790456183547
546,R-HSA-69242,1.6223757011866844,Transcriptomics,S Phase,0.0467,0.8777425373134329,0.8349826024549403
547,R-HSA-8878166,1.622362198198093,Transcriptomics,Transcriptional regulation by RUNX2,0.0609,0.8777425373134329,0.8349475568206628
548,R-HSA-1475029,1.8980815680136711,Proteomics,Reversible hydration of carbon dioxide,0.171,0.8777425373134329,0.8344374999437357
549,R-HSA-9007101,1.896841633230131,Proteomics,Rab regulation of trafficking,0.2836,0.8777425373134329,0.8317323472275805
550,R-HSA-8876198,1.896841633230131,Proteomics,RAB GEFs exchange GTP for GDP on RABs,0.2836,0.8777425373134329,0.8317323472275805
551,R-HSA-75205,1.8965637899418597,Proteomics,Dissolution of Fibrin Clot,0.1256,0.8777425373134329,0.8311261794388306
552,R-HSA-5173214,1.6198229335506236,Transcriptomics,O-glycosylation of TSR domain-containing proteins,0.2064,0.8777425373134329,0.8283571535505998
553,R-HSA-159234,1.6196899574359405,Transcriptomics,Transport of Mature mRNAs Derived from Intronless Transcripts,0.5573,0.8777425373134329,0.8280120275622861
554,R-HSA-159231,1.6196899574359405,Transcriptomics,Transport of Mature mRNA Derived from an Intronless Transcript,0.5573,0.8777425373134329,0.8280120275622861
555,R-HSA-2142753,1.6187974480385485,Transcriptomics,Arachidonic acid metabolism,0.2033,0.8777425373134329,0.8256956101471121
556,R-HSA-1482801,1.6181976625117915,Transcriptomics,Acyl chain remodelling of PS,0.5003,0.8777425373134329,0.8241389277820758
557,R-HSA-9646399,1.8920011188783108,Proteomics,Aggrephagy,0.2892,0.8777425373134329,0.8211718478204832
558,R-HSA-8963896,1.8919123286811308,Proteomics,HDL assembly,0.1406,0.8777425373134329,0.8209781351782879
559,R-HSA-201556,1.890783640463062,Proteomics,Signaling by ALK,0.1832,0.8777425373134329,0.8185156879275673
560,R-HSA-8941333,1.6142245164568858,Transcriptomics,RUNX2 regulates genes involved in differentiation of myeloid cells,0.4552,0.8777425373134329,0.8138270310765534
561,R-HSA-4615885,1.6139797801834714,Transcriptomics,SUMOylation of DNA replication proteins,0.52,0.8777425373134329,0.8131918429569455
562,R-HSA-168638,1.8863594678912108,Proteomics,NOD1/2 Signaling Pathway,0.211,0.8777425373134329,0.808863517016358
563,R-HSA-2022377,1.8854665694843133,Proteomics,Metabolism of Angiotensinogen to Angiotensins,0.1527,0.8777425373134329,0.8069154899243418
564,R-HSA-8982491,1.6107963672900891,Transcriptomics,Glycogen metabolism,0.1636,0.8777425373134329,0.8049296183938555
565,R-HSA-9008059,1.8796783244555644,Proteomics,Interleukin-37 signaling,0.2373,0.8777425373134329,0.7942873364366342
566,R-HSA-6783589,1.606232486388936,Transcriptomics,Interleukin-6 family signaling,0.1008,0.8777425373134329,0.7930845294445354
567,R-HSA-1236974,1.6054090439717266,Transcriptomics,ER-Phagosome pathway,0.1146,0.8777425373134329,0.7909473683555984
568,R-HSA-844456,1.604595446968716,Transcriptomics,The NLRP3 inflammasome,0.315,0.8777425373134329,0.7888357600384039
569,R-HSA-2408522,1.8761678766398906,Proteomics,Selenoamino acid metabolism,0.1391,0.8777425373134329,0.7866286292452944
570,R-HSA-198753,1.8741904413927561,Proteomics,ERK/MAPK targets,0.2875,0.8777425373134329,0.7823144795006327
571,R-HSA-9014843,1.5987682450928302,Transcriptomics,Interleukin-33 signaling,0.1734,0.8777425373134329,0.7737118499188234
572,R-HSA-202670,1.5972391087455924,Transcriptomics,ERKs are inactivated,0.421,0.8777425373134329,0.7697431319700063
573,R-HSA-8948216,1.5970181717391658,Transcriptomics,Collagen chain trimerization,0.2812,0.8777425373134329,0.7691697124286117
574,R-HSA-354194,1.8678235595570425,Proteomics,GRB2:SOS provides linkage to MAPK signaling for Integrins ,0.1442,0.8777425373134329,0.7684239201583536
575,R-HSA-964739,1.5966536301861542,Transcriptomics,N-glycan trimming and elongation in the cis-Golgi,0.3319,0.8777425373134329,0.768223581884308
576,R-HSA-964827,1.5966536301861542,Transcriptomics,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",0.3319,0.8777425373134329,0.768223581884308
577,R-HSA-76061,1.5957988774637761,Transcriptomics,RNA Polymerase III Transcription Initiation From Type 1 Promoter,0.0642,0.8777425373134329,0.7660051580810742
578,R-HSA-450282,1.8662182616481664,Proteomics,MAPK targets/ Nuclear events mediated by MAP kinases,0.3062,0.8777425373134329,0.7649216585425966
579,R-HSA-8964046,1.595163620510046,Transcriptomics,VLDL clearance,0.2192,0.8777425373134329,0.7643564132330859
580,R-HSA-1592230,1.595114091016671,Transcriptomics,Mitochondrial biogenesis,0.0416,0.8777425373134329,0.7642278644678251
581,R-HSA-8964616,1.5944347314432472,Transcriptomics,G beta:gamma signalling through CDC42,0.334,0.8777425373134329,0.762464655753561
582,R-HSA-6807070,1.5940431271469424,Transcriptomics,PTEN Regulation,0.1004,0.8777425373134329,0.7614482866100336
583,R-HSA-9662001,1.8628901471340868,Proteomics,Defective factor VIII causes hemophilia A,0.1422,0.8777425373134329,0.7576607460035247
584,R-HSA-1855183,1.5923258135383405,Transcriptomics,"Synthesis of IP2, IP, and Ins in the cytosol",0.1931,0.8777425373134329,0.7569911737080234
585,R-HSA-167160,1.5922214005987811,Transcriptomics,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,0.0778,0.8777425373134329,0.7567201805372271
586,R-HSA-77075,1.5922214005987811,Transcriptomics,RNA Pol II CTD phosphorylation and interaction with CE,0.0778,0.8777425373134329,0.7567201805372271
587,R-HSA-72086,1.5922214005987811,Transcriptomics,mRNA Capping,0.0778,0.8777425373134329,0.7567201805372271
588,R-HSA-450408,1.591799566393941,Transcriptomics,AUF1 (hnRNP D0) binds and destabilizes mRNA,0.1379,0.8777425373134329,0.7556253527390403
589,R-HSA-2197563,1.8611761758081644,Proteomics,NOTCH2 intracellular domain regulates transcription,0.1448,0.8777425373134329,0.7539213927332716
590,R-HSA-450294,1.8611747119722373,Proteomics,MAP kinase activation,0.2256,0.8777425373134329,0.7539181990977782
591,R-HSA-5619084,1.5896202040992684,Transcriptomics,ABC transporter disorders,0.1049,0.8777425373134329,0.7499690394407094
592,R-HSA-422356,1.5886522112387784,Transcriptomics,Regulation of insulin secretion,0.1988,0.8777425373134329,0.7474567123701424
593,R-HSA-429914,1.5877463340556899,Transcriptomics,Deadenylation-dependent mRNA decay,0.1749,0.8777425373134329,0.7451056002260609
594,R-HSA-163841,1.5873093470824764,Transcriptomics,"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.1128,0.8777425373134329,0.7439714449578767
595,R-HSA-1483115,5.144981632741307,Metabolomics,Hydrolysis of LPC,0.2041,0.8777425373134329,0.7408920220732045
596,R-HSA-9754678,1.5824369033532728,Transcriptomics,SARS-CoV-2 modulates host translation machinery,0.0488,0.8777425373134329,0.7313255125545159
597,R-HSA-5654221,1.8507427906126837,Proteomics,Phospholipase C-mediated cascade; FGFR2,0.1557,0.8777425373134329,0.7311589856495163
598,R-HSA-9637687,1.8504806244645378,Proteomics,Suppression of phagosomal maturation,0.4184,0.8777425373134329,0.7305870205129984
599,R-HSA-1632852,1.8492244703403742,Proteomics,Macroautophagy,0.293,0.8777425373134329,0.7278464822314696
600,R-HSA-9663891,1.8492244703403742,Proteomics,Selective autophagy,0.293,0.8777425373134329,0.7278464822314696
601,R-HSA-209560,1.8490246167244777,Proteomics,NF-kB is activated and signals survival,0.3706,0.8777425373134329,0.7274104636931944
602,R-HSA-1614517,1.580702606997593,Transcriptomics,Sulfide oxidation to sulfate,0.2841,0.8777425373134329,0.7268243226588026
603,R-HSA-9694631,1.8482131534138786,Proteomics,Maturation of nucleoprotein,0.2392,0.8777425373134329,0.7256401026969006
604,R-HSA-9683610,1.8482131534138786,Proteomics,Maturation of nucleoprotein,0.2392,0.8777425373134329,0.7256401026969006
605,R-HSA-382556,1.5792593251904694,Transcriptomics,ABC-family proteins mediated transport,0.0538,0.8777425373134329,0.723078431441529
606,R-HSA-8849472,1.8465598884622965,Proteomics,PTK6 Down-Regulation,0.1674,0.8777425373134329,0.722033191887021
607,R-HSA-5423646,1.578628915609434,Transcriptomics,Aflatoxin activation and detoxification,0.3055,0.8777425373134329,0.7214422674566227
608,R-HSA-1187000,1.5781056994506026,Transcriptomics,Fertilization,0.5803,0.8777425373134329,0.7200843131025745
609,R-HSA-112411,1.8454521810084685,Proteomics,MAPK1 (ERK2) activation,0.1477,0.8777425373134329,0.719616518149655
610,R-HSA-8854518,1.8454443916853904,Proteomics,AURKA Activation by TPX2,0.237,0.8777425373134329,0.7195995242651689
611,R-HSA-389357,1.8453481604338648,Proteomics,CD28 dependent PI3K/Akt signaling,0.3786,0.8777425373134329,0.7193895775527296
612,R-HSA-2393930,1.577781685204277,Transcriptomics,Phosphate bond hydrolysis by NUDT proteins,0.1515,0.8777425373134329,0.7192433670630745
613,R-HSA-71291,1.5761235264638807,Transcriptomics,Metabolism of amino acids and derivatives,0.0218,0.8777425373134329,0.7149397846082554
614,R-HSA-389357,1.5725988704904763,Transcriptomics,CD28 dependent PI3K/Akt signaling,0.225,0.8777425373134329,0.7057918983191594
615,R-HSA-432720,1.5712247239026325,Transcriptomics,Lysosome Vesicle Biogenesis,0.0678,0.8777425373134329,0.7022254405357624
616,R-HSA-425407,1.5704351083802257,Transcriptomics,SLC-mediated transmembrane transport,0.0846,0.8777425373134329,0.7001760737136992
617,R-HSA-376172,1.5695034063340294,Transcriptomics,DSCAM interactions,0.1746,0.8777425373134329,0.6977579357625817
618,R-HSA-2142691,1.5694879865470668,Transcriptomics,Synthesis of Leukotrienes (LT) and Eoxins (EX),0.3246,0.8777425373134329,0.6977179152729791
619,R-HSA-3232118,1.569443273361008,Transcriptomics,SUMOylation of transcription factors,0.4244,0.8777425373134329,0.6976018667437679
620,R-HSA-4420332,1.5679813644325065,Transcriptomics,Defective B3GALT6 causes EDSP2 and SEMDJL1,0.1316,0.8777425373134329,0.6938076307264499
621,R-HSA-3560801,1.5679813644325065,Transcriptomics,Defective B3GAT3 causes JDSSDHD,0.1316,0.8777425373134329,0.6938076307264499
622,R-HSA-977347,1.5673201980469613,Transcriptomics,Serine biosynthesis,0.2396,0.8777425373134329,0.6920916405819428
623,R-HSA-549132,1.5663274514275078,Transcriptomics,Organic cation/anion/zwitterion transport,0.2101,0.8777425373134329,0.6895150676462661
624,R-HSA-549127,1.5663274514275078,Transcriptomics,Organic cation transport,0.2101,0.8777425373134329,0.6895150676462661
625,R-HSA-399954,1.8310644730149384,Proteomics,Sema3A PAK dependent Axon repulsion,0.3383,0.8777425373134329,0.6882270064796754
626,R-HSA-9617324,1.565767972576641,Transcriptomics,Negative regulation of NMDA receptor-mediated neuronal transmission,0.2578,0.8777425373134329,0.6880629971612305
627,R-HSA-9706369,1.8303511813819624,Proteomics,Negative regulation of FLT3,0.3121,0.8777425373134329,0.686670825603092
628,R-HSA-9635465,1.8299631635536076,Proteomics,Suppression of apoptosis,0.2407,0.8777425373134329,0.6858242911754555
629,R-HSA-110313,1.8288940535683424,Proteomics,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,0.3803,0.8777425373134329,0.6834918251305467
630,R-HSA-5656169,1.8288940535683424,Proteomics,Termination of translesion DNA synthesis,0.3803,0.8777425373134329,0.6834918251305467
631,R-HSA-73893,1.8288940535683418,Proteomics,DNA Damage Bypass,0.3803,0.8777425373134329,0.6834918251305453
632,R-HSA-428542,1.5634060272588302,Transcriptomics,Regulation of commissural axon pathfinding by SLIT and ROBO,0.2487,0.8777425373134329,0.6819328081863543
633,R-HSA-69275,1.8276265582418603,Proteomics,G2/M Transition,0.2093,0.8777425373134329,0.6807265438668355
634,R-HSA-453274,1.8276265582418603,Proteomics,Mitotic G2-G2/M phases,0.2093,0.8777425373134329,0.6807265438668355
635,R-HSA-5658623,1.5624649829500048,Transcriptomics,FGFRL1 modulation of FGFR1 signaling,0.2069,0.8777425373134329,0.6794904233422469
636,R-HSA-450302,1.826863867528166,Proteomics,activated TAK1 mediates p38 MAPK activation,0.3202,0.8777425373134329,0.6790625895338137
637,R-HSA-5607763,1.5622289904257665,Transcriptomics,CLEC7A (Dectin-1) induces NFAT activation,0.5539,0.8777425373134329,0.6788779287348018
638,R-HSA-3232142,1.8267352423696446,Proteomics,SUMOylation of ubiquitinylation proteins,0.234,0.8777425373134329,0.6787819693741413
639,R-HSA-211935,1.5613649846171638,Transcriptomics,Fatty acids,0.2746,0.8777425373134329,0.676635489486871
640,R-HSA-8935690,1.5607101533884287,Transcriptomics,Digestion,0.2815,0.8777425373134329,0.6749359415978803
641,R-HSA-189085,1.5607101533884287,Transcriptomics,Digestion of dietary carbohydrate,0.2815,0.8777425373134329,0.6749359415978803
642,R-HSA-9690406,1.8243158837309004,Proteomics,Transcriptional regulation of testis differentiation,0.1976,0.8777425373134329,0.6735036799997061
643,R-HSA-2022854,1.5593193107077945,Transcriptomics,Keratan sulfate biosynthesis,0.0655,0.8777425373134329,0.6713261508028446
644,R-HSA-373076,1.5593144832256938,Transcriptomics,Class A/1 (Rhodopsin-like receptors),0.1953,0.8777425373134329,0.6713136215637775
645,R-HSA-6781823,1.5582806586667384,Transcriptomics,Formation of TC-NER Pre-Incision Complex,0.0969,0.8777425373134329,0.6686304350117962
646,R-HSA-8964539,1.558235044123125,Transcriptomics,Glutamate and glutamine metabolism,0.3175,0.8777425373134329,0.6685120471006772
647,R-HSA-68952,1.557193381174826,Transcriptomics,DNA replication initiation,0.4308,0.8777425373134329,0.6658085168059461
648,R-HSA-380259,1.82016741552816,Proteomics,Loss of Nlp from mitotic centrosomes,0.2975,0.8777425373134329,0.6644530104197413
649,R-HSA-380270,1.82016741552816,Proteomics,Recruitment of mitotic centrosome proteins and complexes,0.2975,0.8777425373134329,0.6644530104197413
650,R-HSA-380284,1.82016741552816,Proteomics,Loss of proteins required for interphase microtubule organization from the centrosome,0.2975,0.8777425373134329,0.6644530104197413
651,R-HSA-380287,1.82016741552816,Proteomics,Centrosome maturation,0.2975,0.8777425373134329,0.6644530104197413
652,R-HSA-5620912,1.82016741552816,Proteomics,Anchoring of the basal body to the plasma membrane,0.2975,0.8777425373134329,0.6644530104197413
653,R-HSA-380320,1.82016741552816,Proteomics,Recruitment of NuMA to mitotic centrosomes,0.2975,0.8777425373134329,0.6644530104197413
654,R-HSA-8957322,4.983407074425699,Metabolomics,Metabolism of steroids,0.266,0.8777425373134329,0.6628338430176924
655,R-HSA-211979,1.5558924973457342,Transcriptomics,Eicosanoids,0.304,0.8777425373134329,0.662432205065552
656,R-HSA-381771,1.8192390056504248,Proteomics,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.1593,0.8777425373134329,0.6624275083241472
657,R-HSA-400508,1.8192390056504248,Proteomics,"Incretin synthesis, secretion, and inactivation",0.1593,0.8777425373134329,0.6624275083241472
658,R-HSA-195253,1.5556271132936434,Transcriptomics,Degradation of beta-catenin by the destruction complex,0.105,0.8777425373134329,0.6617434277352866
659,R-HSA-201451,1.5553737800228096,Transcriptomics,Signaling by BMP,0.2595,0.8777425373134329,0.661085926982782
660,R-HSA-373080,1.8181379478699602,Proteomics,Class B/2 (Secretin family receptors),0.1743,0.8777425373134329,0.660025342109434
661,R-HSA-9026519,1.8180759855786432,Proteomics,Activated NTRK2 signals through RAS,0.1266,0.8777425373134329,0.6598901596281613
662,R-HSA-9028335,1.8180759855786432,Proteomics,Activated NTRK2 signals through PI3K,0.1266,0.8777425373134329,0.6598901596281613
663,R-HSA-70326,1.554506915603944,Transcriptomics,Glucose metabolism,0.1043,0.8777425373134329,0.6588360685024984
664,R-HSA-9706374,1.816921495245386,Proteomics,FLT3 signaling through SRC family kinases,0.2744,0.8777425373134329,0.6573714201732773
665,R-HSA-110056,1.5531390423645326,Transcriptomics,MAPK3 (ERK1) activation,0.3224,0.8777425373134329,0.6552858925572568
666,R-HSA-196780,1.5529018344971466,Transcriptomics,Biotin transport and metabolism,0.5295,0.8777425373134329,0.6546702436502145
667,R-HSA-8948751,1.5521322656377152,Transcriptomics,Regulation of PTEN stability and activity,0.1412,0.8777425373134329,0.6526729059041116
668,R-HSA-166016,1.551805171290597,Transcriptomics,Toll Like Receptor 4 (TLR4) Cascade,0.1512,0.8777425373134329,0.6518239657761041
669,R-HSA-114508,1.5504096378535333,Transcriptomics,Effects of PIP2 hydrolysis,0.6331,0.8777425373134329,0.6482020005995824
670,R-HSA-350562,1.8122736562528208,Proteomics,Regulation of ornithine decarboxylase (ODC),0.2756,0.8777425373134329,0.6472312785772066
671,R-HSA-351202,1.8122736562528208,Proteomics,Metabolism of polyamines,0.2756,0.8777425373134329,0.6472312785772066
672,R-HSA-9748784,1.8101824433479143,Proteomics,Drug ADME,0.2842,0.8777425373134329,0.6426689013095772
673,R-HSA-354192,1.80867007933043,Proteomics,Integrin signaling,0.3861,0.8777425373134329,0.6393693925902295
674,R-HSA-8852276,1.5464712568446155,Transcriptomics,The role of GTSE1 in G2/M progression after G2 checkpoint,0.1449,0.8777425373134329,0.6379803330369702
675,R-HSA-2453902,1.5464518748661287,Transcriptomics,The canonical retinoid cycle in rods (twilight vision),0.5213,0.8777425373134329,0.6379300290820331
676,R-HSA-112315,1.8073585434692914,Proteomics,Transmission across Chemical Synapses,0.4431,0.8777425373134329,0.6365080285538367
677,R-HSA-1268020,1.5453699232524662,Transcriptomics,Mitochondrial protein import,0.145,0.8777425373134329,0.6351219336517923
678,R-HSA-432142,1.5448128905301448,Transcriptomics,Platelet sensitization by LDL,0.2922,0.8777425373134329,0.6336762118447415
679,R-HSA-1839126,1.8056810089483666,Proteomics,FGFR2 mutant receptor activation,0.1799,0.8777425373134329,0.632848169078996
680,R-HSA-2033519,1.8056810089483666,Proteomics,Activated point mutants of FGFR2,0.1799,0.8777425373134329,0.632848169078996
681,R-HSA-9013694,1.805127315176108,Proteomics,Signaling by NOTCH4,0.3791,0.8777425373134329,0.6316401811817076
682,R-HSA-9706374,1.5438402604760832,Transcriptomics,FLT3 signaling through SRC family kinases,0.3044,0.8777425373134329,0.6311518494096416
683,R-HSA-372790,1.543617806774346,Transcriptomics,Signaling by GPCR,0.1519,0.8777425373134329,0.6305744934397439
684,R-HSA-2408522,1.5416390998807386,Transcriptomics,Selenoamino acid metabolism,0.0624,0.8777425373134329,0.6254389608377668
685,R-HSA-1234176,1.5413536305916102,Transcriptomics,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,0.0827,0.8777425373134329,0.6246980543164837
686,R-HSA-111471,1.8017019109581793,Proteomics,Apoptotic factor-mediated response,0.2268,0.8777425373134329,0.6241670127158602
687,R-HSA-8964315,1.5409070720741709,Transcriptomics,G beta:gamma signalling through BTK,0.5044,0.8777425373134329,0.6235390570782321
688,R-HSA-9022702,1.5407922076603486,Transcriptomics,MECP2 regulates transcription of neuronal ligands,0.5059,0.8777425373134329,0.6232409381684042
689,R-HSA-9022538,1.5407922076603486,Transcriptomics,Loss of MECP2 binding ability to 5mC-DNA,0.5059,0.8777425373134329,0.6232409381684042
690,R-HSA-202433,1.5398644282494003,Transcriptomics,Generation of second messenger molecules,0.1933,0.8777425373134329,0.6208329810183274
691,R-HSA-8878159,1.5394688027355083,Transcriptomics,Transcriptional regulation by RUNX3,0.1954,0.8777425373134329,0.6198061752133192
692,R-HSA-9006927,1.7994663324019318,Proteomics,Signaling by Non-Receptor Tyrosine Kinases,0.196,0.8777425373134329,0.6192896744204177
693,R-HSA-8848021,1.7994663324019318,Proteomics,Signaling by PTK6,0.196,0.8777425373134329,0.6192896744204177
694,R-HSA-194002,1.7992400163588491,Proteomics,Glucocorticoid biosynthesis,0.1609,0.8777425373134329,0.618795923082217
695,R-HSA-9609507,1.5388325279523731,Transcriptomics,Protein localization,0.0441,0.8777425373134329,0.6181547886925751
696,R-HSA-9664873,1.7981745795203679,Proteomics,Pexophagy,0.4388,0.8777425373134329,0.6164714707031325
697,R-HSA-6785807,1.5381747266055439,Transcriptomics,Interleukin-4 and Interleukin-13 signaling,0.1919,0.8777425373134329,0.6164475321639908
698,R-HSA-912631,1.797546018189099,Proteomics,Regulation of signaling by CBL,0.3829,0.8777425373134329,0.6151001450373604
699,R-HSA-419408,1.5371860824139416,Transcriptomics,Lysosphingolipid and LPA receptors,0.3479,0.8777425373134329,0.6138816066627801
700,R-HSA-8939246,1.5365546713309597,Transcriptomics,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,0.5141,0.8777425373134329,0.6122428433813769
701,R-HSA-8863795,1.795981935732136,Proteomics,Downregulation of ERBB2 signaling,0.2221,0.8777425373134329,0.6116878027408859
702,R-HSA-1592389,1.5362705256995866,Transcriptomics,Activation of Matrix Metalloproteinases,0.212,0.8777425373134329,0.6115053722792443
703,R-HSA-111461,1.795805296673029,Proteomics,Cytochrome c-mediated apoptotic response,0.2487,0.8777425373134329,0.6113024311577462
704,R-HSA-453279,1.5359664270472566,Transcriptomics,Mitotic G1 phase and G1/S transition,0.0562,0.8777425373134329,0.6107161151394915
705,R-HSA-69190,1.5351601992485024,Transcriptomics,DNA strand elongation,0.2206,0.8777425373134329,0.6086236328428469
706,R-HSA-5663205,1.7945321560996723,Proteomics,Infectious disease,0.396,0.8777425373134329,0.6085248337181212
707,R-HSA-1606322,1.534599969848161,Transcriptomics,ZBP1(DAI) mediated induction of type I IFNs,0.1582,0.8777425373134329,0.6071696143829453
708,R-HSA-373755,1.7936750276794589,Proteomics,Semaphorin interactions,0.3128,0.8777425373134329,0.6066548456309944
709,R-HSA-5610787,1.5337391820116364,Transcriptomics,Hedgehog 'off' state,0.0648,0.8777425373134329,0.6049355270544285
710,R-HSA-1181150,1.7926712065526906,Proteomics,Signaling by NODAL,0.3172,0.8777425373134329,0.6044648196040947
711,R-HSA-2022857,1.7926481815695594,Proteomics,Keratan sulfate degradation,0.1999,0.8777425373134329,0.6044145862398212
712,R-HSA-69481,1.5332542071867747,Transcriptomics,G2/M Checkpoints,0.121,0.8777425373134329,0.6036768241953737
713,R-HSA-112411,1.5329503646439842,Transcriptomics,MAPK1 (ERK2) activation,0.3763,0.8777425373134329,0.6028882317618962
714,R-HSA-352238,1.5316088110147958,Transcriptomics,Breakdown of the nuclear lamina,0.3116,0.8777425373134329,0.5994063656895359
715,R-HSA-187037,1.5313330883287102,Transcriptomics,Signaling by NTRK1 (TRKA),0.101,0.8777425373134329,0.598690755485684
716,R-HSA-8956319,1.5310863503370005,Transcriptomics,Nucleotide catabolism,0.0921,0.8777425373134329,0.59805037210972
717,R-HSA-2024101,1.7883191896113868,Proteomics,CS/DS degradation,0.2502,0.8777425373134329,0.5949700698754767
718,R-HSA-72695,1.5298833105081244,Transcriptomics,"Formation of the ternary complex, and subsequently, the 43S complex",0.0663,0.8777425373134329,0.5949280045258045
719,R-HSA-9024909,1.787616168715545,Proteomics,BDNF activates NTRK2 (TRKB) signaling,0.1363,0.8777425373134329,0.593436296558407
720,R-HSA-212165,4.8383158516702425,Metabolomics,Epigenetic regulation of gene expression,0.3099,0.8777425373134329,0.592738917409998
721,R-HSA-195721,4.8383158516702425,Metabolomics,Signaling by WNT,0.3099,0.8777425373134329,0.592738917409998
722,R-HSA-9679506,4.838315851670242,Metabolomics,SARS-CoV Infections,0.3099,0.8777425373134329,0.5927389174099975
723,R-HSA-9678108,4.838315851670242,Metabolomics,SARS-CoV-1 Infection,0.3099,0.8777425373134329,0.5927389174099975
724,R-HSA-427359,4.838315851670242,Metabolomics,SIRT1 negatively regulates rRNA expression,0.3099,0.8777425373134329,0.5927389174099975
725,R-HSA-5250941,4.838315851670242,Metabolomics,Negative epigenetic regulation of rRNA expression,0.3099,0.8777425373134329,0.5927389174099975
726,R-HSA-5693532,4.838315851670242,Metabolomics,DNA Double-Strand Break Repair,0.3099,0.8777425373134329,0.5927389174099975
727,R-HSA-201681,4.838315851670242,Metabolomics,TCF dependent signaling in response to WNT,0.3099,0.8777425373134329,0.5927389174099975
728,R-HSA-9694635,4.838315851670242,Metabolomics,Translation of Structural Proteins,0.3099,0.8777425373134329,0.5927389174099975
729,R-HSA-9694631,4.838315851670242,Metabolomics,Maturation of nucleoprotein,0.3099,0.8777425373134329,0.5927389174099975
730,R-HSA-9694516,4.838315851670242,Metabolomics,SARS-CoV-2 Infection,0.3099,0.8777425373134329,0.5927389174099975
731,R-HSA-68886,4.838315851670242,Metabolomics,M Phase,0.3099,0.8777425373134329,0.5927389174099975
732,R-HSA-9772573,4.838315851670242,Metabolomics,Late SARS-CoV-2 Infection Events,0.3099,0.8777425373134329,0.5927389174099975
733,R-HSA-9020933,1.5290128765108595,Transcriptomics,Interleukin-23 signaling,0.2009,0.8777425373134329,0.5926688815676419
734,R-HSA-3371511,1.528738916023212,Transcriptomics,HSF1 activation,0.1085,0.8777425373134329,0.5919578449707048
735,R-HSA-429593,4.833511270837807,Metabolomics,Inositol transporters,0.2659,0.8777425373134329,0.5904177795104757
736,R-HSA-6782135,1.5279397376510138,Transcriptomics,Dual incision in TC-NER,0.0914,0.8777425373134329,0.5898836587440944
737,R-HSA-198753,1.526488323379125,Transcriptomics,ERK/MAPK targets,0.3228,0.8777425373134329,0.5861166605412076
738,R-HSA-167044,1.5264788838466679,Transcriptomics,Signalling to RAS,0.194,0.8777425373134329,0.5860921611942663
739,R-HSA-5663213,1.7837585132395868,Proteomics,RHO GTPases Activate WASPs and WAVEs,0.4145,0.8777425373134329,0.585020090055203
740,R-HSA-8943724,1.7834332218277493,Proteomics,Regulation of PTEN gene transcription,0.2994,0.8777425373134329,0.5843104051927768
741,R-HSA-5635838,1.7825196687946412,Proteomics,Activation of SMO,0.2525,0.8777425373134329,0.5823173161193269
742,R-HSA-9006934,1.781491853829032,Proteomics,Signaling by Receptor Tyrosine Kinases,0.454,0.8777425373134329,0.5800749429858107
743,R-HSA-1236975,1.5231789703187502,Transcriptomics,Antigen processing-Cross presentation,0.141,0.8777425373134329,0.5775275710768133
744,R-HSA-162909,1.7782247532610769,Proteomics,Host Interactions of HIV factors,0.3803,0.8777425373134329,0.5729471439332485
745,R-HSA-422085,1.7780100770887965,Proteomics,"Synthesis, secretion, and deacylation of Ghrelin",0.1739,0.8777425373134329,0.5724787871791297
746,R-HSA-1234174,1.5210331794209158,Transcriptomics,Cellular response to hypoxia,0.1068,0.8777425373134329,0.5719583889263616
747,R-HSA-77595,1.5207102707842286,Transcriptomics,Processing of Intronless Pre-mRNAs,0.4654,0.8777425373134329,0.5711203123842905
748,R-HSA-9010553,1.5204437050896742,Transcriptomics,Regulation of expression of SLITs and ROBOs,0.065,0.8777425373134329,0.5704284682211274
749,R-HSA-351200,1.5204059012025568,Transcriptomics,Interconversion of polyamines,0.3595,0.8777425373134329,0.5703303520749715
750,R-HSA-140179,1.5204059012025568,Transcriptomics,Amine Oxidase reactions,0.3595,0.8777425373134329,0.5703303520749715
751,R-HSA-141334,1.5204059012025568,Transcriptomics,PAOs oxidise polyamines to amines,0.3595,0.8777425373134329,0.5703303520749715
752,R-HSA-211945,1.5200297571696042,Transcriptomics,Phase I - Functionalization of compounds,0.173,0.8777425373134329,0.5693541084734013
753,R-HSA-5621575,1.7758473601150753,Proteomics,CD209 (DC-SIGN) signaling,0.3417,0.8777425373134329,0.5677604102343088
754,R-HSA-6796648,1.7756305080499721,Proteomics,TP53 Regulates Transcription of DNA Repair Genes,0.1758,0.8777425373134329,0.5672873063576334
755,R-HSA-6804115,1.5185289361339356,Transcriptomics,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,0.378,0.8777425373134329,0.5654588800374416
756,R-HSA-5685942,1.7744054096954454,Proteomics,HDR through Homologous Recombination (HRR),0.4136,0.8777425373134329,0.564614522123092
757,R-HSA-1655829,1.7742567589106453,Proteomics,Regulation of cholesterol biosynthesis by SREBP (SREBF),0.1746,0.8777425373134329,0.5642902122645426
758,R-HSA-5654696,1.5178557435982862,Transcriptomics,Downstream signaling of activated FGFR2,0.1031,0.8777425373134329,0.5637116772428267
759,R-HSA-5654708,1.5178557435982862,Transcriptomics,Downstream signaling of activated FGFR3,0.1031,0.8777425373134329,0.5637116772428267
760,R-HSA-5654687,1.5178557435982862,Transcriptomics,Downstream signaling of activated FGFR1,0.1031,0.8777425373134329,0.5637116772428267
761,R-HSA-5654716,1.5178557435982862,Transcriptomics,Downstream signaling of activated FGFR4,0.1031,0.8777425373134329,0.5637116772428267
762,R-HSA-9758881,1.5171495948146905,Transcriptomics,Uptake of dietary cobalamins into enterocytes,0.4781,0.8777425373134329,0.5618789398567497
763,R-HSA-9633012,1.516809295511024,Transcriptomics,Response of EIF2AK4 (GCN2) to amino acid deficiency,0.0723,0.8777425373134329,0.5609957276063373
764,R-HSA-9006931,1.772406720804987,Proteomics,Signaling by Nuclear Receptors,0.4455,0.8777425373134329,0.5602540035276414
765,R-HSA-9612973,1.7722240494565524,Proteomics,Autophagy,0.2965,0.8777425373134329,0.5598554713621265
766,R-HSA-380108,1.5163560316808224,Transcriptomics,Chemokine receptors bind chemokines,0.3347,0.8777425373134329,0.5598193274104231
767,R-HSA-2424491,1.515081968993609,Transcriptomics,DAP12 signaling,0.1113,0.8777425373134329,0.5565126272173397
768,R-HSA-389356,1.7704580162832035,Proteomics,CD28 co-stimulation,0.4541,0.8777425373134329,0.5560025353052276
769,R-HSA-9634600,1.513960308816133,Transcriptomics,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",0.2846,0.8777425373134329,0.5536014722461933
770,R-HSA-450321,1.7692095341233363,Proteomics,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.433,0.8777425373134329,0.5532787348677612
771,R-HSA-8849471,1.7679091584114612,Proteomics,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.2951,0.8777425373134329,0.5504417188119993
772,R-HSA-975634,1.5127367101590838,Transcriptomics,Retinoid metabolism and transport,0.1394,0.8777425373134329,0.5504257463136093
773,R-HSA-6806667,1.5127367101590838,Transcriptomics,Metabolism of fat-soluble vitamins,0.1394,0.8777425373134329,0.5504257463136093
774,R-HSA-9032759,1.767519047790783,Proteomics,NTRK2 activates RAC1,0.187,0.8777425373134329,0.5495906185612943
775,R-HSA-9032845,1.767519047790783,Proteomics,Activated NTRK2 signals through CDK5,0.187,0.8777425373134329,0.5495906185612943
776,R-HSA-9701898,1.7674671348677764,Proteomics,STAT3 nuclear events downstream of ALK signaling,0.271,0.8777425373134329,0.5494773606814938
777,R-HSA-937061,1.7672419091962386,Proteomics,TRIF(TICAM1)-mediated TLR4 signaling ,0.3322,0.8777425373134329,0.5489859881954595
778,R-HSA-166166,1.7672419091962372,Proteomics,MyD88-independent TLR4 cascade ,0.3322,0.8777425373134329,0.5489859881954566
779,R-HSA-901042,1.7669928754446078,Proteomics,Calnexin/calreticulin cycle,0.328,0.8777425373134329,0.5484426738707215
780,R-HSA-532668,1.7669928754446078,Proteomics,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,0.328,0.8777425373134329,0.5484426738707215
781,R-HSA-425561,1.5111794208976455,Transcriptomics,Sodium/Calcium exchangers,0.2119,0.8777425373134329,0.546383960337797
782,R-HSA-3270619,1.7658841828163652,Proteomics,IRF3-mediated induction of type I IFN,0.168,0.8777425373134329,0.5460238507886648
783,R-HSA-2408557,1.511000736658358,Transcriptomics,Selenocysteine synthesis,0.0763,0.8777425373134329,0.5459202035584151
784,R-HSA-388396,1.510929596516979,Transcriptomics,GPCR downstream signalling,0.1569,0.8777425373134329,0.5457355665530346
785,R-HSA-2172127,1.5101342165487135,Transcriptomics,DAP12 interactions,0.2327,0.8777425373134329,0.543671238697715
786,R-HSA-168256,1.5099738878353401,Transcriptomics,Immune System,0.1055,0.8777425373134329,0.5432551218199593
787,R-HSA-5357905,1.7641175772185127,Proteomics,Regulation of TNFR1 signaling,0.4248,0.8777425373134329,0.5421696658792284
788,R-HSA-5357956,1.7641175772185127,Proteomics,TNFR1-induced NFkappaB signaling pathway,0.4248,0.8777425373134329,0.5421696658792284
789,R-HSA-75893,1.7641175772185127,Proteomics,TNF signaling,0.4248,0.8777425373134329,0.5421696658792284
790,R-HSA-1638074,1.5095185308013455,Transcriptomics,Keratan sulfate/keratin metabolism,0.0603,0.8777425373134329,0.542073288926379
791,R-HSA-5674135,1.7640567085420091,Proteomics,MAP2K and MAPK activation,0.4227,0.8777425373134329,0.5420368693259272
792,R-HSA-1912420,1.763865659369657,Proteomics,Pre-NOTCH Processing in Golgi,0.1543,0.8777425373134329,0.5416200593498152
793,R-HSA-1912399,1.763865659369657,Proteomics,Pre-NOTCH Processing in the Endoplasmic Reticulum,0.1543,0.8777425373134329,0.5416200593498152
794,R-HSA-5083630,1.763865659369657,Proteomics,Defective LFNG causes SCDO3,0.1543,0.8777425373134329,0.5416200593498152
795,R-HSA-844455,1.7634400789482558,Proteomics,The NLRP1 inflammasome,0.3287,0.8777425373134329,0.5406915750067849
796,R-HSA-5689603,1.508877158027471,Transcriptomics,UCH proteinases,0.3167,0.8777425373134329,0.5404086710888941
797,R-HSA-112316,1.7632117755816796,Proteomics,Neuronal System,0.3964,0.8777425373134329,0.5401934879457561
798,R-HSA-72165,1.508434064876715,Transcriptomics,mRNA Splicing - Minor Pathway,0.2421,0.8777425373134329,0.5392586678576063
799,R-HSA-9705683,1.5074015224314525,Transcriptomics,SARS-CoV-2-host interactions,0.0349,0.8777425373134329,0.5365788089013853
800,R-HSA-2990846,1.7615318242913696,Proteomics,SUMOylation,0.1945,0.8777425373134329,0.5365283558304881
801,R-HSA-3108232,1.7615318242913696,Proteomics,SUMO E3 ligases SUMOylate target proteins,0.1945,0.8777425373134329,0.5365283558304881
802,R-HSA-198725,1.7612443472034496,Proteomics,Nuclear Events (kinase and transcription factor activation),0.4256,0.8777425373134329,0.535901170082058
803,R-HSA-5694530,1.5066250654367614,Transcriptomics,Cargo concentration in the ER,0.1381,0.8777425373134329,0.5345635937004116
804,R-HSA-72766,1.760464697482003,Proteomics,Translation,0.205,0.8777425373134329,0.5342002164596432
805,R-HSA-5632684,1.506322599951732,Transcriptomics,Hedgehog 'on' state,0.0778,0.8777425373134329,0.5337785752803719
806,R-HSA-8939211,1.7601242312931062,Proteomics,ESR-mediated signaling,0.4683,0.8777425373134329,0.5334574249452187
807,R-HSA-9735869,1.5061090351458388,Transcriptomics,SARS-CoV-1 modulates host translation machinery,0.0841,0.8777425373134329,0.5332242895360594
808,R-HSA-6782210,1.505990733251384,Transcriptomics,Gap-filling DNA repair synthesis and ligation in TC-NER,0.1135,0.8777425373134329,0.532917248994678
809,R-HSA-9748787,1.7594131797446748,Proteomics,Azathioprine ADME,0.3734,0.8777425373134329,0.5319061312375982
810,R-HSA-877300,1.5052818711826281,Transcriptomics,Interferon gamma signaling,0.3581,0.8777425373134329,0.53107746955278
811,R-HSA-442755,1.7589627416692624,Proteomics,Activation of NMDA receptors and postsynaptic events,0.4889,0.8777425373134329,0.5309234152114515
812,R-HSA-166520,1.7587912709225095,Proteomics,Signaling by NTRKs,0.4453,0.8777425373134329,0.5305493192811839
813,R-HSA-72702,1.5048776001876003,Transcriptomics,Ribosomal scanning and start codon recognition,0.079,0.8777425373134329,0.5300282252803178
814,R-HSA-9018519,1.758347909910575,Proteomics,Estrogen-dependent gene expression,0.2642,0.8777425373134329,0.5295820432102216
815,R-HSA-163685,1.504225468344579,Transcriptomics,Integration of energy metabolism,0.2933,0.8777425373134329,0.5283356833725483
816,R-HSA-168255,1.5041686767924163,Transcriptomics,Influenza Infection,0.0653,0.8777425373134329,0.5281882866719096
817,R-HSA-2871796,1.7573487817889768,Proteomics,FCERI mediated MAPK activation,0.4559,0.8777425373134329,0.5274022558634939
818,R-HSA-1227986,1.7569979504953164,Proteomics,Signaling by ERBB2,0.3923,0.8777425373134329,0.526636850908688
819,R-HSA-3296482,1.5031989581011906,Transcriptomics,Defects in vitamin and cofactor metabolism,0.587,0.8777425373134329,0.5256714803831032
820,R-HSA-499943,1.7561097836100963,Proteomics,Interconversion of nucleotide di- and triphosphates,0.3823,0.8777425373134329,0.524699146527904
821,R-HSA-4420097,1.7554131316564339,Proteomics,VEGFA-VEGFR2 Pathway,0.5102,0.8777425373134329,0.5231792682652068
822,R-HSA-168643,1.7552478130889715,Proteomics,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.3237,0.8777425373134329,0.5228185944799897
823,R-HSA-8875878,1.7550718654016442,Proteomics,MET promotes cell motility,0.4169,0.8777425373134329,0.5224347312554128
824,R-HSA-195721,1.7542799468663328,Proteomics,Signaling by WNT,0.3781,0.8777425373134329,0.5207070108904314
825,R-HSA-211897,1.5010362196409313,Transcriptomics,Cytochrome P450 - arranged by substrate type,0.2434,0.8777425373134329,0.5200583125571385
826,R-HSA-156584,1.5007588827188365,Transcriptomics,Cytosolic sulfonation of small molecules,0.2636,0.8777425373134329,0.5193385127678161
827,R-HSA-72689,1.5001071003110937,Transcriptomics,Formation of a pool of free 40S subunits,0.0806,0.8777425373134329,0.5176468777837909
828,R-HSA-71288,1.7524702645089352,Proteomics,Creatine metabolism,0.168,0.8777425373134329,0.5167588458663682
829,R-HSA-450408,1.7524615082027806,Proteomics,AUF1 (hnRNP D0) binds and destabilizes mRNA,0.4191,0.8777425373134329,0.5167397423250433
830,R-HSA-3322077,1.7513142561847217,Proteomics,Glycogen synthesis,0.4793,0.8777425373134329,0.5142367946265314
831,R-HSA-8982491,1.7513142561847217,Proteomics,Glycogen metabolism,0.4793,0.8777425373134329,0.5142367946265314
832,R-HSA-112314,1.751049231230757,Proteomics,Neurotransmitter receptors and postsynaptic signal transmission,0.5116,0.8777425373134329,0.5136585924633342
833,R-HSA-9758941,1.7510065099964052,Proteomics,Gastrulation,0.3075,0.8777425373134329,0.5135653879942939
834,R-HSA-9754189,1.7510065099964052,Proteomics,Germ layer formation at gastrulation,0.3075,0.8777425373134329,0.5135653879942939
835,R-HSA-4570464,1.7507590488516442,Proteomics,SUMOylation of RNA binding proteins,0.3204,0.8777425373134329,0.5130255046094745
836,R-HSA-9759194,1.7506328126625221,Proteomics,Nuclear events mediated by NFE2L2,0.4904,0.8777425373134329,0.5127500964392917
837,R-HSA-418457,1.4971803311020573,Transcriptomics,cGMP effects,0.1996,0.8777425373134329,0.5100507458149642
838,R-HSA-420597,1.749386963533057,Proteomics,Nectin/Necl  trans heterodimerization,0.2946,0.8777425373134329,0.5100320404566456
839,R-HSA-351202,1.497125378065463,Transcriptomics,Metabolism of polyamines,0.1694,0.8777425373134329,0.5099081207945939
840,R-HSA-2187338,1.7476627002218748,Proteomics,Visual phototransduction,0.3526,0.8777425373134329,0.5062702332700659
841,R-HSA-8941332,1.4952237200630605,Transcriptomics,RUNX2 regulates genes involved in cell migration,0.2264,0.8777425373134329,0.5049725607575316
842,R-HSA-168273,1.494218930457597,Transcriptomics,Influenza Viral RNA Transcription and Replication,0.0773,0.8777425373134329,0.5023647314758648
843,R-HSA-3858494,1.4940466334627314,Transcriptomics,Beta-catenin independent WNT signaling,0.1597,0.8777425373134329,0.5019175521401007
844,R-HSA-156842,1.4939040866329643,Transcriptomics,Eukaryotic Translation Elongation,0.0834,0.8777425373134329,0.501547586333673
845,R-HSA-375165,1.493244397150506,Transcriptomics,NCAM signaling for neurite out-growth,0.3411,0.8777425373134329,0.49983542934099745
846,R-HSA-202424,1.492986136862642,Transcriptomics,Downstream TCR signaling,0.0525,0.8777425373134329,0.49916514101663445
847,R-HSA-8963676,4.64315305903956,Metabolomics,Intestinal absorption,0.3096,0.8777425373134329,0.498453948470875
848,R-HSA-72706,1.4921658166302654,Transcriptomics,GTP hydrolysis and joining of the 60S ribosomal subunit,0.0834,0.8777425373134329,0.49703608324105286
849,R-HSA-8953750,1.492122707999789,Transcriptomics,Transcriptional Regulation by E2F6,0.4153,0.8777425373134329,0.49692419917274877
850,R-HSA-156902,1.491888212356756,Transcriptomics,Peptide chain elongation,0.0846,0.8777425373134329,0.49631558956831084
851,R-HSA-111996,1.4915491812963302,Transcriptomics,Ca-dependent events,0.2187,0.8777425373134329,0.4954356689143095
852,R-HSA-9657688,1.4914520868314358,Transcriptomics,Defective factor XII causes hereditary angioedema,0.291,0.8777425373134329,0.49518367010056535
853,R-HSA-5633007,4.634686831528571,Metabolomics,Regulation of TP53 Activity,0.3913,0.8777425373134329,0.4943638348424248
854,R-HSA-3700989,4.634686831528568,Metabolomics,Transcriptional Regulation by TP53,0.3913,0.8777425373134329,0.4943638348424235
855,R-HSA-2022928,1.7417213675260217,Proteomics,HS-GAG biosynthesis,0.2055,0.8777425373134329,0.4933080900242081
856,R-HSA-9013695,1.7413087471266242,Proteomics,NOTCH4 Intracellular Domain Regulates Transcription,0.1847,0.8777425373134329,0.4924078804252933
857,R-HSA-6811438,1.489920470416851,Transcriptomics,Intra-Golgi traffic,0.4144,0.8777425373134329,0.49120851538905386
858,R-HSA-418885,1.4890920545996786,Transcriptomics,DCC mediated attractive signaling,0.237,0.8777425373134329,0.48905844634607115
859,R-HSA-1799339,1.4889005825636976,Transcriptomics,SRP-dependent cotranslational protein targeting to membrane,0.0866,0.8777425373134329,0.4885615001402818
860,R-HSA-1793185,1.7393902932948642,Proteomics,Chondroitin sulfate/dermatan sulfate metabolism,0.2998,0.8777425373134329,0.4882224098161158
861,R-HSA-9673324,1.7390891274894622,Proteomics,WNT5:FZD7-mediated leishmania damping,0.4349,0.8777425373134329,0.48756535953628566
862,R-HSA-9664420,1.7390891274894622,Proteomics,Killing mechanisms,0.4349,0.8777425373134329,0.48756535953628566
863,R-HSA-6802955,1.7388465420559094,Proteomics,Paradoxical activation of RAF signaling by kinase inactive BRAF,0.5101,0.8777425373134329,0.4870361134394857
864,R-HSA-9649948,1.7388465420559094,Proteomics,Signaling downstream of RAS mutants,0.5101,0.8777425373134329,0.4870361134394857
865,R-HSA-6802949,1.7388465420559094,Proteomics,Signaling by RAS mutants,0.5101,0.8777425373134329,0.4870361134394857
866,R-HSA-6802946,1.7388465420559094,Proteomics,Signaling by moderate kinase activity BRAF mutants,0.5101,0.8777425373134329,0.4870361134394857
867,R-HSA-6802957,1.7388465420559094,Proteomics,Oncogenic MAPK signaling,0.5101,0.8777425373134329,0.4870361134394857
868,R-HSA-76009,1.7388269862381092,Proteomics,Platelet Aggregation (Plug Formation),0.4498,0.8777425373134329,0.4869934487168397
869,R-HSA-416482,1.738498308192789,Proteomics,G alpha (12/13) signalling events,0.4194,0.8777425373134329,0.48627637527165407
870,R-HSA-166058,1.73840627158462,Proteomics,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,0.4045,0.8777425373134329,0.48607557996864387
871,R-HSA-168188,1.7384062715846187,Proteomics,Toll Like Receptor TLR6:TLR2 Cascade,0.4045,0.8777425373134329,0.4860755799686409
872,R-HSA-983712,1.7380190294172946,Proteomics,Ion channel transport,0.3627,0.8777425373134329,0.4852307377925421
873,R-HSA-6802952,1.7375989883656495,Proteomics,Signaling by BRAF and RAF1 fusions,0.5056,0.8777425373134329,0.4843143386344266
874,R-HSA-164944,1.4872108805199618,Transcriptomics,Nef and signal transduction,0.1456,0.8777425373134329,0.4841760502480987
875,R-HSA-73762,1.4866138911763738,Transcriptomics,RNA Polymerase I Transcription Initiation,0.1367,0.8777425373134329,0.4826266250922387
876,R-HSA-549132,4.609622564517061,Metabolomics,Organic cation/anion/zwitterion transport,0.2907,0.8777425373134329,0.48225505322064294
877,R-HSA-375276,1.4864305604260322,Transcriptomics,Peptide ligand-binding receptors,0.2446,0.8777425373134329,0.4821508087657449
878,R-HSA-8875360,1.7364106700359248,Proteomics,InlB-mediated entry of Listeria monocytogenes into host cell,0.465,0.8777425373134329,0.4817217969943461
879,R-HSA-9755511,1.7362641268073649,Proteomics,KEAP1-NFE2L2 pathway,0.4667,0.8777425373134329,0.4814020851691474
880,R-HSA-4086400,1.7360332261271758,Proteomics,PCP/CE pathway,0.4332,0.8777425373134329,0.480898331576243
881,R-HSA-9692914,1.4857013658675107,Transcriptomics,SARS-CoV-1-host interactions,0.0712,0.8777425373134329,0.48025825841350744
882,R-HSA-438064,1.7356890258811428,Proteomics,Post NMDA receptor activation events,0.5195,0.8777425373134329,0.4801473935085173
883,R-HSA-5661270,1.4854394197767193,Transcriptomics,Formation of xylulose-5-phosphate,0.2502,0.8777425373134329,0.4795784039623175
884,R-HSA-193639,1.7353245405646796,Proteomics,p75NTR signals via NF-kB,0.4591,0.8777425373134329,0.4793521997153291
885,R-HSA-209543,1.7353245405646796,Proteomics,p75NTR recruits signalling complexes,0.4591,0.8777425373134329,0.4793521997153291
886,R-HSA-5632684,1.735051431297412,Proteomics,Hedgehog 'on' state,0.4966,0.8777425373134329,0.4787563600905652
887,R-HSA-68886,1.7341839224704936,Proteomics,M Phase,0.3851,0.8777425373134329,0.4768637251789721
888,R-HSA-389359,1.4843017536902432,Transcriptomics,CD28 dependent Vav1 pathway,0.1259,0.8777425373134329,0.4766257072814007
889,R-HSA-164944,1.7338424110921344,Proteomics,Nef and signal transduction,0.4499,0.8777425373134329,0.47611865338565684
890,R-HSA-4551638,1.4834026840451933,Transcriptomics,SUMOylation of chromatin organization proteins,0.4329,0.8777425373134329,0.4742922634102955
891,R-HSA-73780,1.4832573170181305,Transcriptomics,RNA Polymerase III Chain Elongation,0.116,0.8777425373134329,0.4739149780684668
892,R-HSA-76066,1.4832573170181305,Transcriptomics,RNA Polymerase III Transcription Initiation From Type 2 Promoter,0.116,0.8777425373134329,0.4739149780684668
893,R-HSA-5674400,1.732716348847946,Proteomics,Constitutive Signaling by AKT1 E17K in Cancer,0.4677,0.8777425373134329,0.4736619351946169
894,R-HSA-3858494,1.7319377956046949,Proteomics,Beta-catenin independent WNT signaling,0.4391,0.8777425373134329,0.471963373747184
895,R-HSA-388396,4.587056294509582,Metabolomics,GPCR downstream signalling,0.2148,0.8777425373134329,0.47135307729558334
896,R-HSA-6783589,1.7312752691248945,Proteomics,Interleukin-6 family signaling,0.3338,0.8777425373134329,0.47051794667299573
897,R-HSA-1358803,1.7310279821546377,Proteomics,Downregulation of ERBB2:ERBB3 signaling,0.3738,0.8777425373134329,0.4699784432828658
898,R-HSA-879415,1.481542612807769,Transcriptomics,Advanced glycosylation endproduct receptor signaling,0.2109,0.8777425373134329,0.4694646375943384
899,R-HSA-983169,1.7305713788253483,Proteomics,Class I MHC mediated antigen processing & presentation,0.4185,0.8777425373134329,0.46898227658698016
900,R-HSA-1643685,1.7305611843590323,Proteomics,Disease,0.4786,0.8777425373134329,0.4689600354267106
901,R-HSA-983168,1.7305538746003457,Proteomics,Antigen processing: Ubiquitination & Proteasome degradation,0.4979,0.8777425373134329,0.4689440878028292
902,R-HSA-2161522,4.5813887988984705,Metabolomics,Abacavir ADME,0.3169,0.8777425373134329,0.46861505720244284
903,R-HSA-2161541,4.5813887988984705,Metabolomics,Abacavir metabolism,0.3169,0.8777425373134329,0.46861505720244284
904,R-HSA-1502540,1.730364850509633,Proteomics,Signaling by Activin,0.409,0.8777425373134329,0.4685316959260964
905,R-HSA-72737,1.4811709145895129,Transcriptomics,Cap-dependent Translation Initiation,0.0923,0.8777425373134329,0.4684999326528847
906,R-HSA-72613,1.4811709145895129,Transcriptomics,Eukaryotic Translation Initiation,0.0923,0.8777425373134329,0.4684999326528847
907,R-HSA-192823,1.481056140690542,Transcriptomics,Viral mRNA Translation,0.0866,0.8777425373134329,0.4682020486651526
908,R-HSA-180534,1.7301554436802675,Proteomics,Vpu mediated degradation of CD4,0.5124,0.8777425373134329,0.4680748352421643
909,R-HSA-975956,1.4805073066024363,Transcriptomics,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.0871,0.8777425373134329,0.4667776055797977
910,R-HSA-72163,1.4794806390390423,Transcriptomics,mRNA Splicing - Major Pathway,0.3385,0.8777425373134329,0.4641129942822698
911,R-HSA-9711097,1.4788577645029979,Transcriptomics,Cellular response to starvation,0.0766,0.8777425373134329,0.4624963867406822
912,R-HSA-70635,1.4780407277046301,Transcriptomics,Urea cycle,0.382,0.8777425373134329,0.4603758507843017
913,R-HSA-157118,1.7265870552879812,Proteomics,Signaling by NOTCH,0.3519,0.8777425373134329,0.4602897197023535
914,R-HSA-399955,1.7262283091129909,Proteomics,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,0.3413,0.8777425373134329,0.4595070469339401
915,R-HSA-72613,1.7261980869256317,Proteomics,Eukaryotic Translation Initiation,0.4285,0.8777425373134329,0.45944111150466754
916,R-HSA-72702,1.7261980869256317,Proteomics,Ribosomal scanning and start codon recognition,0.4285,0.8777425373134329,0.45944111150466754
917,R-HSA-72706,1.7261980869256317,Proteomics,GTP hydrolysis and joining of the 60S ribosomal subunit,0.4285,0.8777425373134329,0.45944111150466754
918,R-HSA-72737,1.7261980869256317,Proteomics,Cap-dependent Translation Initiation,0.4285,0.8777425373134329,0.45944111150466754
919,R-HSA-1168372,1.7261881285346137,Proteomics,Downstream signaling events of B Cell Receptor (BCR),0.4966,0.8777425373134329,0.45941938538740024
920,R-HSA-210500,1.4774348832596496,Transcriptomics,Glutamate Neurotransmitter Release Cycle,0.4662,0.8777425373134329,0.4588034431129199
921,R-HSA-437239,1.725900156078253,Proteomics,Recycling pathway of L1,0.2405,0.8777425373134329,0.4587911188988371
922,R-HSA-168164,1.725899690536649,Proteomics,Toll Like Receptor 3 (TLR3) Cascade,0.4077,0.8777425373134329,0.4587901032316012
923,R-HSA-72662,1.477055804766298,Transcriptomics,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.097,0.8777425373134329,0.4578195834176793
924,R-HSA-111932,1.476926638885302,Transcriptomics,CaMK IV-mediated phosphorylation of CREB,0.3148,0.8777425373134329,0.4574843465035808
925,R-HSA-442729,1.476926638885302,Transcriptomics,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,0.3148,0.8777425373134329,0.4574843465035808
926,R-HSA-9012999,1.7250658712877576,Proteomics,RHO GTPase cycle,0.4952,0.8777425373134329,0.4569709685191437
927,R-HSA-72764,1.476402995072804,Transcriptomics,Eukaryotic Translation Termination,0.0873,0.8777425373134329,0.4561252822179126
928,R-HSA-8953897,1.7243921176081027,Proteomics,Cellular responses to stimuli,0.4558,0.8777425373134329,0.4555010471807535
929,R-HSA-2262752,1.7243921176081023,Proteomics,Cellular responses to stress,0.4558,0.8777425373134329,0.45550104718075257
930,R-HSA-450531,1.7236243835137057,Proteomics,Regulation of mRNA stability by proteins that bind AU-rich elements,0.4923,0.8777425373134329,0.4538260897569336
931,R-HSA-5663205,4.549729407949148,Metabolomics,Infectious disease,0.4046,0.8777425373134329,0.4533201095740951
932,R-HSA-74160,4.549729407949148,Metabolomics,Gene expression (Transcription),0.4046,0.8777425373134329,0.4533201095740951
933,R-HSA-73857,4.549729407949148,Metabolomics,RNA Polymerase II Transcription,0.4046,0.8777425373134329,0.4533201095740951
934,R-HSA-212436,4.549729407949148,Metabolomics,Generic Transcription Pathway,0.4046,0.8777425373134329,0.4533201095740951
935,R-HSA-1640170,4.549729407949148,Metabolomics,Cell Cycle,0.4046,0.8777425373134329,0.4533201095740951
936,R-HSA-69278,4.549729407949148,Metabolomics,"Cell Cycle, Mitotic",0.4046,0.8777425373134329,0.4533201095740951
937,R-HSA-111933,1.475052168398106,Transcriptomics,Calmodulin induced events,0.2296,0.8777425373134329,0.45261934889855965
938,R-HSA-111997,1.475052168398106,Transcriptomics,CaM pathway,0.2296,0.8777425373134329,0.45261934889855965
939,R-HSA-9656223,1.7229757111445225,Proteomics,Signaling by RAF1 mutants,0.5176,0.8777425373134329,0.4524108880506142
940,R-HSA-8875555,1.4749051251861012,Transcriptomics,MET activates RAP1 and RAC1,0.3464,0.8777425373134329,0.45223771318910233
941,R-HSA-198323,1.7227934584203106,Proteomics,AKT phosphorylates targets in the cytosol,0.4571,0.8777425373134329,0.45201326919317647
942,R-HSA-177929,1.7225446723439333,Proteomics,Signaling by EGFR,0.4767,0.8777425373134329,0.4514704952189419
943,R-HSA-975155,1.7223599917002577,Proteomics,MyD88 dependent cascade initiated on endosome,0.4188,0.8777425373134329,0.4510675793950677
944,R-HSA-975138,1.7223599917002577,Proteomics,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,0.4188,0.8777425373134329,0.4510675793950677
945,R-HSA-168181,1.7223599917002577,Proteomics,Toll Like Receptor 7/8 (TLR7/8) Cascade,0.4188,0.8777425373134329,0.4510675793950677
946,R-HSA-168138,1.7223599917002577,Proteomics,Toll Like Receptor 9 (TLR9) Cascade,0.4188,0.8777425373134329,0.4510675793950677
947,R-HSA-418594,1.4744209733516487,Transcriptomics,G alpha (i) signalling events,0.1755,0.8777425373134329,0.4509811463179955
948,R-HSA-9620244,1.7222819083541385,Proteomics,Long-term potentiation,0.4693,0.8777425373134329,0.45089722577756725
949,R-HSA-167162,1.4743250702220663,Transcriptomics,RNA Polymerase II HIV Promoter Escape,0.1415,0.8777425373134329,0.4507322394939514
950,R-HSA-73776,1.4743250702220663,Transcriptomics,RNA Polymerase II Promoter Escape,0.1415,0.8777425373134329,0.4507322394939514
951,R-HSA-167161,1.4743250702220663,Transcriptomics,HIV Transcription Initiation,0.1415,0.8777425373134329,0.4507322394939514
952,R-HSA-75953,1.4743250702220663,Transcriptomics,RNA Polymerase II Transcription Initiation,0.1415,0.8777425373134329,0.4507322394939514
953,R-HSA-76042,1.4743250702220663,Transcriptomics,RNA Polymerase II Transcription Initiation And Promoter Clearance,0.1415,0.8777425373134329,0.4507322394939514
954,R-HSA-73779,1.4743250702220663,Transcriptomics,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,0.1415,0.8777425373134329,0.4507322394939514
955,R-HSA-1280218,1.7217584212435721,Proteomics,Adaptive Immune System,0.4322,0.8777425373134329,0.44975513943736656
956,R-HSA-9614085,1.7217496697892387,Proteomics,FOXO-mediated transcription,0.4716,0.8777425373134329,0.44973604648120896
957,R-HSA-168176,1.7216216374444768,Proteomics,Toll Like Receptor 5 (TLR5) Cascade,0.4372,0.8777425373134329,0.4494567196571001
958,R-HSA-168142,1.7216216374444768,Proteomics,Toll Like Receptor 10 (TLR10) Cascade,0.4372,0.8777425373134329,0.4494567196571001
959,R-HSA-975871,1.7216216374444768,Proteomics,MyD88 cascade initiated on plasma membrane,0.4372,0.8777425373134329,0.4494567196571001
960,R-HSA-9694516,1.4738107391353403,Transcriptomics,SARS-CoV-2 Infection,0.0289,0.8777425373134329,0.44939734544136345
961,R-HSA-72312,1.4730891684443124,Transcriptomics,rRNA processing,0.0681,0.8777425373134329,0.44752458206222073
962,R-HSA-187037,1.72069058480016,Proteomics,Signaling by NTRK1 (TRKA),0.4364,0.8777425373134329,0.44742545186536475
963,R-HSA-376176,1.4727979245344014,Transcriptomics,Signaling by ROBO receptors,0.0764,0.8777425373134329,0.4467686880997005
964,R-HSA-389359,1.7203603515480104,Proteomics,CD28 dependent Vav1 pathway,0.4681,0.8777425373134329,0.44670498544174647
965,R-HSA-211859,1.7202470934992449,Proteomics,Biological oxidations,0.284,0.8777425373134329,0.44645789154429993
966,R-HSA-2586552,1.72024605969444,Proteomics,Signaling by Leptin,0.1769,0.8777425373134329,0.4464556361031969
967,R-HSA-373752,1.4725276970038383,Transcriptomics,Netrin-1 signaling,0.1979,0.8777425373134329,0.4460673400134116
968,R-HSA-8875878,1.4721825098713965,Transcriptomics,MET promotes cell motility,0.3053,0.8777425373134329,0.44517144190027264
969,R-HSA-6806834,1.7193350494962878,Proteomics,Signaling by MET,0.4552,0.8777425373134329,0.44446809470610793
970,R-HSA-210745,1.7184772361217808,Proteomics,Regulation of gene expression in beta cells,0.4436,0.8777425373134329,0.44259661226138086
971,R-HSA-392451,1.7179216975922744,Proteomics,G beta:gamma signalling through PI3Kgamma,0.4769,0.8777425373134329,0.44138459967654764
972,R-HSA-1566948,1.717671744261914,Proteomics,Elastic fibre formation,0.2156,0.8777425373134329,0.44083927911653725
973,R-HSA-2129379,1.717671744261914,Proteomics,Molecules associated with elastic fibres,0.2156,0.8777425373134329,0.44083927911653725
974,R-HSA-5663220,1.7176058766447821,Proteomics,RHO GTPases Activate Formins,0.2924,0.8777425373134329,0.4406955764268827
975,R-HSA-5358351,1.7176033303761085,Proteomics,Signaling by Hedgehog,0.5237,0.8777425373134329,0.4406900212592157
976,R-HSA-156827,1.4704440184290575,Transcriptomics,L13a-mediated translational silencing of Ceruloplasmin expression,0.0947,0.8777425373134329,0.44065936408357625
977,R-HSA-114452,1.7175809405508007,Proteomics,Activation of BH3-only proteins,0.4888,0.8777425373134329,0.44064117361210586
978,R-HSA-164940,1.4702261434539177,Transcriptomics,Nef mediated downregulation of MHC class I complex cell surface expression,0.5453,0.8777425373134329,0.4400938917331234
979,R-HSA-927802,1.4699426036717294,Transcriptomics,Nonsense-Mediated Decay (NMD),0.0896,0.8777425373134329,0.43935799305096396
980,R-HSA-975957,1.4699426036717294,Transcriptomics,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.0896,0.8777425373134329,0.43935799305096396
981,R-HSA-73887,1.7169588434332015,Proteomics,Death Receptor Signalling,0.2961,0.8777425373134329,0.4392839508535176
982,R-HSA-212436,1.716433784229898,Proteomics,Generic Transcription Pathway,0.4471,0.8777425373134329,0.43813843469507624
983,R-HSA-450531,1.4694179025696616,Transcriptomics,Regulation of mRNA stability by proteins that bind AU-rich elements,0.1546,0.8777425373134329,0.4379961846776938
984,R-HSA-5673000,1.468941330769793,Transcriptomics,RAF activation,0.1966,0.8777425373134329,0.43675929101582023
985,R-HSA-3781865,1.7157618281125087,Proteomics,Diseases of glycosylation,0.2486,0.8777425373134329,0.4366724350794327
986,R-HSA-9013418,1.4683499030150564,Transcriptomics,RHOBTB2 GTPase cycle,0.2967,0.8777425373134329,0.4352243003984751
987,R-HSA-69052,1.714823530073429,Proteomics,Switching of origins to a post-replicative state,0.5406,0.8777425373134329,0.43462536008591346
988,R-HSA-174113,1.714823530073429,Proteomics,SCF-beta-TrCP mediated degradation of Emi1,0.5406,0.8777425373134329,0.43462536008591346
989,R-HSA-5607761,1.714823530073429,Proteomics,Dectin-1 mediated noncanonical NF-kB signaling,0.5406,0.8777425373134329,0.43462536008591346
990,R-HSA-9762114,1.714823530073429,Proteomics,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,0.5406,0.8777425373134329,0.43462536008591346
991,R-HSA-5676590,1.714823530073429,Proteomics,NIK-->noncanonical NF-kB signaling,0.5406,0.8777425373134329,0.43462536008591346
992,R-HSA-195253,1.714823530073429,Proteomics,Degradation of beta-catenin by the destruction complex,0.5406,0.8777425373134329,0.43462536008591346
993,R-HSA-68949,1.714823530073429,Proteomics,Orc1 removal from chromatin,0.5406,0.8777425373134329,0.43462536008591346
994,R-HSA-9010642,1.4678419127602078,Transcriptomics,ROBO receptors bind AKAP5,0.3132,0.8777425373134329,0.43390586333046377
995,R-HSA-2029480,1.7142276807698806,Proteomics,Fcgamma receptor (FCGR) dependent phagocytosis,0.525,0.8777425373134329,0.4333254019080238
996,R-HSA-163560,1.467588203179554,Transcriptomics,Triglyceride catabolism,0.2631,0.8777425373134329,0.43324738590407424
997,R-HSA-187687,1.7140377428057982,Proteomics,Signalling to ERKs,0.4544,0.8777425373134329,0.4329110162433427
998,R-HSA-1234176,1.7119912194336608,Proteomics,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,0.4999,0.8777425373134329,0.4284461376607721
999,R-HSA-73857,1.7115660002273068,Proteomics,RNA Polymerase II Transcription,0.4417,0.8777425373134329,0.42751844137682243
1000,R-HSA-6791226,1.4651100798231098,Transcriptomics,Major pathway of rRNA processing in the nucleolus and cytosol,0.0739,0.8777425373134329,0.4268156686397059
1001,R-HSA-8874081,1.7102179900040515,Proteomics,MET activates PTK2 signaling,0.3801,0.8777425373134329,0.42457750160704466
1002,R-HSA-5683057,1.7101924165315951,Proteomics,MAPK family signaling cascades,0.4571,0.8777425373134329,0.42452170823033225
1003,R-HSA-9604323,1.709235880278977,Proteomics,Negative regulation of NOTCH4 signaling,0.5375,0.8777425373134329,0.42243484311756974
1004,R-HSA-389513,1.7080739421606361,Proteomics,CTLA4 inhibitory signaling,0.4502,0.8777425373134329,0.4198998549080607
1005,R-HSA-6807004,1.7080010236568572,Proteomics,Negative regulation of MET activity,0.4908,0.8777425373134329,0.419740769372939
1006,R-HSA-2559585,1.707987792705802,Proteomics,Oncogene Induced Senescence,0.4953,0.8777425373134329,0.41971190354575244
1007,R-HSA-74160,1.7076125330158778,Proteomics,Gene expression (Transcription),0.4603,0.8777425373134329,0.418893203414957
1008,R-HSA-9009391,1.707600160704079,Proteomics,Extra-nuclear estrogen signaling,0.5427,0.8777425373134329,0.4188662108720329
1009,R-HSA-2534343,1.4617393458767391,Transcriptomics,Interaction With Cumulus Cells And The Zona Pellucida,0.5529,0.8777425373134329,0.4180672713252264
1010,R-HSA-5620916,1.461737077788107,Transcriptomics,VxPx cargo-targeting to cilium,0.5686,0.8777425373134329,0.41806138473173815
1011,R-HSA-6796648,1.4616657575317715,Transcriptomics,TP53 Regulates Transcription of DNA Repair Genes,0.1618,0.8777425373134329,0.4178762802562977
1012,R-HSA-1169091,1.7071021790845293,Proteomics,Activation of NF-kappaB in B cells,0.5422,0.8777425373134329,0.41777976959415064
1013,R-HSA-3371556,1.707080613959602,Proteomics,Cellular response to heat stress,0.4811,0.8777425373134329,0.41773272118721355
1014,R-HSA-5610787,1.7069432218490153,Proteomics,Hedgehog 'off' state,0.5447,0.8777425373134329,0.41743297426014464
1015,R-HSA-5610785,1.7069432218490153,Proteomics,GLI3 is processed to GLI3R by the proteasome,0.5447,0.8777425373134329,0.41743297426014464
1016,R-HSA-5610783,1.7069432218490153,Proteomics,Degradation of GLI2 by the proteasome,0.5447,0.8777425373134329,0.41743297426014464
1017,R-HSA-5610780,1.7069432218490153,Proteomics,Degradation of GLI1 by the proteasome,0.5447,0.8777425373134329,0.41743297426014464
1018,R-HSA-5654741,1.4614737882129152,Transcriptomics,Signaling by FGFR3,0.0512,0.8777425373134329,0.41737804340335544
1019,R-HSA-1855191,1.4613826756270312,Transcriptomics,Synthesis of IPs in the nucleus,0.3046,0.8777425373134329,0.41714156994851004
1020,R-HSA-162599,1.7065815186030537,Proteomics,Late Phase of HIV Life Cycle,0.4461,0.8777425373134329,0.41664385008099925
1021,R-HSA-397795,1.7059446063969579,Proteomics,G-protein beta:gamma signalling,0.4946,0.8777425373134329,0.41525430539917857
1022,R-HSA-416476,1.4604172962992523,Transcriptomics,G alpha (q) signalling events,0.2961,0.8777425373134329,0.4146360260364229
1023,R-HSA-4570464,1.4600584550251319,Transcriptomics,SUMOylation of RNA binding proteins,0.4647,0.8777425373134329,0.41370468998653387
1024,R-HSA-202040,1.4600134660456656,Transcriptomics,G-protein activation,0.5278,0.8777425373134329,0.41358792566356867
1025,R-HSA-194315,1.7050808303423801,Proteomics,Signaling by Rho GTPases,0.5629,0.8777425373134329,0.41336981423786157
1026,R-HSA-9716542,1.7050808303423801,Proteomics,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.5629,0.8777425373134329,0.41336981423786157
1027,R-HSA-72649,1.4598364496093403,Transcriptomics,Translation initiation complex formation,0.108,0.8777425373134329,0.41312849749723884
1028,R-HSA-392851,1.4597361931668738,Transcriptomics,Prostacyclin signalling through prostacyclin receptor,0.5558,0.8777425373134329,0.41286829209212866
1029,R-HSA-9636667,1.7046121202205755,Proteomics,Manipulation of host energy metabolism,0.2739,0.8777425373134329,0.412347234279689
1030,R-HSA-112040,1.4591244019191696,Transcriptomics,G-protein mediated events,0.2054,0.8777425373134329,0.4112804500987848
1031,R-HSA-194138,1.703617901242229,Proteomics,Signaling by VEGF,0.5592,0.8777425373134329,0.41017815715931955
1032,R-HSA-211945,1.7036147082550739,Proteomics,Phase I - Functionalization of compounds,0.2784,0.8777425373134329,0.41017119105272265
1033,R-HSA-2871837,1.7033704745945892,Proteomics,FCERI mediated NF-kB activation,0.5182,0.8777425373134329,0.4096383490365077
1034,R-HSA-450341,1.7028114846214761,Proteomics,Activation of the AP-1 family of transcription factors,0.4464,0.8777425373134329,0.40841880647334716
1035,R-HSA-3371571,1.7026431807370168,Proteomics,HSF1-dependent transactivation,0.3597,0.8777425373134329,0.4080516196533398
1036,R-HSA-199991,1.7026355729728078,Proteomics,Membrane Trafficking,0.48,0.8777425373134329,0.40803502187393464
1037,R-HSA-5696399,1.7023028800224558,Proteomics,Global Genome Nucleotide Excision Repair (GG-NER),0.4973,0.8777425373134329,0.4073091891525388
1038,R-HSA-2142770,1.4570697422447139,Transcriptomics,Synthesis of 15-eicosatetraenoic acid derivatives,0.2831,0.8777425373134329,0.40594778977490137
1039,R-HSA-389661,1.4569677762562292,Transcriptomics,Glyoxylate metabolism and glycine degradation,0.1642,0.8777425373134329,0.40568314741688083
1040,R-HSA-8868773,1.4567888426601472,Transcriptomics,rRNA processing in the nucleus and cytosol,0.0774,0.8777425373134329,0.40521874345728637
1041,R-HSA-2424491,1.701067665219546,Proteomics,DAP12 signaling,0.4809,0.8777425373134329,0.40461433396863433
1042,R-HSA-110312,1.70101122971061,Proteomics,Translesion synthesis by REV1,0.5223,0.8777425373134329,0.404491209210532
1043,R-HSA-5696397,1.70101122971061,Proteomics,Gap-filling DNA repair synthesis and ligation in GG-NER,0.5223,0.8777425373134329,0.404491209210532
1044,R-HSA-5655862,1.70101122971061,Proteomics,Translesion synthesis by POLK,0.5223,0.8777425373134329,0.404491209210532
1045,R-HSA-5656121,1.70101122971061,Proteomics,Translesion synthesis by POLI,0.5223,0.8777425373134329,0.404491209210532
1046,R-HSA-110320,1.70101122971061,Proteomics,Translesion Synthesis by POLH,0.5223,0.8777425373134329,0.404491209210532
1047,R-HSA-5696400,1.70101122971061,Proteomics,Dual Incision in GG-NER,0.5223,0.8777425373134329,0.404491209210532
1048,R-HSA-110314,1.70101122971061,Proteomics,Recognition of DNA damage by PCNA-containing replication complex,0.5223,0.8777425373134329,0.404491209210532
1049,R-HSA-72766,1.4562624865756217,Transcriptomics,Translation,0.0833,0.8777425373134329,0.40385263974528013
1050,R-HSA-69278,1.70038605326891,Proteomics,"Cell Cycle, Mitotic",0.4571,0.8777425373134329,0.4031272683228407
1051,R-HSA-1253288,1.70024756413557,Proteomics,Downregulation of ERBB4 signaling,0.4067,0.8777425373134329,0.402825128032734
1052,R-HSA-1834949,1.700101492867402,Proteomics,Cytosolic sensors of pathogen-associated DNA ,0.4826,0.8777425373134329,0.40250644587857365
1053,R-HSA-174048,1.6997438350834841,Proteomics,APC/C:Cdc20 mediated degradation of Cyclin B,0.5224,0.8777425373134329,0.4017261476415508
1054,R-HSA-8953854,1.4552541946280309,Transcriptomics,Metabolism of RNA,0.0671,0.8777425373134329,0.4012357204906433
1055,R-HSA-5696398,1.6992616667916993,Proteomics,Nucleotide Excision Repair,0.5004,0.8777425373134329,0.4006742061350454
1056,R-HSA-9692916,1.4550117971235552,Transcriptomics,SARS-CoV-1 activates/modulates innate immune responses,0.2109,0.8777425373134329,0.4006066024080743
1057,R-HSA-166520,1.4546616564524608,Transcriptomics,Signaling by NTRKs,0.1534,0.8777425373134329,0.39969784788890184
1058,R-HSA-2408508,1.4540085245646621,Transcriptomics,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.3912,0.8777425373134329,0.39800271046656943
1059,R-HSA-392499,1.6979209643072968,Proteomics,Metabolism of proteins,0.4133,0.8777425373134329,0.3977492095824987
1060,R-HSA-1266738,1.6978766281701605,Proteomics,Developmental Biology,0.4539,0.8777425373134329,0.3976524818969864
1061,R-HSA-399954,1.4538297981368298,Transcriptomics,Sema3A PAK dependent Axon repulsion,0.0891,0.8777425373134329,0.3975388441911078
1062,R-HSA-5362768,1.6977638507203312,Proteomics,Hh mutants are degraded by ERAD,0.5492,0.8777425373134329,0.39740643651719976
1063,R-HSA-8948747,1.697698522666569,Proteomics,Regulation of PTEN localization,0.5234,0.8777425373134329,0.39726391098729147
1064,R-HSA-428540,1.4536955782775094,Transcriptomics,Activation of RAC1,0.1612,0.8777425373134329,0.3971904901900178
1065,R-HSA-72172,1.4535737631472534,Transcriptomics,mRNA Splicing,0.374,0.8777425373134329,0.3968743314022434
1066,R-HSA-2022870,1.6974292382914382,Proteomics,Chondroitin sulfate biosynthesis,0.2653,0.8777425373134329,0.3966764160895973
1067,R-HSA-5387390,1.6973086186319404,Proteomics,Hh mutants abrogate ligand secretion,0.5551,0.8777425373134329,0.39641326144320477
1068,R-HSA-9020956,1.4531407005164008,Transcriptomics,Interleukin-27 signaling,0.2458,0.8777425373134329,0.3957503613657379
1069,R-HSA-182971,1.6968689645391424,Proteomics,EGFR downregulation,0.5166,0.8777425373134329,0.3954540727188546
1070,R-HSA-2122947,1.6962112098557827,Proteomics,NOTCH1 Intracellular Domain Regulates Transcription,0.5294,0.8777425373134329,0.3940190562229271
1071,R-HSA-162587,1.6961951286987755,Proteomics,HIV Life Cycle,0.4684,0.8777425373134329,0.3939839721313005
1072,R-HSA-8978868,1.4522913875353487,Transcriptomics,Fatty acid metabolism,0.2394,0.8777425373134329,0.39354605585815294
1073,R-HSA-2644605,1.4521840080879498,Transcriptomics,FBXW7 Mutants and NOTCH1 in Cancer,0.4751,0.8777425373134329,0.3932673634178117
1074,R-HSA-2644607,1.4521840080879498,Transcriptomics,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,0.4751,0.8777425373134329,0.3932673634178117
1075,R-HSA-9637690,1.6957500448390184,Proteomics,Response of Mtb to phagocytosis,0.49,0.8777425373134329,0.39301293734130827
1076,R-HSA-112314,1.4520610804272667,Transcriptomics,Neurotransmitter receptors and postsynaptic signal transmission,0.437,0.8777425373134329,0.3929483171704052
1077,R-HSA-195399,1.6956785215492682,Proteomics,VEGF binds to VEGFR leading to receptor dimerization,0.1881,0.8777425373134329,0.3928568957300039
1078,R-HSA-194313,1.6956785215492682,Proteomics,VEGF ligand-receptor interactions,0.1881,0.8777425373134329,0.3928568957300039
1079,R-HSA-193704,1.695607428139242,Proteomics,p75 NTR receptor-mediated signalling,0.4972,0.8777425373134329,0.39270179198278554
1080,R-HSA-69183,1.451876691153107,Transcriptomics,Processive synthesis on the lagging strand,0.1632,0.8777425373134329,0.39246975355294295
1081,R-HSA-168643,1.4517955671228893,Transcriptomics,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.149,0.8777425373134329,0.3922592043789685
1082,R-HSA-9664417,1.6950267245342847,Proteomics,Leishmania phagocytosis,0.5475,0.8777425373134329,0.39143487701670476
1083,R-HSA-9664407,1.6950267245342847,Proteomics,Parasite infection,0.5475,0.8777425373134329,0.39143487701670476
1084,R-HSA-9664422,1.6950267245342847,Proteomics,FCGR3A-mediated phagocytosis,0.5475,0.8777425373134329,0.39143487701670476
1085,R-HSA-166058,1.4508194970718737,Transcriptomics,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,0.2069,0.8777425373134329,0.38972591378145865
1086,R-HSA-181438,1.4508194970718737,Transcriptomics,Toll Like Receptor 2 (TLR2) Cascade,0.2069,0.8777425373134329,0.38972591378145865
1087,R-HSA-168188,1.4508194970718737,Transcriptomics,Toll Like Receptor TLR6:TLR2 Cascade,0.2069,0.8777425373134329,0.38972591378145865
1088,R-HSA-168179,1.4508194970718737,Transcriptomics,Toll Like Receptor TLR1:TLR2 Cascade,0.2069,0.8777425373134329,0.38972591378145865
1089,R-HSA-162582,1.6940749122030936,Proteomics,Signal Transduction,0.5383,0.8777425373134329,0.3893583180337876
1090,R-HSA-2454202,1.6940324219654288,Proteomics,Fc epsilon receptor (FCERI) signaling,0.5377,0.8777425373134329,0.3892656175277974
1091,R-HSA-3371453,1.693155707845377,Proteomics,Regulation of HSF1-mediated heat shock response,0.4765,0.8777425373134329,0.38735289952469515
1092,R-HSA-162710,1.4496418689976849,Transcriptomics,Synthesis of glycosylphosphatidylinositol (GPI),0.4703,0.8777425373134329,0.386669499823667
1093,R-HSA-937072,1.6925034163573334,Proteomics,TRAF6-mediated induction of TAK1 complex within TLR4 complex,0.5129,0.8777425373134329,0.3859298020247056
1094,R-HSA-975163,1.6925034163573318,Proteomics,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,0.5129,0.8777425373134329,0.38592980202470223
1095,R-HSA-2025928,1.6919748592577564,Proteomics,Calcineurin activates NFAT,0.3693,0.8777425373134329,0.3847766545426408
1096,R-HSA-1362277,1.4486640614108037,Transcriptomics,Transcription of E2F targets under negative control by DREAM complex,0.2388,0.8777425373134329,0.3841316996284427
1097,R-HSA-6804759,1.6915202139071426,Proteomics,Regulation of TP53 Activity through Association with Co-factors,0.4733,0.8777425373134329,0.3837847595483019
1098,R-HSA-448424,1.6913977374298166,Proteomics,Interleukin-17 signaling,0.3781,0.8777425373134329,0.38351755390192294
1099,R-HSA-109581,1.6906957057561562,Proteomics,Apoptosis,0.4038,0.8777425373134329,0.38198593876051434
1100,R-HSA-8866654,1.6906922508827416,Proteomics,E3 ubiquitin ligases ubiquitinate target proteins,0.5243,0.8777425373134329,0.3819784012994109
1101,R-HSA-5675221,1.6899595491587898,Proteomics,Negative regulation of MAPK pathway,0.515,0.8777425373134329,0.3803798736308663
1102,R-HSA-1852241,1.689443860195227,Proteomics,Organelle biogenesis and maintenance,0.4216,0.8777425373134329,0.37925480042621756
1103,R-HSA-9013973,1.689352292202168,Proteomics,TICAM1-dependent activation of IRF3/IRF7,0.5079,0.8777425373134329,0.3790550274958789
1104,R-HSA-3134975,1.689352292202168,Proteomics,Regulation of innate immune responses to cytosolic DNA,0.5079,0.8777425373134329,0.3790550274958789
1105,R-HSA-187577,1.6892289831584926,Proteomics,SCF(Skp2)-mediated degradation of p27/p21,0.5234,0.8777425373134329,0.37878600544822516
1106,R-HSA-1640170,1.688363234606783,Proteomics,Cell Cycle,0.4852,0.8777425373134329,0.3768972109105978
1107,R-HSA-109606,1.6883560067632346,Proteomics,Intrinsic Pathway for Apoptosis,0.5132,0.8777425373134329,0.37688144200011453
1108,R-HSA-204998,1.688118738329259,Proteomics,"Cell death signalling via NRAGE, NRIF and NADE",0.4895,0.8777425373134329,0.376363795945542
1109,R-HSA-6802948,1.6870945339279124,Proteomics,Signaling by high-kinase activity BRAF mutants,0.5208,0.8777425373134329,0.37412929994221944
1110,R-HSA-72203,1.4447959692645358,Transcriptomics,Processing of Capped Intron-Containing Pre-mRNA,0.4125,0.8777425373134329,0.3740924596638038
1111,R-HSA-1295596,1.6869423053981667,Proteomics,Spry regulation of FGF signaling,0.4894,0.8777425373134329,0.37379718455503574
1112,R-HSA-9034793,1.6860594047033433,Proteomics,Activated NTRK3 signals through PLCG1,0.2772,0.8777425373134329,0.3718709693666224
1113,R-HSA-9013419,1.4437682473397513,Transcriptomics,RHOT2 GTPase cycle,0.2905,0.8777425373134329,0.3714251118784655
1114,R-HSA-9715370,1.4437682473397513,Transcriptomics,Miro GTPase Cycle,0.2905,0.8777425373134329,0.3714251118784655
1115,R-HSA-168179,1.6854526978454483,Proteomics,Toll Like Receptor TLR1:TLR2 Cascade,0.4936,0.8777425373134329,0.3705473233762593
1116,R-HSA-181438,1.6854526978454483,Proteomics,Toll Like Receptor 2 (TLR2) Cascade,0.4936,0.8777425373134329,0.3705473233762593
1117,R-HSA-5663084,1.6853071476302945,Proteomics,Diseases of carbohydrate metabolism,0.5356,0.8777425373134329,0.37022977799799683
1118,R-HSA-937041,1.6845876677899194,Proteomics,IKK complex recruitment mediated by RIP1,0.5242,0.8777425373134329,0.36866009637421593
1119,R-HSA-168927,1.6833683341225365,Proteomics,"TICAM1, RIP1-mediated IKK complex recruitment",0.5291,0.8777425373134329,0.3659998888971719
1120,R-HSA-180585,1.683360825515931,Proteomics,Vif-mediated degradation of APOBEC3G,0.5592,0.8777425373134329,0.3659835074488705
1121,R-HSA-75815,1.683360825515931,Proteomics,Ubiquitin-dependent degradation of Cyclin D,0.5592,0.8777425373134329,0.3659835074488705
1122,R-HSA-174184,1.683360825515931,Proteomics,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,0.5592,0.8777425373134329,0.3659835074488705
1123,R-HSA-4641258,1.683360825515931,Proteomics,Degradation of DVL,0.5592,0.8777425373134329,0.3659835074488705
1124,R-HSA-174154,1.683360825515931,Proteomics,APC/C:Cdc20 mediated degradation of Securin,0.5592,0.8777425373134329,0.3659835074488705
1125,R-HSA-211733,1.683360825515931,Proteomics,Regulation of activated PAK-2p34 by proteasome mediated degradation,0.5592,0.8777425373134329,0.3659835074488705
1126,R-HSA-4641257,1.683360825515931,Proteomics,Degradation of AXIN,0.5592,0.8777425373134329,0.3659835074488705
1127,R-HSA-4608870,1.683360825515931,Proteomics,Asymmetric localization of PCP proteins,0.5592,0.8777425373134329,0.3659835074488705
1128,R-HSA-5678895,1.683360825515931,Proteomics,Defective CFTR causes cystic fibrosis,0.5592,0.8777425373134329,0.3659835074488705
1129,R-HSA-174084,1.683360825515931,Proteomics,Autodegradation of Cdh1 by Cdh1:APC/C,0.5592,0.8777425373134329,0.3659835074488705
1130,R-HSA-169911,1.683360825515931,Proteomics,Regulation of Apoptosis,0.5592,0.8777425373134329,0.3659835074488705
1131,R-HSA-179419,1.683360825515931,Proteomics,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,0.5592,0.8777425373134329,0.3659835074488705
1132,R-HSA-69017,1.683360825515931,Proteomics,CDK-mediated phosphorylation and removal of Cdc6,0.5592,0.8777425373134329,0.3659835074488705
1133,R-HSA-445144,1.6833116170099796,Proteomics,Signal transduction by L1,0.3599,0.8777425373134329,0.3658761497674026
1134,R-HSA-388841,1.6831322339930153,Proteomics,Costimulation by the CD28 family,0.5375,0.8777425373134329,0.3654847917201772
1135,R-HSA-1643713,1.6830225569355812,Proteomics,Signaling by EGFR in Cancer,0.5023,0.8777425373134329,0.3652455104339708
1136,R-HSA-5693567,1.6825483893090765,Proteomics,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),0.5369,0.8777425373134329,0.36421102389501747
1137,R-HSA-5693538,1.6825483893090765,Proteomics,Homology Directed Repair,0.5369,0.8777425373134329,0.36421102389501747
1138,R-HSA-418885,1.6823795025220332,Proteomics,DCC mediated attractive signaling,0.4756,0.8777425373134329,0.3638425653625546
1139,R-HSA-175474,1.6822664813319772,Proteomics,Assembly Of The HIV Virion,0.4656,0.8777425373134329,0.3635959882172711
1140,R-HSA-9705462,1.6821717871549962,Proteomics,Inactivation of CSF3 (G-CSF) signaling,0.542,0.8777425373134329,0.3633893949242489
1141,R-HSA-5684264,1.6821402692988812,Proteomics,MAP3K8 (TPL2)-dependent MAPK1/3 activation,0.5511,0.8777425373134329,0.36332063274803716
1142,R-HSA-9711123,1.6821331169782914,Proteomics,Cellular response to chemical stress,0.564,0.8777425373134329,0.36330502860520064
1143,R-HSA-5633007,1.6811586556484515,Proteomics,Regulation of TP53 Activity,0.349,0.8777425373134329,0.36117905653941307
1144,R-HSA-390471,1.6810397714030747,Proteomics,Association of TriC/CCT with target proteins during biosynthesis,0.5206,0.8777425373134329,0.36091968802781216
1145,R-HSA-446728,1.6808934615585285,Proteomics,Cell junction organization,0.3187,0.8777425373134329,0.360600485374069
1146,R-HSA-421270,1.6808934615585285,Proteomics,Cell-cell junction organization,0.3187,0.8777425373134329,0.360600485374069
1147,R-HSA-69239,1.680301719495834,Proteomics,Synthesis of DNA,0.5683,0.8777425373134329,0.35930948792048456
1148,R-HSA-5339562,1.6802923435647201,Proteomics,Uptake and actions of bacterial toxins,0.3145,0.8777425373134329,0.35928903254988276
1149,R-HSA-186712,1.6800603469899429,Proteomics,Regulation of beta-cell development,0.4633,0.8777425373134329,0.3587828880552461
1150,R-HSA-2173796,1.6793531080647337,Proteomics,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,0.5132,0.8777425373134329,0.357239912307733
1151,R-HSA-2173793,1.6793531080647337,Proteomics,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,0.5132,0.8777425373134329,0.357239912307733
1152,R-HSA-9658195,1.6784750209028811,Proteomics,Leishmania infection,0.4742,0.8777425373134329,0.3553241987537309
1153,R-HSA-202424,1.6778694237863965,Proteomics,Downstream TCR signaling,0.5337,0.8777425373134329,0.3540029738745667
1154,R-HSA-9678108,1.6772430062465393,Proteomics,SARS-CoV-1 Infection,0.5319,0.8777425373134329,0.3526363252960393
1155,R-HSA-8941858,1.6771598688415625,Proteomics,Regulation of RUNX3 expression and activity,0.5505,0.8777425373134329,0.35245494529132243
1156,R-HSA-162658,1.6771451582473784,Proteomics,Golgi Cisternae Pericentriolar Stack Reorganization,0.304,0.8777425373134329,0.352422851342236
1157,R-HSA-9674555,1.67660723147027,Proteomics,Signaling by CSF3 (G-CSF),0.5709,0.8777425373134329,0.3512492621329449
1158,R-HSA-195258,1.675894792135936,Proteomics,RHO GTPase Effectors,0.5588,0.8777425373134329,0.3496949407073719
1159,R-HSA-70171,1.6752775465893919,Proteomics,Glycolysis,0.4116,0.8777425373134329,0.34834830257048444
1160,R-HSA-389948,1.4347877596416356,Transcriptomics,PD-1 signaling,0.2524,0.8777425373134329,0.3481171689464808
1161,R-HSA-8849469,1.6751165223968871,Proteomics,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,0.5364,0.8777425373134329,0.3479969977780846
1162,R-HSA-111885,1.4344540752260666,Transcriptomics,Opioid Signalling,0.233,0.8777425373134329,0.347251124965706
1163,R-HSA-9020702,1.674578551568257,Proteomics,Interleukin-1 signaling,0.5046,0.8777425373134329,0.34682331246205034
1164,R-HSA-349425,1.6738831416260054,Proteomics,Autodegradation of the E3 ubiquitin ligase COP1,0.5453,0.8777425373134329,0.3453061438826253
1165,R-HSA-9668250,1.6734579639051772,Proteomics,Defective factor IX causes hemophilia B,0.1803,0.8777425373134329,0.34437853810721253
1166,R-HSA-5655253,1.6734483428199616,Proteomics,Signaling by FGFR2 in disease,0.2359,0.8777425373134329,0.3443575478864776
1167,R-HSA-5628897,1.6731028999961137,Proteomics,TP53 Regulates Metabolic Genes,0.5582,0.8777425373134329,0.3436038988997621
1168,R-HSA-5654710,1.672902154948918,Proteomics,PI-3K cascade:FGFR3,0.2183,0.8777425373134329,0.3431659355351683
1169,R-HSA-5654706,1.672902154948918,Proteomics,FRS-mediated FGFR3 signaling,0.2183,0.8777425373134329,0.3431659355351683
1170,R-HSA-162906,1.6727043475203611,Proteomics,HIV Infection,0.4938,0.8777425373134329,0.3427343811423569
1171,R-HSA-112409,1.6716786159777597,Proteomics,RAF-independent MAPK1/3 activation,0.2973,0.8777425373134329,0.3404965533909713
1172,R-HSA-210990,1.6716219864334767,Proteomics,PECAM1 interactions,0.4763,0.8777425373134329,0.34037300530798714
1173,R-HSA-2029482,1.6715420502249654,Proteomics,Regulation of actin dynamics for phagocytic cup formation,0.5731,0.8777425373134329,0.34019860932003354
1174,R-HSA-8939243,1.4315488333979907,Transcriptomics,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,0.6497,0.8777425373134329,0.3397108651258515
1175,R-HSA-72306,1.6706176331320677,Proteomics,tRNA processing,0.2727,0.8777425373134329,0.3381818182412537
1176,R-HSA-9032500,1.6701866748097896,Proteomics,Activated NTRK2 signals through FYN,0.4072,0.8777425373134329,0.3372416009882689
1177,R-HSA-4090294,1.668866423049335,Proteomics,SUMOylation of intracellular receptors,0.4429,0.8777425373134329,0.3343612215657276
1178,R-HSA-917729,1.6687922806747382,Proteomics,Endosomal Sorting Complex Required For Transport (ESCRT),0.5088,0.8777425373134329,0.33419946592447497
1179,R-HSA-9020958,1.6687371345561393,Proteomics,Interleukin-21 signaling,0.4513,0.8777425373134329,0.3340791542157516
1180,R-HSA-381753,1.429201694550149,Transcriptomics,Olfactory Signaling Pathway,0.5545,0.8777425373134329,0.33361910483866586
1181,R-HSA-5693607,1.6682930954720547,Proteomics,Processing of DNA double-strand break ends,0.5591,0.8777425373134329,0.3331103988018896
1182,R-HSA-913709,1.428880890624473,Transcriptomics,O-linked glycosylation of mucins,0.1282,0.8777425373134329,0.33278649086007545
1183,R-HSA-9678108,1.428303773420402,Transcriptomics,SARS-CoV-1 Infection,0.0862,0.8777425373134329,0.33128864182228046
1184,R-HSA-70263,1.667348262259795,Proteomics,Gluconeogenesis,0.4451,0.8777425373134329,0.3310490660895669
1185,R-HSA-173736,1.4279249033821664,Transcriptomics,Alternative complement activation,0.3123,0.8777425373134329,0.3303053231511031
1186,R-HSA-425407,1.6668864388702984,Proteomics,SLC-mediated transmembrane transport,0.2058,0.8777425373134329,0.33004151084306116
1187,R-HSA-193648,1.6663831215229528,Proteomics,NRAGE signals death through JNK,0.5236,0.8777425373134329,0.328943428663793
1188,R-HSA-5607764,1.6662412249210776,Proteomics,CLEC7A (Dectin-1) signaling,0.5483,0.8777425373134329,0.32863385433531117
1189,R-HSA-2660825,1.426879430874884,Transcriptomics,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.2734,0.8777425373134329,0.3275919055332816
1190,R-HSA-2660826,1.426879430874884,Transcriptomics,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.2734,0.8777425373134329,0.3275919055332816
1191,R-HSA-5362798,1.665631233875057,Proteomics,Release of Hh-Np from the secreting cell,0.2768,0.8777425373134329,0.32730304326615
1192,R-HSA-983705,1.6649365113111947,Proteomics,Signaling by the B Cell Receptor (BCR),0.5756,0.8777425373134329,0.3257873743329496
1193,R-HSA-1296052,1.4260447409935546,Transcriptomics,Ca2+ activated K+ channels,0.2573,0.8777425373134329,0.32542555279455304
1194,R-HSA-9754706,1.6645364489123127,Proteomics,Atorvastatin ADME,0.3018,0.8777425373134329,0.32491456239208494
1195,R-HSA-112313,1.4257813768043412,Transcriptomics,Neurotransmitter uptake and metabolism In glial cells,0.3323,0.8777425373134329,0.3247420178130619
1196,R-HSA-210455,1.4257813768043412,Transcriptomics,Astrocytic Glutamate-Glutamine Uptake And Metabolism,0.3323,0.8777425373134329,0.3247420178130619
1197,R-HSA-2995410,1.6643556593094435,Proteomics,Nuclear Envelope (NE) Reassembly,0.4262,0.8777425373134329,0.3245201356111394
1198,R-HSA-5620912,1.42567452434108,Transcriptomics,Anchoring of the basal body to the plasma membrane,0.269,0.8777425373134329,0.32446469310648074
1199,R-HSA-168273,1.6640766506135805,Proteomics,Influenza Viral RNA Transcription and Replication,0.3744,0.8777425373134329,0.3239114252648662
1200,R-HSA-5638302,1.4251249486795756,Transcriptomics,Signaling by Overexpressed Wild-Type EGFR in Cancer,0.2211,0.8777425373134329,0.32303832534275234
1201,R-HSA-5638303,1.4251249486795756,Transcriptomics,Inhibition of Signaling by Overexpressed EGFR,0.2211,0.8777425373134329,0.32303832534275234
1202,R-HSA-212718,1.4251249486795756,Transcriptomics,EGFR interacts with phospholipase C-gamma,0.2211,0.8777425373134329,0.32303832534275234
1203,R-HSA-9708530,1.663186854302422,Proteomics,Regulation of BACH1 activity,0.5607,0.8777425373134329,0.32197016598259737
1204,R-HSA-9018677,1.4245422641493115,Transcriptomics,Biosynthesis of DHA-derived SPMs,0.2752,0.8777425373134329,0.3215260268757553
1205,R-HSA-5693606,1.6627413318546782,Proteomics,DNA Double Strand Break Response,0.5472,0.8777425373134329,0.3209981743297935
1206,R-HSA-442755,1.4240800378128742,Transcriptomics,Activation of NMDA receptors and postsynaptic events,0.3569,0.8777425373134329,0.3203263654059665
1207,R-HSA-73884,4.273717385080831,Metabolomics,Base Excision Repair,0.4154,0.8777425373134329,0.31997612196160957
1208,R-HSA-140342,1.4237544726409457,Transcriptomics,Apoptosis induced DNA fragmentation,0.3854,0.8777425373134329,0.3194813940967197
1209,R-HSA-5627123,1.661366015851967,Proteomics,RHO GTPases activate PAKs,0.4705,0.8777425373134329,0.317997661827286
1210,R-HSA-8878171,1.422709440736084,Transcriptomics,Transcriptional regulation by RUNX1,0.4818,0.8777425373134329,0.31676912001769303
1211,R-HSA-168249,1.660684090210778,Proteomics,Innate Immune System,0.5212,0.8777425373134329,0.31650991180610233
1212,R-HSA-8878159,1.6599780402730582,Proteomics,Transcriptional regulation by RUNX3,0.5418,0.8777425373134329,0.31496953006012784
1213,R-HSA-5358346,1.6598996318298458,Proteomics,Hedgehog ligand biogenesis,0.5821,0.8777425373134329,0.31479846718170784
1214,R-HSA-5696395,1.6597084335933925,Proteomics,Formation of Incision Complex in GG-NER,0.525,0.8777425373134329,0.31438133199400947
1215,R-HSA-5687128,1.659427242283872,Proteomics,MAPK6/MAPK4 signaling,0.4388,0.8777425373134329,0.31376785986240535
1216,R-HSA-2672351,1.6589149550552296,Proteomics,Stimuli-sensing channels,0.5371,0.8777425373134329,0.3126502081871638
1217,R-HSA-163560,4.257261340955647,Metabolomics,Triglyceride catabolism,0.3522,0.8777425373134329,0.3120260532610662
1218,R-HSA-8979227,4.257261340955647,Metabolomics,Triglyceride metabolism,0.3522,0.8777425373134329,0.3120260532610662
1219,R-HSA-9013407,1.658598126922548,Proteomics,RHOH GTPase cycle,0.5239,0.8777425373134329,0.31195898757213214
1220,R-HSA-9706574,1.420112292361152,Transcriptomics,RHOBTB GTPase Cycle,0.2106,0.8777425373134329,0.3100284854170226
1221,R-HSA-170670,1.4199113097215246,Transcriptomics,Adenylate cyclase inhibitory pathway,0.2068,0.8777425373134329,0.30950685540624506
1222,R-HSA-74182,1.4198465273055676,Transcriptomics,Ketone body metabolism,0.2779,0.8777425373134329,0.30933871923091927
1223,R-HSA-5673001,1.6573074517459625,Proteomics,RAF/MAP kinase cascade,0.4931,0.8777425373134329,0.3091431350724982
1224,R-HSA-8953854,1.6571663629462745,Proteomics,Metabolism of RNA,0.4917,0.8777425373134329,0.308835323117578
1225,R-HSA-5689880,1.6571478323420492,Proteomics,Ub-specific processing proteases,0.3858,0.8777425373134329,0.3087948950926387
1226,R-HSA-5625900,1.656728382710513,Proteomics,RHO GTPases activate CIT,0.4639,0.8777425373134329,0.3078797862295735
1227,R-HSA-8964038,1.4192406366232033,Transcriptomics,LDL clearance,0.678,0.8786055923473142,0.3077661915551082
1228,R-HSA-112315,1.4191078230236969,Transcriptomics,Transmission across Chemical Synapses,0.3869,0.8777425373134329,0.30742148735841546
1229,R-HSA-112043,1.4187764617770002,Transcriptomics,PLC beta mediated events,0.2393,0.8777425373134329,0.30656147292629315
1230,R-HSA-8856828,1.6553746091735797,Proteomics,Clathrin-mediated endocytosis,0.34,0.8777425373134329,0.30492627269877437
1231,R-HSA-9679506,1.6553607610758574,Proteomics,SARS-CoV Infections,0.5958,0.8777425373134329,0.3048960604491751
1232,R-HSA-166016,1.654834811176776,Proteomics,Toll Like Receptor 4 (TLR4) Cascade,0.5284,0.8777425373134329,0.3037486010690945
1233,R-HSA-5693565,1.6542639432688688,Proteomics,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,0.5534,0.8777425373134329,0.3025031445401373
1234,R-HSA-5368286,1.416905186755469,Transcriptomics,Mitochondrial translation initiation,0.1283,0.8777425373134329,0.30170476882757796
1235,R-HSA-5368287,1.416905186755469,Transcriptomics,Mitochondrial translation,0.1283,0.8777425373134329,0.30170476882757796
1236,R-HSA-5684996,1.6533924062000984,Proteomics,MAPK1/MAPK3 signaling,0.4954,0.8777425373134329,0.3006017212555328
1237,R-HSA-8852276,1.6532344154262943,Proteomics,The role of GTSE1 in G2/M progression after G2 checkpoint,0.4752,0.8777425373134329,0.3002570344409059
1238,R-HSA-2173791,1.652892209343979,Proteomics,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),0.5227,0.8777425373134329,0.2995104470192538
1239,R-HSA-2173788,1.6526207093568257,Proteomics,Downregulation of TGF-beta receptor signaling,0.4903,0.8777425373134329,0.2989181183440414
1240,R-HSA-9706377,1.65229308697724,Proteomics,FLT3 signaling by CBL mutants,0.5624,0.8777425373134329,0.29820334803372
1241,R-HSA-388396,1.6520373150804109,Proteomics,GPCR downstream signalling,0.5545,0.8777425373134329,0.297645333168254
1242,R-HSA-1059683,1.6519890550542298,Proteomics,Interleukin-6 signaling,0.4783,0.8777425373134329,0.29754004477515583
1243,R-HSA-6783310,1.6515144003325424,Proteomics,Fanconi Anemia Pathway,0.5427,0.8777425373134329,0.2965044955457499
1244,R-HSA-9014325,1.6515144003325424,Proteomics,"TICAM1,TRAF6-dependent induction of TAK1 complex",0.5427,0.8777425373134329,0.2965044955457499
1245,R-HSA-901032,1.6515144003325408,Proteomics,ER Quality Control Compartment (ERQC),0.5427,0.8777425373134329,0.29650449554574654
1246,R-HSA-3785653,1.6515144003325408,Proteomics,Myoclonic epilepsy of Lafora,0.5427,0.8777425373134329,0.29650449554574654
1247,R-HSA-3229121,1.6515144003325408,Proteomics,Glycogen storage diseases,0.5427,0.8777425373134329,0.29650449554574654
1248,R-HSA-174495,1.6515144003325408,Proteomics,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",0.5427,0.8777425373134329,0.29650449554574654
1249,R-HSA-9636383,1.6515144003325408,Proteomics,Prevention of phagosomal-lysosomal fusion,0.5427,0.8777425373134329,0.29650449554574654
1250,R-HSA-9645460,1.6515144003325408,Proteomics,Alpha-protein kinase 1 signaling pathway,0.5427,0.8777425373134329,0.29650449554574654
1251,R-HSA-5689877,1.6515144003325408,Proteomics,Josephin domain DUBs,0.5427,0.8777425373134329,0.29650449554574654
1252,R-HSA-5696394,1.6515144003325408,Proteomics,DNA Damage Recognition in GG-NER,0.5427,0.8777425373134329,0.29650449554574654
1253,R-HSA-937042,1.6515144003325408,Proteomics,IRAK2 mediated activation of TAK1 complex,0.5427,0.8777425373134329,0.29650449554574654
1254,R-HSA-9694493,1.6515144003325408,Proteomics,Maturation of protein E,0.5427,0.8777425373134329,0.29650449554574654
1255,R-HSA-9683683,1.6515144003325408,Proteomics,Maturation of protein E,0.5427,0.8777425373134329,0.29650449554574654
1256,R-HSA-174490,1.6515144003325408,Proteomics,Membrane binding and targetting of GAG proteins,0.5427,0.8777425373134329,0.29650449554574654
1257,R-HSA-5205685,1.6515144003325408,Proteomics,PINK1-PRKN Mediated Mitophagy,0.5427,0.8777425373134329,0.29650449554574654
1258,R-HSA-179409,1.6515144003325408,Proteomics,APC-Cdc20 mediated degradation of Nek2A,0.5427,0.8777425373134329,0.29650449554574654
1259,R-HSA-5675221,1.4146292557618732,Transcriptomics,Negative regulation of MAPK pathway,0.5552,0.8777425373134329,0.2957978212876357
1260,R-HSA-6804758,1.6509386498282508,Proteomics,Regulation of TP53 Activity through Acetylation,0.4883,0.8777425373134329,0.2952483867074565
1261,R-HSA-376172,1.650788862369226,Proteomics,DSCAM interactions,0.4326,0.8777425373134329,0.2949215969786692
1262,R-HSA-9694635,1.6496499123335702,Proteomics,Translation of Structural Proteins,0.5418,0.8777425373134329,0.2924367616281174
1263,R-HSA-9683701,1.6496499123335702,Proteomics,Translation of Structural Proteins,0.5418,0.8777425373134329,0.2924367616281174
1264,R-HSA-9772573,1.6496499123335702,Proteomics,Late SARS-CoV-2 Infection Events,0.5418,0.8777425373134329,0.2924367616281174
1265,R-HSA-8939242,1.4126476151172456,Transcriptomics,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,0.6107,0.8777425373134329,0.29065467443310883
1266,R-HSA-8939236,1.4125028419361791,Transcriptomics,RUNX1 regulates transcription of genes involved in differentiation of HSCs,0.4225,0.8777425373134329,0.29027893035819785
1267,R-HSA-2995410,1.4124086623104293,Transcriptomics,Nuclear Envelope (NE) Reassembly,0.3425,0.8777425373134329,0.2900344967131527
1268,R-HSA-982772,1.6485435081242734,Proteomics,Growth hormone receptor signaling,0.5576,0.8777425373134329,0.2900229311656802
1269,R-HSA-3134963,1.4118103593044313,Transcriptomics,DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,0.244,0.8777425373134329,0.2884816620800446
1270,R-HSA-210993,1.4116472920447034,Transcriptomics,Tie2 Signaling,0.1117,0.8777425373134329,0.2880584375836054
1271,R-HSA-73621,1.4113413153791685,Transcriptomics,Pyrimidine catabolism,0.3037,0.8777425373134329,0.2872643062514838
1272,R-HSA-5419276,1.411320530251822,Transcriptomics,Mitochondrial translation termination,0.1343,0.8777425373134329,0.2872103605663146
1273,R-HSA-5389840,1.411320530251822,Transcriptomics,Mitochondrial translation elongation,0.1343,0.8777425373134329,0.2872103605663146
1274,R-HSA-879518,1.4111220843147267,Transcriptomics,Transport of organic anions,0.3102,0.8777425373134329,0.2866953143090975
1275,R-HSA-2644602,1.6463554544878083,Proteomics,Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.507,0.8777425373134329,0.28524927748941376
1276,R-HSA-2644603,1.6463554544878083,Proteomics,Signaling by NOTCH1 in Cancer,0.507,0.8777425373134329,0.28524927748941376
1277,R-HSA-2644606,1.6463554544878083,Proteomics,Constitutive Signaling by NOTCH1 PEST Domain Mutants,0.507,0.8777425373134329,0.28524927748941376
1278,R-HSA-2894862,1.6463554544878083,Proteomics,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.507,0.8777425373134329,0.28524927748941376
1279,R-HSA-2894858,1.6463554544878083,Proteomics,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,0.507,0.8777425373134329,0.28524927748941376
1280,R-HSA-425397,1.4103935306526667,Transcriptomics,"Transport of vitamins, nucleosides, and related molecules",0.3128,0.8777425373134329,0.2848044273384771
1281,R-HSA-390466,1.6458107783167528,Proteomics,Chaperonin-mediated protein folding,0.5554,0.8777425373134329,0.28406096319811774
1282,R-HSA-391251,1.6458107783167528,Proteomics,Protein folding,0.5554,0.8777425373134329,0.28406096319811774
1283,R-HSA-202733,1.4099358125617643,Transcriptomics,Cell surface interactions at the vascular wall,0.2321,0.8777425373134329,0.2836164665616999
1284,R-HSA-2161522,1.4097527190221544,Transcriptomics,Abacavir ADME,0.3524,0.8777425373134329,0.2831412658915473
1285,R-HSA-167044,1.645007042482708,Proteomics,Signalling to RAS,0.4711,0.8777425373134329,0.2823074611563972
1286,R-HSA-72764,1.6447314077587891,Proteomics,Eukaryotic Translation Termination,0.3463,0.8777425373134329,0.28170611176933774
1287,R-HSA-170834,1.644375098295236,Proteomics,Signaling by TGF-beta Receptor Complex,0.4992,0.8777425373134329,0.28092875514871746
1288,R-HSA-2173789,1.6442055042230135,Proteomics,TGF-beta receptor signaling activates SMADs,0.4655,0.8777425373134329,0.280558753539595
1289,R-HSA-111453,1.643897017557308,Proteomics,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,0.54,0.8777425373134329,0.279885731415602
1290,R-HSA-392451,1.4081907625119998,Transcriptomics,G beta:gamma signalling through PI3Kgamma,0.4859,0.8777425373134329,0.2790873665461294
1291,R-HSA-9735804,4.184690691327768,Metabolomics,Diseases of nucleotide metabolism,0.4103,0.8777425373134329,0.2769664942445861
1292,R-HSA-162588,1.6423600051083225,Proteomics,Budding and maturation of HIV virion,0.5007,0.8777425373134329,0.2765324474716945
1293,R-HSA-74259,4.182636672750619,Metabolomics,Purine catabolism,0.4748,0.8777425373134329,0.27597417867492036
1294,R-HSA-2173795,1.6420139412527393,Proteomics,Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.5262,0.8777425373134329,0.27577744358655365
1295,R-HSA-8856688,1.6414673018518395,Proteomics,Golgi-to-ER retrograde transport,0.4279,0.8777425373134329,0.2745848461372915
1296,R-HSA-176408,1.6414347264869182,Proteomics,Regulation of APC/C activators between G1/S and early anaphase,0.5754,0.8777425373134329,0.27451377680520533
1297,R-HSA-391903,1.4062799934779753,Transcriptomics,Eicosanoid ligand-binding receptors,0.4514,0.8777425373134329,0.2741281597526507
1298,R-HSA-8941332,1.6409488186741699,Proteomics,RUNX2 regulates genes involved in cell migration,0.5154,0.8777425373134329,0.2734536768250238
1299,R-HSA-5668599,1.6409012184574119,Proteomics,RHO GTPases Activate NADPH Oxidases,0.614,0.8777425373134329,0.2733498279312257
1300,R-HSA-1234174,1.6406531383584835,Proteomics,Cellular response to hypoxia,0.566,0.8777425373134329,0.27280859418058906
1301,R-HSA-9013149,1.640396185825957,Proteomics,RAC1 GTPase cycle,0.5677,0.8777425373134329,0.27224800353460177
1302,R-HSA-512988,1.6402120375584404,Proteomics,"Interleukin-3, Interleukin-5 and GM-CSF signaling",0.5781,0.8777425373134329,0.2718462491902114
1303,R-HSA-9662001,1.405206781384228,Transcriptomics,Defective factor VIII causes hemophilia A,0.3125,0.8777425373134329,0.27134274685795595
1304,R-HSA-68867,1.6396295415402609,Proteomics,Assembly of the pre-replicative complex,0.5177,0.8777425373134329,0.27057542373499754
1305,R-HSA-69002,1.6396295415402609,Proteomics,DNA Replication Pre-Initiation,0.5177,0.8777425373134329,0.27057542373499754
1306,R-HSA-446219,1.4047310822462702,Transcriptomics,Synthesis of substrates in N-glycan biosythesis,0.41,0.8777425373134329,0.27010811810136404
1307,R-HSA-2514856,1.6393468332079495,Proteomics,The phototransduction cascade,0.5378,0.8777425373134329,0.26995864193067687
1308,R-HSA-2514859,1.6393468332079495,Proteomics,"Inactivation, recovery and regulation of the phototransduction cascade",0.5378,0.8777425373134329,0.26995864193067687
1309,R-HSA-199920,1.6392943360246632,Proteomics,CREB phosphorylation,0.5125,0.8777425373134329,0.2698441093763502
1310,R-HSA-6781827,1.403998943862023,Transcriptomics,Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.1876,0.8777425373134329,0.2682079273487028
1311,R-HSA-112316,1.403749868694743,Transcriptomics,Neuronal System,0.3814,0.8777425373134329,0.2675614780711254
1312,R-HSA-168898,1.6377759472899172,Proteomics,Toll-like Receptor Cascades,0.5336,0.8777425373134329,0.26653145659452354
1313,R-HSA-2219530,1.403253962989129,Transcriptomics,Constitutive Signaling by Aberrant PI3K in Cancer,0.1958,0.8777425373134329,0.2662744052222286
1314,R-HSA-1489509,1.6375502577801628,Proteomics,DAG and IP3 signaling,0.5778,0.8777425373134329,0.2660390721575159
1315,R-HSA-8854518,1.4031203015911995,Transcriptomics,AURKA Activation by TPX2,0.4374,0.8777425373134329,0.2659275006509097
1316,R-HSA-196791,1.6374705520994997,Proteomics,Vitamin D (calciferol) metabolism,0.4118,0.8777425373134329,0.2658651791097514
1317,R-HSA-5357801,1.6374663325031313,Proteomics,Programmed Cell Death,0.4591,0.8777425373134329,0.2658559732605984
1318,R-HSA-8849471,1.4027665245035417,Transcriptomics,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.1966,0.8777425373134329,0.26500930818219753
1319,R-HSA-5218920,1.6370068743498534,Proteomics,VEGFR2 mediated vascular permeability,0.5937,0.8777425373134329,0.26485357822515065
1320,R-HSA-5689880,1.4024850139306058,Transcriptomics,Ub-specific processing proteases,0.3545,0.8777425373134329,0.2642786761063786
1321,R-HSA-159236,1.4024737189399208,Transcriptomics,Transport of Mature mRNA derived from an Intron-Containing Transcript,0.3625,0.8777425373134329,0.2642493611062191
1322,R-HSA-9725371,1.4023086343658309,Transcriptomics,Nuclear events stimulated by ALK signaling in cancer,0.22,0.8777425373134329,0.26382090087541826
1323,R-HSA-69306,1.636513748745252,Proteomics,DNA Replication,0.5615,0.8777425373134329,0.263777731264164
1324,R-HSA-5358351,1.4020929937279916,Transcriptomics,Signaling by Hedgehog,0.0913,0.8777425373134329,0.26326122752030306
1325,R-HSA-372790,1.6359870935297112,Proteomics,Signaling by GPCR,0.5568,0.8777425373134329,0.26262873310255924
1326,R-HSA-71387,1.4015502687546209,Transcriptomics,Metabolism of carbohydrates,0.0733,0.8777425373134329,0.2618526400212364
1327,R-HSA-5619084,1.635534683373339,Proteomics,ABC transporter disorders,0.5979,0.8777425373134329,0.2616417146080607
1328,R-HSA-382556,1.635534683373339,Proteomics,ABC-family proteins mediated transport,0.5979,0.8777425373134329,0.2616417146080607
1329,R-HSA-975576,1.4012957042210452,Transcriptomics,N-glycan antennae elongation in the medial/trans-Golgi,0.2271,0.8777425373134329,0.2611919436514465
1330,R-HSA-422475,1.4010695041878867,Transcriptomics,Axon guidance,0.0605,0.8777425373134329,0.2606048644591685
1331,R-HSA-373752,1.634986625727217,Proteomics,Netrin-1 signaling,0.4544,0.8777425373134329,0.2604460229880676
1332,R-HSA-8964058,1.400772009057434,Transcriptomics,HDL remodeling,0.2947,0.8777425373134329,0.25983274608918416
1333,R-HSA-9619665,1.4003723443263736,Transcriptomics,EGR2 and SOX10-mediated initiation of Schwann cell myelination,0.5707,0.8777425373134329,0.25879545690661127
1334,R-HSA-176409,1.6333860782079805,Proteomics,APC/C:Cdc20 mediated degradation of mitotic proteins,0.5882,0.8777425373134329,0.25695412524757827
1335,R-HSA-8851708,1.63302198500276,Proteomics,Signaling by FGFR2 IIIa TM,0.2168,0.8777425373134329,0.256159786919377
1336,R-HSA-418597,1.3987223474297001,Transcriptomics,G alpha (z) signalling events,0.4656,0.8777425373134329,0.25451305768750365
1337,R-HSA-2187338,1.3987067190537228,Transcriptomics,Visual phototransduction,0.2239,0.8777425373134329,0.2544724958263169
1338,R-HSA-9705462,1.398520379667523,Transcriptomics,Inactivation of CSF3 (G-CSF) signaling,0.1687,0.8777425373134329,0.2539888708912883
1339,R-HSA-111996,1.6309128213671205,Proteomics,Ca-dependent events,0.609,0.8777425373134329,0.2515582467307259
1340,R-HSA-112040,1.6309128213671205,Proteomics,G-protein mediated events,0.609,0.8777425373134329,0.2515582467307259
1341,R-HSA-112043,1.6309128213671205,Proteomics,PLC beta mediated events,0.609,0.8777425373134329,0.2515582467307259
1342,R-HSA-2172127,1.6305817099022137,Proteomics,DAP12 interactions,0.5003,0.8777425373134329,0.2508358643195436
1343,R-HSA-196836,1.397002360267595,Transcriptomics,Vitamin C (ascorbate) metabolism,0.605,0.8777425373134329,0.250049005849149
1344,R-HSA-5637815,1.6300803262698367,Proteomics,Signaling by Ligand-Responsive EGFR Variants in Cancer,0.5326,0.8777425373134329,0.2497420009059468
1345,R-HSA-1236382,1.6300803262698367,Proteomics,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.5326,0.8777425373134329,0.2497420009059468
1346,R-HSA-1482798,1.39688340730748,Transcriptomics,Acyl chain remodeling of CL,0.4893,0.8777425373134329,0.24974027553302933
1347,R-HSA-397014,1.630061686477072,Proteomics,Muscle contraction,0.507,0.8777425373134329,0.24970133466551614
1348,R-HSA-8876493,1.6288799801329341,Proteomics,InlA-mediated entry of Listeria monocytogenes into host cells,0.4768,0.8777425373134329,0.2471232183250617
1349,R-HSA-8852135,1.6288544068243476,Proteomics,Protein ubiquitination,0.5905,0.8777425373134329,0.24706742530586237
1350,R-HSA-5693571,1.3958181422467926,Transcriptomics,Nonhomologous End-Joining (NHEJ),0.539,0.8777425373134329,0.24697548835480615
1351,R-HSA-1839130,1.6283482971357839,Proteomics,Signaling by activated point mutants of FGFR3,0.233,0.8777425373134329,0.2459632511050374
1352,R-HSA-2033514,1.6283482971357839,Proteomics,FGFR3 mutant receptor activation,0.233,0.8777425373134329,0.2459632511050374
1353,R-HSA-6811436,1.6268420834430741,Proteomics,COPI-independent Golgi-to-ER retrograde traffic,0.2156,0.8777425373134329,0.24267716048476234
1354,R-HSA-8868766,1.3940255166594206,Transcriptomics,rRNA processing in the mitochondrion,0.2517,0.8777425373134329,0.24232291086754482
1355,R-HSA-111997,1.6261915525753643,Proteomics,CaM pathway,0.5974,0.8777425373134329,0.2412579041116943
1356,R-HSA-111933,1.6261915525753643,Proteomics,Calmodulin induced events,0.5974,0.8777425373134329,0.2412579041116943
1357,R-HSA-5673000,1.6259208406615422,Proteomics,RAF activation,0.6102,0.8777425373134329,0.24066729476780557
1358,R-HSA-2660825,1.6253387506583898,Proteomics,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.2279,0.8777425373134329,0.23939735511131927
1359,R-HSA-2660826,1.6253387506583898,Proteomics,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,0.2279,0.8777425373134329,0.23939735511131927
1360,R-HSA-9679191,1.392548690503842,Transcriptomics,Potential therapeutics for SARS,0.284,0.8777425373134329,0.23848995870372058
1361,R-HSA-426496,1.3921315595354165,Transcriptomics,Post-transcriptional silencing by small RNAs,0.6383,0.8777425373134329,0.23740733767755223
1362,R-HSA-9768778,1.3921315595354165,Transcriptomics,Regulation of NPAS4 mRNA translation,0.6383,0.8777425373134329,0.23740733767755223
1363,R-HSA-8948700,1.3921315595354165,Transcriptomics,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.6383,0.8777425373134329,0.23740733767755223
1364,R-HSA-9768759,1.3921315595354165,Transcriptomics,Regulation of NPAS4 gene expression,0.6383,0.8777425373134329,0.23740733767755223
1365,R-HSA-8943723,1.3921315595354165,Transcriptomics,Regulation of PTEN mRNA translation,0.6383,0.8777425373134329,0.23740733767755223
1366,R-HSA-5687128,1.3919599448973554,Transcriptomics,MAPK6/MAPK4 signaling,0.1893,0.8777425373134329,0.23696192932951127
1367,R-HSA-3249367,1.6238195528412407,Proteomics,STAT6-mediated induction of chemokines,0.2045,0.8777425373134329,0.23608293716289727
1368,R-HSA-111458,1.6234124976526694,Proteomics,Formation of apoptosome,0.4579,0.8777425373134329,0.235194869126089
1369,R-HSA-9627069,1.6234124976526694,Proteomics,Regulation of the apoptosome activity,0.4579,0.8777425373134329,0.235194869126089
1370,R-HSA-264642,1.3912253909803085,Transcriptomics,Acetylcholine Neurotransmitter Release Cycle,0.5492,0.8777425373134329,0.235055469307013
1371,R-HSA-9675108,1.3911339608395183,Transcriptomics,Nervous system development,0.0654,0.8777425373134329,0.2348181716706889
1372,R-HSA-9037629,1.3910447307806888,Transcriptomics,Lewis blood group biosynthesis,0.3663,0.8777425373134329,0.2345865841234499
1373,R-HSA-2586552,1.3902017829307713,Transcriptomics,Signaling by Leptin,0.2884,0.8777425373134329,0.23239879866669372
1374,R-HSA-69481,1.6221288869659654,Proteomics,G2/M Checkpoints,0.532,0.8777425373134329,0.23239442914995628
1375,R-HSA-8854050,1.6219519623542178,Proteomics,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,0.5939,0.8777425373134329,0.23200843457961512
1376,R-HSA-180292,1.621897807950758,Proteomics,GAB1 signalosome,0.6142,0.8777425373134329,0.23189028648541232
1377,R-HSA-9674519,1.3898805364863225,Transcriptomics,Defective F8 sulfation at Y1699,0.3248,0.8777425373134329,0.23156503617561117
1378,R-HSA-9705671,1.3898684108424413,Transcriptomics,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.2348,0.8777425373134329,0.2315335652995188
1379,R-HSA-975144,1.6216479138962057,Proteomics,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,0.5751,0.8777425373134329,0.23134509524681085
1380,R-HSA-937039,1.6216479138962057,Proteomics,IRAK1 recruits IKK complex,0.5751,0.8777425373134329,0.23134509524681085
1381,R-HSA-975110,1.6216479138962057,Proteomics,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,0.5751,0.8777425373134329,0.23134509524681085
1382,R-HSA-597592,1.6213673930714516,Proteomics,Post-translational protein modification,0.4874,0.8777425373134329,0.2307330859047913
1383,R-HSA-69306,1.3894650565002615,Transcriptomics,DNA Replication,0.4289,0.8777425373134329,0.23048670010634376
1384,R-HSA-168256,1.6212207241555132,Proteomics,Immune System,0.5356,0.8777425373134329,0.2304130998687568
1385,R-HSA-70326,1.6196218324133276,Proteomics,Glucose metabolism,0.4729,0.8777425373134329,0.22692481451969784
1386,R-HSA-9705683,1.6190250612467725,Proteomics,SARS-CoV-2-host interactions,0.6082,0.8777425373134329,0.22562284512295222
1387,R-HSA-350054,1.6188767966479454,Proteomics,Notch-HLH transcription pathway,0.2157,0.8777425373134329,0.22529937780229065
1388,R-HSA-6790901,1.3865283846245156,Transcriptomics,rRNA modification in the nucleus and cytosol,0.1124,0.8777425373134329,0.22286486677270267
1389,R-HSA-201681,1.3864950628957178,Transcriptomics,TCF dependent signaling in response to WNT,0.5074,0.8777425373134329,0.22277838361284305
1390,R-HSA-9634635,1.6169304237025406,Proteomics,Estrogen-stimulated signaling through PRKCZ,0.5816,0.8777425373134329,0.22105299635561482
1391,R-HSA-1430728,1.6167205009210865,Proteomics,Metabolism,0.5186,0.8777425373134329,0.2205950100244209
1392,R-HSA-9657689,1.3851792652482373,Transcriptomics,Defective SERPING1 causes hereditary angioedema,0.3573,0.8777425373134329,0.2193633645728471
1393,R-HSA-9022692,1.615995185775036,Proteomics,Regulation of MECP2 expression and activity,0.5051,0.8777425373134329,0.2190125975754331
1394,R-HSA-399719,1.6159487182098504,Proteomics,Trafficking of AMPA receptors,0.5934,0.8777425373134329,0.21891121977569408
1395,R-HSA-399721,1.6159487182098504,Proteomics,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.5934,0.8777425373134329,0.21891121977569408
1396,R-HSA-76002,1.6157023119129603,Proteomics,"Platelet activation, signaling and aggregation",0.6504,0.8777425373134329,0.2183736377414141
1397,R-HSA-111447,1.615547654638083,Proteomics,Activation of BAD and translocation to mitochondria ,0.6265,0.8777425373134329,0.21803622358644278
1398,R-HSA-382556,4.061275311727367,Metabolomics,ABC-family proteins mediated transport,0.4526,0.8777425373134329,0.21734337102840132
1399,R-HSA-9026527,1.6151605832027591,Proteomics,Activated NTRK2 signals through PLCG1,0.2021,0.8777425373134329,0.2171917538945589
1400,R-HSA-3371497,1.6142370556003813,Proteomics,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,0.4225,0.8777425373134329,0.21517690340791973
1401,R-HSA-5668541,1.3835111258845985,Transcriptomics,TNFR2 non-canonical NF-kB pathway,0.0746,0.8777425373134329,0.21503387842495675
1402,R-HSA-113418,1.3834661624570443,Transcriptomics,Formation of the Early Elongation Complex,0.227,0.8777425373134329,0.2149171804193821
1403,R-HSA-167158,1.3834661624570443,Transcriptomics,Formation of the HIV-1 Early Elongation Complex,0.227,0.8777425373134329,0.2149171804193821
1404,R-HSA-193775,4.0550409657134034,Metabolomics,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,0.4652,0.8777425373134329,0.21433150020835923
1405,R-HSA-199991,4.0550409657134034,Metabolomics,Membrane Trafficking,0.4652,0.8777425373134329,0.21433150020835923
1406,R-HSA-4086398,1.6133181407952066,Proteomics,Ca2+ pathway,0.5559,0.8777425373134329,0.21317211661257202
1407,R-HSA-202430,1.381741197816977,Transcriptomics,Translocation of ZAP-70 to Immunological synapse,0.2847,0.8777425373134329,0.21044021004294927
1408,R-HSA-8963691,1.3813830400965859,Transcriptomics,Phenylalanine and tyrosine metabolism,0.2479,0.8777425373134329,0.20951064808727998
1409,R-HSA-422475,1.6111667494287452,Proteomics,Axon guidance,0.5434,0.8777425373134329,0.20847844862635748
1410,R-HSA-372790,4.040005082010596,Metabolomics,Signaling by GPCR,0.3208,0.8777425373134329,0.20706752427943234
1411,R-HSA-9013409,1.60968396635909,Proteomics,RHOJ GTPase cycle,0.2174,0.8777425373134329,0.2052434763507235
1412,R-HSA-1433557,1.609545550394025,Proteomics,Signaling by SCF-KIT,0.6342,0.8777425373134329,0.20494149569107475
1413,R-HSA-8935690,4.035466525391237,Metabolomics,Digestion,0.4058,0.8777425373134329,0.20487490516327453
1414,R-HSA-8963743,4.035466525391237,Metabolomics,Digestion and absorption,0.4058,0.8777425373134329,0.20487490516327453
1415,R-HSA-1630316,1.6094498779474196,Proteomics,Glycosaminoglycan metabolism,0.3436,0.8777425373134329,0.20473276811747038
1416,R-HSA-453274,1.3793936545666465,Transcriptomics,Mitotic G2-G2/M phases,0.1634,0.8777425373134329,0.20434740017021294
1417,R-HSA-9708296,1.379104584877003,Transcriptomics,"tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",0.3002,0.8777425373134329,0.20359714917538188
1418,R-HSA-9694516,1.6088913430367977,Proteomics,SARS-CoV-2 Infection,0.6263,0.8777425373134329,0.2035142183593755
1419,R-HSA-5689603,1.6088318585400718,Proteomics,UCH proteinases,0.5433,0.8777425373134329,0.20338444165658173
1420,R-HSA-418555,1.37857595255581,Transcriptomics,G alpha (s) signalling events,0.364,0.8777425373134329,0.20222513772248993
1421,R-HSA-442742,1.6082128736419716,Proteomics,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,0.5973,0.8777425373134329,0.20203400879464192
1422,R-HSA-2559580,1.6081491759333102,Proteomics,Oxidative Stress Induced Senescence,0.4598,0.8777425373134329,0.20189504017154516
1423,R-HSA-69002,1.3784247787816477,Transcriptomics,DNA Replication Pre-Initiation,0.419,0.8777425373134329,0.20183278155883477
1424,R-HSA-8937144,1.6079079447410003,Proteomics,Aryl hydrocarbon receptor signalling,0.3522,0.8777425373134329,0.20136874860866527
1425,R-HSA-451326,1.3773926686615547,Transcriptomics,Activation of kainate receptors upon glutamate binding,0.5442,0.8777425373134329,0.1991540446586441
1426,R-HSA-9674555,1.376208305994332,Transcriptomics,Signaling by CSF3 (G-CSF),0.1656,0.8777425373134329,0.19608015174922075
1427,R-HSA-6794362,1.3756772515802658,Transcriptomics,Protein-protein interactions at synapses,0.3357,0.8777425373134329,0.19470185400048817
1428,R-HSA-9707564,1.3748829855168283,Transcriptomics,Cytoprotection by HMOX1,0.149,0.8777425373134329,0.1926404171719185
1429,R-HSA-1482925,1.3748332052851808,Transcriptomics,Acyl chain remodelling of PG,0.5094,0.8777425373134329,0.1925112176409594
1430,R-HSA-68867,1.3741589162589805,Transcriptomics,Assembly of the pre-replicative complex,0.4165,0.8777425373134329,0.1907611690165802
1431,R-HSA-9709957,1.6027460711480948,Proteomics,Sensory Perception,0.3977,0.8777425373134329,0.19010714311484175
1432,R-HSA-176814,1.602601568867854,Proteomics,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.5855,0.8777425373134329,0.18979188400519117
1433,R-HSA-427601,1.3730715703508356,Transcriptomics,Multifunctional anion exchangers,0.3068,0.8777425373134329,0.1879390732433534
1434,R-HSA-549127,3.99967376404714,Metabolomics,Organic cation transport,0.4075,0.8777425373134329,0.18758308767037882
1435,R-HSA-5689896,1.601458084070872,Proteomics,Ovarian tumor domain proteases,0.6043,0.8777425373134329,0.1872971552134023
1436,R-HSA-427975,1.3724640144230977,Transcriptomics,Proton/oligopeptide cotransporters,0.3043,0.8777425373134329,0.18636222359245141
1437,R-HSA-432720,1.6009197439950709,Proteomics,Lysosome Vesicle Biogenesis,0.2404,0.8777425373134329,0.1861226643146866
1438,R-HSA-9752946,1.3722738092748188,Transcriptomics,Expression and translocation of olfactory receptors,0.579,0.8777425373134329,0.1858685654649106
1439,R-HSA-456926,1.3720658385199604,Transcriptomics,Thrombin signalling through proteinase activated receptors (PARs),0.5425,0.8777425373134329,0.18532879851141015
1440,R-HSA-8983432,1.3715434290822563,Transcriptomics,Interleukin-15 signaling,0.2403,0.8777425373134329,0.18397293792004246
1441,R-HSA-156580,1.371468561802322,Transcriptomics,Phase II - Conjugation of compounds,0.3008,0.8777425373134329,0.1837786275054142
1442,R-HSA-5654704,1.5996104322346165,Proteomics,SHC-mediated cascade:FGFR3,0.2429,0.8777425373134329,0.18326615257543638
1443,R-HSA-190239,1.5996104322346165,Proteomics,FGFR3 ligand binding and activation,0.2429,0.8777425373134329,0.18326615257543638
1444,R-HSA-190372,1.5996104322346165,Proteomics,FGFR3c ligand binding and activation,0.2429,0.8777425373134329,0.18326615257543638
1445,R-HSA-5685938,1.5995751686031328,Proteomics,HDR through Single Strand Annealing (SSA),0.2064,0.8777425373134329,0.18318921828037818
1446,R-HSA-8939902,1.599354830283035,Proteomics,Regulation of RUNX2 expression and activity,0.5883,0.8777425373134329,0.18270850847773523
1447,R-HSA-419037,1.371042248855551,Transcriptomics,NCAM1 interactions,0.4709,0.8777425373134329,0.18267217558782078
1448,R-HSA-5653656,1.5989597194738114,Proteomics,Vesicle-mediated transport,0.5969,0.8777425373134329,0.18184649936810962
1449,R-HSA-8951664,1.598685276876136,Proteomics,Neddylation,0.5761,0.8777425373134329,0.18124775083037528
1450,R-HSA-199992,1.5985218000118062,Proteomics,trans-Golgi Network Vesicle Budding,0.3011,0.8777425373134329,0.1808910950695719
1451,R-HSA-69236,1.5980373572585247,Proteomics,G1 Phase,0.5141,0.8777425373134329,0.1798341913942676
1452,R-HSA-69231,1.5980373572585242,Proteomics,Cyclin D associated events in G1,0.5141,0.8777425373134329,0.17983419139426662
1453,R-HSA-9619229,1.5975788018406576,Proteomics,Activation of RAC1 downstream of NMDARs,0.5342,0.8777425373134329,0.17883376584720032
1454,R-HSA-428930,1.3695467322346873,Transcriptomics,Thromboxane signalling through TP receptor,0.5735,0.8777425373134329,0.17879071422128065
1455,R-HSA-9725371,1.59741106476116,Proteomics,Nuclear events stimulated by ALK signaling in cancer,0.6072,0.8777425373134329,0.17846781561963462
1456,R-HSA-351143,1.3690381878983633,Transcriptomics,Agmatine biosynthesis,0.3642,0.8777425373134329,0.17747083909112374
1457,R-HSA-8963889,1.596712803111047,Proteomics,Assembly of active LPL and LIPC lipase complexes,0.3554,0.8777425373134329,0.1769444254990694
1458,R-HSA-8866652,1.596588227122508,Proteomics,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,0.6016,0.8777425373134329,0.17667263937109137
1459,R-HSA-418886,1.5962698202463002,Proteomics,Netrin mediated repulsion signals,0.5784,0.8777425373134329,0.1759779744278618
1460,R-HSA-180746,1.5962136630506953,Proteomics,Nuclear import of Rev protein,0.3144,0.8777425373134329,0.17585545686303614
1461,R-HSA-177243,1.5962136630506953,Proteomics,Interactions of Rev with host cellular proteins,0.3144,0.8777425373134329,0.17585545686303614
1462,R-HSA-179812,1.3682327373298915,Transcriptomics,GRB2 events in EGFR signaling,0.23,0.8777425373134329,0.17538037401666962
1463,R-HSA-8950505,1.595667992098715,Proteomics,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,0.5801,0.8777425373134329,0.1746649722686267
1464,R-HSA-9012852,1.5949540037505794,Proteomics,Signaling by NOTCH3,0.4672,0.8777425373134329,0.17310727137588497
1465,R-HSA-8851680,1.3672132599878404,Transcriptomics,Butyrophilin (BTN) family interactions,0.3761,0.8777425373134329,0.17273442420773394
1466,R-HSA-171007,1.5943102748197255,Proteomics,p38MAPK events,0.5172,0.8777425373134329,0.17170285471713526
1467,R-HSA-1483206,1.3666971879718475,Transcriptomics,Glycerophospholipid biosynthesis,0.3571,0.8777425373134329,0.17139501175020327
1468,R-HSA-8866376,1.3664838547179874,Transcriptomics,Reelin signalling pathway,0.3105,0.8777425373134329,0.17084132697565493
1469,R-HSA-4085377,1.5937479148890012,Proteomics,SUMOylation of SUMOylation proteins,0.5566,0.8777425373134329,0.1704759599527894
1470,R-HSA-8985947,1.5934897903166616,Proteomics,Interleukin-9 signaling,0.5805,0.8777425373134329,0.16991281227983085
1471,R-HSA-9635486,1.593464105908541,Proteomics,Infection with Mycobacterium tuberculosis,0.5616,0.8777425373134329,0.16985677687594308
1472,R-HSA-375165,1.5931605221668574,Proteomics,NCAM signaling for neurite out-growth,0.3756,0.8777425373134329,0.16919445140988007
1473,R-HSA-111885,1.5930376085935967,Proteomics,Opioid Signalling,0.6199,0.8777425373134329,0.1689262921558833
1474,R-HSA-917937,1.5924141659901982,Proteomics,Iron uptake and transport,0.6189,0.8777425373134329,0.16756613396503478
1475,R-HSA-196071,3.957252466179278,Metabolomics,Metabolism of steroid hormones,0.4953,0.8777425373134329,0.16708896223839914
1476,R-HSA-9664323,1.592159644807341,Proteomics,FCGR3A-mediated IL10 synthesis,0.4287,0.8777425373134329,0.16701084776912722
1477,R-HSA-9675108,1.5908678182852118,Proteomics,Nervous system development,0.5663,0.8777425373134329,0.16419248339099313
1478,R-HSA-9614399,1.5907292484055213,Proteomics,Regulation of localization of FOXO transcription factors,0.6097,0.8777425373134329,0.16389016693741976
1479,R-HSA-5689901,1.5904386817947072,Proteomics,Metalloprotease DUBs,0.596,0.8777425373134329,0.163256240809286
1480,R-HSA-8983711,1.3635140740238658,Transcriptomics,OAS antiviral response,0.228,0.8777425373134329,0.16313356306951213
1481,R-HSA-202427,1.3634132464068263,Transcriptomics,Phosphorylation of CD3 and TCR zeta chains,0.2957,0.8777425373134329,0.1628718752388591
1482,R-HSA-392518,1.363291134451337,Transcriptomics,Signal amplification,0.5609,0.8777425373134329,0.16255494607136475
1483,R-HSA-3000484,1.363208143455188,Transcriptomics,Scavenging by Class F Receptors,0.2122,0.8777425373134329,0.16233955137709702
1484,R-HSA-3304356,1.5896942713926576,Proteomics,SMAD2/3 Phosphorylation Motif Mutants in Cancer,0.5514,0.8777425373134329,0.16163216844050457
1485,R-HSA-3304351,1.5896942713926576,Proteomics,Signaling by TGF-beta Receptor Complex in Cancer,0.5514,0.8777425373134329,0.16163216844050457
1486,R-HSA-3304349,1.5896942713926576,Proteomics,Loss of Function of SMAD2/3 in Cancer,0.5514,0.8777425373134329,0.16163216844050457
1487,R-HSA-3656532,1.5896942713926558,Proteomics,TGFBR1 KD Mutants in Cancer,0.5514,0.8777425373134329,0.16163216844050068
1488,R-HSA-3656534,1.5896942713926558,Proteomics,Loss of Function of TGFBR1 in Cancer,0.5514,0.8777425373134329,0.16163216844050068
1489,R-HSA-2187338,3.945780061428781,Metabolomics,Visual phototransduction,0.3279,0.8777425373134329,0.16154653629246293
1490,R-HSA-975634,3.945780061428781,Metabolomics,Retinoid metabolism and transport,0.3279,0.8777425373134329,0.16154653629246293
1491,R-HSA-448706,1.589585431009658,Proteomics,Interleukin-1 processing,0.2723,0.8777425373134329,0.16139471251813886
1492,R-HSA-6807062,1.3627605530420668,Transcriptomics,Cholesterol biosynthesis via lathosterol,0.26,0.8777425373134329,0.16117787595849808
1493,R-HSA-6807047,1.3627605530420668,Transcriptomics,Cholesterol biosynthesis via desmosterol,0.26,0.8777425373134329,0.16117787595849808
1494,R-HSA-9609507,1.5888940397361637,Proteomics,Protein localization,0.5808,0.8777425373134329,0.15988631142620474
1495,R-HSA-418990,1.5884914320422379,Proteomics,Adherens junctions interactions,0.3506,0.8777425373134329,0.1590079464418311
1496,R-HSA-69275,1.361648173768324,Transcriptomics,G2/M Transition,0.1868,0.8777425373134329,0.15829080862956432
1497,R-HSA-168181,1.3613649684351679,Transcriptomics,Toll Like Receptor 7/8 (TLR7/8) Cascade,0.2767,0.8777425373134329,0.1575557779758705
1498,R-HSA-400253,1.5877068185467258,Proteomics,Circadian Clock,0.572,0.8777425373134329,0.15729616340558417
1499,R-HSA-5576892,1.3609250836660005,Transcriptomics,Phase 0 - rapid depolarisation,0.3461,0.8777425373134329,0.15641410177285617
1500,R-HSA-9664433,1.587152822034349,Proteomics,Leishmania parasite growth and survival,0.4115,0.8777425373134329,0.1560875150233539
1501,R-HSA-9662851,1.587152822034349,Proteomics,Anti-inflammatory response favouring Leishmania parasite infection,0.4115,0.8777425373134329,0.1560875150233539
1502,R-HSA-8868773,3.934444850922598,Metabolomics,rRNA processing in the nucleus and cytosol,0.4673,0.8777425373134329,0.1560703901680514
1503,R-HSA-72312,3.934444850922598,Metabolomics,rRNA processing,0.4673,0.8777425373134329,0.1560703901680514
1504,R-HSA-6790901,3.934444850922598,Metabolomics,rRNA modification in the nucleus and cytosol,0.4673,0.8777425373134329,0.1560703901680514
1505,R-HSA-6782861,3.934444850922598,Metabolomics,Synthesis of wybutosine at G37 of tRNA(Phe),0.4673,0.8777425373134329,0.1560703901680514
1506,R-HSA-5218859,1.5868682538171455,Proteomics,Regulated Necrosis,0.3213,0.8777425373134329,0.15546667552766566
1507,R-HSA-198693,1.5865859043371136,Proteomics,AKT phosphorylates targets in the nucleus,0.5346,0.8777425373134329,0.1548506766276004
1508,R-HSA-211163,1.5865859043371136,Proteomics,AKT-mediated inactivation of FOXO1A,0.5346,0.8777425373134329,0.1548506766276004
1509,R-HSA-9634638,1.586425892018471,Proteomics,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.5706,0.8777425373134329,0.15450157942979603
1510,R-HSA-388841,1.3600660163500806,Transcriptomics,Costimulation by the CD28 family,0.2029,0.8777425373134329,0.15418447988067369
1511,R-HSA-6798695,1.585954415409394,Proteomics,Neutrophil degranulation,0.5513,0.8777425373134329,0.15347296385534878
1512,R-HSA-3315487,1.5855554429083805,Proteomics,SMAD2/3 MH2 Domain Mutants in Cancer,0.4663,0.8777425373134329,0.1526025297332357
1513,R-HSA-3304347,1.5855554429083805,Proteomics,Loss of Function of SMAD4 in Cancer,0.4663,0.8777425373134329,0.1526025297332357
1514,R-HSA-3311021,1.5855554429083805,Proteomics,SMAD4 MH2 Domain Mutants in Cancer,0.4663,0.8777425373134329,0.1526025297332357
1515,R-HSA-380994,1.5855293905411076,Proteomics,ATF4 activates genes in response to endoplasmic reticulum  stress,0.2144,0.8777425373134329,0.1525456915567236
1516,R-HSA-381042,1.5855293905411076,Proteomics,PERK regulates gene expression,0.2144,0.8777425373134329,0.1525456915567236
1517,R-HSA-8963743,1.359067305575497,Transcriptomics,Digestion and absorption,0.3861,0.8777425373134329,0.15159242758662744
1518,R-HSA-1655829,3.924332107689163,Metabolomics,Regulation of cholesterol biosynthesis by SREBP (SREBF),0.5017,0.8777425373134329,0.15118482940720454
1519,R-HSA-1266738,3.924332107689163,Metabolomics,Developmental Biology,0.5017,0.8777425373134329,0.15118482940720454
1520,R-HSA-9707616,3.924332107689163,Metabolomics,Heme signaling,0.5017,0.8777425373134329,0.15118482940720454
1521,R-HSA-444257,1.5845997874728874,Proteomics,RSK activation,0.6276,0.8777425373134329,0.15051758628995918
1522,R-HSA-9634597,1.5842406704573508,Proteomics,GPER1 signaling,0.5457,0.8777425373134329,0.1497341044626144
1523,R-HSA-68884,1.3582073852612333,Transcriptomics,Mitotic Telophase/Cytokinesis,0.5219,0.8777425373134329,0.14936059182395317
1524,R-HSA-451927,1.358060154799021,Transcriptomics,Interleukin-2 family signaling,0.2176,0.8777425373134329,0.1489784701256166
1525,R-HSA-69620,1.3579522050961017,Transcriptomics,Cell Cycle Checkpoints,0.1905,0.8777425373134329,0.1486982976450402
1526,R-HSA-1474228,1.3572157153646787,Transcriptomics,Degradation of the extracellular matrix,0.3098,0.8777425373134329,0.1467868134131089
1527,R-HSA-69620,1.5826993931739692,Proteomics,Cell Cycle Checkpoints,0.4648,0.8777425373134329,0.14637151597422302
1528,R-HSA-1462054,1.3569273125439751,Transcriptomics,Alpha-defensins,0.3975,0.8777425373134329,0.14603829320882294
1529,R-HSA-9620244,1.3567618457494262,Transcriptomics,Long-term potentiation,0.1717,0.8777425373134329,0.1456088409636742
1530,R-HSA-6811434,1.581235685765944,Proteomics,COPI-dependent Golgi-to-ER retrograde traffic,0.5424,0.8777425373134329,0.14317816086955276
1531,R-HSA-6807070,1.5809918909259453,Proteomics,PTEN Regulation,0.4958,0.8777425373134329,0.14264627622339082
1532,R-HSA-416476,1.5809135259283988,Proteomics,G alpha (q) signalling events,0.6414,0.8777425373134329,0.14247530812992468
1533,R-HSA-8980692,1.5801279100937577,Proteomics,RHOA GTPase cycle,0.5002,0.8777425373134329,0.14076133830090976
1534,R-HSA-6782315,1.354761207859609,Transcriptomics,tRNA modification in the nucleus and cytosol,0.1968,0.8777425373134329,0.140416388690374
1535,R-HSA-5658442,1.5797120215655032,Proteomics,Regulation of RAS by GAPs,0.6254,0.8777425373134329,0.13985399865953477
1536,R-HSA-9613829,1.5786911602361524,Proteomics,Chaperone Mediated Autophagy,0.505,0.8777425373134329,0.13762679620133253
1537,R-HSA-6782135,1.5784863260694628,Proteomics,Dual incision in TC-NER,0.6087,0.8777425373134329,0.13717991164761453
1538,R-HSA-6782210,1.5784863260694628,Proteomics,Gap-filling DNA repair synthesis and ligation in TC-NER,0.6087,0.8777425373134329,0.13717991164761453
1539,R-HSA-6781827,1.5784863260694628,Proteomics,Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.6087,0.8777425373134329,0.13717991164761453
1540,R-HSA-2122948,1.5775586748549093,Proteomics,Activated NOTCH1 Transmits Signal to the Nucleus,0.5469,0.8777425373134329,0.13515606471952896
1541,R-HSA-936964,1.3526170703673834,Transcriptomics,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,0.5827,0.8777425373134329,0.13485149778610747
1542,R-HSA-163765,1.352462502922257,Transcriptomics,ChREBP activates metabolic gene expression,0.508,0.8777425373134329,0.13445033369443957
1543,R-HSA-110373,1.3522002828534496,Transcriptomics,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,0.2239,0.8777425373134329,0.13376976816115943
1544,R-HSA-937061,1.3518734252293498,Transcriptomics,TRIF(TICAM1)-mediated TLR4 signaling ,0.2809,0.8777425373134329,0.13292144242368303
1545,R-HSA-166166,1.3518734252293498,Transcriptomics,MyD88-independent TLR4 cascade ,0.2809,0.8777425373134329,0.13292144242368303
1546,R-HSA-180024,1.575515444211012,Proteomics,DARPP-32 events,0.2617,0.8777425373134329,0.13069836984763444
1547,R-HSA-9755779,1.5754241212868996,Proteomics,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,0.6434,0.8777425373134329,0.13049913158164714
1548,R-HSA-198745,1.5753657861780535,Proteomics,Signalling to STAT3,0.4809,0.8777425373134329,0.13037186248633895
1549,R-HSA-2871809,1.5749097115165536,Proteomics,FCERI mediated Ca+2 mobilization,0.6414,0.8777425373134329,0.12937684917942655
1550,R-HSA-9700206,1.574753716897389,Proteomics,Signaling by ALK in cancer,0.6475,0.8777425373134329,0.12903651735444652
1551,R-HSA-9725370,1.574753716897389,Proteomics,Signaling by ALK fusions and activated point mutants,0.6475,0.8777425373134329,0.12903651735444652
1552,R-HSA-5357786,1.3503309574297384,Transcriptomics,TNFR1-induced proapoptotic signaling,0.4543,0.8777425373134329,0.1289181240454049
1553,R-HSA-69202,1.5743501282288592,Proteomics,Cyclin E associated events during G1/S transition ,0.5406,0.8777425373134329,0.1281560121880652
1554,R-HSA-69656,1.5743501282288592,Proteomics,Cyclin A:Cdk2-associated events at S phase entry,0.5406,0.8777425373134329,0.1281560121880652
1555,R-HSA-5173105,1.5740278919592918,Proteomics,O-linked glycosylation,0.3052,0.8777425373134329,0.12745299269749552
1556,R-HSA-5693532,1.5730667255987552,Proteomics,DNA Double-Strand Break Repair,0.4696,0.8777425373134329,0.12535602612683502
1557,R-HSA-376176,1.5728367638358172,Proteomics,Signaling by ROBO receptors,0.5911,0.8777425373134329,0.12485432095985241
1558,R-HSA-2467813,1.3484711829820764,Transcriptomics,Separation of Sister Chromatids,0.1712,0.8777425373134329,0.12409126851710593
1559,R-HSA-72202,1.3484417523391505,Transcriptomics,Transport of Mature Transcript to Cytoplasm,0.4695,0.8777425373134329,0.1240148842750886
1560,R-HSA-174417,1.348403554491346,Transcriptomics,Telomere C-strand (Lagging Strand) Synthesis,0.2003,0.8777425373134329,0.12391574564401622
1561,R-HSA-9609736,1.5723466270111393,Proteomics,Assembly and cell surface presentation of NMDA receptors,0.512,0.8777425373134329,0.12378499458868666
1562,R-HSA-192105,3.864605851273327,Metabolomics,Synthesis of bile acids and bile salts,0.5202,0.8777425373134329,0.1223305167838266
1563,R-HSA-193368,3.864605851273327,Metabolomics,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,0.5202,0.8777425373134329,0.1223305167838266
1564,R-HSA-194068,3.864605851273327,Metabolomics,Bile acid and bile salt metabolism,0.5202,0.8777425373134329,0.1223305167838266
1565,R-HSA-71240,3.861452219425517,Metabolomics,Tryptophan catabolism,0.4214,0.8777425373134329,0.12080696776708932
1566,R-HSA-168256,3.8598641612746047,Metabolomics,Immune System,0.5327,0.8777425373134329,0.1200397620337934
1567,R-HSA-168249,3.8598641612746047,Metabolomics,Innate Immune System,0.5327,0.8777425373134329,0.1200397620337934
1568,R-HSA-3769402,1.5700403179847087,Proteomics,Deactivation of the beta-catenin transactivating complex,0.6049,0.8777425373134329,0.1187533443680764
1569,R-HSA-2029480,1.3463908226810322,Transcriptomics,Fcgamma receptor (FCGR) dependent phagocytosis,0.293,0.8777425373134329,0.11869190482944356
1570,R-HSA-71291,3.8558143194240286,Metabolomics,Metabolism of amino acids and derivatives,0.4783,0.8777425373134329,0.11808324558953191
1571,R-HSA-169893,1.569563731704752,Proteomics,Prolonged ERK activation events,0.5477,0.8777425373134329,0.11771358107824728
1572,R-HSA-69473,1.5692628491529095,Proteomics,G2/M DNA damage checkpoint,0.6023,0.8777425373134329,0.11705714876973787
1573,R-HSA-4551638,1.5691596436691189,Proteomics,SUMOylation of chromatin organization proteins,0.5891,0.8777425373134329,0.11683198644789286
1574,R-HSA-1660661,1.5688634468681624,Proteomics,Sphingolipid de novo biosynthesis,0.5907,0.8777425373134329,0.11618577699295984
1575,R-HSA-8956321,1.3453578571402582,Transcriptomics,Nucleotide salvage,0.3256,0.8777425373134329,0.11601094777183107
1576,R-HSA-9617324,1.5687473680270632,Proteomics,Negative regulation of NMDA receptor-mediated neuronal transmission,0.4715,0.8777425373134329,0.11593252900245574
1577,R-HSA-156842,1.5684685437467352,Proteomics,Eukaryotic Translation Elongation,0.5372,0.8777425373134329,0.11532422099362175
1578,R-HSA-9028731,1.5684194894845136,Proteomics,Activated NTRK2 signals through FRS2 and FRS3,0.2301,0.8777425373134329,0.11521719982408184
1579,R-HSA-9758274,1.3448688814732137,Transcriptomics,Regulation of NF-kappa B signaling,0.3703,0.8777425373134329,0.11474186113358596
1580,R-HSA-112382,1.3438136489787467,Transcriptomics,Formation of RNA Pol II elongation complex ,0.3025,0.8777425373134329,0.11200311246115315
1581,R-HSA-75955,1.3438136489787467,Transcriptomics,RNA Polymerase II Transcription Elongation,0.3025,0.8777425373134329,0.11200311246115315
1582,R-HSA-69601,1.5668349937101778,Proteomics,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,0.5998,0.8777425373134329,0.11176032200713466
1583,R-HSA-69613,1.5668349937101778,Proteomics,p53-Independent G1/S DNA damage checkpoint,0.5998,0.8777425373134329,0.11176032200713466
1584,R-HSA-69610,1.5668349937101778,Proteomics,p53-Independent DNA Damage Response,0.5998,0.8777425373134329,0.11176032200713466
1585,R-HSA-390471,1.3435441693143102,Transcriptomics,Association of TriC/CCT with target proteins during biosynthesis,0.2288,0.8777425373134329,0.11130370538537335
1586,R-HSA-1266738,1.343468894475884,Transcriptomics,Developmental Biology,0.1043,0.8777425373134329,0.11110833719410881
1587,R-HSA-3232118,1.56629766666903,Proteomics,SUMOylation of transcription factors,0.6107,0.8777425373134329,0.11058804123550052
1588,R-HSA-9758274,1.5662780985178253,Proteomics,Regulation of NF-kappa B signaling,0.6146,0.8777425373134329,0.11054534960519517
1589,R-HSA-211859,1.3429477322698131,Transcriptomics,Biological oxidations,0.2387,0.8777425373134329,0.10975571366566124
1590,R-HSA-1474290,1.5657390943101313,Proteomics,Collagen formation,0.2489,0.8777425373134329,0.10936940977689255
1591,R-HSA-9662851,1.34240146388202,Transcriptomics,Anti-inflammatory response favouring Leishmania parasite infection,0.3048,0.8777425373134329,0.10833792959465817
1592,R-HSA-9664433,1.34240146388202,Transcriptomics,Leishmania parasite growth and survival,0.3048,0.8777425373134329,0.10833792959465817
1593,R-HSA-8866654,1.3423345726998424,Transcriptomics,E3 ubiquitin ligases ubiquitinate target proteins,0.6353,0.8777425373134329,0.10816432033096766
1594,R-HSA-5652084,1.3422678136662443,Transcriptomics,Fructose metabolism,0.3163,0.8777425373134329,0.10799105404548237
1595,R-HSA-170968,1.5648249182569778,Proteomics,Frs2-mediated activation,0.6483,0.8777425373134329,0.10737496146714229
1596,R-HSA-8941326,1.564778946101693,Proteomics,RUNX2 regulates bone development,0.6143,0.8777425373134329,0.10727466449798952
1597,R-HSA-8940973,1.564778946101693,Proteomics,RUNX2 regulates osteoblast differentiation,0.6143,0.8777425373134329,0.10727466449798952
1598,R-HSA-195721,1.3419782692948476,Transcriptomics,Signaling by WNT,0.5112,0.8777425373134329,0.10723957106241391
1599,R-HSA-380284,1.3419500277864818,Transcriptomics,Loss of proteins required for interphase microtubule organization from the centrosome,0.4304,0.8777425373134329,0.10716627309826844
1600,R-HSA-380259,1.3419500277864818,Transcriptomics,Loss of Nlp from mitotic centrosomes,0.4304,0.8777425373134329,0.10716627309826844
1601,R-HSA-1280218,1.3419375848660287,Transcriptomics,Adaptive Immune System,0.2278,0.8777425373134329,0.10713397876308561
1602,R-HSA-9010553,1.564690964428751,Proteomics,Regulation of expression of SLITs and ROBOs,0.5583,0.8777425373134329,0.10708271580464664
1603,R-HSA-8856825,1.5646162509529462,Proteomics,Cargo recognition for clathrin-mediated endocytosis,0.4284,0.8777425373134329,0.10691971419787691
1604,R-HSA-1280215,1.5645555993804194,Proteomics,Cytokine Signaling in Immune system,0.5781,0.8777425373134329,0.10678739129804547
1605,R-HSA-181430,1.3417266957468712,Transcriptomics,Norepinephrine Neurotransmitter Release Cycle,0.5576,0.8777425373134329,0.10658663749170569
1606,R-HSA-6814122,1.3416380812443713,Transcriptomics,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,0.5433,0.8777425373134329,0.10635664755834758
1607,R-HSA-1227990,1.3413373041043346,Transcriptomics,Signaling by ERBB2 in Cancer,0.129,0.8777425373134329,0.105576011066112
1608,R-HSA-173107,1.341145947213495,Transcriptomics,Binding and entry of HIV virion,0.4392,0.8777425373134329,0.10507936370783241
1609,R-HSA-416482,1.3401838719446542,Transcriptomics,G alpha (12/13) signalling events,0.3247,0.8777425373134329,0.10258239514485322
1610,R-HSA-9034015,1.3401500537861466,Transcriptomics,Signaling by NTRK3 (TRKC),0.2016,0.8777425373134329,0.10249462355214513
1611,R-HSA-2691230,1.5623169503461853,Proteomics,Signaling by NOTCH1 HD Domain Mutants in Cancer,0.5887,0.8777425373134329,0.10190335417297465
1612,R-HSA-2691232,1.5623169503461853,Proteomics,Constitutive Signaling by NOTCH1 HD Domain Mutants,0.5887,0.8777425373134329,0.10190335417297465
1613,R-HSA-1300642,1.3398179920652777,Transcriptomics,Sperm Motility And Taxes,0.5727,0.8777425373134329,0.10163279111051371
1614,R-HSA-204005,1.5617903241849003,Proteomics,COPII-mediated vesicle transport,0.475,0.8777425373134329,0.10075441939873488
1615,R-HSA-163125,1.561564476581565,Proteomics,Post-translational modification: synthesis of GPI-anchored proteins,0.3592,0.8777425373134329,0.10026169005061943
1616,R-HSA-8939236,1.5609707573016605,Proteomics,RUNX1 regulates transcription of genes involved in differentiation of HSCs,0.5322,0.8777425373134329,0.09896637892297926
1617,R-HSA-5576892,1.5608958274648759,Proteomics,Phase 0 - rapid depolarisation,0.547,0.8777425373134329,0.09880290528372851
1618,R-HSA-73863,1.33846962792657,Transcriptomics,RNA Polymerase I Transcription Termination,0.194,0.8777425373134329,0.09813324905300058
1619,R-HSA-8878166,1.5603327129366655,Proteomics,Transcriptional regulation by RUNX2,0.5628,0.8777425373134329,0.09757436422195953
1620,R-HSA-9026519,1.337827314826281,Transcriptomics,Activated NTRK2 signals through RAS,0.1761,0.8777425373134329,0.09646619069389333
1621,R-HSA-5654719,1.337827314826281,Transcriptomics,SHC-mediated cascade:FGFR4,0.1761,0.8777425373134329,0.09646619069389333
1622,R-HSA-5654699,1.337827314826281,Transcriptomics,SHC-mediated cascade:FGFR2,0.1761,0.8777425373134329,0.09646619069389333
1623,R-HSA-9034864,1.337827314826281,Transcriptomics,Activated NTRK3 signals through RAS,0.1761,0.8777425373134329,0.09646619069389333
1624,R-HSA-5654704,1.337827314826281,Transcriptomics,SHC-mediated cascade:FGFR3,0.1761,0.8777425373134329,0.09646619069389333
1625,R-HSA-5654688,1.337827314826281,Transcriptomics,SHC-mediated cascade:FGFR1,0.1761,0.8777425373134329,0.09646619069389333
1626,R-HSA-3371571,1.3377798632236193,Transcriptomics,HSF1-dependent transactivation,0.3208,0.8777425373134329,0.09634303488275622
1627,R-HSA-422085,3.8105794981262817,Metabolomics,"Synthesis, secretion, and deacylation of Ghrelin",0.3986,0.8777425373134329,0.0962298806958676
1628,R-HSA-68877,1.559463007368737,Proteomics,Mitotic Prometaphase,0.4507,0.8777425373134329,0.0956769367035379
1629,R-HSA-432142,1.5594404077901813,Proteomics,Platelet sensitization by LDL,0.5172,0.8777425373134329,0.09562763143996648
1630,R-HSA-9031525,1.3372096256404875,Transcriptomics,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,0.4096,0.8777425373134329,0.09486304120177858
1631,R-HSA-1369062,1.337096219690514,Transcriptomics,ABC transporters in lipid homeostasis,0.3139,0.8777425373134329,0.09456870758661387
1632,R-HSA-6794361,1.3369833797311732,Transcriptomics,Neurexins and neuroligins,0.6513,0.8777425373134329,0.0942758429426017
1633,R-HSA-5218921,1.5582347404996528,Proteomics,VEGFR2 mediated cell proliferation,0.6255,0.8777425373134329,0.09299723975400959
1634,R-HSA-1236974,1.5575639460176463,Proteomics,ER-Phagosome pathway,0.5718,0.8777425373134329,0.09153377446610052
1635,R-HSA-162909,1.335890683535836,Transcriptomics,Host Interactions of HIV factors,0.2259,0.8777425373134329,0.0914398610428368
1636,R-HSA-162594,1.5573071113899344,Proteomics,Early Phase of HIV Life Cycle,0.5521,0.8777425373134329,0.09097344105181092
1637,R-HSA-983695,1.3351520792463152,Transcriptomics,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,0.2989,0.8777425373134329,0.08952288869031284
1638,R-HSA-2161541,1.3348393224425767,Transcriptomics,Abacavir metabolism,0.3611,0.8777425373134329,0.08871116019870154
1639,R-HSA-5654708,1.5560299323138151,Proteomics,Downstream signaling of activated FGFR3,0.2721,0.8777425373134329,0.08818703285305361
1640,R-HSA-3928662,1.5556997632058744,Proteomics,EPHB-mediated forward signaling,0.5837,0.8777425373134329,0.08746670637218315
1641,R-HSA-68875,1.3342085253482934,Transcriptomics,Mitotic Prophase,0.5944,0.8777425373134329,0.08707399046255195
1642,R-HSA-5619084,3.7908574681143663,Metabolomics,ABC transporter disorders,0.5222,0.8777425373134329,0.08670198369242232
1643,R-HSA-5696398,1.3339197116707315,Transcriptomics,Nucleotide Excision Repair,0.1881,0.8777425373134329,0.08632440392105482
1644,R-HSA-5619115,1.3337834049055368,Transcriptomics,Disorders of transmembrane transporters,0.2595,0.8777425373134329,0.08597063356790703
1645,R-HSA-450513,1.3337709171499832,Transcriptomics,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.4089,0.8777425373134329,0.0859382228677784
1646,R-HSA-2024096,1.5542474595236013,Proteomics,HS-GAG degradation,0.4238,0.8777425373134329,0.08429823065641481
1647,R-HSA-5653656,3.783601310723916,Metabolomics,Vesicle-mediated transport,0.5266,0.8777425373134329,0.0831964662474519
1648,R-HSA-5576891,1.553626267733156,Proteomics,Cardiac conduction,0.5517,0.8777425373134329,0.08294298304058566
1649,R-HSA-140875,1.5535324909139079,Proteomics,Common Pathway of Fibrin Clot Formation,0.2488,0.8777425373134329,0.08273839113731049
1650,R-HSA-5205647,1.5529371269066663,Proteomics,Mitophagy,0.6177,0.8777425373134329,0.08143949172528468
1651,R-HSA-4411364,1.3318600940176322,Transcriptomics,Binding of TCF/LEF:CTNNB1 to target gene promoters,0.3421,0.8777425373134329,0.0809788756675925
1652,R-HSA-8951430,1.3318600940176322,Transcriptomics,RUNX3 regulates WNT signaling,0.3421,0.8777425373134329,0.0809788756675925
1653,R-HSA-5663213,1.3312062492456733,Transcriptomics,RHO GTPases Activate WASPs and WAVEs,0.1599,0.8777425373134329,0.07928188802688887
1654,R-HSA-9665247,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to osimertinib,0.488,0.8777425373134329,0.0781965310740518
1655,R-HSA-9665249,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to afatinib,0.488,0.8777425373134329,0.0781965310740518
1656,R-HSA-9665246,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to neratinib,0.488,0.8777425373134329,0.0781965310740518
1657,R-HSA-9665251,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to lapatinib,0.488,0.8777425373134329,0.0781965310740518
1658,R-HSA-9665737,1.5514506822822642,Proteomics,Drug resistance in ERBB2 TMD/JMD mutants,0.488,0.8777425373134329,0.0781965310740518
1659,R-HSA-9665233,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to trastuzumab,0.488,0.8777425373134329,0.0781965310740518
1660,R-HSA-9665245,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to tesevatinib,0.488,0.8777425373134329,0.0781965310740518
1661,R-HSA-9665244,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to sapitinib,0.488,0.8777425373134329,0.0781965310740518
1662,R-HSA-9652282,1.5514506822822642,Proteomics,Drug-mediated inhibition of ERBB2 signaling,0.488,0.8777425373134329,0.0781965310740518
1663,R-HSA-9665230,1.5514506822822642,Proteomics,Drug resistance in ERBB2 KD mutants,0.488,0.8777425373134329,0.0781965310740518
1664,R-HSA-9665250,1.5514506822822642,Proteomics,Resistance of ERBB2 KD mutants to AEE788,0.488,0.8777425373134329,0.0781965310740518
1665,R-HSA-109582,1.5506609814897712,Proteomics,Hemostasis,0.6733,0.8786055923473142,0.07647364913532326
1666,R-HSA-75892,1.550511626386309,Proteomics,Platelet Adhesion to exposed collagen,0.5656,0.8777425373134329,0.0761478026721337
1667,R-HSA-3299685,1.5502608681900893,Proteomics,Detoxification of Reactive Oxygen Species,0.6109,0.8777425373134329,0.0756007261447174
1668,R-HSA-3899300,1.329700904082206,Transcriptomics,SUMOylation of transcription cofactors,0.6645,0.8777425373134329,0.07537491767711652
1669,R-HSA-5621481,1.5501328974421948,Proteomics,C-type lectin receptors (CLRs),0.6191,0.8777425373134329,0.07532153370584826
1670,R-HSA-5654743,1.3295575447759553,Transcriptomics,Signaling by FGFR4,0.1308,0.8777425373134329,0.07500284317056576
1671,R-HSA-174411,1.3294848881397163,Transcriptomics,Polymerase switching on the C-strand of the telomere,0.2953,0.8777425373134329,0.07481427025693166
1672,R-HSA-2408557,1.5497310927064951,Proteomics,Selenocysteine synthesis,0.5144,0.8777425373134329,0.07444492052701733
1673,R-HSA-156902,1.5497310927064951,Proteomics,Peptide chain elongation,0.5144,0.8777425373134329,0.07444492052701733
1674,R-HSA-192823,1.5497310927064951,Proteomics,Viral mRNA Translation,0.5144,0.8777425373134329,0.07444492052701733
1675,R-HSA-72695,1.5497310927064951,Proteomics,"Formation of the ternary complex, and subsequently, the 43S complex",0.5144,0.8777425373134329,0.07444492052701733
1676,R-HSA-1799339,1.5497310927064951,Proteomics,SRP-dependent cotranslational protein targeting to membrane,0.5144,0.8777425373134329,0.07444492052701733
1677,R-HSA-975956,1.5497310927064951,Proteomics,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.5144,0.8777425373134329,0.07444492052701733
1678,R-HSA-72689,1.5497310927064951,Proteomics,Formation of a pool of free 40S subunits,0.5144,0.8777425373134329,0.07444492052701733
1679,R-HSA-373760,1.5494357919619184,Proteomics,L1CAM interactions,0.4271,0.8777425373134329,0.07380066598889262
1680,R-HSA-8866427,1.54921324298862,Proteomics,VLDLR internalisation and degradation,0.6326,0.8777425373134329,0.07331513322734153
1681,R-HSA-5578775,1.549165739151099,Proteomics,Ion homeostasis,0.5549,0.8777425373134329,0.07321149460311381
1682,R-HSA-500753,1.328732030337009,Transcriptomics,Pyrimidine biosynthesis,0.3377,0.8777425373134329,0.07286030435983619
1683,R-HSA-1445148,1.3277829237884724,Transcriptomics,Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.5156,0.8777425373134329,0.0703969947921048
1684,R-HSA-5688426,1.5477112617136937,Proteomics,Deubiquitination,0.5319,0.8777425373134329,0.07003827642856622
1685,R-HSA-4615885,1.5471099490145062,Proteomics,SUMOylation of DNA replication proteins,0.4771,0.8777425373134329,0.06872639881769584
1686,R-HSA-5625740,1.5470707362735234,Proteomics,RHO GTPases activate PKNs,0.674,0.8786055923473142,0.06864084879185135
1687,R-HSA-191859,1.3270672145108986,Transcriptomics,snRNP Assembly,0.2784,0.8777425373134329,0.06853944411575541
1688,R-HSA-194441,1.3270672145108986,Transcriptomics,Metabolism of non-coding RNA,0.2784,0.8777425373134329,0.06853944411575541
1689,R-HSA-2022928,1.3269630890052033,Transcriptomics,HS-GAG biosynthesis,0.2508,0.8777425373134329,0.0682691969503349
1690,R-HSA-1433559,1.5467820682512836,Proteomics,Regulation of KIT signaling,0.5996,0.8777425373134329,0.06801106479450299
1691,R-HSA-202403,1.326429452663984,Transcriptomics,TCR signaling,0.1341,0.8777425373134329,0.0668841980721354
1692,R-HSA-114604,1.5460589854825886,Proteomics,GPVI-mediated activation cascade,0.6749,0.8786055923473142,0.06643352269978432
1693,R-HSA-5655332,1.5455170646051053,Proteomics,Signaling by FGFR3 in disease,0.2723,0.8777425373134329,0.06525121960358468
1694,R-HSA-9006925,3.7449072308738494,Metabolomics,Intracellular signaling by second messengers,0.8141,0.9044257614213198,0.06450299467115973
1695,R-HSA-168276,1.3245810032312375,Transcriptomics,NS1 Mediated Effects on Host Pathways,0.2675,0.8777425373134329,0.062086735468834565
1696,R-HSA-6804759,1.3243827707293383,Transcriptomics,Regulation of TP53 Activity through Association with Co-factors,0.5492,0.8777425373134329,0.0615722431609724
1697,R-HSA-5666185,1.3242966828272356,Transcriptomics,RHO GTPases Activate Rhotekin and Rhophilins,0.5122,0.8777425373134329,0.06134881076210993
1698,R-HSA-918233,1.5434720864391867,Proteomics,TRAF3-dependent IRF activation pathway,0.2286,0.8777425373134329,0.06078971218121958
1699,R-HSA-8949215,1.323584664473492,Transcriptomics,Mitochondrial calcium ion transport,0.356,0.8777425373134329,0.05950083950337078
1700,R-HSA-111932,1.5427101333395485,Proteomics,CaMK IV-mediated phosphorylation of CREB,0.5921,0.8777425373134329,0.05912736709304968
1701,R-HSA-1445148,1.5421247629558092,Proteomics,Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.6875,0.8802487198244331,0.05785027066463262
1702,R-HSA-8953897,1.3226893255052132,Transcriptomics,Cellular responses to stimuli,0.1599,0.8777425373134329,0.0571770782245925
1703,R-HSA-2187335,3.7291660518930216,Metabolomics,The retinoid cycle in cones (daylight vision),0.3035,0.8777425373134329,0.056898284002353784
1704,R-HSA-2453864,3.7291660518930216,Metabolomics,Retinoid cycle disease events,0.3035,0.8777425373134329,0.056898284002353784
1705,R-HSA-5365859,3.7291660518930216,Metabolomics,RA biosynthesis pathway,0.3035,0.8777425373134329,0.056898284002353784
1706,R-HSA-2474795,3.7291660518930216,Metabolomics,Diseases associated with visual transduction,0.3035,0.8777425373134329,0.056898284002353784
1707,R-HSA-2453902,3.7291660518930216,Metabolomics,The canonical retinoid cycle in rods (twilight vision),0.3035,0.8777425373134329,0.056898284002353784
1708,R-HSA-9675143,3.7291660518930216,Metabolomics,Diseases of the neuronal system,0.3035,0.8777425373134329,0.056898284002353784
1709,R-HSA-9652169,1.5415163487408483,Proteomics,Signaling by MAP2K mutants,0.4824,0.8777425373134329,0.05652289975126089
1710,R-HSA-5674499,1.5415163487408483,Proteomics,Negative feedback regulation of MAPK pathway,0.4824,0.8777425373134329,0.05652289975126089
1711,R-HSA-173107,1.540725992106907,Proteomics,Binding and entry of HIV virion,0.5343,0.8777425373134329,0.05479858697012137
1712,R-HSA-1839117,1.5404979103214107,Proteomics,Signaling by cytosolic FGFR1 fusion mutants,0.5605,0.8777425373134329,0.054300983330211224
1713,R-HSA-1638091,1.3211671709335666,Transcriptomics,Heparan sulfate/heparin (HS-GAG) metabolism,0.4495,0.8777425373134329,0.05322648076460788
1714,R-HSA-162906,1.3211346144278713,Transcriptomics,HIV Infection,0.1801,0.8777425373134329,0.05314198366352383
1715,R-HSA-418346,1.5394226312253783,Proteomics,Platelet homeostasis,0.5804,0.8777425373134329,0.051955058201026416
1716,R-HSA-9027277,1.3204969858802065,Transcriptomics,Erythropoietin activates Phospholipase C gamma (PLCG),0.3787,0.8777425373134329,0.05148708358455664
1717,R-HSA-9754678,1.538862377365885,Proteomics,SARS-CoV-2 modulates host translation machinery,0.4754,0.8777425373134329,0.05073275823020238
1718,R-HSA-9702518,1.5385385297798477,Proteomics,STAT5 activation downstream of FLT3 ITD mutants,0.5649,0.8777425373134329,0.05002622334738569
1719,R-HSA-9703648,1.5385385297798477,Proteomics,Signaling by FLT3 ITD and TKD mutants,0.5649,0.8777425373134329,0.05002622334738569
1720,R-HSA-5218859,1.319856441354545,Transcriptomics,Regulated Necrosis,0.3136,0.8777425373134329,0.049824615381115496
1721,R-HSA-9679191,1.5383188037198472,Proteomics,Potential therapeutics for SARS,0.6635,0.8777425373134329,0.049546849306177254
1722,R-HSA-2465910,1.5375670599298423,Proteomics,MASTL Facilitates Mitotic Progression,0.5723,0.8777425373134329,0.047906777761786486
1723,R-HSA-68875,1.5370213642975168,Proteomics,Mitotic Prophase,0.6123,0.8777425373134329,0.04671623932252695
1724,R-HSA-382551,1.5362776088179784,Proteomics,Transport of small molecules,0.6271,0.8777425373134329,0.04509359579132095
1725,R-HSA-71387,1.5362221801488167,Proteomics,Metabolism of carbohydrates,0.6186,0.8777425373134329,0.0449726676449975
1726,R-HSA-3214858,1.3179441463281467,Transcriptomics,RMTs methylate histone arginines,0.5961,0.8777425373134329,0.044861448029551415
1727,R-HSA-202403,1.5359053890525405,Proteomics,TCR signaling,0.5702,0.8777425373134329,0.04428152783190285
1728,R-HSA-3065678,1.5358197398782516,Proteomics,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",0.5931,0.8777425373134329,0.044094667926414505
1729,R-HSA-3215018,1.5358197398782516,Proteomics,Processing and activation of SUMO,0.5931,0.8777425373134329,0.044094667926414505
1730,R-HSA-111464,1.5355003852316542,Proteomics,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,0.3673,0.8777425373134329,0.04339793524246384
1731,R-HSA-111469,1.5355003852316542,Proteomics,"SMAC, XIAP-regulated apoptotic response",0.3673,0.8777425373134329,0.04339793524246384
1732,R-HSA-111463,1.5355003852316542,Proteomics,SMAC (DIABLO) binds to IAPs ,0.3673,0.8777425373134329,0.04339793524246384
1733,R-HSA-400451,1.3173770536151455,Transcriptomics,Free fatty acids regulate insulin secretion,0.417,0.8777425373134329,0.04338961653931385
1734,R-HSA-73929,3.7011459318615243,Metabolomics,"Base-Excision Repair, AP Site Formation",0.5371,0.8777425373134329,0.04336150216382172
1735,R-HSA-199418,1.3167083874651109,Transcriptomics,Negative regulation of the PI3K/AKT network,0.3334,0.8777425373134329,0.04165416151844387
1736,R-HSA-379724,1.534425253191611,Proteomics,tRNA Aminoacylation,0.2566,0.8777425373134329,0.04105233094378867
1737,R-HSA-379716,1.534425253191611,Proteomics,Cytosolic tRNA aminoacylation,0.2566,0.8777425373134329,0.04105233094378867
1738,R-HSA-9615710,1.5339584089107512,Proteomics,Late endosomal microautophagy,0.6207,0.8777425373134329,0.04003382167124159
1739,R-HSA-2262752,1.3159738744804899,Transcriptomics,Cellular responses to stress,0.1703,0.8777425373134329,0.039747807731896116
1740,R-HSA-3108232,1.315950993826222,Transcriptomics,SUMO E3 ligases SUMOylate target proteins,0.6119,0.8777425373134329,0.03968842331961803
1741,R-HSA-1268020,1.5332461024815267,Proteomics,Mitochondrial protein import,0.3174,0.8777425373134329,0.038479790203352626
1742,R-HSA-5358493,1.3153838530192525,Transcriptomics,Synthesis of diphthamide-EEF2,0.3553,0.8777425373134329,0.03821646700637502
1743,R-HSA-888590,1.5328087060231907,Proteomics,"GABA synthesis, release, reuptake and degradation",0.2967,0.8777425373134329,0.03752552693643629
1744,R-HSA-982772,1.3149704633223283,Transcriptomics,Growth hormone receptor signaling,0.295,0.8777425373134329,0.03714355607007884
1745,R-HSA-2892247,1.314904055209087,Transcriptomics,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",0.3616,0.8777425373134329,0.03697120056270764
1746,R-HSA-9748784,3.683235976763758,Metabolomics,Drug ADME,0.4311,0.8777425373134329,0.034709035485455036
1747,R-HSA-8876384,1.5314701534807074,Proteomics,Listeria monocytogenes entry into host cells,0.5689,0.8777425373134329,0.03460522088963183
1748,R-HSA-8953854,3.679159039744533,Metabolomics,Metabolism of RNA,0.5355,0.8777425373134329,0.032739429112011574
1749,R-HSA-6782315,3.679159039744533,Metabolomics,tRNA modification in the nucleus and cytosol,0.5355,0.8777425373134329,0.032739429112011574
1750,R-HSA-72306,3.679159039744533,Metabolomics,tRNA processing,0.5355,0.8777425373134329,0.032739429112011574
1751,R-HSA-69200,1.3131874111734296,Transcriptomics,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,0.3417,0.8777425373134329,0.03251582546921159
1752,R-HSA-181429,1.313000389168429,Transcriptomics,Serotonin Neurotransmitter Release Cycle,0.6019,0.8777425373134329,0.0320304288664753
1753,R-HSA-449147,1.5301626730981763,Proteomics,Signaling by Interleukins,0.629,0.8777425373134329,0.031752704648394345
1754,R-HSA-499943,1.3124496442892855,Transcriptomics,Interconversion of nucleotide di- and triphosphates,0.2739,0.8777425373134329,0.030601026517218296
1755,R-HSA-202670,1.529632518206305,Proteomics,ERKs are inactivated,0.6452,0.8777425373134329,0.03059607127963453
1756,R-HSA-425393,1.31207282377389,Transcriptomics,Transport of inorganic cations/anions and amino acids/oligopeptides,0.2569,0.8777425373134329,0.029623027174233436
1757,R-HSA-75944,1.3118165048053414,Transcriptomics,Transcription from mitochondrial promoters,0.2542,0.8777425373134329,0.028957777346814033
1758,R-HSA-9706574,1.5288800707838228,Proteomics,RHOBTB GTPase Cycle,0.5644,0.8777425373134329,0.028954464627645633
1759,R-HSA-1980143,1.528857371605285,Proteomics,Signaling by NOTCH1,0.571,0.8777425373134329,0.028904942067837256
1760,R-HSA-9657689,1.528405262784399,Proteomics,Defective SERPING1 causes hereditary angioedema,0.2889,0.8777425373134329,0.02791858099380916
1761,R-HSA-6781823,1.5277752990626328,Proteomics,Formation of TC-NER Pre-Incision Complex,0.6312,0.8777425373134329,0.026544195747393633
1762,R-HSA-73894,1.5276095315398313,Proteomics,DNA Repair,0.5373,0.8777425373134329,0.026182542481020605
1763,R-HSA-452723,1.3105102278031153,Transcriptomics,Transcriptional regulation of pluripotent stem cells,0.2459,0.8777425373134329,0.02556746817377905
1764,R-HSA-2173782,3.6625973847020186,Metabolomics,Binding and Uptake of Ligands by Scavenger Receptors,0.5484,0.8777425373134329,0.024738338790359592
1765,R-HSA-3000480,3.6625973847020186,Metabolomics,Scavenging by Class A Receptors,0.5484,0.8777425373134329,0.024738338790359592
1766,R-HSA-442982,1.5261493073527157,Proteomics,Ras activation upon Ca2+ influx through NMDA receptor,0.5434,0.8777425373134329,0.02299678668288643
1767,R-HSA-438066,1.5261493073527157,Proteomics,"Unblocking of NMDA receptors, glutamate binding and activation",0.5434,0.8777425373134329,0.02299678668288643
1768,R-HSA-936837,1.5261493073527157,Proteomics,Ion transport by P-type ATPases,0.5434,0.8777425373134329,0.02299678668288643
1769,R-HSA-4755510,1.5261312044447322,Proteomics,SUMOylation of immune response proteins,0.6244,0.8777425373134329,0.022957291758353246
1770,R-HSA-3108214,1.5261312044447322,Proteomics,SUMOylation of DNA damage response and repair proteins,0.6244,0.8777425373134329,0.022957291758353246
1771,R-HSA-8849932,1.3094766134980949,Transcriptomics,Synaptic adhesion-like molecules,0.3803,0.8777425373134329,0.022884827314513124
1772,R-HSA-139853,1.3094682887811626,Transcriptomics,Elevation of cytosolic Ca2+ levels,0.5856,0.8777425373134329,0.022863221357943272
1773,R-HSA-76046,1.309194198412703,Transcriptomics,RNA Polymerase III Transcription Initiation,0.3495,0.8777425373134329,0.02215184766856045
1774,R-HSA-69242,1.5255940719413041,Proteomics,S Phase,0.5915,0.8777425373134329,0.021785435407622414
1775,R-HSA-918233,1.3086179800979172,Transcriptomics,TRAF3-dependent IRF activation pathway,0.4641,0.8777425373134329,0.020656331606531006
1776,R-HSA-3656253,1.5245827700203076,Proteomics,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",0.3297,0.8777425373134329,0.019579088610393296
1777,R-HSA-3656237,1.5245827700203076,Proteomics,Defective EXT2 causes exostoses 2,0.3297,0.8777425373134329,0.019579088610393296
1778,R-HSA-74749,1.524468932164155,Proteomics,Signal attenuation,0.6499,0.8777425373134329,0.01933072975324956
1779,R-HSA-8957275,1.3081063925745327,Transcriptomics,Post-translational protein phosphorylation,0.3172,0.8777425373134329,0.01932855819370576
1780,R-HSA-1483249,1.3076907396206552,Transcriptomics,Inositol phosphate metabolism,0.3592,0.8777425373134329,0.01824977320405318
1781,R-HSA-5620924,1.5236833595059662,Proteomics,Intraflagellar transport,0.4855,0.8777425373134329,0.017616854121848158
1782,R-HSA-74217,3.647646365214306,Metabolomics,Purine salvage,0.5271,0.8777425373134329,0.017515361556810848
1783,R-HSA-9615017,1.5234826860839739,Proteomics,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",0.6249,0.8777425373134329,0.017179047021209422
1784,R-HSA-399956,1.3072267947494578,Transcriptomics,CRMPs in Sema3A signaling,0.3458,0.8777425373134329,0.01704565145198791
1785,R-HSA-157118,1.3066998504889613,Transcriptomics,Signaling by NOTCH,0.5338,0.8777425373134329,0.015678021189038376
1786,R-HSA-174437,1.3063192307507259,Transcriptomics,Removal of the Flap Intermediate from the C-strand,0.2617,0.8777425373134329,0.014690161349372862
1787,R-HSA-8854691,1.3057884910568505,Transcriptomics,Interleukin-20 family signaling,0.3744,0.8777425373134329,0.01331268042490341
1788,R-HSA-420597,1.3054739764880443,Transcriptomics,Nectin/Necl  trans heterodimerization,0.3671,0.8777425373134329,0.012496389832739931
1789,R-HSA-211000,1.3047860735039278,Transcriptomics,Gene Silencing by RNA,0.644,0.8777425373134329,0.010711007564481498
1790,R-HSA-2470946,1.304757033239753,Transcriptomics,Cohesin Loading onto Chromatin,0.5402,0.8777425373134329,0.010635636510829114
1791,R-HSA-8934593,1.5193779610450096,Proteomics,Regulation of RUNX1 Expression and Activity,0.5812,0.8777425373134329,0.008223811442994578
1792,R-HSA-193648,1.3037242311647645,Transcriptomics,NRAGE signals death through JNK,0.2439,0.8777425373134329,0.007955103712046396
1793,R-HSA-9617828,1.518617506914741,Proteomics,FOXO-mediated transcription of cell cycle genes,0.589,0.8777425373134329,0.006564736640581006
1794,R-HSA-2206281,1.5183139771700551,Proteomics,Mucopolysaccharidoses,0.3964,0.8777425373134329,0.005902528979201834
1795,R-HSA-2682334,1.5178607211796415,Proteomics,EPH-Ephrin signaling,0.4531,0.8777425373134329,0.004913665137443807
1796,R-HSA-168138,1.3020601279168744,Transcriptomics,Toll Like Receptor 9 (TLR9) Cascade,0.3044,0.8777425373134329,0.0036360928923008474
1797,R-HSA-975155,1.3020601279168744,Transcriptomics,MyD88 dependent cascade initiated on endosome,0.3044,0.8777425373134329,0.0036360928923008474
1798,R-HSA-5637812,1.5169599757364605,Proteomics,Signaling by EGFRvIII in Cancer,0.5192,0.8777425373134329,0.002948518248646252
1799,R-HSA-5637810,1.5169599757364605,Proteomics,Constitutive Signaling by EGFRvIII,0.5192,0.8777425373134329,0.002948518248646252
1800,R-HSA-8984722,1.516654934055531,Proteomics,Interleukin-35 Signalling,0.6195,0.8777425373134329,0.002283012011817669
1801,R-HSA-73894,3.614008132025283,Metabolomics,DNA Repair,0.6535,0.8777425373134329,0.0012644167499502113
1802,R-HSA-8986944,1.5156821132921297,Proteomics,Transcriptional Regulation by MECP2,0.6103,0.8777425373134329,0.00016061915262707304
1803,R-HSA-68882,1.5149827515581098,Proteomics,Mitotic Anaphase,0.6333,0.8777425373134329,-0.001365171009463023
1804,R-HSA-2555396,1.5149827515581098,Proteomics,Mitotic Metaphase and Anaphase,0.6333,0.8777425373134329,-0.001365171009463023
1805,R-HSA-9006335,1.5148673400686268,Proteomics,Signaling by Erythropoietin,0.7175,0.8854020979020979,-0.0016169630459434694
1806,R-HSA-912526,1.5148176950233647,Proteomics,Interleukin receptor SHC signaling,0.4843,0.8777425373134329,-0.0017252731206482668
1807,R-HSA-428157,1.2993689438784974,Transcriptomics,Sphingolipid metabolism,0.3279,0.8777425373134329,-0.0033486017138863186
1808,R-HSA-9615933,1.5137067863220204,Proteomics,Postmitotic nuclear pore complex (NPC) reformation,0.5838,0.8777425373134329,-0.004148930986154753
1809,R-HSA-201681,1.5129386286721636,Proteomics,TCF dependent signaling in response to WNT,0.5679,0.8777425373134329,-0.005824812476480217
1810,R-HSA-72187,1.2983950871678773,Transcriptomics,mRNA 3'-end processing,0.4326,0.8777425373134329,-0.005876147811391318
1811,R-HSA-5654227,1.5128824235962615,Proteomics,Phospholipase C-mediated cascade; FGFR3,0.2854,0.8777425373134329,-0.0059474345012484565
1812,R-HSA-9609690,1.298321466150779,Transcriptomics,HCMV Early Events,0.6194,0.8777425373134329,-0.006067223677514297
1813,R-HSA-9009391,1.2972516488273524,Transcriptomics,Extra-nuclear estrogen signaling,0.4745,0.8777425373134329,-0.008843825790927918
1814,R-HSA-9006115,1.5114063818581132,Proteomics,Signaling by NTRK2 (TRKB),0.6749,0.8786055923473142,-0.009167699284618934
1815,R-HSA-9018678,3.5920874285841076,Metabolomics,Biosynthesis of specialized proresolving mediators (SPMs),0.4345,0.8777425373134329,-0.009325679934032173
1816,R-HSA-2022870,1.296951029138484,Transcriptomics,Chondroitin sulfate biosynthesis,0.3373,0.8777425373134329,-0.009624053634661402
1817,R-HSA-109582,3.5894339810910174,Metabolomics,Hemostasis,0.6054,0.8777425373134329,-0.010607585214722784
1818,R-HSA-9708530,1.2962545284102438,Transcriptomics,Regulation of BACH1 activity,0.6666,0.8777425373134329,-0.0114317504738114
1819,R-HSA-1236975,1.5092918936362982,Proteomics,Antigen processing-Cross presentation,0.6083,0.8777425373134329,-0.013780856067098831
1820,R-HSA-351906,1.2952172115641403,Transcriptomics,Apoptotic cleavage of cell adhesion  proteins,0.4587,0.8777425373134329,-0.014124000902086082
1821,R-HSA-1430728,1.2946246075036083,Transcriptomics,Metabolism,0.1252,0.8777425373134329,-0.015662044501548907
1822,R-HSA-442729,1.5072640882376351,Proteomics,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,0.6427,0.8777425373134329,-0.018204897843204216
1823,R-HSA-168255,1.5072092530858074,Proteomics,Influenza Infection,0.5003,0.8777425373134329,-0.018324531118983405
1824,R-HSA-186763,1.5066019365454508,Proteomics,Downstream signal transduction,0.6784,0.8786055923473142,-0.01964950724718034
1825,R-HSA-73980,1.292995750083186,Transcriptomics,RNA Polymerase III Transcription Termination,0.2622,0.8777425373134329,-0.019889578358926293
1826,R-HSA-68962,1.2924665906713029,Transcriptomics,Activation of the pre-replicative complex,0.4224,0.8777425373134329,-0.021262957822124055
1827,R-HSA-8849474,1.505816696277855,Proteomics,PTK6 Activates STAT3,0.6685,0.8777425373134329,-0.021362657705510584
1828,R-HSA-71336,1.5054542287350219,Proteomics,Pentose phosphate pathway,0.6003,0.8777425373134329,-0.02215344934312683
1829,R-HSA-6811558,1.2920106639059268,Transcriptomics,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.3234,0.8777425373134329,-0.022446269395590166
1830,R-HSA-8875791,1.291345210792448,Transcriptomics,MET activates STAT3,0.3419,0.8777425373134329,-0.024173385306692812
1831,R-HSA-9734207,1.289694405513146,Transcriptomics,Nucleotide salvage defects,0.3823,0.8777425373134329,-0.028457882600738393
1832,R-HSA-400511,1.289682052225207,Transcriptomics,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",0.3331,0.8777425373134329,-0.02848994430384229
1833,R-HSA-381426,1.2893527703715586,Transcriptomics,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),0.3548,0.8777425373134329,-0.02934456188268341
1834,R-HSA-983695,1.5017476202241529,Proteomics,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,0.6909,0.8829806639912441,-0.030240118266369357
1835,R-HSA-1462054,1.5008650311313703,Proteomics,Alpha-defensins,0.2353,0.8777425373134329,-0.03216565363587742
1836,R-HSA-2990846,1.2877390714352872,Transcriptomics,SUMOylation,0.6183,0.8777425373134329,-0.033532753435343725
1837,R-HSA-3700989,1.2874642062963726,Transcriptomics,Transcriptional Regulation by TP53,0.1629,0.8777425373134329,-0.03424613796268495
1838,R-HSA-168274,1.4996863118443244,Proteomics,Export of Viral Ribonucleoproteins from Nucleus,0.3334,0.8777425373134329,-0.03473725314519418
1839,R-HSA-74713,1.2871312252272755,Transcriptomics,IRS activation,0.3303,0.8777425373134329,-0.035110356479188705
1840,R-HSA-425381,1.2869860005425153,Transcriptomics,Bicarbonate transporters,0.5151,0.8777425373134329,-0.03548727238604043
1841,R-HSA-8876725,1.286980759366976,Transcriptomics,Protein methylation,0.3562,0.8777425373134329,-0.035500875324374535
1842,R-HSA-5688426,1.2868619742918874,Transcriptomics,Deubiquitination,0.4207,0.8777425373134329,-0.03580916991197433
1843,R-HSA-165158,1.4989332553542627,Proteomics,Activation of AKT2,0.6123,0.8777425373134329,-0.03638018859353497
1844,R-HSA-2559583,1.4984721948955353,Proteomics,Cellular Senescence,0.5228,0.8777425373134329,-0.03738607936198106
1845,R-HSA-975138,1.2862456198330545,Transcriptomics,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,0.3146,0.8777425373134329,-0.03740885525594133
1846,R-HSA-933541,1.286107901635678,Transcriptomics,TRAF6 mediated IRF7 activation,0.5033,0.8777425373134329,-0.037766288837841465
1847,R-HSA-5578775,1.2861016836956987,Transcriptomics,Ion homeostasis,0.5143,0.8777425373134329,-0.0377824268689891
1848,R-HSA-912694,1.2859964975237856,Transcriptomics,Regulation of IFNA/IFNB signaling,0.3278,0.8777425373134329,-0.038055426885758456
1849,R-HSA-9662834,1.4978951800046738,Proteomics,CD163 mediating an anti-inflammatory response,0.3833,0.8777425373134329,-0.038644946699196485
1850,R-HSA-5619102,3.5281809352513394,Metabolomics,SLC transporter disorders,0.4539,0.8777425373134329,-0.040199504076785436
1851,R-HSA-6803205,1.4970089054930955,Proteomics,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.2718,0.8777425373134329,-0.04057852250824838
1852,R-HSA-446652,1.4965642765621632,Proteomics,Interleukin-1 family signaling,0.6495,0.8777425373134329,-0.041548564784793546
1853,R-HSA-429958,1.2841471192498517,Transcriptomics,mRNA decay by 3' to 5' exoribonuclease,0.339,0.8777425373134329,-0.04285530020194252
1854,R-HSA-2151209,1.4958866319004709,Proteomics,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,0.5743,0.8777425373134329,-0.043026975037896716
1855,R-HSA-5690714,1.2839752919192595,Transcriptomics,CD22 mediated BCR regulation,0.3143,0.8777425373134329,-0.04330126057182734
1856,R-HSA-192105,1.283923579497318,Transcriptomics,Synthesis of bile acids and bile salts,0.3392,0.8777425373134329,-0.04343547490628261
1857,R-HSA-6811442,1.4955209204413524,Proteomics,Intra-Golgi and retrograde Golgi-to-ER traffic,0.5483,0.8777425373134329,-0.043824843893659295
1858,R-HSA-2559585,1.2836118205104934,Transcriptomics,Oncogene Induced Senescence,0.5267,0.8777425373134329,-0.044244613665524776
1859,R-HSA-198765,1.2835827993055953,Transcriptomics,Signalling to ERK5,0.6144,0.8777425373134329,-0.04431993525276159
1860,R-HSA-418360,1.2835741393153934,Transcriptomics,Platelet calcium homeostasis,0.6623,0.8777425373134329,-0.044342411377021315
1861,R-HSA-2142691,1.4952577449602096,Proteomics,Synthesis of Leukotrienes (LT) and Eoxins (EX),0.6424,0.8777425373134329,-0.04439901108139349
1862,R-HSA-937041,1.2834452009552209,Transcriptomics,IKK complex recruitment mediated by RIP1,0.5215,0.8777425373134329,-0.04467705778395051
1863,R-HSA-913531,1.4939042717075939,Proteomics,Interferon Signaling,0.5985,0.8777425373134329,-0.04735186948504543
1864,R-HSA-209952,1.4938368907383446,Proteomics,Peptide hormone biosynthesis,0.3859,0.8777425373134329,-0.04749887383914662
1865,R-HSA-202427,1.4938159004090485,Proteomics,Phosphorylation of CD3 and TCR zeta chains,0.6657,0.8777425373134329,-0.04754466822048177
1866,R-HSA-167172,1.282200127368026,Transcriptomics,Transcription of the HIV genome,0.2583,0.8777425373134329,-0.04790851971474858
1867,R-HSA-3000497,1.4932204543786678,Proteomics,Scavenging by Class H Receptors,0.2252,0.8777425373134329,-0.048843746581530276
1868,R-HSA-211976,1.2818353047197146,Transcriptomics,Endogenous sterols,0.3392,0.8777425373134329,-0.048855379813328645
1869,R-HSA-3214841,1.2806141740492822,Transcriptomics,PKMTs methylate histone lysines,0.5806,0.8777425373134329,-0.05202470033752538
1870,R-HSA-5578749,1.27976861100679,Transcriptomics,Transcriptional regulation by small RNAs,0.6434,0.8777425373134329,-0.05421927326076853
1871,R-HSA-157579,1.2796577510718161,Transcriptomics,Telomere Maintenance,0.633,0.8777425373134329,-0.054506998952810685
1872,R-HSA-5607764,1.2791680916882524,Transcriptomics,CLEC7A (Dectin-1) signaling,0.3166,0.8777425373134329,-0.05577786010777987
1873,R-HSA-9665348,1.4892662128617034,Proteomics,Signaling by ERBB2 ECD mutants,0.5605,0.8777425373134329,-0.05747067383766362
1874,R-HSA-9033241,1.4892377181908854,Proteomics,Peroxisomal protein import,0.6086,0.8777425373134329,-0.05753284036221194
1875,R-HSA-8848021,1.2783523041299671,Transcriptomics,Signaling by PTK6,0.2205,0.8777425373134329,-0.057895153788514564
1876,R-HSA-9006927,1.2783523041299671,Transcriptomics,Signaling by Non-Receptor Tyrosine Kinases,0.2205,0.8777425373134329,-0.057895153788514564
1877,R-HSA-168928,1.2782689926173247,Transcriptomics,DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.2295,0.8777425373134329,-0.058111380350759495
1878,R-HSA-5689901,1.2782414136118492,Transcriptomics,Metalloprotease DUBs,0.4912,0.8777425373134329,-0.05818295885599816
1879,R-HSA-109581,1.2777657275432617,Transcriptomics,Apoptosis,0.3118,0.8777425373134329,-0.059417553692368126
1880,R-HSA-5694530,1.48790865998527,Proteomics,Cargo concentration in the ER,0.3995,0.8777425373134329,-0.06043243271382243
1881,R-HSA-397795,1.2767863563955475,Transcriptomics,G-protein beta:gamma signalling,0.3683,0.8777425373134329,-0.0619594119507948
1882,R-HSA-8948751,1.487105316009729,Proteomics,Regulation of PTEN stability and activity,0.5874,0.8777425373134329,-0.062185079841953816
1883,R-HSA-1306955,1.2766529022063577,Transcriptomics,GRB7 events in ERBB2 signaling,0.2826,0.8777425373134329,-0.06230577873289302
1884,R-HSA-2559584,1.4868671039477084,Proteomics,Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.2961,0.8777425373134329,-0.06270478459993799
1885,R-HSA-156827,1.486495480480938,Proteomics,L13a-mediated translational silencing of Ceruloplasmin expression,0.6812,0.8786055923473142,-0.06351555162080547
1886,R-HSA-72649,1.486495480480938,Proteomics,Translation initiation complex formation,0.6812,0.8786055923473142,-0.06351555162080547
1887,R-HSA-72662,1.486495480480938,Proteomics,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.6812,0.8786055923473142,-0.06351555162080547
1888,R-HSA-392499,1.2760821659109511,Transcriptomics,Metabolism of proteins,0.206,0.8777425373134329,-0.06378706677088462
1889,R-HSA-69541,1.4862308736699925,Proteomics,Stabilization of p53,0.6491,0.8777425373134329,-0.06409284152576224
1890,R-HSA-9759218,1.2756528127533864,Transcriptomics,Cobalamin (Cbl) metabolism,0.3401,0.8777425373134329,-0.06490140924654847
1891,R-HSA-8953750,1.4848390627987182,Proteomics,Transcriptional Regulation by E2F6,0.262,0.8777425373134329,-0.06712934071005996
1892,R-HSA-9755779,1.27477948058564,Transcriptomics,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,0.2765,0.8777425373134329,-0.06716805411158946
1893,R-HSA-72306,1.2747357651681617,Transcriptomics,tRNA processing,0.2491,0.8777425373134329,-0.06728151303387582
1894,R-HSA-163200,1.48476246640584,Proteomics,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.3044,0.8777425373134329,-0.0672964502572657
1895,R-HSA-8957322,1.4844520251953053,Proteomics,Metabolism of steroids,0.5689,0.8777425373134329,-0.06797373659121875
1896,R-HSA-9034013,1.484104807790487,Proteomics,NTF3 activates NTRK3 signaling,0.3739,0.8777425373134329,-0.06873125716263036
1897,R-HSA-9034864,1.484104807790487,Proteomics,Activated NTRK3 signals through RAS,0.3739,0.8777425373134329,-0.06873125716263036
1898,R-HSA-75153,1.4839305349667178,Proteomics,Apoptotic execution phase,0.4206,0.8777425373134329,-0.06911146635494403
1899,R-HSA-881907,1.2733247306544548,Transcriptomics,Gastrin-CREB signalling pathway via PKC and MAPK,0.3207,0.8777425373134329,-0.0709437096791026
1900,R-HSA-73886,1.2730812469624044,Transcriptomics,Chromosome Maintenance,0.6116,0.8777425373134329,-0.07157564685110836
1901,R-HSA-1236978,1.4826053835043334,Proteomics,Cross-presentation of soluble exogenous antigens (endosomes),0.5076,0.8777425373134329,-0.07200253540581102
1902,R-HSA-1433557,1.2717448156886177,Transcriptomics,Signaling by SCF-KIT,0.3197,0.8777425373134329,-0.07504421837072367
1903,R-HSA-5635838,1.2710105295611025,Transcriptomics,Activation of SMO,0.337,0.8777425373134329,-0.076949983372714
1904,R-HSA-168638,1.2709423184757052,Transcriptomics,NOD1/2 Signaling Pathway,0.239,0.8777425373134329,-0.07712701831103962
1905,R-HSA-73856,1.2707869651598815,Transcriptomics,RNA Polymerase II Transcription Termination,0.444,0.8777425373134329,-0.07753022205021641
1906,R-HSA-162582,3.4502246904363623,Metabolomics,Signal Transduction,0.4515,0.8777425373134329,-0.07786089445717308
1907,R-HSA-881907,1.4796696053742895,Proteomics,Gastrin-CREB signalling pathway via PKC and MAPK,0.7001,0.8854020979020979,-0.0784074917695989
1908,R-HSA-6804760,1.4795728997438804,Proteomics,Regulation of TP53 Activity through Methylation,0.5917,0.8777425373134329,-0.07861847342947438
1909,R-HSA-73614,3.448556905596243,Metabolomics,Pyrimidine salvage,0.4481,0.8777425373134329,-0.07866661689908017
1910,R-HSA-418346,1.2700050014578883,Transcriptomics,Platelet homeostasis,0.2868,0.8777425373134329,-0.07955972935022264
1911,R-HSA-389356,1.26997821932279,Transcriptomics,CD28 co-stimulation,0.2216,0.8777425373134329,-0.07962923965940098
1912,R-HSA-2559582,1.4787789226637482,Proteomics,Senescence-Associated Secretory Phenotype (SASP),0.5389,0.8777425373134329,-0.08035068490010698
1913,R-HSA-3928664,1.4782579390035937,Proteomics,Ephrin signaling,0.6176,0.8777425373134329,-0.08148730948879357
1914,R-HSA-167060,1.2691889855599618,Transcriptomics,NGF processing,0.4385,0.8777425373134329,-0.08167761566328477
1915,R-HSA-9036866,1.2691889855599618,Transcriptomics,Expression and Processing of Neurotrophins,0.4385,0.8777425373134329,-0.08167761566328477
1916,R-HSA-1638074,1.4774418003864929,Proteomics,Keratan sulfate/keratin metabolism,0.367,0.8777425373134329,-0.08326787055226022
1917,R-HSA-186797,1.4772994687945442,Proteomics,Signaling by PDGF,0.6851,0.8789743589743589,-0.08357839389402445
1918,R-HSA-190371,1.4764787756019684,Proteomics,FGFR3b ligand binding and activation,0.3189,0.8777425373134329,-0.08536889162704878
1919,R-HSA-9034015,1.47614227154314,Proteomics,Signaling by NTRK3 (TRKC),0.6263,0.8777425373134329,-0.08610303900384692
1920,R-HSA-8948747,1.2671667108619762,Transcriptomics,Regulation of PTEN localization,0.4046,0.8777425373134329,-0.08692622407275194
1921,R-HSA-453279,1.4756979371419812,Proteomics,Mitotic G1 phase and G1/S transition,0.5699,0.8777425373134329,-0.08707243870787355
1922,R-HSA-8951664,1.267080064674815,Transcriptomics,Neddylation,0.2814,0.8777425373134329,-0.08715110544373246
1923,R-HSA-5423646,1.4756299708764598,Proteomics,Aflatoxin activation and detoxification,0.3789,0.8777425373134329,-0.08722071999671462
1924,R-HSA-1474165,1.2666793475430511,Transcriptomics,Reproduction,0.6445,0.8777425373134329,-0.08819112602535209
1925,R-HSA-6784531,1.266529237414291,Transcriptomics,tRNA processing in the nucleus,0.4631,0.8777425373134329,-0.08858072160548856
1926,R-HSA-450513,1.4748394711117014,Proteomics,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",0.7142,0.8854020979020979,-0.08894534504485675
1927,R-HSA-450385,1.4748394711117014,Proteomics,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,0.7142,0.8854020979020979,-0.08894534504485675
1928,R-HSA-1855167,1.265726897688884,Transcriptomics,Synthesis of pyrophosphates in the cytosol,0.3463,0.8777425373134329,-0.09066311280299244
1929,R-HSA-1250347,1.4734112442804048,Proteomics,SHC1 events in ERBB4 signaling,0.3954,0.8777425373134329,-0.09206129254730279
1930,R-HSA-8936459,1.2650257382947592,Transcriptomics,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,0.6285,0.8777425373134329,-0.09248290073588121
1931,R-HSA-9020558,1.472674455731353,Proteomics,Interleukin-2 signaling,0.5837,0.8777425373134329,-0.09366873639931675
1932,R-HSA-418359,1.2645393884915588,Transcriptomics,Reduction of cytosolic Ca++ levels,0.6265,0.8777425373134329,-0.09374517221144431
1933,R-HSA-9705671,1.4726233774703257,Proteomics,SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.6554,0.8777425373134329,-0.09378017330582873
1934,R-HSA-3214847,1.26446922573587,Transcriptomics,HATs acetylate histones,0.6665,0.8777425373134329,-0.09392727251161916
1935,R-HSA-9610379,1.264450166105025,Transcriptomics,HCMV Late Events,0.6205,0.8777425373134329,-0.09397673984601977
1936,R-HSA-1852241,1.263939264227042,Transcriptomics,Organelle biogenesis and maintenance,0.1566,0.8777425373134329,-0.09530273373590278
1937,R-HSA-167290,1.2634894207871705,Transcriptomics,Pausing and recovery of HIV elongation,0.3912,0.8777425373134329,-0.09647025665640639
1938,R-HSA-167287,1.2634894207871705,Transcriptomics,HIV elongation arrest and recovery,0.3912,0.8777425373134329,-0.09647025665640639
1939,R-HSA-167243,1.2634894207871705,Transcriptomics,Tat-mediated HIV elongation arrest and recovery,0.3912,0.8777425373134329,-0.09647025665640639
1940,R-HSA-167238,1.2634894207871705,Transcriptomics,Pausing and recovery of Tat-mediated HIV elongation,0.3912,0.8777425373134329,-0.09647025665640639
1941,R-HSA-162592,1.4711201020481801,Proteomics,Integration of provirus,0.6287,0.8777425373134329,-0.09705985353202255
1942,R-HSA-9662361,1.4703460157675976,Proteomics,Sensory processing of sound by outer hair cells of the cochlea,0.2834,0.8777425373134329,-0.09874866945383874
1943,R-HSA-1059683,1.2623465687429931,Transcriptomics,Interleukin-6 signaling,0.3354,0.8777425373134329,-0.09943641296337159
1944,R-HSA-168164,1.261492079652842,Transcriptomics,Toll Like Receptor 3 (TLR3) Cascade,0.341,0.8777425373134329,-0.10165415253595918
1945,R-HSA-5250941,1.2611927773844642,Transcriptomics,Negative epigenetic regulation of rRNA expression,0.6698,0.8777425373134329,-0.10243096114872806
1946,R-HSA-427413,1.2611927773844642,Transcriptomics,NoRC negatively regulates rRNA expression,0.6698,0.8777425373134329,-0.10243096114872806
1947,R-HSA-983170,1.2611099563766741,Transcriptomics,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.5485,0.8777425373134329,-0.10264591465548989
1948,R-HSA-9609646,1.2610448364972155,Transcriptomics,HCMV Infection,0.6399,0.8777425373134329,-0.10281492668303004
1949,R-HSA-9679506,1.260712857566906,Transcriptomics,SARS-CoV Infections,0.1994,0.8777425373134329,-0.10367654425018066
1950,R-HSA-73894,1.2605324191429468,Transcriptomics,DNA Repair,0.4538,0.8777425373134329,-0.10414485383756097
1951,R-HSA-9759194,1.260160248953443,Transcriptomics,Nuclear events mediated by NFE2L2,0.269,0.8777425373134329,-0.1051107837324109
1952,R-HSA-165159,1.4673551199670976,Proteomics,MTOR signalling,0.6817,0.8786055923473142,-0.10527387546133528
1953,R-HSA-844455,1.259702709391461,Transcriptomics,The NLRP1 inflammasome,0.4465,0.8777425373134329,-0.10629828115552271
1954,R-HSA-15869,1.4668501674239238,Proteomics,Metabolism of nucleotides,0.5506,0.8777425373134329,-0.10637552513019603
1955,R-HSA-9012546,1.2595463147699717,Transcriptomics,Interleukin-18 signaling,0.3768,0.8777425373134329,-0.10670418749770355
1956,R-HSA-5654693,1.258943729809722,Transcriptomics,FRS-mediated FGFR1 signaling,0.3672,0.8777425373134329,-0.10826813550780118
1957,R-HSA-9028731,1.258943729809722,Transcriptomics,Activated NTRK2 signals through FRS2 and FRS3,0.3672,0.8777425373134329,-0.10826813550780118
1958,R-HSA-5654712,1.258943729809722,Transcriptomics,FRS-mediated FGFR4 signaling,0.3672,0.8777425373134329,-0.10826813550780118
1959,R-HSA-5654706,1.258943729809722,Transcriptomics,FRS-mediated FGFR3 signaling,0.3672,0.8777425373134329,-0.10826813550780118
1960,R-HSA-5654700,1.258943729809722,Transcriptomics,FRS-mediated FGFR2 signaling,0.3672,0.8777425373134329,-0.10826813550780118
1961,R-HSA-1793185,1.257206388523729,Transcriptomics,Chondroitin sulfate/dermatan sulfate metabolism,0.3558,0.8777425373134329,-0.11277722821061731
1962,R-HSA-156588,1.2562959378736123,Transcriptomics,Glucuronidation,0.3356,0.8777425373134329,-0.11514021032346648
1963,R-HSA-192456,3.371787485092818,Metabolomics,Digestion of dietary lipid,0.6346,0.8777425373134329,-0.1157546413635443
1964,R-HSA-977606,1.2551834122678316,Transcriptomics,Regulation of Complement cascade,0.3423,0.8777425373134329,-0.11802765744232938
1965,R-HSA-166658,1.2545849656897656,Transcriptomics,Complement cascade,0.3417,0.8777425373134329,-0.11958086470214552
1966,R-HSA-9013423,1.4589484303804747,Proteomics,RAC3 GTPase cycle,0.5934,0.8777425373134329,-0.12361466198576675
1967,R-HSA-9013404,1.4589361688664308,Proteomics,RAC2 GTPase cycle,0.6225,0.8777425373134329,-0.12364141280239056
1968,R-HSA-8963898,1.2520874438437004,Transcriptomics,Plasma lipoprotein assembly,0.4554,0.8777425373134329,-0.12606292877442163
1969,R-HSA-8963896,1.2520874438437004,Transcriptomics,HDL assembly,0.4554,0.8777425373134329,-0.12606292877442163
1970,R-HSA-5690714,1.4568583786322007,Proteomics,CD22 mediated BCR regulation,0.6379,0.8777425373134329,-0.12817450597014637
1971,R-HSA-111463,1.2510193142231285,Transcriptomics,SMAC (DIABLO) binds to IAPs ,0.3143,0.8777425373134329,-0.1288351506266353
1972,R-HSA-111464,1.2510193142231285,Transcriptomics,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,0.3143,0.8777425373134329,-0.1288351506266353
1973,R-HSA-111469,1.2510193142231285,Transcriptomics,"SMAC, XIAP-regulated apoptotic response",0.3143,0.8777425373134329,-0.1288351506266353
1974,R-HSA-111459,1.2510193142231285,Transcriptomics,Activation of caspases through apoptosome-mediated cleavage,0.3143,0.8777425373134329,-0.1288351506266353
1975,R-HSA-428540,1.4559693039157178,Proteomics,Activation of RAC1,0.7331,0.8897836538461539,-0.13011419095687765
1976,R-HSA-3214815,1.2504472212187874,Transcriptomics,HDACs deacetylate histones,0.6393,0.8777425373134329,-0.1303199598647537
1977,R-HSA-450604,1.4557453337300956,Proteomics,KSRP (KHSRP) binds and destabilizes mRNA,0.6838,0.8788546255506609,-0.13060282436245382
1978,R-HSA-1247673,1.455673486748765,Proteomics,Erythrocytes take up oxygen and release carbon dioxide,0.5825,0.8777425373134329,-0.13075957216828518
1979,R-HSA-1237044,1.455673486748765,Proteomics,Erythrocytes take up carbon dioxide and release oxygen,0.5825,0.8777425373134329,-0.13075957216828518
1980,R-HSA-1480926,1.455673486748765,Proteomics,O2/CO2 exchange in erythrocytes,0.5825,0.8777425373134329,-0.13075957216828518
1981,R-HSA-428157,3.3392674117819166,Metabolomics,Sphingolipid metabolism,0.5815,0.8777425373134329,-0.13146539268394877
1982,R-HSA-77387,1.2499113359364549,Transcriptomics,Insulin receptor recycling,0.3639,0.8777425373134329,-0.13171079564100194
1983,R-HSA-2467813,1.4537316852489421,Proteomics,Separation of Sister Chromatids,0.669,0.8777425373134329,-0.13499598014006808
1984,R-HSA-674695,1.2486282975908944,Transcriptomics,RNA Polymerase II Pre-transcription Events,0.4157,0.8777425373134329,-0.13504079124292737
1985,R-HSA-381038,1.4533349141611207,Proteomics,XBP1(S) activates chaperone genes,0.5546,0.8777425373134329,-0.13586161146210227
1986,R-HSA-381070,1.4533349141611207,Proteomics,IRE1alpha activates chaperones,0.5546,0.8777425373134329,-0.13586161146210227
1987,R-HSA-5223345,1.248174974793677,Transcriptomics,Miscellaneous transport and binding events,0.5558,0.8777425373134329,-0.1362173444817374
1988,R-HSA-75035,1.4523389316624655,Proteomics,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,0.7129,0.8854020979020979,-0.13803453603623808
1989,R-HSA-8983432,1.4507006911226592,Proteomics,Interleukin-15 signaling,0.7113,0.8854020979020979,-0.14160866824448198
1990,R-HSA-1266695,1.4496372811491345,Proteomics,Interleukin-7 signaling,0.5783,0.8777425373134329,-0.14392869863354305
1991,R-HSA-418555,1.4496168924038184,Proteomics,G alpha (s) signalling events,0.514,0.8777425373134329,-0.1439731805454169
1992,R-HSA-68882,1.2447268476689834,Transcriptomics,Mitotic Anaphase,0.275,0.8777425373134329,-0.14516660792334862
1993,R-HSA-176412,1.2441238364054275,Transcriptomics,Phosphorylation of the APC/C,0.47,0.8777425373134329,-0.14673166236034274
1994,R-HSA-15869,1.2439812662815166,Transcriptomics,Metabolism of nucleotides,0.2392,0.8777425373134329,-0.14710168862435255
1995,R-HSA-2029482,1.2438969049831372,Transcriptomics,Regulation of actin dynamics for phagocytic cup formation,0.3494,0.8777425373134329,-0.14732063979876459
1996,R-HSA-6804758,1.2434067386281376,Transcriptomics,Regulation of TP53 Activity through Acetylation,0.5838,0.8777425373134329,-0.14859281674656089
1997,R-HSA-9664422,1.2424849792469195,Transcriptomics,FCGR3A-mediated phagocytosis,0.3491,0.8777425373134329,-0.15098514952142347
1998,R-HSA-9664417,1.2424849792469195,Transcriptomics,Leishmania phagocytosis,0.3491,0.8777425373134329,-0.15098514952142347
1999,R-HSA-9664407,1.2424849792469195,Transcriptomics,Parasite infection,0.3491,0.8777425373134329,-0.15098514952142347
2000,R-HSA-2980766,1.4459641889834052,Proteomics,Nuclear Envelope Breakdown,0.6652,0.8777425373134329,-0.1519422452980234
2001,R-HSA-5655253,1.2416806409820105,Transcriptomics,Signaling by FGFR2 in disease,0.294,0.8777425373134329,-0.15307272772504868
2002,R-HSA-1834941,1.2413727877860048,Transcriptomics,STING mediated induction of host immune responses,0.7223,0.8854020979020979,-0.15387172940125332
2003,R-HSA-2299718,1.241040396317483,Transcriptomics,Condensation of Prophase Chromosomes,0.602,0.8777425373134329,-0.15473441766939833
2004,R-HSA-3247509,1.2410071412042543,Transcriptomics,Chromatin modifying enzymes,0.7155,0.8854020979020979,-0.15482072793532012
2005,R-HSA-4839726,1.2410071412042543,Transcriptomics,Chromatin organization,0.7155,0.8854020979020979,-0.15482072793532012
2006,R-HSA-418457,1.4445239520929114,Proteomics,cGMP effects,0.5301,0.8777425373134329,-0.1550843950206907
2007,R-HSA-392154,1.4445239520929114,Proteomics,Nitric oxide stimulates guanylate cyclase,0.5301,0.8777425373134329,-0.1550843950206907
2008,R-HSA-450604,1.2404662699572648,Transcriptomics,KSRP (KHSRP) binds and destabilizes mRNA,0.4213,0.8777425373134329,-0.15622450427599993
2009,R-HSA-9013149,1.240403699113209,Transcriptomics,RAC1 GTPase cycle,0.404,0.8777425373134329,-0.1563869005412679
2010,R-HSA-5602680,1.2403960671618577,Transcriptomics,MyD88 deficiency (TLR5),0.3432,0.8777425373134329,-0.15640670849519384
2011,R-HSA-76071,1.2403283474611209,Transcriptomics,RNA Polymerase III Transcription Initiation From Type 3 Promoter,0.4773,0.8777425373134329,-0.15658246809458354
2012,R-HSA-9634285,1.4432961057989049,Proteomics,Constitutive Signaling by Overexpressed ERBB2,0.6683,0.8777425373134329,-0.15776317440598195
2013,R-HSA-2029481,1.442935583189084,Proteomics,FCGR activation,0.4923,0.8777425373134329,-0.15854972280363872
2014,R-HSA-159418,1.2391321443336432,Transcriptomics,Recycling of bile acids and salts,0.2491,0.8777425373134329,-0.1596870917149869
2015,R-HSA-70895,1.442161156125461,Proteomics,Branched-chain amino acid catabolism,0.5004,0.8777425373134329,-0.16023928220824105
2016,R-HSA-1912422,1.2388861389334,Transcriptomics,Pre-NOTCH Expression and Processing,0.6856,0.8789743589743589,-0.16032557372426906
2017,R-HSA-1912408,1.238308168052165,Transcriptomics,Pre-NOTCH Transcription and Translation,0.6814,0.8786055923473142,-0.161825638394365
2018,R-HSA-1640170,1.2376936633370335,Transcriptomics,Cell Cycle,0.4347,0.8777425373134329,-0.16342052291658618
2019,R-HSA-168142,1.2376566877511253,Transcriptomics,Toll Like Receptor 10 (TLR10) Cascade,0.3309,0.8777425373134329,-0.16351648929115245
2020,R-HSA-168176,1.2376566877511253,Transcriptomics,Toll Like Receptor 5 (TLR5) Cascade,0.3309,0.8777425373134329,-0.16351648929115245
2021,R-HSA-975871,1.2376566877511253,Transcriptomics,MyD88 cascade initiated on plasma membrane,0.3309,0.8777425373134329,-0.16351648929115245
2022,R-HSA-73854,1.2374489331096759,Transcriptomics,RNA Polymerase I Promoter Clearance,0.6479,0.8777425373134329,-0.16405569534426842
2023,R-HSA-73864,1.2374489331096759,Transcriptomics,RNA Polymerase I Transcription,0.6479,0.8777425373134329,-0.16405569534426842
2024,R-HSA-5213460,1.2369741585631522,Transcriptomics,RIPK1-mediated regulated necrosis,0.4723,0.8777425373134329,-0.16528792441778015
2025,R-HSA-5675482,1.2369741585631522,Transcriptomics,Regulation of necroptotic cell death,0.4723,0.8777425373134329,-0.16528792441778015
2026,R-HSA-5663205,1.2362413680923299,Transcriptomics,Infectious disease,0.2898,0.8777425373134329,-0.1671898075948611
2027,R-HSA-5617833,1.2360754473507047,Transcriptomics,Cilium Assembly,0.3679,0.8777425373134329,-0.16762043801350113
2028,R-HSA-2555396,1.2360239236591721,Transcriptomics,Mitotic Metaphase and Anaphase,0.2897,0.8777425373134329,-0.16775416251736514
2029,R-HSA-1221632,1.235566461551303,Transcriptomics,Meiotic synapsis,0.6374,0.8777425373134329,-0.16894145891620088
2030,R-HSA-179409,1.2353899189885869,Transcriptomics,APC-Cdc20 mediated degradation of Nek2A,0.5412,0.8777425373134329,-0.16939965719174835
2031,R-HSA-1369007,1.2341769424585374,Transcriptomics,Mitochondrial ABC transporters,0.5719,0.8777425373134329,-0.1725478144734695
2032,R-HSA-2028269,1.2335367778315451,Transcriptomics,Signaling by Hippo,0.4174,0.8777425373134329,-0.17420929668853238
2033,R-HSA-2161517,1.2332249127755603,Transcriptomics,Abacavir transmembrane transport,0.3847,0.8777425373134329,-0.17501871073949746
2034,R-HSA-392170,1.2331821419842897,Transcriptomics,ADP signalling through P2Y purinoceptor 12,0.6852,0.8789743589743589,-0.1751297179804853
2035,R-HSA-9027284,1.4351559689518316,Proteomics,Erythropoietin activates RAS,0.7838,0.9003598298985933,-0.1755224256134249
2036,R-HSA-427359,1.2325992191706132,Transcriptomics,SIRT1 negatively regulates rRNA expression,0.6305,0.8777425373134329,-0.17664263488785695
2037,R-HSA-9013700,1.23245465145771,Transcriptomics,NOTCH4 Activation and Transmission of Signal to the Nucleus,0.4213,0.8777425373134329,-0.17701784569103685
2038,R-HSA-201722,1.2323139257102467,Transcriptomics,Formation of the beta-catenin:TCF transactivating complex,0.6863,0.8792276720351391,-0.17738308506346234
2039,R-HSA-9006936,1.4341961839648478,Proteomics,Signaling by TGFB family members,0.6587,0.8777425373134329,-0.1776163784558892
2040,R-HSA-3371568,1.4337974286373547,Proteomics,Attenuation phase,0.4862,0.8777425373134329,-0.17848633877280973
2041,R-HSA-168928,1.4337689900001749,Proteomics,DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.6024,0.8777425373134329,-0.1785483830493572
2042,R-HSA-6785470,1.2313059672905005,Transcriptomics,tRNA processing in the mitochondrion,0.3308,0.8777425373134329,-0.17999913868048226
2043,R-HSA-5676934,1.231167848784563,Transcriptomics,Protein repair,0.4218,0.8777425373134329,-0.18035761122256003
2044,R-HSA-72172,1.4327810069907239,Proteomics,mRNA Splicing,0.4839,0.8777425373134329,-0.18070385522177337
2045,R-HSA-72163,1.4327810069907239,Proteomics,mRNA Splicing - Major Pathway,0.4839,0.8777425373134329,-0.18070385522177337
2046,R-HSA-72203,1.4327810069907239,Proteomics,Processing of Capped Intron-Containing Pre-mRNA,0.4839,0.8777425373134329,-0.18070385522177337
2047,R-HSA-70268,1.2300599567339663,Transcriptomics,Pyruvate metabolism,0.5047,0.8777425373134329,-0.18323303241995506
2048,R-HSA-1834941,1.4314598408535497,Proteomics,STING mediated induction of host immune responses,0.2827,0.8777425373134329,-0.18358622953041645
2049,R-HSA-5658034,1.4312077351000718,Proteomics,HHAT G278V doesn't palmitoylate Hh-Np,0.5279,0.8777425373134329,-0.18413624600937348
2050,R-HSA-877300,1.4309503333671194,Proteomics,Interferon gamma signaling,0.6249,0.8777425373134329,-0.1846978166712201
2051,R-HSA-9710421,1.229293351866322,Transcriptomics,Defective pyroptosis,0.6353,0.8777425373134329,-0.18522267742667142
2052,R-HSA-1500931,1.2291944230663088,Transcriptomics,Cell-Cell communication,0.2941,0.8777425373134329,-0.18547943707075212
2053,R-HSA-9645723,1.229132287088827,Transcriptomics,Diseases of programmed cell death,0.6164,0.8777425373134329,-0.1856407046840323
2054,R-HSA-73884,1.2289222573023157,Transcriptomics,Base Excision Repair,0.6759,0.8786055923473142,-0.1861858156448824
2055,R-HSA-8957275,1.4302320424769899,Proteomics,Post-translational protein phosphorylation,0.392,0.8777425373134329,-0.1862649043747167
2056,R-HSA-8851907,1.2288257026357294,Transcriptomics,MET activates PI3K/AKT signaling,0.468,0.8777425373134329,-0.18643641346698986
2057,R-HSA-8865999,1.2288257026357294,Transcriptomics,MET activates PTPN11,0.468,0.8777425373134329,-0.18643641346698986
2058,R-HSA-936837,1.228142846816898,Transcriptomics,Ion transport by P-type ATPases,0.4734,0.8777425373134329,-0.1882086963308076
2059,R-HSA-425393,3.2146529467572416,Metabolomics,Transport of inorganic cations/anions and amino acids/oligopeptides,0.5425,0.8777425373134329,-0.1916678052741944
2060,R-HSA-5620924,1.2267811783365663,Transcriptomics,Intraflagellar transport,0.2798,0.8777425373134329,-0.19174276845458693
2061,R-HSA-69206,1.4267917927989002,Proteomics,G1/S Transition,0.6248,0.8777425373134329,-0.19377046102533807
2062,R-HSA-163841,1.4263847984363436,Proteomics,"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.2933,0.8777425373134329,-0.1946583963586679
2063,R-HSA-9664323,1.225396410633306,Transcriptomics,FCGR3A-mediated IL10 synthesis,0.361,0.8777425373134329,-0.19533679226338518
2064,R-HSA-162587,1.2253129092337949,Transcriptomics,HIV Life Cycle,0.2939,0.8777425373134329,-0.1955535116576953
2065,R-HSA-2025928,1.224483511325398,Transcriptomics,Calcineurin activates NFAT,0.6046,0.8777425373134329,-0.1977061296186194
2066,R-HSA-912631,1.2241216309456646,Transcriptomics,Regulation of signaling by CBL,0.2316,0.8777425373134329,-0.1986453533581943
2067,R-HSA-1234158,1.2235259695502931,Transcriptomics,Regulation of gene expression by Hypoxia-inducible Factor,0.5471,0.8777425373134329,-0.20019133195944758
2068,R-HSA-1489509,1.2235003524695383,Transcriptomics,DAG and IP3 signaling,0.4428,0.8777425373134329,-0.20025781848850813
2069,R-HSA-6811555,1.2229065888515194,Transcriptomics,PI5P Regulates TP53 Acetylation,0.5402,0.8777425373134329,-0.2017988716015564
2070,R-HSA-9711097,1.422849634312436,Proteomics,Cellular response to starvation,0.5497,0.8777425373134329,-0.20237102686052347
2071,R-HSA-9633012,1.422849634312436,Proteomics,Response of EIF2AK4 (GCN2) to amino acid deficiency,0.5497,0.8777425373134329,-0.20237102686052347
2072,R-HSA-174143,1.4216072949582408,Proteomics,APC/C-mediated degradation of cell cycle proteins,0.6801,0.8786055923473142,-0.20508142560326412
2073,R-HSA-453276,1.4216072949582408,Proteomics,Regulation of mitotic cell cycle,0.6801,0.8786055923473142,-0.20508142560326412
2074,R-HSA-167826,1.2209057767315603,Transcriptomics,The fatty acid cycling model,0.7143,0.8854020979020979,-0.20699177607147892
2075,R-HSA-167827,1.2209057767315603,Transcriptomics,The proton buffering model,0.7143,0.8854020979020979,-0.20699177607147892
2076,R-HSA-166187,1.2209057767315603,Transcriptomics,Mitochondrial Uncoupling,0.7143,0.8854020979020979,-0.20699177607147892
2077,R-HSA-9027283,1.2202741703407547,Transcriptomics,Erythropoietin activates STAT5,0.4492,0.8777425373134329,-0.20863104625448503
2078,R-HSA-438066,1.2195457258342248,Transcriptomics,"Unblocking of NMDA receptors, glutamate binding and activation",0.4002,0.8777425373134329,-0.2105216499230228
2079,R-HSA-500792,3.175514804483776,Metabolomics,GPCR ligand binding,0.5186,0.8777425373134329,-0.21057580755704608
2080,R-HSA-73927,3.1699558860799604,Metabolomics,Depurination,0.7232,0.8854020979020979,-0.2132613729866755
2081,R-HSA-9734207,3.1699558860799604,Metabolomics,Nucleotide salvage defects,0.7232,0.8854020979020979,-0.2132613729866755
2082,R-HSA-110331,3.1699558860799604,Metabolomics,Cleavage of the damaged purine,0.7232,0.8854020979020979,-0.2132613729866755
2083,R-HSA-438064,1.2180800315852762,Transcriptomics,Post NMDA receptor activation events,0.5588,0.8777425373134329,-0.2143257103547742
2084,R-HSA-449836,1.2177102464493441,Transcriptomics,Other interleukin signaling,0.53,0.8777425373134329,-0.21528545008552516
2085,R-HSA-5250924,1.2171242462336482,Transcriptomics,B-WICH complex positively regulates rRNA expression,0.6516,0.8777425373134329,-0.21680635407701287
2086,R-HSA-198693,1.2169947296656245,Transcriptomics,AKT phosphorylates targets in the nucleus,0.6468,0.8777425373134329,-0.2171425011636435
2087,R-HSA-3371511,1.414818135286204,Proteomics,HSF1 activation,0.6138,0.8777425373134329,-0.21989326407333773
2088,R-HSA-5633008,1.2158632836823777,Transcriptomics,TP53 Regulates Transcription of Cell Death Genes,0.3905,0.8777425373134329,-0.22007905419891713
2089,R-HSA-8869496,1.2154740238052413,Transcriptomics,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,0.4028,0.8777425373134329,-0.221089338640809
2090,R-HSA-6783783,1.4140508339023774,Proteomics,Interleukin-10 signaling,0.3846,0.8777425373134329,-0.2215672774570431
2091,R-HSA-8952158,1.2147279939629463,Transcriptomics,RUNX3 regulates BCL2L11 (BIM) transcription,0.7038,0.8854020979020979,-0.2230255832607329
2092,R-HSA-5250913,1.2146531928724518,Transcriptomics,Positive epigenetic regulation of rRNA expression,0.6715,0.8777425373134329,-0.22321972188739816
2093,R-HSA-69205,1.2144699733856212,Transcriptomics,G1/S-Specific Transcription,0.2958,0.8777425373134329,-0.22369524944075916
2094,R-HSA-69278,1.214419052370544,Transcriptomics,"Cell Cycle, Mitotic",0.5031,0.8777425373134329,-0.22382740975914667
2095,R-HSA-5619115,1.4120341571708683,Proteomics,Disorders of transmembrane transporters,0.7076,0.8854020979020979,-0.225967039936706
2096,R-HSA-597592,3.1409260442026317,Metabolomics,Post-translational protein modification,0.6801,0.8786055923473142,-0.22728596088489803
2097,R-HSA-2022923,1.2124916609214629,Transcriptomics,Dermatan sulfate biosynthesis,0.5757,0.8777425373134329,-0.22882975834119584
2098,R-HSA-9022707,1.212215907076663,Transcriptomics,MECP2 regulates transcription factors,0.5856,0.8777425373134329,-0.2295454494143233
2099,R-HSA-425986,1.212015818511609,Transcriptomics,Sodium/Proton exchangers,0.4756,0.8777425373134329,-0.23006475894543021
2100,R-HSA-9603381,1.4101543658573548,Proteomics,Activated NTRK3 signals through PI3K,0.6791,0.8786055923473142,-0.23006816093521348
2101,R-HSA-9669938,1.4100832918711834,Proteomics,Signaling by KIT in disease,0.7768,0.9003598298985933,-0.23022322230561107
2102,R-HSA-9670439,1.4100832918711834,Proteomics,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",0.7768,0.9003598298985933,-0.23022322230561107
2103,R-HSA-70263,1.211857214947623,Transcriptomics,Gluconeogenesis,0.4539,0.8777425373134329,-0.23047639837331685
2104,R-HSA-9013418,1.4098116670877796,Proteomics,RHOBTB2 GTPase cycle,0.5913,0.8777425373134329,-0.2308158232474945
2105,R-HSA-9749641,3.132453941465922,Metabolomics,Aspirin ADME,0.5372,0.8777425373134329,-0.2313789128897985
2106,R-HSA-73772,1.2110825593567316,Transcriptomics,RNA Polymerase I Promoter Escape,0.6628,0.8777425373134329,-0.23248693821384556
2107,R-HSA-512988,1.2110478062502603,Transcriptomics,"Interleukin-3, Interleukin-5 and GM-CSF signaling",0.2917,0.8777425373134329,-0.23257713636895375
2108,R-HSA-68886,1.2109959671470483,Transcriptomics,M Phase,0.5336,0.8777425373134329,-0.23271167949176935
2109,R-HSA-912526,1.2108346016762912,Transcriptomics,Interleukin receptor SHC signaling,0.3582,0.8777425373134329,-0.2331304871679257
2110,R-HSA-8963889,1.2106297080028836,Transcriptomics,Assembly of active LPL and LIPC lipase complexes,0.4818,0.8777425373134329,-0.23366226786931354
2111,R-HSA-3000480,1.2097253583323129,Transcriptomics,Scavenging by Class A Receptors,0.7042,0.8854020979020979,-0.23600941550993051
2112,R-HSA-9013422,1.2095192519654465,Transcriptomics,RHOBTB1 GTPase cycle,0.371,0.8777425373134329,-0.23654434363391733
2113,R-HSA-9735804,1.2094035433222796,Transcriptomics,Diseases of nucleotide metabolism,0.5622,0.8777425373134329,-0.23684465365519128
2114,R-HSA-2173788,1.2093352946570923,Transcriptomics,Downregulation of TGF-beta receptor signaling,0.737,0.8897836538461539,-0.23702178612804162
2115,R-HSA-8863795,1.2092212697556683,Transcriptomics,Downregulation of ERBB2 signaling,0.3447,0.8777425373134329,-0.23731772616877828
2116,R-HSA-9645723,1.4061286193717837,Proteomics,Diseases of programmed cell death,0.45,0.8777425373134329,-0.23885108983160452
2117,R-HSA-2559580,1.2083288841765294,Transcriptomics,Oxidative Stress Induced Senescence,0.6364,0.8777425373134329,-0.23963382222626312
2118,R-HSA-5579029,1.2076516550138603,Transcriptomics,Metabolic disorders of biological oxidation enzymes,0.4067,0.8777425373134329,-0.2413915016759749
2119,R-HSA-8878171,1.4047883710920757,Proteomics,Transcriptional regulation by RUNX1,0.6955,0.8845385174418605,-0.24177509545053166
2120,R-HSA-1500620,1.207415640329571,Transcriptomics,Meiosis,0.657,0.8777425373134329,-0.24200405379757942
2121,R-HSA-74752,1.2071037553728958,Transcriptomics,Signaling by Insulin receptor,0.3461,0.8777425373134329,-0.24281351949876354
2122,R-HSA-264870,1.4042263867220723,Proteomics,Caspase-mediated cleavage of cytoskeletal proteins,0.4136,0.8777425373134329,-0.24300117085799045
2123,R-HSA-110331,1.2063777942540985,Transcriptomics,Cleavage of the damaged purine,0.6652,0.8777425373134329,-0.24469767778688387
2124,R-HSA-73927,1.2063777942540985,Transcriptomics,Depurination,0.6652,0.8777425373134329,-0.24469767778688387
2125,R-HSA-110330,1.2063777942540985,Transcriptomics,Recognition and association of DNA glycosylase with site containing an affected purine,0.6652,0.8777425373134329,-0.24469767778688387
2126,R-HSA-8875656,1.2063588000251049,Transcriptomics,MET receptor recycling,0.4837,0.8777425373134329,-0.24474697537742718
2127,R-HSA-9696273,1.2063481287940423,Transcriptomics,RND1 GTPase cycle,0.5643,0.8777425373134329,-0.24477467147289345
2128,R-HSA-6785807,1.4028356766783292,Proteomics,Interleukin-4 and Interleukin-13 signaling,0.4839,0.8777425373134329,-0.246035268378406
2129,R-HSA-6806942,1.4026096418046434,Proteomics,MET Receptor Activation,0.3691,0.8777425373134329,-0.24652840629228168
2130,R-HSA-5696399,1.2054723581720317,Transcriptomics,Global Genome Nucleotide Excision Repair (GG-NER),0.3657,0.8777425373134329,-0.24704764509810256
2131,R-HSA-556833,1.4020941577762827,Proteomics,Metabolism of lipids,0.6059,0.8777425373134329,-0.24765303239194916
2132,R-HSA-3000497,1.2043157965397622,Transcriptomics,Scavenging by Class H Receptors,0.4418,0.8777425373134329,-0.25004938324734777
2133,R-HSA-3899300,1.4006829866512698,Proteomics,SUMOylation of transcription cofactors,0.6661,0.8777425373134329,-0.25073176963883026
2134,R-HSA-3371599,1.2037455175840988,Transcriptomics,Defective HLCS causes multiple carboxylase deficiency,0.6815,0.8786055923473142,-0.2515294843065256
2135,R-HSA-3323169,1.2037455175840988,Transcriptomics,Defects in biotin (Btn) metabolism,0.6815,0.8786055923473142,-0.2515294843065256
2136,R-HSA-9648895,1.203734983026834,Transcriptomics,Response of EIF2AK1 (HRI) to heme deficiency,0.4406,0.8777425373134329,-0.2515568256790428
2137,R-HSA-8949664,1.2030744258255843,Transcriptomics,Processing of SMDT1,0.4914,0.8777425373134329,-0.253271234747636
2138,R-HSA-5683826,1.2024299730147592,Transcriptomics,Surfactant metabolism,0.3533,0.8777425373134329,-0.2549438465079329
2139,R-HSA-9614399,1.2018555999336389,Transcriptomics,Regulation of localization of FOXO transcription factors,0.6617,0.8777425373134329,-0.25643457345355625
2140,R-HSA-2980736,3.077306249356995,Metabolomics,Peptide hormone metabolism,0.5496,0.8777425373134329,-0.2580212783092869
2141,R-HSA-2032785,1.2007804403788538,Transcriptomics,YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.5507,0.8777425373134329,-0.2592250407854103
2142,R-HSA-3295583,1.1993954801436126,Transcriptomics,TRP channels,0.4788,0.8777425373134329,-0.2628195642913934
2143,R-HSA-1250196,1.395086661613407,Proteomics,SHC1 events in ERBB2 signaling,0.6322,0.8777425373134329,-0.2629412132947611
2144,R-HSA-5334118,1.1991658154116025,Transcriptomics,DNA methylation,0.638,0.8777425373134329,-0.2634156357573456
2145,R-HSA-9673767,1.198721851246407,Transcriptomics,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",0.3265,0.8777425373134329,-0.2645678996180703
2146,R-HSA-9673770,1.198721851246407,Transcriptomics,Signaling by PDGFRA extracellular domain mutants,0.3265,0.8777425373134329,-0.2645678996180703
2147,R-HSA-69563,1.3942199596476135,Proteomics,p53-Dependent G1 DNA Damage Response,0.6781,0.8786055923473142,-0.26483208788589846
2148,R-HSA-69580,1.3942199596476135,Proteomics,p53-Dependent G1/S DNA damage checkpoint,0.6781,0.8786055923473142,-0.26483208788589846
2149,R-HSA-399956,1.3937206819356405,Proteomics,CRMPs in Sema3A signaling,0.3861,0.8777425373134329,-0.26592135683503093
2150,R-HSA-1839117,1.198108425288156,Transcriptomics,Signaling by cytosolic FGFR1 fusion mutants,0.4473,0.8777425373134329,-0.2661599843364665
2151,R-HSA-5655302,1.198108425288156,Transcriptomics,Signaling by FGFR1 in disease,0.4473,0.8777425373134329,-0.2661599843364665
2152,R-HSA-1839124,1.198108425288156,Transcriptomics,FGFR1 mutant receptor activation,0.4473,0.8777425373134329,-0.2661599843364665
2153,R-HSA-196071,1.3929088143772146,Proteomics,Metabolism of steroid hormones,0.2846,0.8777425373134329,-0.2676925997745698
2154,R-HSA-74158,1.1973689826151992,Transcriptomics,RNA Polymerase III Transcription,0.5458,0.8777425373134329,-0.26807913262797484
2155,R-HSA-749476,1.1973689826151992,Transcriptomics,RNA Polymerase III Abortive And Retractive Initiation,0.5458,0.8777425373134329,-0.26807913262797484
2156,R-HSA-3595177,1.197181866283303,Transcriptomics,Defective CHSY1 causes TPBS,0.3855,0.8777425373134329,-0.2685647740465802
2157,R-HSA-5365859,1.196786401421755,Transcriptomics,RA biosynthesis pathway,0.4458,0.8777425373134329,-0.26959116289476004
2158,R-HSA-1474244,1.1961288512447195,Transcriptomics,Extracellular matrix organization,0.4657,0.8777425373134329,-0.271297767537677
2159,R-HSA-9013408,1.3911057328060996,Proteomics,RHOG GTPase cycle,0.7855,0.9003598298985933,-0.27162636393241124
2160,R-HSA-70635,3.0482675277026927,Metabolomics,Urea cycle,0.566,0.8777425373134329,-0.272050156110748
2161,R-HSA-427389,1.1954275348489647,Transcriptomics,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.661,0.8777425373134329,-0.2731179629523366
2162,R-HSA-9012999,1.1953934001633593,Transcriptomics,RHO GTPase cycle,0.38,0.8777425373134329,-0.27320655605895144
2163,R-HSA-9670095,1.1950468567321557,Transcriptomics,Inhibition of DNA recombination at telomere,0.6772,0.8786055923473142,-0.2741059743076554
2164,R-HSA-917977,1.1948832921061892,Transcriptomics,Transferrin endocytosis and recycling,0.5445,0.8777425373134329,-0.2745304896676085
2165,R-HSA-9645135,1.1941867995367015,Transcriptomics,STAT5 Activation,0.4817,0.8777425373134329,-0.2763381653315456
2166,R-HSA-381119,1.1940539407177155,Transcriptomics,Unfolded Protein Response (UPR),0.3356,0.8777425373134329,-0.2766829868908007
2167,R-HSA-9735871,1.19401066200816,Transcriptomics,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.6561,0.8777425373134329,-0.2767953123820655
2168,R-HSA-9013425,1.1938831569593744,Transcriptomics,RHOT1 GTPase cycle,0.6951,0.8845385174418605,-0.27712623877498954
2169,R-HSA-8941855,1.1934536408197318,Transcriptomics,RUNX3 regulates CDKN1A transcription,0.7537,0.8946156451066711,-0.2782410042540689
2170,R-HSA-9013700,1.387643288578577,Proteomics,NOTCH4 Activation and Transmission of Signal to the Nucleus,0.7039,0.8854020979020979,-0.27918034219881394
2171,R-HSA-2142753,1.3876192131950644,Proteomics,Arachidonic acid metabolism,0.5607,0.8777425373134329,-0.27923286721058554
2172,R-HSA-8978868,1.3876192131950644,Proteomics,Fatty acid metabolism,0.5607,0.8777425373134329,-0.27923286721058554
2173,R-HSA-167246,1.1929887300560622,Transcriptomics,Tat-mediated elongation of the HIV-1 transcript,0.3585,0.8777425373134329,-0.2794476328818605
2174,R-HSA-167169,1.1929887300560622,Transcriptomics,HIV Transcription Elongation,0.3585,0.8777425373134329,-0.2794476328818605
2175,R-HSA-167200,1.1929887300560622,Transcriptomics,Formation of HIV-1 elongation complex containing HIV-1 Tat,0.3585,0.8777425373134329,-0.2794476328818605
2176,R-HSA-167152,1.1929887300560622,Transcriptomics,Formation of HIV elongation complex in the absence of HIV Tat,0.3585,0.8777425373134329,-0.2794476328818605
2177,R-HSA-5625900,1.1928481841567218,Transcriptomics,RHO GTPases activate CIT,0.4014,0.8777425373134329,-0.27981240547676517
2178,R-HSA-9615933,1.1928476392996197,Transcriptomics,Postmitotic nuclear pore complex (NPC) reformation,0.4045,0.8777425373134329,-0.2798138195979876
2179,R-HSA-983705,1.19275887150584,Transcriptomics,Signaling by the B Cell Receptor (BCR),0.3397,0.8777425373134329,-0.28004420738328023
2180,R-HSA-5621480,1.3872356138863087,Proteomics,Dectin-2 family,0.7256,0.8861130495464062,-0.28006976180034227
2181,R-HSA-9696273,1.3852827120111468,Proteomics,RND1 GTPase cycle,0.6603,0.8777425373134329,-0.28433038734461125
2182,R-HSA-9013424,1.1910630179098753,Transcriptomics,RHOV GTPase cycle,0.4545,0.8777425373134329,-0.2844456230039527
2183,R-HSA-9027284,1.1907153323960573,Transcriptomics,Erythropoietin activates RAS,0.4578,0.8777425373134329,-0.28534800541198707
2184,R-HSA-5619102,1.1904880376897122,Transcriptomics,SLC transporter disorders,0.5525,0.8777425373134329,-0.2859379257172446
2185,R-HSA-9018519,1.190475436715043,Transcriptomics,Estrogen-dependent gene expression,0.6987,0.8854020979020979,-0.28597063026607883
2186,R-HSA-9671555,1.1902275760760177,Transcriptomics,Signaling by PDGFR in disease,0.402,0.8777425373134329,-0.2866139273590305
2187,R-HSA-5654736,1.1901885567971595,Transcriptomics,Signaling by FGFR1,0.3097,0.8777425373134329,-0.28671519793090205
2188,R-HSA-417957,1.1900585351900486,Transcriptomics,P2Y receptors,0.3191,0.8777425373134329,-0.2870526557951451
2189,R-HSA-451927,1.3834166432525343,Proteomics,Interleukin-2 family signaling,0.7686,0.9001672240802675,-0.28840156998897626
2190,R-HSA-73728,1.1887636259308814,Transcriptomics,RNA Polymerase I Promoter Opening,0.6385,0.8777425373134329,-0.2904134611466296
2191,R-HSA-6804756,1.1885748722166558,Transcriptomics,Regulation of TP53 Activity through Phosphorylation,0.3419,0.8777425373134329,-0.29090335222462665
2192,R-HSA-72312,1.3821164151546543,Proteomics,rRNA processing,0.5128,0.8777425373134329,-0.29123826399683295
2193,R-HSA-912446,1.188073372139908,Transcriptomics,Meiotic recombination,0.6707,0.8777425373134329,-0.29220494469512
2194,R-HSA-400253,1.1878480334771213,Transcriptomics,Circadian Clock,0.3604,0.8777425373134329,-0.2927897882881581
2195,R-HSA-2871796,1.1873722758510223,Transcriptomics,FCERI mediated MAPK activation,0.3709,0.8777425373134329,-0.29402456884477507
2196,R-HSA-389948,1.380664182933406,Proteomics,PD-1 signaling,0.7849,0.9003598298985933,-0.2944065838068326
2197,R-HSA-977225,1.1871072120183306,Transcriptomics,Amyloid fiber formation,0.5522,0.8777425373134329,-0.29471251507814156
2198,R-HSA-5336415,1.3801118979735352,Proteomics,Uptake and function of diphtheria toxin,0.6311,0.8777425373134329,-0.2956114981129068
2199,R-HSA-1280215,1.186613178701475,Transcriptomics,Cytokine Signaling in Immune system,0.3795,0.8777425373134329,-0.2959947283323486
2200,R-HSA-212165,1.1864072477373078,Transcriptomics,Epigenetic regulation of gene expression,0.7227,0.8854020979020979,-0.29652920121646015
2201,R-HSA-5693532,1.186341539133191,Transcriptomics,DNA Double-Strand Break Repair,0.6511,0.8777425373134329,-0.2966997412190052
2202,R-HSA-448424,1.185556308849819,Transcriptomics,Interleukin-17 signaling,0.5442,0.8777425373134329,-0.29873772659892395
2203,R-HSA-5603037,1.1855373949861503,Transcriptomics,IRAK4 deficiency (TLR5),0.3908,0.8777425373134329,-0.298786815609436
2204,R-HSA-74160,1.1852308581995055,Transcriptomics,Gene expression (Transcription),0.4188,0.8777425373134329,-0.29958240067896075
2205,R-HSA-2029485,1.1845292424487273,Transcriptomics,Role of phospholipids in phagocytosis,0.3751,0.8777425373134329,-0.30140337303915354
2206,R-HSA-8853659,1.18442360406551,Transcriptomics,RET signaling,0.4346,0.8777425373134329,-0.3016775467243945
2207,R-HSA-73857,1.1832829441900632,Transcriptomics,RNA Polymerase II Transcription,0.407,0.8777425373134329,-0.3046380134802589
2208,R-HSA-5654733,1.1832564302525006,Transcriptomics,Negative regulation of FGFR4 signaling,0.3251,0.8777425373134329,-0.3047068277099962
2209,R-HSA-5654732,1.1832564302525006,Transcriptomics,Negative regulation of FGFR3 signaling,0.3251,0.8777425373134329,-0.3047068277099962
2210,R-HSA-5654726,1.1832564302525006,Transcriptomics,Negative regulation of FGFR1 signaling,0.3251,0.8777425373134329,-0.3047068277099962
2211,R-HSA-1295596,1.1832564302525006,Transcriptomics,Spry regulation of FGF signaling,0.3251,0.8777425373134329,-0.3047068277099962
2212,R-HSA-5654727,1.1832564302525006,Transcriptomics,Negative regulation of FGFR2 signaling,0.3251,0.8777425373134329,-0.3047068277099962
2213,R-HSA-2428933,1.1830615561588376,Transcriptomics,SHC-related events triggered by IGF1R,0.3579,0.8777425373134329,-0.3052126036106717
2214,R-HSA-6787450,1.1825493320931568,Transcriptomics,tRNA modification in the mitochondrion,0.3384,0.8777425373134329,-0.3065420291043207
2215,R-HSA-174178,1.3746704084168806,Proteomics,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,0.6951,0.8845385174418605,-0.30748313882298295
2216,R-HSA-9748787,1.1821664067190225,Transcriptomics,Azathioprine ADME,0.3481,0.8777425373134329,-0.3075358729875882
2217,R-HSA-2029481,1.1821525258807415,Transcriptomics,FCGR activation,0.3761,0.8777425373134329,-0.30757189929232553
2218,R-HSA-9037628,1.1813311042686847,Transcriptomics,Rhesus blood group biosynthesis,0.6077,0.8777425373134329,-0.3097038155869089
2219,R-HSA-8852135,1.1812701730352029,Transcriptomics,Protein ubiquitination,0.4915,0.8777425373134329,-0.30986195640960257
2220,R-HSA-445717,2.9688475626281075,Metabolomics,Aquaporin-mediated transport,0.5535,0.8777425373134329,-0.31041868342719026
2221,R-HSA-432047,2.9688475626281075,Metabolomics,Passive transport by Aquaporins,0.5535,0.8777425373134329,-0.31041868342719026
2222,R-HSA-112310,1.3727424303284808,Proteomics,Neurotransmitter release cycle,0.4357,0.8777425373134329,-0.3116893884030068
2223,R-HSA-3928663,1.1802738417957643,Transcriptomics,EPHA-mediated growth cone collapse,0.3703,0.8777425373134329,-0.3124478328620651
2224,R-HSA-5693616,1.1802275029808142,Transcriptomics,Presynaptic phase of homologous DNA pairing and strand exchange,0.366,0.8777425373134329,-0.3125681005458145
2225,R-HSA-114604,1.1801597379142417,Transcriptomics,GPVI-mediated activation cascade,0.3733,0.8777425373134329,-0.3127439778876194
2226,R-HSA-1483148,1.1801419937776991,Transcriptomics,Synthesis of PG,0.4831,0.8777425373134329,-0.3127900309902808
2227,R-HSA-975957,1.371683363670573,Proteomics,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.6527,0.8777425373134329,-0.3139999430259274
2228,R-HSA-927802,1.371683363670573,Proteomics,Nonsense-Mediated Decay (NMD),0.6527,0.8777425373134329,-0.3139999430259274
2229,R-HSA-110314,1.1794533986427047,Transcriptomics,Recognition of DNA damage by PCNA-containing replication complex,0.544,0.8777425373134329,-0.3145772096657841
2230,R-HSA-5693606,1.179309461227503,Transcriptomics,DNA Double Strand Break Response,0.6854,0.8789743589743589,-0.3149507845953508
2231,R-HSA-74749,1.1790520631649275,Transcriptomics,Signal attenuation,0.4467,0.8777425373134329,-0.3156188351016248
2232,R-HSA-9607240,1.1789462936237523,Transcriptomics,FLT3 Signaling,0.3639,0.8777425373134329,-0.3158933491940134
2233,R-HSA-6788467,1.3706901676766032,Proteomics,IL-6-type cytokine receptor ligand interactions,0.4173,0.8777425373134329,-0.31616678831200834
2234,R-HSA-9662834,1.178815315996201,Transcriptomics,CD163 mediating an anti-inflammatory response,0.4406,0.8777425373134329,-0.3162332883121276
2235,R-HSA-418597,1.370436345214149,Proteomics,G alpha (z) signalling events,0.7484,0.8945240532241556,-0.3167205501169387
2236,R-HSA-380270,1.17755361576294,Transcriptomics,Recruitment of mitotic centrosome proteins and complexes,0.4693,0.8777425373134329,-0.3195079030126507
2237,R-HSA-380287,1.1775536157629392,Transcriptomics,Centrosome maturation,0.4693,0.8777425373134329,-0.319507903012653
2238,R-HSA-2485179,1.1774278144817325,Transcriptomics,Activation of the phototransduction cascade,0.3896,0.8777425373134329,-0.31983440745001784
2239,R-HSA-9006934,1.176898424162524,Transcriptomics,Signaling by Receptor Tyrosine Kinases,0.3505,0.8777425373134329,-0.3212083862097066
2240,R-HSA-1643685,1.1761413390226003,Transcriptomics,Disease,0.3594,0.8777425373134329,-0.3231733237308278
2241,R-HSA-212300,1.1760883062778325,Transcriptomics,PRC2 methylates histones and DNA,0.6471,0.8777425373134329,-0.323310964828965
2242,R-HSA-5693565,1.176061918451816,Transcriptomics,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,0.6914,0.8829806639912441,-0.3233794517490039
2243,R-HSA-165158,1.1748993038407518,Transcriptomics,Activation of AKT2,0.652,0.8777425373134329,-0.3263968997894105
2244,R-HSA-416700,1.17443267108125,Transcriptomics,Other semaphorin interactions,0.5356,0.8777425373134329,-0.3276079976823394
2245,R-HSA-112412,1.1742535166045414,Transcriptomics,SOS-mediated signalling,0.5206,0.8777425373134329,-0.32807297491514736
2246,R-HSA-450294,1.173560935931508,Transcriptomics,MAP kinase activation,0.6448,0.8777425373134329,-0.32987049764949106
2247,R-HSA-68616,1.1735551822619295,Transcriptomics,Assembly of the ORC complex at the origin of replication,0.6676,0.8777425373134329,-0.3298854307140076
2248,R-HSA-9694614,1.1732075071169916,Transcriptomics,Attachment and Entry,0.4205,0.8777425373134329,-0.33078778621066746
2249,R-HSA-173623,1.1729392098873266,Transcriptomics,Classical antibody-mediated complement activation,0.3666,0.8777425373134329,-0.3314841243971954
2250,R-HSA-166786,1.1729392098873266,Transcriptomics,Creation of C4 and C2 activators,0.3666,0.8777425373134329,-0.3314841243971954
2251,R-HSA-204174,1.1722789384473946,Transcriptomics,Regulation of pyruvate dehydrogenase (PDH) complex,0.6355,0.8777425373134329,-0.3331977918013368
2252,R-HSA-1663150,1.1719320817064547,Transcriptomics,The activation of arylsulfatases,0.4411,0.8777425373134329,-0.3340980232136128
2253,R-HSA-9013407,1.1715702598193052,Transcriptomics,RHOH GTPase cycle,0.4235,0.8777425373134329,-0.33503709514163216
2254,R-HSA-606279,1.1710587916324933,Transcriptomics,Deposition of new CENPA-containing nucleosomes at the centromere,0.7131,0.8854020979020979,-0.336364558828514
2255,R-HSA-774815,1.1710587916324933,Transcriptomics,Nucleosome assembly,0.7131,0.8854020979020979,-0.336364558828514
2256,R-HSA-71406,1.1705115904898111,Transcriptomics,Pyruvate metabolism and Citric Acid (TCA) cycle,0.4583,0.8777425373134329,-0.33778476377001493
2257,R-HSA-5619063,2.910513201351923,Metabolomics,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),0.5821,0.8777425373134329,-0.33860055850117876
2258,R-HSA-212436,1.1701600214401455,Transcriptomics,Generic Transcription Pathway,0.3989,0.8777425373134329,-0.33869722550057074
2259,R-HSA-75072,1.1699119895674417,Transcriptomics,mRNA Editing,0.527,0.8777425373134329,-0.3393409670131288
2260,R-HSA-2219528,1.1695853905191855,Transcriptomics,PI3K/AKT Signaling in Cancer,0.4467,0.8777425373134329,-0.340188621643288
2261,R-HSA-6803204,1.1694289712223673,Transcriptomics,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,0.6162,0.8777425373134329,-0.3405945920277767
2262,R-HSA-2559582,1.1693466507247618,Transcriptomics,Senescence-Associated Secretory Phenotype (SASP),0.6444,0.8777425373134329,-0.34080824651123237
2263,R-HSA-69186,1.1692114859937621,Transcriptomics,Lagging Strand Synthesis,0.3452,0.8777425373134329,-0.3411590528307176
2264,R-HSA-75067,1.1688200347880755,Transcriptomics,Processing of Capped Intronless Pre-mRNA,0.6419,0.8777425373134329,-0.3421750246431076
2265,R-HSA-9013405,1.1687688970390293,Transcriptomics,RHOD GTPase cycle,0.5129,0.8777425373134329,-0.3423077474724801
2266,R-HSA-6783310,1.1687480687238632,Transcriptomics,Fanconi Anemia Pathway,0.3925,0.8777425373134329,-0.3423618052472448
2267,R-HSA-4419969,1.3583556234031433,Proteomics,Depolymerisation of the Nuclear Lamina,0.7187,0.8854020979020979,-0.3430769342219583
2268,R-HSA-9020558,1.167741251723399,Transcriptomics,Interleukin-2 signaling,0.4831,0.8777425373134329,-0.3449748964265464
2269,R-HSA-73929,1.1674558038062661,Transcriptomics,"Base-Excision Repair, AP Site Formation",0.6967,0.8850998185117968,-0.3457157474789877
2270,R-HSA-532668,1.1674236396929067,Transcriptomics,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,0.6823,0.8786055923473142,-0.3457992261656514
2271,R-HSA-5621481,1.1670505279098575,Transcriptomics,C-type lectin receptors (CLRs),0.4823,0.8777425373134329,-0.346767599870833
2272,R-HSA-2730905,1.1660004370697137,Transcriptomics,Role of LAT2/NTAL/LAB on calcium mobilization,0.3827,0.8777425373134329,-0.34949300390213167
2273,R-HSA-9754706,1.1659570184262982,Transcriptomics,Atorvastatin ADME,0.4096,0.8777425373134329,-0.3496056925775057
2274,R-HSA-1630316,1.1655170729310584,Transcriptomics,Glycosaminoglycan metabolism,0.4677,0.8777425373134329,-0.3507475263888679
2275,R-HSA-8941326,1.1649405747670478,Transcriptomics,RUNX2 regulates bone development,0.3821,0.8777425373134329,-0.35224376877111324
2276,R-HSA-5625886,1.1649403530635805,Transcriptomics,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,0.6703,0.8777425373134329,-0.3522443441799261
2277,R-HSA-5576891,1.1624211344912023,Transcriptomics,Cardiac conduction,0.5629,0.8777425373134329,-0.35878271989982224
2278,R-HSA-9027276,1.3510884088460944,Proteomics,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.6668,0.8777425373134329,-0.3589317400221115
2279,R-HSA-392154,1.162295142735815,Transcriptomics,Nitric oxide stimulates guanylate cyclase,0.4178,0.8777425373134329,-0.3591097186935608
2280,R-HSA-9662360,1.161967480659888,Transcriptomics,Sensory processing of sound by inner hair cells of the cochlea,0.4684,0.8777425373134329,-0.3599601323039801
2281,R-HSA-171306,1.161804556865732,Transcriptomics,Packaging Of Telomere Ends,0.6848,0.8789743589743589,-0.36038298445011113
2282,R-HSA-2142700,1.161327085666995,Transcriptomics,Synthesis of Lipoxins (LX),0.4819,0.8777425373134329,-0.3616222124103213
2283,R-HSA-1433617,1.1610208281091214,Transcriptomics,Regulation of signaling by NODAL,0.4524,0.8777425373134329,-0.3624170727699546
2284,R-HSA-8951936,1.34916653625443,Proteomics,RUNX3 regulates p14-ARF,0.4411,0.8777425373134329,-0.3631246693039254
2285,R-HSA-170984,1.348982084422739,Proteomics,ARMS-mediated activation,0.6818,0.8786055923473142,-0.36352708593109223
2286,R-HSA-9013404,1.1603973053353815,Transcriptomics,RAC2 GTPase cycle,0.4966,0.8777425373134329,-0.36403536274658604
2287,R-HSA-5693579,1.1598175479946913,Transcriptomics,Homologous DNA Pairing and Strand Exchange,0.3906,0.8777425373134329,-0.36554006399060013
2288,R-HSA-180746,1.159811690790884,Transcriptomics,Nuclear import of Rev protein,0.6501,0.8777425373134329,-0.36555526576768294
2289,R-HSA-177243,1.159811690790884,Transcriptomics,Interactions of Rev with host cellular proteins,0.6501,0.8777425373134329,-0.36555526576768294
2290,R-HSA-71384,1.1589664987457473,Transcriptomics,Ethanol oxidation,0.6305,0.8777425373134329,-0.36774887580500265
2291,R-HSA-9669938,1.1587000765904654,Transcriptomics,Signaling by KIT in disease,0.4719,0.8777425373134329,-0.36844034742657517
2292,R-HSA-9670439,1.1587000765904654,Transcriptomics,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",0.4719,0.8777425373134329,-0.36844034742657517
2293,R-HSA-5218920,1.1586640640832375,Transcriptomics,VEGFR2 mediated vascular permeability,0.3678,0.8777425373134329,-0.3685338142283258
2294,R-HSA-9020958,1.1585882416126707,Transcriptomics,Interleukin-21 signaling,0.5208,0.8777425373134329,-0.3687306037431429
2295,R-HSA-2028269,1.3463688685951523,Proteomics,Signaling by Hippo,0.7927,0.902319257837492,-0.3692283115017734
2296,R-HSA-9639288,1.1579036606433497,Transcriptomics,Amino acids regulate mTORC1,0.4802,0.8777425373134329,-0.37050736405969065
2297,R-HSA-442660,2.842133207634468,Metabolomics,Na+/Cl- dependent neurotransmitter transporters,0.54,0.8777425373134329,-0.3716355724851613
2298,R-HSA-888590,2.842133207634468,Metabolomics,"GABA synthesis, release, reuptake and degradation",0.54,0.8777425373134329,-0.3716355724851613
2299,R-HSA-888593,2.842133207634468,Metabolomics,Reuptake of GABA,0.54,0.8777425373134329,-0.3716355724851613
2300,R-HSA-5619507,1.1565535733710526,Transcriptomics,Activation of HOX genes during differentiation,0.7107,0.8854020979020979,-0.37401137833527426
2301,R-HSA-5617472,1.1565535733710508,Transcriptomics,Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.7107,0.8854020979020979,-0.37401137833527887
2302,R-HSA-418990,1.1551232707723018,Transcriptomics,Adherens junctions interactions,0.5057,0.8777425373134329,-0.37772358333658473
2303,R-HSA-351202,2.825680122230057,Metabolomics,Metabolism of polyamines,0.7103,0.8854020979020979,-0.37958421180004953
2304,R-HSA-450520,1.3414672023724916,Proteomics,HuR (ELAVL1) binds and stabilizes mRNA,0.7382,0.8897836538461539,-0.3799222253042872
2305,R-HSA-9755088,1.1532177786352447,Transcriptomics,Ribavirin ADME,0.4867,0.8777425373134329,-0.38266909448039405
2306,R-HSA-456926,1.3399211214119495,Proteomics,Thrombin signalling through proteinase activated receptors (PARs),0.7063,0.8854020979020979,-0.3832952939247716
2307,R-HSA-2894858,1.152937540229318,Transcriptomics,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,0.7099,0.8854020979020979,-0.38339642477605923
2308,R-HSA-2894862,1.152937540229318,Transcriptomics,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.7099,0.8854020979020979,-0.38339642477605923
2309,R-HSA-2644606,1.152937540229318,Transcriptomics,Constitutive Signaling by NOTCH1 PEST Domain Mutants,0.7099,0.8854020979020979,-0.38339642477605923
2310,R-HSA-2644603,1.152937540229318,Transcriptomics,Signaling by NOTCH1 in Cancer,0.7099,0.8854020979020979,-0.38339642477605923
2311,R-HSA-2644602,1.152937540229318,Transcriptomics,Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.7099,0.8854020979020979,-0.38339642477605923
2312,R-HSA-180336,1.1525683321930813,Transcriptomics,SHC1 events in EGFR signaling,0.4266,0.8777425373134329,-0.38435466670321444
2313,R-HSA-69615,1.3393363988947613,Proteomics,G1/S DNA Damage Checkpoints,0.7012,0.8854020979020979,-0.38457097690952724
2314,R-HSA-196025,1.1524157601340688,Transcriptomics,Formation of annular gap junctions,0.3465,0.8777425373134329,-0.38475065197305963
2315,R-HSA-190873,1.1524157601340688,Transcriptomics,Gap junction degradation,0.3465,0.8777425373134329,-0.38475065197305963
2316,R-HSA-211736,1.1524059245139737,Transcriptomics,Stimulation of the cell death response by PAK-2p34,0.6943,0.8845385174418605,-0.38477617932520153
2317,R-HSA-73817,1.339013179790506,Proteomics,Purine ribonucleoside monophosphate biosynthesis,0.5205,0.8777425373134329,-0.3852761406402301
2318,R-HSA-8956320,1.339013179790506,Proteomics,Nucleotide biosynthesis,0.5205,0.8777425373134329,-0.3852761406402301
2319,R-HSA-1428517,1.3380205322798873,Proteomics,The citric acid (TCA) cycle and respiratory electron transport,0.4762,0.8777425373134329,-0.38744178930593526
2320,R-HSA-2871809,1.1493367593766388,Transcriptomics,FCERI mediated Ca+2 mobilization,0.3891,0.8777425373134329,-0.39274188545103356
2321,R-HSA-9711123,1.1486532136840144,Transcriptomics,Cellular response to chemical stress,0.4424,0.8777425373134329,-0.3945159588121536
2322,R-HSA-162599,1.1479872301986798,Transcriptomics,Late Phase of HIV Life Cycle,0.4201,0.8777425373134329,-0.3962444512494943
2323,R-HSA-109582,1.1473653344557313,Transcriptomics,Hemostasis,0.5379,0.8777425373134329,-0.3978585184330982
2324,R-HSA-8853659,1.333125920934975,Proteomics,RET signaling,0.6373,0.8777425373134329,-0.3981203115556379
2325,R-HSA-9013423,1.1469118232313786,Transcriptomics,RAC3 GTPase cycle,0.4608,0.8777425373134329,-0.39903556071538365
2326,R-HSA-2024101,1.14615608751119,Transcriptomics,CS/DS degradation,0.5147,0.8777425373134329,-0.4009969959547543
2327,R-HSA-71737,1.1458841806211804,Transcriptomics,Pyrophosphate hydrolysis,0.5748,0.8777425373134329,-0.4017027026477759
2328,R-HSA-8941856,1.145829345901572,Transcriptomics,RUNX3 regulates NOTCH signaling,0.6833,0.8788546255506609,-0.40184502058843635
2329,R-HSA-392517,1.3313436056341084,Proteomics,Rap1 signalling,0.7448,0.8923563611491109,-0.4020087701594194
2330,R-HSA-8980692,1.145698535256178,Transcriptomics,RHOA GTPase cycle,0.4927,0.8777425373134329,-0.40218452632133567
2331,R-HSA-194138,1.145567075956405,Transcriptomics,Signaling by VEGF,0.3961,0.8777425373134329,-0.4025257155707381
2332,R-HSA-196854,1.145528849447021,Transcriptomics,Metabolism of vitamins and cofactors,0.5182,0.8777425373134329,-0.4026249285900261
2333,R-HSA-74751,1.1453474829902133,Transcriptomics,Insulin receptor signalling cascade,0.4577,0.8777425373134329,-0.403095646792328
2334,R-HSA-114516,1.3308098853626917,Proteomics,Disinhibition of SNARE formation,0.7091,0.8854020979020979,-0.40317318207934927
2335,R-HSA-5099900,1.3308098853626917,Proteomics,WNT5A-dependent internalization of FZD4,0.7091,0.8854020979020979,-0.40317318207934927
2336,R-HSA-416993,1.3308098853626917,Proteomics,Trafficking of GluR2-containing AMPA receptors,0.7091,0.8854020979020979,-0.40317318207934927
2337,R-HSA-194068,1.145268399382912,Transcriptomics,Bile acid and bile salt metabolism,0.5058,0.8777425373134329,-0.4033009002560369
2338,R-HSA-162658,1.144976207166357,Transcriptomics,Golgi Cisternae Pericentriolar Stack Reorganization,0.6982,0.8854020979020979,-0.4040592554520542
2339,R-HSA-388844,1.1447960447597163,Transcriptomics,Receptor-type tyrosine-protein phosphatases,0.5477,0.8777425373134329,-0.404526848664542
2340,R-HSA-140875,1.1446638533653122,Transcriptomics,Common Pathway of Fibrin Clot Formation,0.5134,0.8777425373134329,-0.4048699379911403
2341,R-HSA-9675135,1.1444860273484967,Transcriptomics,Diseases of DNA repair,0.4393,0.8777425373134329,-0.4053314673413366
2342,R-HSA-5619115,2.7716232012595476,Metabolomics,Disorders of transmembrane transporters,0.6431,0.8777425373134329,-0.4056996154891839
2343,R-HSA-421270,1.1440241752712361,Transcriptomics,Cell-cell junction organization,0.5541,0.8777425373134329,-0.4065301574594765
2344,R-HSA-111457,1.3280851527870192,Proteomics,Release of apoptotic factors from the mitochondria,0.3498,0.8777425373134329,-0.40911770257004215
2345,R-HSA-3000480,1.327832496380799,Proteomics,Scavenging by Class A Receptors,0.3233,0.8777425373134329,-0.4096689204023133
2346,R-HSA-389957,1.1426077937623504,Transcriptomics,Prefoldin mediated transfer of substrate  to CCT/TriC,0.4475,0.8777425373134329,-0.4102062316871549
2347,R-HSA-3065678,1.1414098793335006,Transcriptomics,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",0.3858,0.8777425373134329,-0.4133152968163118
2348,R-HSA-3215018,1.1414098793335006,Transcriptomics,Processing and activation of SUMO,0.3858,0.8777425373134329,-0.4133152968163118
2349,R-HSA-445355,1.3258926391892112,Proteomics,Smooth Muscle Contraction,0.7268,0.8869595536959554,-0.41390108649720636
2350,R-HSA-110329,1.141021915854767,Transcriptomics,Cleavage of the damaged pyrimidine ,0.7087,0.8854020979020979,-0.4143222165879311
2351,R-HSA-110328,1.141021915854767,Transcriptomics,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,0.7087,0.8854020979020979,-0.4143222165879311
2352,R-HSA-73928,1.141021915854767,Transcriptomics,Depyrimidination,0.7087,0.8854020979020979,-0.4143222165879311
2353,R-HSA-69166,1.140878522078992,Transcriptomics,Removal of the Flap Intermediate,0.4406,0.8777425373134329,-0.41469438055662783
2354,R-HSA-2122948,1.1408238646506106,Transcriptomics,Activated NOTCH1 Transmits Signal to the Nucleus,0.4309,0.8777425373134329,-0.41483623835593114
2355,R-HSA-3371556,1.1402077762293168,Transcriptomics,Cellular response to heat stress,0.5768,0.8777425373134329,-0.41643523322650877
2356,R-HSA-112316,2.7443215770985865,Metabolomics,Neuronal System,0.6558,0.8777425373134329,-0.41888928525823155
2357,R-HSA-112310,2.7443215770985865,Metabolomics,Neurotransmitter release cycle,0.6558,0.8777425373134329,-0.41888928525823155
2358,R-HSA-112315,2.7443215770985865,Metabolomics,Transmission across Chemical Synapses,0.6558,0.8777425373134329,-0.41888928525823155
2359,R-HSA-446652,1.1391046920210472,Transcriptomics,Interleukin-1 family signaling,0.5118,0.8777425373134329,-0.41929817615787257
2360,R-HSA-933541,1.3231412194007086,Proteomics,TRAF6 mediated IRF7 activation,0.315,0.8777425373134329,-0.419903830200307
2361,R-HSA-174824,1.3224405646360864,Proteomics,"Plasma lipoprotein assembly, remodeling, and clearance",0.7332,0.8897836538461539,-0.4214324413537045
2362,R-HSA-446203,1.3218302808041176,Proteomics,Asparagine N-linked glycosylation,0.6419,0.8777425373134329,-0.4227638911908988
2363,R-HSA-5663202,1.1373021851008729,Transcriptomics,Diseases of signal transduction by growth factor receptors and second messengers,0.4577,0.8777425373134329,-0.4239763996399611
2364,R-HSA-5362517,1.1371548587948939,Transcriptomics,Signaling by Retinoic Acid,0.4493,0.8777425373134329,-0.42435877009105133
2365,R-HSA-6802957,1.1370300336886898,Transcriptomics,Oncogenic MAPK signaling,0.4297,0.8777425373134329,-0.42468274096542746
2366,R-HSA-111446,1.3204997478637983,Proteomics,Activation of BIM and translocation to mitochondria ,0.4462,0.8777425373134329,-0.42566670095574977
2367,R-HSA-8935964,1.1364948217769577,Transcriptomics,RUNX1 regulates expression of components of tight junctions,0.7398,0.8897836538461539,-0.4260718290767322
2368,R-HSA-1169410,1.1359658935082035,Transcriptomics,Antiviral mechanism by IFN-stimulated genes,0.3727,0.8777425373134329,-0.42744460863143524
2369,R-HSA-6811436,1.135474857569465,Transcriptomics,COPI-independent Golgi-to-ER retrograde traffic,0.5691,0.8777425373134329,-0.42871904249543025
2370,R-HSA-5684264,1.134211851274328,Transcriptomics,MAP3K8 (TPL2)-dependent MAPK1/3 activation,0.7195,0.8854020979020979,-0.4319970469467887
2371,R-HSA-426486,1.134063532334912,Transcriptomics,Small interfering RNA (siRNA) biogenesis,0.3963,0.8777425373134329,-0.4323819936770611
2372,R-HSA-140534,1.3169516658092029,Proteomics,Caspase activation via Death Receptors in the presence of ligand,0.3571,0.8777425373134329,-0.43340751437153846
2373,R-HSA-180292,1.1336016923586811,Transcriptomics,GAB1 signalosome,0.4335,0.8777425373134329,-0.4335806523882084
2374,R-HSA-9020702,1.132581626707967,Transcriptomics,Interleukin-1 signaling,0.4621,0.8777425373134329,-0.4362281290924762
2375,R-HSA-447115,1.1323134329618378,Transcriptomics,Interleukin-12 family signaling,0.4097,0.8777425373134329,-0.4369241986980059
2376,R-HSA-9664535,1.1320239909221497,Transcriptomics,LTC4-CYSLTR mediated IL4 production,0.5295,0.8777425373134329,-0.43767541608952737
2377,R-HSA-877312,1.3141292937199944,Proteomics,Regulation of IFNG signaling,0.7543,0.8946156451066711,-0.4395650539651326
2378,R-HSA-9749641,1.3138723923522468,Proteomics,Aspirin ADME,0.3687,0.8777425373134329,-0.44012553298545837
2379,R-HSA-9665686,1.1309431942658443,Transcriptomics,Signaling by ERBB2 TMD/JMD mutants,0.4134,0.8777425373134329,-0.4404805139453521
2380,R-HSA-9664565,1.1309431942658434,Transcriptomics,Signaling by ERBB2 KD Mutants,0.4134,0.8777425373134329,-0.4404805139453544
2381,R-HSA-3301854,1.1308778206384784,Transcriptomics,Nuclear Pore Complex (NPC) Disassembly,0.7969,0.902319257837492,-0.4406501845497917
2382,R-HSA-1500931,1.3135486360952382,Proteomics,Cell-Cell communication,0.667,0.8777425373134329,-0.44083186861669105
2383,R-HSA-9754560,1.1306219015114507,Transcriptomics,SARS-CoV-2 modulates autophagy,0.4352,0.8777425373134329,-0.4413143966291888
2384,R-HSA-434316,1.1291025180775083,Transcriptomics,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,0.4742,0.8777425373134329,-0.4452578018829551
2385,R-HSA-1480926,1.1288011227212111,Transcriptomics,O2/CO2 exchange in erythrocytes,0.6425,0.8777425373134329,-0.44604004289265137
2386,R-HSA-1237044,1.1288011227212111,Transcriptomics,Erythrocytes take up carbon dioxide and release oxygen,0.6425,0.8777425373134329,-0.44604004289265137
2387,R-HSA-8868773,1.3095517701402073,Proteomics,rRNA processing in the nucleus and cytosol,0.6511,0.8777425373134329,-0.4495517891624238
2388,R-HSA-6791226,1.3095517701402073,Proteomics,Major pathway of rRNA processing in the nucleolus and cytosol,0.6511,0.8777425373134329,-0.4495517891624238
2389,R-HSA-381340,1.12742288210117,Transcriptomics,Transcriptional regulation of white adipocyte differentiation,0.6344,0.8777425373134329,-0.449617126320448
2390,R-HSA-163210,1.3094672866122912,Proteomics,Formation of ATP by chemiosmotic coupling,0.428,0.8777425373134329,-0.4497361059894428
2391,R-HSA-8949613,1.3094672866122912,Proteomics,Cristae formation,0.428,0.8777425373134329,-0.4497361059894428
2392,R-HSA-418594,1.3092418597738416,Proteomics,G alpha (i) signalling events,0.7817,0.9003598298985933,-0.4502279173592192
2393,R-HSA-2453864,1.1271618980543463,Transcriptomics,Retinoid cycle disease events,0.7104,0.8854020979020979,-0.4502944838843142
2394,R-HSA-2474795,1.1271618980543463,Transcriptomics,Diseases associated with visual transduction,0.7104,0.8854020979020979,-0.4502944838843142
2395,R-HSA-9675143,1.1271618980543463,Transcriptomics,Diseases of the neuronal system,0.7104,0.8854020979020979,-0.4502944838843142
2396,R-HSA-418038,1.1266457745098175,Transcriptomics,Nucleotide-like (purinergic) receptors,0.3847,0.8777425373134329,-0.4516340300789217
2397,R-HSA-9725370,1.1261482438430501,Transcriptomics,Signaling by ALK fusions and activated point mutants,0.5726,0.8777425373134329,-0.45292532034931093
2398,R-HSA-9700206,1.1261482438430501,Transcriptomics,Signaling by ALK in cancer,0.5726,0.8777425373134329,-0.45292532034931093
2399,R-HSA-2408550,1.1261273248164332,Transcriptomics,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,0.4463,0.8777425373134329,-0.45297961355642513
2400,R-HSA-174362,1.1261273248164332,Transcriptomics,Transport and synthesis of PAPS,0.4463,0.8777425373134329,-0.45297961355642513
2401,R-HSA-8873719,1.1257932660246976,Transcriptomics,RAB geranylgeranylation,0.6176,0.8777425373134329,-0.45384662919248386
2402,R-HSA-2565942,1.125632401349865,Transcriptomics,Regulation of PLK1 Activity at G2/M Transition,0.6912,0.8829806639912441,-0.4542641371037253
2403,R-HSA-1461973,1.307292081417915,Proteomics,Defensins,0.2974,0.8777425373134329,-0.45448172835432366
2404,R-HSA-9020591,1.125050840089246,Transcriptomics,Interleukin-12 signaling,0.4309,0.8777425373134329,-0.4557735202385417
2405,R-HSA-8951936,1.1248842209427699,Transcriptomics,RUNX3 regulates p14-ARF,0.7889,0.9014183240952072,-0.45620596329597807
2406,R-HSA-166658,1.3063083632026027,Proteomics,Complement cascade,0.3921,0.8777425373134329,-0.4566278960700851
2407,R-HSA-9006335,1.1247054769513736,Transcriptomics,Signaling by Erythropoietin,0.4715,0.8777425373134329,-0.4566698751558845
2408,R-HSA-3371568,1.1246841592970127,Transcriptomics,Attenuation phase,0.6057,0.8777425373134329,-0.45672520296078656
2409,R-HSA-5693607,1.1240751751424627,Transcriptomics,Processing of DNA double-strand break ends,0.7254,0.8861130495464062,-0.45830575942919677
2410,R-HSA-69473,1.1236055399439846,Transcriptomics,G2/M DNA damage checkpoint,0.7372,0.8897836538461539,-0.4595246498472834
2411,R-HSA-9755511,1.123309486644906,Transcriptomics,KEAP1-NFE2L2 pathway,0.507,0.8777425373134329,-0.46029302609050204
2412,R-HSA-1566948,1.1232268837720947,Transcriptomics,Elastic fibre formation,0.5641,0.8777425373134329,-0.4605074134501005
2413,R-HSA-2730905,1.304464258227693,Proteomics,Role of LAT2/NTAL/LAB on calcium mobilization,0.7576,0.8967196482921881,-0.46065116055784244
2414,R-HSA-166663,1.1231665432149607,Transcriptomics,Initial triggering of complement,0.3965,0.8777425373134329,-0.460664021232377
2415,R-HSA-422085,1.123102608267973,Transcriptomics,"Synthesis, secretion, and deacylation of Ghrelin",0.5227,0.8777425373134329,-0.4608299578881404
2416,R-HSA-193775,1.1223226587031905,Transcriptomics,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,0.5259,0.8777425373134329,-0.462854237699758
2417,R-HSA-5083635,1.3030802522738276,Proteomics,Defective B3GALTL causes PpS,0.5759,0.8777425373134329,-0.46367063183566626
2418,R-HSA-5173214,1.3030802522738276,Proteomics,O-glycosylation of TSR domain-containing proteins,0.5759,0.8777425373134329,-0.46367063183566626
2419,R-HSA-159854,1.1219328351802678,Transcriptomics,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",0.6191,0.8777425373134329,-0.46386598502699217
2420,R-HSA-159782,1.1219328351802678,Transcriptomics,Removal of aminoterminal propeptides from gamma-carboxylated proteins,0.6191,0.8777425373134329,-0.46386598502699217
2421,R-HSA-2559586,1.121174925295528,Transcriptomics,DNA Damage/Telomere Stress Induced Senescence,0.7332,0.8897836538461539,-0.46583306308944594
2422,R-HSA-2179392,1.3015064558037406,Proteomics,EGFR Transactivation by Gastrin,0.7175,0.8854020979020979,-0.4671041670927193
2423,R-HSA-449147,1.1203170691116346,Transcriptomics,Signaling by Interleukins,0.4856,0.8777425373134329,-0.4680595416115683
2424,R-HSA-193807,1.1202468704434643,Transcriptomics,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,0.4455,0.8777425373134329,-0.4682417351189387
2425,R-HSA-164952,1.30084151969332,Proteomics,The role of Nef in HIV-1 replication and disease pathogenesis,0.8479,0.913966738527872,-0.46855485123276586
2426,R-HSA-1483226,1.1191197112936557,Transcriptomics,Synthesis of PI,0.7594,0.8969559367642113,-0.47116716211379045
2427,R-HSA-109704,1.1188636670382746,Transcriptomics,PI3K Cascade,0.5468,0.8777425373134329,-0.4718316989511093
2428,R-HSA-112399,1.1188636670382746,Transcriptomics,IRS-mediated signalling,0.5468,0.8777425373134329,-0.4718316989511093
2429,R-HSA-937072,1.1183926237921786,Transcriptomics,TRAF6-mediated induction of TAK1 complex within TLR4 complex,0.7681,0.9001672240802675,-0.4730542438136567
2430,R-HSA-111367,1.118037650350636,Transcriptomics,SLBP independent Processing of Histone Pre-mRNAs,0.5427,0.8777425373134329,-0.47397554129726466
2431,R-HSA-77588,1.118037650350636,Transcriptomics,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,0.5427,0.8777425373134329,-0.47397554129726466
2432,R-HSA-9645135,1.2983240961590967,Proteomics,STAT5 Activation,0.6316,0.8777425373134329,-0.4740470877614276
2433,R-HSA-4420097,1.117842256863982,Transcriptomics,VEGFA-VEGFR2 Pathway,0.4572,0.8777425373134329,-0.4744826652296504
2434,R-HSA-9675136,1.1175461337385184,Transcriptomics,Diseases of DNA Double-Strand Break Repair,0.4495,0.8777425373134329,-0.4752512227001535
2435,R-HSA-9701190,1.1175461337385184,Transcriptomics,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,0.4495,0.8777425373134329,-0.4752512227001535
2436,R-HSA-71240,1.1162082476516257,Transcriptomics,Tryptophan catabolism,0.5354,0.8777425373134329,-0.4787235700393001
2437,R-HSA-3906995,1.1148827549014007,Transcriptomics,Diseases associated with O-glycosylation of proteins,0.4838,0.8777425373134329,-0.4821637517329389
2438,R-HSA-8851805,1.114760683089525,Transcriptomics,MET activates RAS signaling,0.529,0.8777425373134329,-0.48248057671176503
2439,R-HSA-3781865,1.11470808049175,Transcriptomics,Diseases of glycosylation,0.4999,0.8777425373134329,-0.48261710140710756
2440,R-HSA-1257604,1.1145404638527283,Transcriptomics,PIP3 activates AKT signaling,0.4928,0.8777425373134329,-0.48305213335504815
2441,R-HSA-69478,1.1145309281932765,Transcriptomics,G2/M DNA replication checkpoint,0.4956,0.8777425373134329,-0.4830768821898323
2442,R-HSA-9013420,1.2939247576531208,Proteomics,RHOU GTPase cycle,0.7402,0.8897836538461539,-0.4836450784515098
2443,R-HSA-162582,1.112650248879601,Transcriptomics,Signal Transduction,0.4626,0.8777425373134329,-0.48795799417283836
2444,R-HSA-9748784,1.112236821481142,Transcriptomics,Drug ADME,0.45,0.8777425373134329,-0.48903100295963564
2445,R-HSA-9635486,1.1116727957631936,Transcriptomics,Infection with Mycobacterium tuberculosis,0.6015,0.8777425373134329,-0.49049487437598116
2446,R-HSA-77111,1.1115340243308025,Transcriptomics,Synthesis of Ketone Bodies,0.4573,0.8777425373134329,-0.4908550415222976
2447,R-HSA-419037,1.289887612251498,Proteomics,NCAM1 interactions,0.4071,0.8777425373134329,-0.49245287624352974
2448,R-HSA-9627069,1.110902936342436,Transcriptomics,Regulation of the apoptosome activity,0.5758,0.8777425373134329,-0.49249296624446964
2449,R-HSA-111458,1.110902936342436,Transcriptomics,Formation of apoptosome,0.5758,0.8777425373134329,-0.49249296624446964
2450,R-HSA-983168,1.1106986851580563,Transcriptomics,Antigen processing: Ubiquitination & Proteasome degradation,0.5171,0.8777425373134329,-0.4930230794308965
2451,R-HSA-5693538,1.1105646312988386,Transcriptomics,Homology Directed Repair,0.7537,0.8946156451066711,-0.49337100259559413
2452,R-HSA-8939211,1.1099121296636645,Transcriptomics,ESR-mediated signaling,0.7141,0.8854020979020979,-0.4950645042613062
2453,R-HSA-216083,1.1098793333587569,Transcriptomics,Integrin cell surface interactions,0.639,0.8777425373134329,-0.49514962373686955
2454,R-HSA-5633007,1.1097186388077265,Transcriptomics,Regulation of TP53 Activity,0.5411,0.8777425373134329,-0.49556669010907595
2455,R-HSA-9673767,1.288259362735435,Proteomics,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",0.8542,0.9176488643339472,-0.49600521114003154
2456,R-HSA-9673770,1.288259362735435,Proteomics,Signaling by PDGFRA extracellular domain mutants,0.8542,0.9176488643339472,-0.49600521114003154
2457,R-HSA-1368108,1.1091978184597853,Transcriptomics,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.5357,0.8777425373134329,-0.4969184263794989
2458,R-HSA-2173782,1.1089627532896698,Transcriptomics,Binding and Uptake of Ligands by Scavenger Receptors,0.4012,0.8777425373134329,-0.49752851413358595
2459,R-HSA-75153,1.1089136322237807,Transcriptomics,Apoptotic execution phase,0.6816,0.8786055923473142,-0.4976560028668249
2460,R-HSA-8854691,1.2869959722310405,Proteomics,Interleukin-20 family signaling,0.752,0.8946156451066711,-0.4987615369564346
2461,R-HSA-9683701,1.1078770398363278,Transcriptomics,Translation of Structural Proteins,0.5419,0.8777425373134329,-0.5003463730363148
2462,R-HSA-5693567,1.1076119360422072,Transcriptomics,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),0.7558,0.8948917456021651,-0.5010344229855077
2463,R-HSA-9006925,1.107607459562645,Transcriptomics,Intracellular signaling by second messengers,0.4844,0.8777425373134329,-0.5010460412331661
2464,R-HSA-2160916,1.285601770622668,Proteomics,Hyaluronan uptake and degradation,0.3416,0.8777425373134329,-0.501803251986792
2465,R-HSA-2142845,1.285601770622668,Proteomics,Hyaluronan metabolism,0.3416,0.8777425373134329,-0.501803251986792
2466,R-HSA-9020956,1.2849086272840469,Proteomics,Interleukin-27 signaling,0.8722,0.9239406779661016,-0.5033154755408423
2467,R-HSA-2142845,1.1062527231024128,Transcriptomics,Hyaluronan metabolism,0.4739,0.8777425373134329,-0.504562122003434
2468,R-HSA-1170546,1.105055855642061,Transcriptomics,Prolactin receptor signaling,0.6889,0.8812682748538011,-0.5076684698322809
2469,R-HSA-9018896,1.1044703039313513,Transcriptomics,Biosynthesis of E-series 18(S)-resolvins,0.4223,0.8777425373134329,-0.5091882097746689
2470,R-HSA-111453,1.1037763757476053,Transcriptomics,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,0.6563,0.8777425373134329,-0.5109892298360893
2471,R-HSA-6806834,1.1036716662960568,Transcriptomics,Signaling by MET,0.4622,0.8777425373134329,-0.5112609925736123
2472,R-HSA-397014,1.1035843987452274,Transcriptomics,Muscle contraction,0.5189,0.8777425373134329,-0.5114874866308309
2473,R-HSA-71406,1.2796995689991149,Proteomics,Pyruvate metabolism and Citric Acid (TCA) cycle,0.5024,0.8777425373134329,-0.5146800233825141
2474,R-HSA-70268,1.2796995689991149,Proteomics,Pyruvate metabolism,0.5024,0.8777425373134329,-0.5146800233825141
2475,R-HSA-1236394,1.2793573068177229,Proteomics,Signaling by ERBB4,0.7695,0.9003598298985933,-0.5154267331949337
2476,R-HSA-556833,1.1020280381362242,Transcriptomics,Metabolism of lipids,0.5031,0.8777425373134329,-0.5155268623836474
2477,R-HSA-445355,1.1015302810268364,Transcriptomics,Smooth Muscle Contraction,0.5104,0.8777425373134329,-0.5168187403628395
2478,R-HSA-373076,2.538774616864282,Metabolomics,Class A/1 (Rhodopsin-like receptors),0.6761,0.8786055923473142,-0.5181909426079312
2479,R-HSA-5357801,1.0997576676939491,Transcriptomics,Programmed Cell Death,0.5255,0.8777425373134329,-0.5214193780778803
2480,R-HSA-983231,1.0995098566355133,Transcriptomics,Factors involved in megakaryocyte development and platelet production,0.6478,0.8777425373134329,-0.5220625464894522
2481,R-HSA-9033658,1.0992868331344336,Transcriptomics,Blood group systems biosynthesis,0.6767,0.8786055923473142,-0.5226413813156215
2482,R-HSA-381070,1.0991373489284137,Transcriptomics,IRE1alpha activates chaperones,0.4983,0.8777425373134329,-0.5230293523769121
2483,R-HSA-9013507,1.2756784977624012,Proteomics,NOTCH3 Activation and Transmission of Signal to the Nucleus,0.5412,0.8777425373134329,-0.5234527523374943
2484,R-HSA-163359,1.0987697675280548,Transcriptomics,Glucagon signaling in metabolic regulation,0.7418,0.8906689536878216,-0.5239833725359981
2485,R-HSA-2162123,1.0983161028393427,Transcriptomics,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),0.5173,0.8777425373134329,-0.5251608131194284
2486,R-HSA-210990,1.0981892992316247,Transcriptomics,PECAM1 interactions,0.4883,0.8777425373134329,-0.5254899189933645
2487,R-HSA-69618,1.0979890874093043,Transcriptomics,Mitotic Spindle Checkpoint,0.5167,0.8777425373134329,-0.526009548426177
2488,R-HSA-9013695,1.0971291537879313,Transcriptomics,NOTCH4 Intracellular Domain Regulates Transcription,0.7951,0.902319257837492,-0.5282414187261011
2489,R-HSA-1483257,1.096634856220154,Transcriptomics,Phospholipid metabolism,0.5691,0.8777425373134329,-0.5295243178167138
2490,R-HSA-400206,1.096179041197736,Transcriptomics,Regulation of lipid metabolism by PPARalpha,0.7538,0.8946156451066711,-0.5307073393726914
2491,R-HSA-201556,1.0956937074623598,Transcriptomics,Signaling by ALK,0.6707,0.8777425373134329,-0.5319669737475022
2492,R-HSA-9664565,1.2717104192479871,Proteomics,Signaling by ERBB2 KD Mutants,0.6633,0.8777425373134329,-0.5321098676258784
2493,R-HSA-9665686,1.2717104192479871,Proteomics,Signaling by ERBB2 TMD/JMD mutants,0.6633,0.8777425373134329,-0.5321098676258784
2494,R-HSA-1227990,1.2717104192479867,Proteomics,Signaling by ERBB2 in Cancer,0.6633,0.8777425373134329,-0.5321098676258793
2495,R-HSA-9013508,1.0955355861326355,Transcriptomics,NOTCH3 Intracellular Domain Regulates Transcription,0.7067,0.8854020979020979,-0.5323773615853831
2496,R-HSA-445144,1.095402053130202,Transcriptomics,Signal transduction by L1,0.6534,0.8777425373134329,-0.5327239329192438
2497,R-HSA-2871837,1.0953068191412643,Transcriptomics,FCERI mediated NF-kB activation,0.4101,0.8777425373134329,-0.5329711030567645
2498,R-HSA-73887,1.0951920650744311,Transcriptomics,Death Receptor Signalling,0.5136,0.8777425373134329,-0.5332689355721992
2499,R-HSA-444473,1.0947623648473304,Transcriptomics,Formyl peptide receptors bind formyl peptides and many other ligands,0.5951,0.8777425373134329,-0.5343841788315633
2500,R-HSA-379724,1.094280286071878,Transcriptomics,tRNA Aminoacylation,0.4937,0.8777425373134329,-0.5356353652887664
2501,R-HSA-5685938,1.0928292494963703,Transcriptomics,HDR through Single Strand Annealing (SSA),0.4611,0.8777425373134329,-0.5394013832190906
2502,R-HSA-5637812,1.092748831767262,Transcriptomics,Signaling by EGFRvIII in Cancer,0.4747,0.8777425373134329,-0.5396100992603329
2503,R-HSA-5637810,1.092748831767262,Transcriptomics,Constitutive Signaling by EGFRvIII,0.4747,0.8777425373134329,-0.5396100992603329
2504,R-HSA-3928665,1.2682059843845863,Proteomics,EPH-ephrin mediated repulsion of cells,0.7355,0.8897836538461539,-0.5397554564222918
2505,R-HSA-111459,1.2680369887715954,Proteomics,Activation of caspases through apoptosome-mediated cleavage,0.6014,0.8777425373134329,-0.5401241523791835
2506,R-HSA-390918,1.0922125716401667,Transcriptomics,Peroxisomal lipid metabolism,0.5181,0.8777425373134329,-0.541001907908059
2507,R-HSA-446203,1.0907615213389068,Transcriptomics,Asparagine N-linked glycosylation,0.7248,0.8857541899441341,-0.5447679614621774
2508,R-HSA-3229121,1.0896121990997065,Transcriptomics,Glycogen storage diseases,0.7299,0.8888830897703549,-0.5477509105026134
2509,R-HSA-2454202,1.0893220821176182,Transcriptomics,Fc epsilon receptor (FCERI) signaling,0.4435,0.8777425373134329,-0.548503879638525
2510,R-HSA-9707564,1.2636382423609527,Proteomics,Cytoprotection by HMOX1,0.7879,0.9008983992159426,-0.5497208513010855
2511,R-HSA-2142789,1.0884882059348995,Transcriptomics,Ubiquinol biosynthesis,0.5356,0.8777425373134329,-0.5506681205052238
2512,R-HSA-5651801,1.0884451063812666,Transcriptomics,PCNA-Dependent Long Patch Base Excision Repair,0.5544,0.8777425373134329,-0.5507799810155033
2513,R-HSA-193697,1.0883556394847027,Transcriptomics,p75NTR regulates axonogenesis,0.48,0.8777425373134329,-0.5510121832510066
2514,R-HSA-193634,1.0883556394847027,Transcriptomics,Axonal growth inhibition (RHOA activation),0.48,0.8777425373134329,-0.5510121832510066
2515,R-HSA-5673001,1.088123611769467,Transcriptomics,RAF/MAP kinase cascade,0.5113,0.8777425373134329,-0.5516143875997177
2516,R-HSA-8865999,1.262394474738314,Proteomics,MET activates PTPN11,0.3979,0.8777425373134329,-0.5524343660821135
2517,R-HSA-9772573,1.0875433374038461,Transcriptomics,Late SARS-CoV-2 Infection Events,0.5499,0.8777425373134329,-0.5531204307293824
2518,R-HSA-163685,1.260820712042335,Proteomics,Integration of energy metabolism,0.619,0.8777425373134329,-0.5558678276545493
2519,R-HSA-8864260,1.0863131301406435,Transcriptomics,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,0.6155,0.8777425373134329,-0.5563133086274566
2520,R-HSA-264876,1.2603687625317364,Proteomics,Insulin processing,0.3826,0.8777425373134329,-0.5568538411629939
2521,R-HSA-1253288,1.0860429490409778,Transcriptomics,Downregulation of ERBB4 signaling,0.6862,0.8792276720351391,-0.5570145362070713
2522,R-HSA-2168880,1.0859236681666067,Transcriptomics,Scavenging of heme from plasma,0.411,0.8777425373134329,-0.5573241175913097
2523,R-HSA-3214842,1.0859074758451475,Transcriptomics,HDMs demethylate histones,0.7461,0.8927033492822967,-0.5573661431156681
2524,R-HSA-9664873,1.0854031615653663,Transcriptomics,Pexophagy,0.7292,0.8887708913649024,-0.5586750395640637
2525,R-HSA-8856825,1.0853235515737567,Transcriptomics,Cargo recognition for clathrin-mediated endocytosis,0.5182,0.8777425373134329,-0.5588816592047366
2526,R-HSA-2559583,1.085161477206421,Transcriptomics,Cellular Senescence,0.7382,0.8897836538461539,-0.5593023067499017
2527,R-HSA-9013405,1.2588839316137068,Proteomics,RHOD GTPase cycle,0.8462,0.9134751773049644,-0.560093281207954
2528,R-HSA-5696400,1.084749022252989,Transcriptomics,Dual Incision in GG-NER,0.6431,0.8777425373134329,-0.5603727916544828
2529,R-HSA-1834949,1.0842666645395578,Transcriptomics,Cytosolic sensors of pathogen-associated DNA ,0.6664,0.8777425373134329,-0.5616247020668557
2530,R-HSA-1989781,1.0837329111734033,Transcriptomics,PPARA activates gene expression,0.7092,0.8854020979020979,-0.5630100046713783
2531,R-HSA-9013148,1.257331770657244,Proteomics,CDC42 GTPase cycle,0.8106,0.9035918626827718,-0.5634796144917881
2532,R-HSA-9733458,1.0831135381966985,Transcriptomics,Induction of Cell-Cell Fusion,0.6401,0.8777425373134329,-0.564617524271642
2533,R-HSA-2408508,2.440928656510863,Metabolomics,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",0.6656,0.8777425373134329,-0.56546124043667
2534,R-HSA-9012852,1.0825961249676601,Transcriptomics,Signaling by NOTCH3,0.5954,0.8777425373134329,-0.5659604177112947
2535,R-HSA-2024096,1.082142052111311,Transcriptomics,HS-GAG degradation,0.6509,0.8777425373134329,-0.5671389176523357
2536,R-HSA-909733,1.2550721097811395,Proteomics,Interferon alpha/beta signaling,0.6645,0.8777425373134329,-0.568409492931952
2537,R-HSA-6794361,1.2546472959592774,Proteomics,Neurexins and neuroligins,0.4486,0.8777425373134329,-0.5693363047928061
2538,R-HSA-5653656,1.0812001925665704,Transcriptomics,Vesicle-mediated transport,0.5605,0.8777425373134329,-0.5695834183583903
2539,R-HSA-6798163,2.431823049475645,Metabolomics,Choline catabolism,0.6899,0.8822250639386189,-0.569860244288352
2540,R-HSA-373755,1.081050425206186,Transcriptomics,Semaphorin interactions,0.585,0.8777425373134329,-0.5699721243180503
2541,R-HSA-8875555,1.2538356527298926,Proteomics,MET activates RAP1 and RAC1,0.6821,0.8786055923473142,-0.5711070583160281
2542,R-HSA-389958,1.080481670955233,Transcriptomics,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,0.5562,0.8777425373134329,-0.5714482681611427
2543,R-HSA-381771,2.426994419832586,Metabolomics,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.707,0.8854020979020979,-0.5721930003930255
2544,R-HSA-400508,2.426994419832586,Metabolomics,"Incretin synthesis, secretion, and inactivation",0.707,0.8854020979020979,-0.5721930003930255
2545,R-HSA-416476,2.4236246736123706,Metabolomics,G alpha (q) signalling events,0.7168,0.8854020979020979,-0.5738209562826861
2546,R-HSA-8849469,1.0795438715467904,Transcriptomics,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,0.7104,0.8854020979020979,-0.5738822311961584
2547,R-HSA-176407,1.0795034464011644,Transcriptomics,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,0.7829,0.9003598298985933,-0.5739871505523163
2548,R-HSA-5696394,1.0793909862832178,Transcriptomics,DNA Damage Recognition in GG-NER,0.6495,0.8777425373134329,-0.5742790293566012
2549,R-HSA-381119,1.2522170792841325,Proteomics,Unfolded Protein Response (UPR),0.5846,0.8777425373134329,-0.5746382830314068
2550,R-HSA-9709570,1.0789682032690766,Transcriptomics,Impaired BRCA2 binding to RAD51,0.4969,0.8777425373134329,-0.5753763196928804
2551,R-HSA-5627117,1.0787918811735207,Transcriptomics,RHO GTPases Activate ROCKs,0.6218,0.8777425373134329,-0.5758339457683249
2552,R-HSA-5083627,1.0786551435560747,Transcriptomics,Defective LARGE causes MDDGA6 and MDDGB6,0.5413,0.8777425373134329,-0.5761888343546936
2553,R-HSA-9649948,1.0782683154927266,Transcriptomics,Signaling downstream of RAS mutants,0.5144,0.8777425373134329,-0.5771928072710976
2554,R-HSA-6802946,1.0782683154927266,Transcriptomics,Signaling by moderate kinase activity BRAF mutants,0.5144,0.8777425373134329,-0.5771928072710976
2555,R-HSA-6802949,1.0782683154927266,Transcriptomics,Signaling by RAS mutants,0.5144,0.8777425373134329,-0.5771928072710976
2556,R-HSA-6802955,1.0782683154927266,Transcriptomics,Paradoxical activation of RAF signaling by kinase inactive BRAF,0.5144,0.8777425373134329,-0.5771928072710976
2557,R-HSA-2173796,1.0775485504859341,Transcriptomics,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,0.679,0.8786055923473142,-0.5790608841803593
2558,R-HSA-2428924,1.0773913386904843,Transcriptomics,IGF1R signaling cascade,0.613,0.8777425373134329,-0.5794689114144869
2559,R-HSA-2404192,1.0773913386904843,Transcriptomics,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.613,0.8777425373134329,-0.5794689114144869
2560,R-HSA-525793,1.249912846309499,Proteomics,Myogenesis,0.6527,0.8777425373134329,-0.5796654039515793
2561,R-HSA-422356,2.4093121055743776,Metabolomics,Regulation of insulin secretion,0.7328,0.8897836538461539,-0.5807354916544715
2562,R-HSA-400451,2.409312105574377,Metabolomics,Free fatty acids regulate insulin secretion,0.7328,0.8897836538461539,-0.5807354916544717
2563,R-HSA-163685,2.409312105574377,Metabolomics,Integration of energy metabolism,0.7328,0.8897836538461539,-0.5807354916544717
2564,R-HSA-8866911,1.0767648710240525,Transcriptomics,TFAP2 (AP-2) family regulates transcription of cell cycle factors,0.5118,0.8777425373134329,-0.5810948445607447
2565,R-HSA-1980145,1.076112447094097,Transcriptomics,Signaling by NOTCH2,0.7215,0.8854020979020979,-0.5827881445504606
2566,R-HSA-5663220,1.076087834850306,Transcriptomics,RHO GTPases Activate Formins,0.5682,0.8777425373134329,-0.5828520231273255
2567,R-HSA-163841,2.4041173264597004,Metabolomics,"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.7799,0.9003598298985933,-0.5832451379905935
2568,R-HSA-5358493,2.4041173264597004,Metabolomics,Synthesis of diphthamide-EEF2,0.7799,0.9003598298985933,-0.5832451379905935
2569,R-HSA-163282,1.0748586384826693,Transcriptomics,Mitochondrial transcription initiation,0.4945,0.8777425373134329,-0.5860422773487184
2570,R-HSA-1660514,1.0746178741510182,Transcriptomics,Synthesis of PIPs at the Golgi membrane,0.6425,0.8777425373134329,-0.5866671566972375
2571,R-HSA-5684996,1.0742727984694964,Transcriptomics,MAPK1/MAPK3 signaling,0.5336,0.8777425373134329,-0.5875627655508426
2572,R-HSA-197264,2.393402103627608,Metabolomics,Nicotinamide salvaging,0.786,0.9003598298985933,-0.5884217622757945
2573,R-HSA-196807,2.393402103627608,Metabolomics,Nicotinate metabolism,0.786,0.9003598298985933,-0.5884217622757945
2574,R-HSA-913531,1.0737248955009744,Transcriptomics,Interferon Signaling,0.5539,0.8777425373134329,-0.5889847920099687
2575,R-HSA-8875656,1.2453291740505843,Proteomics,MET receptor recycling,0.3851,0.8777425373134329,-0.5896655536576524
2576,R-HSA-199977,1.2450904610224514,Proteomics,ER to Golgi Anterograde Transport,0.6888,0.8812682748538011,-0.5901863513681512
2577,R-HSA-193704,1.0732539978418565,Transcriptomics,p75 NTR receptor-mediated signalling,0.5198,0.8777425373134329,-0.5902069590163137
2578,R-HSA-983712,1.0727290725736223,Transcriptomics,Ion channel transport,0.5375,0.8777425373134329,-0.5915693491900821
2579,R-HSA-6807505,1.0720688262028097,Transcriptomics,RNA polymerase II transcribes snRNA genes,0.8055,0.902319257837492,-0.5932829515298723
2580,R-HSA-9694635,1.0720664422970974,Transcriptomics,Translation of Structural Proteins,0.5269,0.8777425373134329,-0.5932891387148189
2581,R-HSA-3000170,1.2433924628106436,Proteomics,Syndecan interactions,0.5357,0.8777425373134329,-0.5938908562628231
2582,R-HSA-2022857,1.0716277874514462,Transcriptomics,Keratan sulfate degradation,0.4944,0.8777425373134329,-0.5944276227763718
2583,R-HSA-68884,1.2430209786140043,Proteomics,Mitotic Telophase/Cytokinesis,0.7047,0.8854020979020979,-0.5947013194395061
2584,R-HSA-917937,1.0714095353836017,Transcriptomics,Iron uptake and transport,0.8269,0.9091865577889446,-0.5949940738326072
2585,R-HSA-391160,1.2423416816217263,Proteomics,Signal regulatory protein family interactions,0.6803,0.8786055923473142,-0.5961833345649229
2586,R-HSA-1250342,1.0700219759963043,Transcriptomics,PI3K events in ERBB4 signaling,0.4977,0.8777425373134329,-0.5985953431735421
2587,R-HSA-5619070,1.0700101816337753,Transcriptomics,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.7089,0.8854020979020979,-0.5986259542425606
2588,R-HSA-9635465,1.069506314043555,Transcriptomics,Suppression of apoptosis,0.5592,0.8777425373134329,-0.599933691353608
2589,R-HSA-382551,1.0694052147944841,Transcriptomics,Transport of small molecules,0.6234,0.8777425373134329,-0.6001960841775862
2590,R-HSA-1368108,1.2404541948980852,Proteomics,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",0.3804,0.8777425373134329,-0.600301244559017
2591,R-HSA-5685942,1.069192304729834,Transcriptomics,HDR through Homologous Recombination (HRR),0.5184,0.8777425373134329,-0.6007486706075584
2592,R-HSA-8950505,1.0687089378522194,Transcriptomics,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,0.5688,0.8777425373134329,-0.6020032002029851
2593,R-HSA-5696397,1.0683136973936758,Transcriptomics,Gap-filling DNA repair synthesis and ligation in GG-NER,0.6134,0.8777425373134329,-0.6030290066359787
2594,R-HSA-380320,1.0678997095979845,Transcriptomics,Recruitment of NuMA to mitotic centrosomes,0.7036,0.8854020979020979,-0.6041034698768264
2595,R-HSA-8862803,1.0678861431172681,Transcriptomics,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.6463,0.8777425373134329,-0.6041386802984599
2596,R-HSA-8863678,1.0678861431172681,Transcriptomics,Neurodegenerative Diseases,0.6463,0.8777425373134329,-0.6041386802984599
2597,R-HSA-983169,1.0673595590641287,Transcriptomics,Class I MHC mediated antigen processing & presentation,0.5839,0.8777425373134329,-0.6055053756798301
2598,R-HSA-5140745,1.0670364790874942,Transcriptomics,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",0.8088,0.9035918626827718,-0.6063438969173175
2599,R-HSA-5602415,1.0670111272185145,Transcriptomics,UNC93B1 deficiency - HSE,0.4966,0.8777425373134329,-0.6064096951161749
2600,R-HSA-9027276,1.0669158853451506,Transcriptomics,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.5692,0.8777425373134329,-0.6066568857169223
2601,R-HSA-948021,1.0662412460728217,Transcriptomics,Transport to the Golgi and subsequent modification,0.6953,0.8845385174418605,-0.6084078433695248
2602,R-HSA-901032,1.0661270011036008,Transcriptomics,ER Quality Control Compartment (ERQC),0.7306,0.8891168289290682,-0.6087043545738579
2603,R-HSA-901042,1.0661270011036008,Transcriptomics,Calnexin/calreticulin cycle,0.7306,0.8891168289290682,-0.6087043545738579
2604,R-HSA-5625740,1.0647585326315676,Transcriptomics,RHO GTPases activate PKNs,0.7617,0.8969559367642113,-0.6122560753848627
2605,R-HSA-975144,1.0642703769459276,Transcriptomics,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,0.7235,0.8854020979020979,-0.6135230338447254
2606,R-HSA-937039,1.0642703769459276,Transcriptomics,IRAK1 recruits IKK complex,0.7235,0.8854020979020979,-0.6135230338447254
2607,R-HSA-6802952,1.063926451270158,Transcriptomics,Signaling by BRAF and RAF1 fusions,0.5737,0.8777425373134329,-0.6144156579753016
2608,R-HSA-2428928,1.0636565975029235,Transcriptomics,IRS-related events triggered by IGF1R,0.6392,0.8777425373134329,-0.6151160359968654
2609,R-HSA-3656243,1.2330522090447544,Proteomics,Defective ST3GAL3 causes MCT12 and EIEE15,0.4543,0.8777425373134329,-0.61645007948315
2610,R-HSA-3656244,1.2330522090447544,Proteomics,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),0.4543,0.8777425373134329,-0.61645007948315
2611,R-HSA-6811442,1.0628578911346416,Transcriptomics,Intra-Golgi and retrograde Golgi-to-ER traffic,0.672,0.8777425373134329,-0.6171889971852911
2612,R-HSA-1474244,1.2301221143720311,Proteomics,Extracellular matrix organization,0.5675,0.8777425373134329,-0.6228426363076944
2613,R-HSA-622312,1.2297294695772585,Proteomics,Inflammasomes,0.5239,0.8777425373134329,-0.6236992653394495
2614,R-HSA-1592230,1.2297037157375115,Proteomics,Mitochondrial biogenesis,0.7359,0.8897836538461539,-0.6237554522215887
2615,R-HSA-6791312,1.060285017264951,Transcriptomics,TP53 Regulates Transcription of Cell Cycle Genes,0.5663,0.8777425373134329,-0.6238666297751699
2616,R-HSA-3560782,1.0602043542256518,Transcriptomics,Diseases associated with glycosaminoglycan metabolism,0.5682,0.8777425373134329,-0.6240759824940761
2617,R-HSA-6794362,1.229440799969411,Proteomics,Protein-protein interactions at synapses,0.7585,0.8969559367642113,-0.6243290527961015
2618,R-HSA-193368,1.0593164721518715,Transcriptomics,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,0.5635,0.8777425373134329,-0.626380390161195
2619,R-HSA-9716542,1.05926333402205,Transcriptomics,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.6411,0.8777425373134329,-0.6265183047755261
2620,R-HSA-597592,1.0592205324259076,Transcriptomics,Post-translational protein modification,0.6094,0.8777425373134329,-0.6266293919674271
2621,R-HSA-983231,1.2283383961603396,Proteomics,Factors involved in megakaryocyte development and platelet production,0.6025,0.8777425373134329,-0.6267341556273126
2622,R-HSA-9706369,1.058922704396473,Transcriptomics,Negative regulation of FLT3,0.5477,0.8777425373134329,-0.627402374342879
2623,R-HSA-9013106,1.0587769595227667,Transcriptomics,RHOC GTPase cycle,0.6629,0.8777425373134329,-0.627780640347262
2624,R-HSA-9018679,1.0575451713353572,Transcriptomics,Biosynthesis of EPA-derived SPMs,0.5021,0.8777425373134329,-0.6309776213734104
2625,R-HSA-8866907,1.057322249357135,Transcriptomics,Activation of the TFAP2 (AP-2) family of transcription factors,0.7514,0.8946156451066711,-0.6315561927073232
2626,R-HSA-141444,1.057019785809269,Transcriptomics,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,0.6274,0.8777425373134329,-0.6323412060996525
2627,R-HSA-141424,1.057019785809269,Transcriptomics,Amplification of signal from the kinetochores,0.6274,0.8777425373134329,-0.6323412060996525
2628,R-HSA-2514853,1.0569927536505235,Transcriptomics,Condensation of Prometaphase Chromosomes,0.6049,0.8777425373134329,-0.6324113653197915
2629,R-HSA-5668914,1.0569172509781821,Transcriptomics,Diseases of metabolism,0.646,0.8777425373134329,-0.6326073248308227
2630,R-HSA-8875513,1.0568963474327064,Transcriptomics,MET interacts with TNS proteins,0.4857,0.8777425373134329,-0.6326615778582084
2631,R-HSA-445989,1.056459288917352,Transcriptomics,TAK1-dependent IKK and NF-kappa-B activation  ,0.5651,0.8777425373134329,-0.6337959188067468
2632,R-HSA-2559584,1.0561306557791055,Transcriptomics,Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.765,0.897887323943662,-0.6346488527107059
2633,R-HSA-194315,1.0558422787108046,Transcriptomics,Signaling by Rho GTPases,0.6575,0.8777425373134329,-0.6353973060772486
2634,R-HSA-381676,1.0555074408677536,Transcriptomics,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,0.7202,0.8854020979020979,-0.6362663436618041
2635,R-HSA-5683057,1.0554674509822422,Transcriptomics,MAPK family signaling cascades,0.5732,0.8777425373134329,-0.6363701333445798
2636,R-HSA-432722,1.0553830313681591,Transcriptomics,Golgi Associated Vesicle Biogenesis,0.6215,0.8777425373134329,-0.6365892358714725
2637,R-HSA-9656223,1.0553201912080643,Transcriptomics,Signaling by RAF1 mutants,0.5478,0.8777425373134329,-0.6367523311191432
2638,R-HSA-8851805,1.2234331761414092,Proteomics,MET activates RAS signaling,0.408,0.8777425373134329,-0.6374358227098854
2639,R-HSA-8851907,1.2234331761414092,Proteomics,MET activates PI3K/AKT signaling,0.408,0.8777425373134329,-0.6374358227098854
2640,R-HSA-8875513,1.2234331761414092,Proteomics,MET interacts with TNS proteins,0.408,0.8777425373134329,-0.6374358227098854
2641,R-HSA-9734091,1.2234331761414092,Proteomics,Drug-mediated inhibition of MET activation,0.408,0.8777425373134329,-0.6374358227098854
2642,R-HSA-164952,1.0550551489058089,Transcriptomics,The role of Nef in HIV-1 replication and disease pathogenesis,0.5804,0.8777425373134329,-0.6374402214724508
2643,R-HSA-429947,1.055035845788714,Transcriptomics,Deadenylation of mRNA,0.8259,0.909009433962264,-0.6374903207506619
2644,R-HSA-210991,1.0546195368606894,Transcriptomics,Basigin interactions,0.7875,0.9008983992159426,-0.6385708082545316
2645,R-HSA-1222556,1.2226191554766075,Proteomics,ROS and RNS production in phagocytes,0.3602,0.8777425373134329,-0.6392117630590285
2646,R-HSA-8941413,1.2226191554766075,Proteomics,Events associated with phagocytolytic activity of PMN cells,0.3602,0.8777425373134329,-0.6392117630590285
2647,R-HSA-4791275,1.0541139863796425,Transcriptomics,Signaling by WNT in cancer,0.5796,0.8777425373134329,-0.6398829131376498
2648,R-HSA-8856828,1.0538991954479637,Transcriptomics,Clathrin-mediated endocytosis,0.58,0.8777425373134329,-0.6404403811667999
2649,R-HSA-373753,1.0536315080315868,Transcriptomics,Nephrin family interactions,0.7335,0.8897836538461539,-0.6411351366449277
2650,R-HSA-9662361,1.0530448690265792,Transcriptomics,Sensory processing of sound by outer hair cells of the cochlea,0.5843,0.8777425373134329,-0.6426576985491393
2651,R-HSA-204998,1.052945636663142,Transcriptomics,"Cell death signalling via NRAGE, NRIF and NADE",0.5695,0.8777425373134329,-0.6429152460612289
2652,R-HSA-3000484,1.2201467266198622,Proteomics,Scavenging by Class F Receptors,0.5178,0.8777425373134329,-0.6446058351716192
2653,R-HSA-975577,1.0518711553128959,Transcriptomics,N-Glycan antennae elongation,0.5385,0.8777425373134329,-0.6457039531821432
2654,R-HSA-381038,1.0512659968161968,Transcriptomics,XBP1(S) activates chaperone genes,0.5841,0.8777425373134329,-0.6472745805444887
2655,R-HSA-5663084,1.0512213099349572,Transcriptomics,Diseases of carbohydrate metabolism,0.582,0.8777425373134329,-0.6473905608022156
2656,R-HSA-164938,1.051153304708566,Transcriptomics,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.6339,0.8777425373134329,-0.6475670614544171
2657,R-HSA-9614657,1.0499267524345492,Transcriptomics,FOXO-mediated transcription of cell death genes,0.6322,0.8777425373134329,-0.6507504531995977
2658,R-HSA-193692,1.049538424029267,Transcriptomics,Regulated proteolysis of p75NTR,0.7615,0.8969559367642113,-0.6517583201009786
2659,R-HSA-9013420,1.0495237271270292,Transcriptomics,RHOU GTPase cycle,0.7541,0.8946156451066711,-0.6517964644167605
2660,R-HSA-6782861,1.0479239643534837,Transcriptomics,Synthesis of wybutosine at G37 of tRNA(Phe),0.5085,0.8777425373134329,-0.6559484860757109
2661,R-HSA-9013148,1.047869329171172,Transcriptomics,CDC42 GTPase cycle,0.7454,0.8923563611491109,-0.6560902861376012
2662,R-HSA-445717,1.047697776686275,Transcriptomics,Aquaporin-mediated transport,0.8046,0.902319257837492,-0.6565355331734232
2663,R-HSA-432040,1.0475792348796766,Transcriptomics,Vasopressin regulates renal water homeostasis via Aquaporins,0.7999,0.902319257837492,-0.6568431963823853
2664,R-HSA-1632852,1.0473940725106834,Transcriptomics,Macroautophagy,0.8347,0.9123129675810474,-0.6573237664889009
2665,R-HSA-186763,1.0469018454880612,Transcriptomics,Downstream signal transduction,0.5744,0.8777425373134329,-0.6586012916900397
2666,R-HSA-1236382,1.046294707844979,Transcriptomics,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.6418,0.8777425373134329,-0.6601770557256377
2667,R-HSA-5637815,1.046294707844979,Transcriptomics,Signaling by Ligand-Responsive EGFR Variants in Cancer,0.6418,0.8777425373134329,-0.6601770557256377
2668,R-HSA-433692,2.2444048492142747,Metabolomics,Proton-coupled monocarboxylate transport,0.7813,0.9003598298985933,-0.660403728279734
2669,R-HSA-5619070,2.2444048492142747,Metabolomics,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.7813,0.9003598298985933,-0.660403728279734
2670,R-HSA-8956319,1.2122576542358265,Proteomics,Nucleotide catabolism,0.3993,0.8777425373134329,-0.6618173416725405
2671,R-HSA-8850843,1.2122576542358265,Proteomics,Phosphate bond hydrolysis by NTPDase proteins,0.3993,0.8777425373134329,-0.6618173416725405
2672,R-HSA-111446,1.045436190317347,Transcriptomics,Activation of BIM and translocation to mitochondria ,0.8127,0.903860819828408,-0.662405250698206
2673,R-HSA-9659379,1.0452150725565006,Transcriptomics,Sensory processing of sound,0.5881,0.8777425373134329,-0.6629791393693233
2674,R-HSA-804914,2.236343153791053,Metabolomics,Transport of fatty acids,0.7899,0.9014183240952072,-0.664298408676184
2675,R-HSA-5619108,2.236343153791053,Metabolomics,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),0.7899,0.9014183240952072,-0.664298408676184
2676,R-HSA-1237112,1.0433415273633624,Transcriptomics,Methionine salvage pathway,0.5089,0.8777425373134329,-0.6678417354676758
2677,R-HSA-9020933,1.209429877105847,Proteomics,Interleukin-23 signaling,0.6924,0.8838074398249453,-0.6679866733869116
2678,R-HSA-1250347,1.0426778725253703,Transcriptomics,SHC1 events in ERBB4 signaling,0.5566,0.8777425373134329,-0.6695641841375517
2679,R-HSA-9013026,1.0424512053089205,Transcriptomics,RHOB GTPase cycle,0.635,0.8777425373134329,-0.6701524758565716
2680,R-HSA-446728,1.0422892684101999,Transcriptomics,Cell junction organization,0.7012,0.8854020979020979,-0.6705727666159205
2681,R-HSA-156580,1.206691480291513,Proteomics,Phase II - Conjugation of compounds,0.6297,0.8777425373134329,-0.6739610050038185
2682,R-HSA-73893,1.0407062262048619,Transcriptomics,DNA Damage Bypass,0.7035,0.8854020979020979,-0.6746813917397746
2683,R-HSA-5083630,1.0405907462925246,Transcriptomics,Defective LFNG causes SCDO3,0.5328,0.8777425373134329,-0.6749811081134314
2684,R-HSA-1912399,1.0405907462925246,Transcriptomics,Pre-NOTCH Processing in the Endoplasmic Reticulum,0.5328,0.8777425373134329,-0.6749811081134314
2685,R-HSA-975163,1.040061619708186,Transcriptomics,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,0.7973,0.902319257837492,-0.6763544023760745
2686,R-HSA-9006931,1.039930821538147,Transcriptomics,Signaling by Nuclear Receptors,0.7751,0.9003598298985933,-0.6766938757304575
2687,R-HSA-73762,1.2050687278976966,Proteomics,RNA Polymerase I Transcription Initiation,0.4127,0.8777425373134329,-0.677501346886354
2688,R-HSA-1430728,2.20819849827402,Metabolomics,Metabolism,0.777,0.9003598298985933,-0.6778953547715769
2689,R-HSA-205043,1.0393546659709036,Transcriptomics,NRIF signals cell death from the nucleus,0.8037,0.902319257837492,-0.6781892289376195
2690,R-HSA-199991,1.0392937460647909,Transcriptomics,Membrane Trafficking,0.6423,0.8777425373134329,-0.6783473403612782
2691,R-HSA-8877330,1.0391722939310934,Transcriptomics,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),0.8221,0.9077917981072556,-0.6786625570283842
2692,R-HSA-1433559,1.0390180958269712,Transcriptomics,Regulation of KIT signaling,0.637,0.8777425373134329,-0.6790627625330201
2693,R-HSA-9772572,1.0387651417804202,Transcriptomics,Early SARS-CoV-2 Infection Events,0.7816,0.9003598298985933,-0.6797192790474476
2694,R-HSA-9665348,1.0383504704846753,Transcriptomics,Signaling by ERBB2 ECD mutants,0.5626,0.8777425373134329,-0.680795516243205
2695,R-HSA-112310,1.0381065291459655,Transcriptomics,Neurotransmitter release cycle,0.6767,0.8786055923473142,-0.6814286411905944
2696,R-HSA-9010642,1.2026716092665686,Proteomics,ROBO receptors bind AKAP5,0.7773,0.9003598298985933,-0.6827311154693663
2697,R-HSA-202733,1.202518696618795,Proteomics,Cell surface interactions at the vascular wall,0.7907,0.9020371577574968,-0.6830647233896779
2698,R-HSA-9013408,1.0365841709887127,Transcriptomics,RHOG GTPase cycle,0.7532,0.8946156451066711,-0.6853797670363249
2699,R-HSA-68877,1.0363729770270758,Transcriptomics,Mitotic Prometaphase,0.6058,0.8777425373134329,-0.6859278994953724
2700,R-HSA-9022699,1.0358745343693783,Transcriptomics,MECP2 regulates neuronal receptors and channels,0.7867,0.9004087638979725,-0.6872215567455146
2701,R-HSA-5627123,1.0356721060155851,Transcriptomics,RHO GTPases activate PAKs,0.5986,0.8777425373134329,-0.6877469389604488
2702,R-HSA-5609975,1.0339899507395234,Transcriptomics,Diseases associated with glycosylation precursor biosynthesis,0.6219,0.8777425373134329,-0.6921128019842812
2703,R-HSA-75035,1.033442005101983,Transcriptomics,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,0.5312,0.8777425373134329,-0.6935349391865068
2704,R-HSA-1980143,1.0331757921362597,Transcriptomics,Signaling by NOTCH1,0.7864,0.9003598298985933,-0.6942258678778447
2705,R-HSA-9707616,1.0323150081577244,Transcriptomics,Heme signaling,0.6368,0.8777425373134329,-0.6964599451933424
2706,R-HSA-5218921,1.0319716789711801,Transcriptomics,VEGFR2 mediated cell proliferation,0.8301,0.9110536218250236,-0.697351021196769
2707,R-HSA-71291,1.1957879159737603,Proteomics,Metabolism of amino acids and derivatives,0.5976,0.8777425373134329,-0.697749196948663
2708,R-HSA-400511,2.1601834329572602,Metabolomics,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",0.7716,0.9003598298985933,-0.7010918815325335
2709,R-HSA-9648002,1.0303939133798339,Transcriptomics,RAS processing,0.7356,0.8897836538461539,-0.7014459514053882
2710,R-HSA-5654738,1.0295229875697274,Transcriptomics,Signaling by FGFR2,0.663,0.8777425373134329,-0.7037063508137872
2711,R-HSA-180024,1.029210293826879,Transcriptomics,DARPP-32 events,0.5798,0.8777425373134329,-0.7045179156372686
2712,R-HSA-2151201,1.0281576215461854,Transcriptomics,Transcriptional activation of mitochondrial biogenesis,0.7298,0.8888830897703549,-0.7072500195351045
2713,R-HSA-9609736,1.0280528975322367,Transcriptomics,Assembly and cell surface presentation of NMDA receptors,0.8331,0.911421875,-0.7075218200678569
2714,R-HSA-933542,1.0277897326382341,Transcriptomics,TRAF6 mediated NF-kB activation,0.55,0.8777425373134329,-0.7082048377988873
2715,R-HSA-1660516,1.0276878741816422,Transcriptomics,Synthesis of PIPs at the early endosome membrane,0.7149,0.8854020979020979,-0.7084692010688112
2716,R-HSA-9659379,1.1905175730664725,Proteomics,Sensory processing of sound,0.4283,0.8777425373134329,-0.7092474488083403
2717,R-HSA-159418,2.1423796488329474,Metabolomics,Recycling of bile acids and salts,0.9485,0.962804524361949,-0.7096930560214447
2718,R-HSA-75158,1.1899907189720285,Proteomics,TRAIL  signaling,0.4857,0.8777425373134329,-0.7103968808619632
2719,R-HSA-379716,1.0268250915214059,Transcriptomics,Cytosolic tRNA aminoacylation,0.6405,0.8777425373134329,-0.7107084657594931
2720,R-HSA-390247,1.0264057954602546,Transcriptomics,Beta-oxidation of very long chain fatty acids,0.615,0.8777425373134329,-0.7117967060637442
2721,R-HSA-2173793,1.0259162540078512,Transcriptomics,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,0.7555,0.8948392554991539,-0.7130672611403747
2722,R-HSA-177929,1.025876431460905,Transcriptomics,Signaling by EGFR,0.6575,0.8777425373134329,-0.7131706165129146
2723,R-HSA-9645460,1.0253737415582587,Transcriptomics,Alpha-protein kinase 1 signaling pathway,0.7043,0.8854020979020979,-0.7144752970555787
2724,R-HSA-68911,1.0253033526522732,Transcriptomics,G2 Phase,0.4704,0.8777425373134329,-0.7146579843058599
2725,R-HSA-392499,2.131411570506786,Metabolomics,Metabolism of proteins,0.7791,0.9003598298985933,-0.7149918371587946
2726,R-HSA-195258,1.0247690791077988,Transcriptomics,RHO GTPase Effectors,0.7126,0.8854020979020979,-0.7160446369803346
2727,R-HSA-73942,1.0243196932360539,Transcriptomics,DNA Damage Reversal,0.6839,0.8788546255506609,-0.7172109723292789
2728,R-HSA-916853,1.0242555310168386,Transcriptomics,Degradation of GABA,0.5233,0.8777425373134329,-0.717377498847006
2729,R-HSA-190236,1.0240478078491149,Transcriptomics,Signaling by FGFR,0.6677,0.8777425373134329,-0.7179166232132664
2730,R-HSA-9734009,1.0233370755478468,Transcriptomics,Defective Intrinsic Pathway for Apoptosis,0.7192,0.8854020979020979,-0.7197612566535361
2731,R-HSA-9006936,1.0232594232097676,Transcriptomics,Signaling by TGFB family members,0.7668,0.8996982903117667,-0.7199627954034711
2732,R-HSA-8963693,2.1186892878280816,Metabolomics,Aspartate and asparagine metabolism,0.7548,0.8946156451066711,-0.721138090812104
2733,R-HSA-176187,1.0223551636854147,Transcriptomics,Activation of ATR in response to replication stress,0.6266,0.8777425373134329,-0.7223097090787433
2734,R-HSA-9013424,1.18391664009379,Proteomics,RHOV GTPase cycle,0.8663,0.9239406779661016,-0.7236486350620471
2735,R-HSA-199992,1.0209918321840128,Transcriptomics,trans-Golgi Network Vesicle Budding,0.6978,0.8854020979020979,-0.7258480974046602
2736,R-HSA-182971,1.0208664300576236,Transcriptomics,EGFR downregulation,0.6518,0.8777425373134329,-0.7261735658762715
2737,R-HSA-8866423,1.1816755583685643,Proteomics,VLDL assembly,0.3692,0.8777425373134329,-0.7285379795635467
2738,R-HSA-8964041,1.1816755583685643,Proteomics,LDL remodeling,0.3692,0.8777425373134329,-0.7285379795635467
2739,R-HSA-186797,1.0198645766148697,Transcriptomics,Signaling by PDGF,0.6332,0.8777425373134329,-0.7287737746460934
2740,R-HSA-9013406,1.0194980617845892,Transcriptomics,RHOQ GTPase cycle,0.7832,0.9003598298985933,-0.7297250266309602
2741,R-HSA-9023661,1.0191710379963324,Transcriptomics,Biosynthesis of E-series 18(R)-resolvins,0.4613,0.8777425373134329,-0.7305737836306153
2742,R-HSA-9018681,1.0191710379963324,Transcriptomics,Biosynthesis of protectins,0.4613,0.8777425373134329,-0.7305737836306153
2743,R-HSA-9013973,1.01899465682793,Transcriptomics,TICAM1-dependent activation of IRF3/IRF7,0.7544,0.8946156451066711,-0.7310315630236277
2744,R-HSA-444209,2.0976199497920045,Metabolomics,Free fatty acid receptors,0.7854,0.9003598298985933,-0.7313168849127737
2745,R-HSA-9024446,1.018631437415339,Transcriptomics,NR1H2 and NR1H3-mediated signaling,0.6963,0.8849128540305011,-0.7319742620868689
2746,R-HSA-9648025,1.018536481554497,Transcriptomics,EML4 and NUDC in mitotic spindle formation,0.6367,0.8777425373134329,-0.7322207103711891
2747,R-HSA-9660826,1.1796407443555048,Proteomics,Purinergic signaling in leishmaniasis infection,0.6587,0.8777425373134329,-0.7329773119601932
2748,R-HSA-9664424,1.1796407443555048,Proteomics,Cell recruitment (pro-inflammatory response),0.6587,0.8777425373134329,-0.7329773119601932
2749,R-HSA-9616222,1.0180925846451379,Transcriptomics,Transcriptional regulation of granulopoiesis,0.8011,0.902319257837492,-0.7333727996762275
2750,R-HSA-111465,1.1793225617544167,Proteomics,Apoptotic cleavage of cellular proteins,0.6776,0.8786055923473142,-0.7336714876047455
2751,R-HSA-5621575,1.0179356951480807,Transcriptomics,CD209 (DC-SIGN) signaling,0.7429,0.8907673860911272,-0.7337799904176394
2752,R-HSA-391251,1.0177987045255505,Transcriptomics,Protein folding,0.722,0.8854020979020979,-0.7341355356529856
2753,R-HSA-76002,1.0175229166776785,Transcriptomics,"Platelet activation, signaling and aggregation",0.7543,0.8946156451066711,-0.7348513149776302
2754,R-HSA-9671555,1.1780303220796604,Proteomics,Signaling by PDGFR in disease,0.8434,0.9132457496136012,-0.7364907533536343
2755,R-HSA-3000471,1.0162658623833334,Transcriptomics,Scavenging by Class B Receptors,0.4892,0.8777425373134329,-0.7381138716159684
2756,R-HSA-2500257,1.0146248290194426,Transcriptomics,Resolution of Sister Chromatid Cohesion,0.6402,0.8777425373134329,-0.7423730068969036
2757,R-HSA-1614603,1.0141219260464236,Transcriptomics,Cysteine formation from homocysteine,0.4567,0.8777425373134329,-0.7436782404420609
2758,R-HSA-69236,1.0137028772248415,Transcriptomics,G1 Phase,0.844,0.9132457496136012,-0.7447658390611425
2759,R-HSA-69231,1.0137028772248415,Transcriptomics,Cyclin D associated events in G1,0.844,0.9132457496136012,-0.7447658390611425
2760,R-HSA-6804760,1.013627240815409,Transcriptomics,Regulation of TP53 Activity through Methylation,0.7148,0.8854020979020979,-0.7449621456731992
2761,R-HSA-3642278,1.1739370504848035,Proteomics,Loss of Function of TGFBR2 in Cancer,0.6014,0.8777425373134329,-0.7454210010729331
2762,R-HSA-3656535,1.1739370504848035,Proteomics,TGFBR1 LBD Mutants in Cancer,0.6014,0.8777425373134329,-0.7454210010729331
2763,R-HSA-3645790,1.1739370504848035,Proteomics,TGFBR2 Kinase Domain Mutants in Cancer,0.6014,0.8777425373134329,-0.7454210010729331
2764,R-HSA-3642279,1.1739370504848035,Proteomics,TGFBR2 MSI Frameshift Mutants in Cancer,0.6014,0.8777425373134329,-0.7454210010729331
2765,R-HSA-162588,1.0132730889683048,Transcriptomics,Budding and maturation of HIV virion,0.7534,0.8946156451066711,-0.7458813107919592
2766,R-HSA-1251985,1.013176162179338,Transcriptomics,Nuclear signaling by ERBB4,0.6072,0.8777425373134329,-0.746132874419878
2767,R-HSA-2426168,1.0130406760086026,Transcriptomics,Activation of gene expression by SREBF (SREBP),0.8253,0.9086347908147216,-0.7464845150035222
2768,R-HSA-9663891,1.0124389373033464,Transcriptomics,Selective autophagy,0.8221,0.9077917981072556,-0.7480462666448077
2769,R-HSA-2453902,1.1724448185687206,Proteomics,The canonical retinoid cycle in rods (twilight vision),0.3982,0.8777425373134329,-0.7486765877977444
2770,R-HSA-5674135,1.0117449396550076,Transcriptomics,MAP2K and MAPK activation,0.6219,0.8777425373134329,-0.749847466994518
2771,R-HSA-8940973,1.0112399096573486,Transcriptomics,RUNX2 regulates osteoblast differentiation,0.5692,0.8777425373134329,-0.751158221015911
2772,R-HSA-5362517,2.0521667210890855,Metabolomics,Signaling by Retinoic Acid,0.7119,0.8854020979020979,-0.7532757644649195
2773,R-HSA-425366,2.0497192374089286,Metabolomics,"Transport of bile salts and organic acids, metal ions and amine compounds",0.8011,0.902319257837492,-0.7544581667028261
2774,R-HSA-109606,1.009861176463921,Transcriptomics,Intrinsic Pathway for Apoptosis,0.6686,0.8777425373134329,-0.7547365828678612
2775,R-HSA-9634285,1.0098384863334984,Transcriptomics,Constitutive Signaling by Overexpressed ERBB2,0.6287,0.8777425373134329,-0.7547954727948658
2776,R-HSA-156711,1.1695727107249032,Proteomics,Polo-like kinase mediated events,0.3946,0.8777425373134329,-0.7549426353656744
2777,R-HSA-2980767,1.1695727107249032,Proteomics,"Activation of NIMA Kinases NEK9, NEK6, NEK7",0.3946,0.8777425373134329,-0.7549426353656744
2778,R-HSA-176412,1.1695727107249019,Proteomics,Phosphorylation of the APC/C,0.3946,0.8777425373134329,-0.7549426353656773
2779,R-HSA-176417,1.1695727107249019,Proteomics,Phosphorylation of Emi1,0.3946,0.8777425373134329,-0.7549426353656773
2780,R-HSA-216083,1.1695224509940274,Proteomics,Integrin cell surface interactions,0.53,0.8777425373134329,-0.7550522864935375
2781,R-HSA-1852241,2.043782286361933,Metabolomics,Organelle biogenesis and maintenance,0.8078,0.9031140210795272,-0.757326363235135
2782,R-HSA-1592230,2.043782286361933,Metabolomics,Mitochondrial biogenesis,0.8078,0.9031140210795272,-0.757326363235135
2783,R-HSA-6804756,1.167775909938738,Proteomics,Regulation of TP53 Activity through Phosphorylation,0.6086,0.8777425373134329,-0.7588626968008471
2784,R-HSA-186712,1.0077441967274554,Transcriptomics,Regulation of beta-cell development,0.8185,0.9059734513274336,-0.7602309885777047
2785,R-HSA-6802948,1.0073530293496638,Transcriptomics,Signaling by high-kinase activity BRAF mutants,0.6355,0.8777425373134329,-0.761246223743645
2786,R-HSA-9637690,1.0072260226578487,Transcriptomics,Response of Mtb to phagocytosis,0.7498,0.8946156451066711,-0.7615758567017111
2787,R-HSA-442660,1.0069812390052468,Transcriptomics,Na+/Cl- dependent neurotransmitter transporters,0.509,0.8777425373134329,-0.762211167789184
2788,R-HSA-9701898,1.0066998208190048,Transcriptomics,STAT3 nuclear events downstream of ALK signaling,0.7962,0.902319257837492,-0.7629415600847304
2789,R-HSA-5653890,1.0066067870864484,Transcriptomics,Lactose synthesis,0.8165,0.905784469096672,-0.7631830196804748
2790,R-HSA-2160916,1.0065641811137416,Transcriptomics,Hyaluronan uptake and degradation,0.5842,0.8777425373134329,-0.7632935991516342
2791,R-HSA-6803207,1.0062346692432478,Transcriptomics,TP53 Regulates Transcription of Caspase Activators and Caspases,0.6794,0.8786055923473142,-0.7641488137158156
2792,R-HSA-8957322,1.0056186019941533,Transcriptomics,Metabolism of steroids,0.7928,0.902319257837492,-0.765747753636102
2793,R-HSA-76005,1.005218859193674,Transcriptomics,Response to elevated platelet cytosolic Ca2+,0.7226,0.8854020979020979,-0.7667852454399158
2794,R-HSA-1226099,1.0049976370970135,Transcriptomics,Signaling by FGFR in disease,0.7831,0.9003598298985933,-0.7673594049040323
2795,R-HSA-373760,1.0041565553436145,Transcriptomics,L1CAM interactions,0.8527,0.9174193548387096,-0.7695423470969682
2796,R-HSA-390466,1.004122013579375,Transcriptomics,Chaperonin-mediated protein folding,0.7685,0.9001672240802675,-0.7696319967347974
2797,R-HSA-8876198,1.0041176298675116,Transcriptomics,RAB GEFs exchange GTP for GDP on RABs,0.709,0.8854020979020979,-0.7696433742133236
2798,R-HSA-933543,1.0035780520203812,Transcriptomics,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,0.5984,0.8777425373134329,-0.7710437936661466
2799,R-HSA-9007101,1.0030843787964017,Transcriptomics,Rab regulation of trafficking,0.6993,0.8854020979020979,-0.7723250723358984
2800,R-HSA-1655829,1.0030700062804256,Transcriptomics,Regulation of cholesterol biosynthesis by SREBP (SREBF),0.8143,0.9044257614213198,-0.7723623747401128
2801,R-HSA-983189,1.0029839952040462,Transcriptomics,Kinesins,0.8675,0.9239406779661016,-0.7725856077456199
2802,R-HSA-205025,1.1612726926503791,Proteomics,NADE modulates death signalling,0.6374,0.8777425373134329,-0.7730506977706433
2803,R-HSA-1169408,1.0020161036652606,Transcriptomics,ISG15 antiviral mechanism,0.5738,0.8777425373134329,-0.7750976718460028
2804,R-HSA-416572,1.0018914195412851,Transcriptomics,Sema4D induced cell migration and growth-cone collapse,0.7454,0.8923563611491109,-0.7754212768153359
2805,R-HSA-74217,0.9992852492018883,Transcriptomics,Purine salvage,0.6402,0.8777425373134329,-0.7821853270076699
2806,R-HSA-1483255,0.9986751953569721,Transcriptomics,PI Metabolism,0.7287,0.888658536585366,-0.7837686597486888
2807,R-HSA-114608,0.9984690712813894,Transcriptomics,Platelet degranulation ,0.7338,0.8897836538461539,-0.7843036338338488
2808,R-HSA-189483,1.1559947090061315,Proteomics,Heme degradation,0.6199,0.8777425373134329,-0.7845656193460304
2809,R-HSA-189445,1.1559947090061315,Proteomics,Metabolism of porphyrins,0.6199,0.8777425373134329,-0.7845656193460304
2810,R-HSA-373076,1.1559385556266788,Proteomics,Class A/1 (Rhodopsin-like receptors),0.5909,0.8777425373134329,-0.7846881285851972
2811,R-HSA-375276,1.1559385556266788,Proteomics,Peptide ligand-binding receptors,0.5909,0.8777425373134329,-0.7846881285851972
2812,R-HSA-442742,0.9973055763965154,Transcriptomics,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,0.7008,0.8854020979020979,-0.7873233665354469
2813,R-HSA-191273,0.9970661638221483,Transcriptomics,Cholesterol biosynthesis,0.7674,0.9001005361930295,-0.7879447375353447
2814,R-HSA-1227986,0.9969136629081867,Transcriptomics,Signaling by ERBB2,0.6961,0.8849128540305011,-0.7883405381554421
2815,R-HSA-400685,0.9967250285275567,Transcriptomics,Sema4D in semaphorin signaling,0.6951,0.8845385174418605,-0.7888301195152225
2816,R-HSA-354192,0.9962437471202832,Transcriptomics,Integrin signaling,0.6541,0.8777425373134329,-0.7900792364843723
2817,R-HSA-1358803,0.99569273575231,Transcriptomics,Downregulation of ERBB2:ERBB3 signaling,0.8182,0.9059734513274336,-0.7915093304782975
2818,R-HSA-8934903,0.9955172147723743,Transcriptomics,Receptor Mediated Mitophagy,0.6659,0.8777425373134329,-0.7919648773395849
2819,R-HSA-844456,1.1523896662418074,Proteomics,The NLRP3 inflammasome,0.4427,0.8777425373134329,-0.7924307033449839
2820,R-HSA-8956321,1.9695115239217504,Metabolomics,Nucleotide salvage,0.8362,0.9123129675810474,-0.7932072626389934
2821,R-HSA-888590,0.9944992008598758,Transcriptomics,"GABA synthesis, release, reuptake and degradation",0.7399,0.8897836538461539,-0.7946070289658781
2822,R-HSA-1483248,0.9944782866810438,Transcriptomics,Synthesis of PIPs at the ER membrane,0.8392,0.9132457496136012,-0.7946613095910593
2823,R-HSA-8875360,0.9944424353618383,Transcriptomics,InlB-mediated entry of Listeria monocytogenes into host cell,0.7615,0.8969559367642113,-0.7947543580456831
2824,R-HSA-3371453,0.9943507274664467,Transcriptomics,Regulation of HSF1-mediated heat shock response,0.6837,0.8788546255506609,-0.7949923765658407
2825,R-HSA-8964043,0.9941253787698197,Transcriptomics,Plasma lipoprotein clearance,0.8601,0.9205288902476306,-0.7955772462006917
2826,R-HSA-8854214,0.9940442151703897,Transcriptomics,TBC/RABGAPs,0.7137,0.8854020979020979,-0.7957878980725344
2827,R-HSA-9612973,0.9940249735436657,Transcriptomics,Autophagy,0.8765,0.9276534623525854,-0.7958378377587382
2828,R-HSA-9018677,1.1505008066171678,Proteomics,Biosynthesis of DHA-derived SPMs,0.5007,0.8777425373134329,-0.796551608582791
2829,R-HSA-9018678,1.1505008066171678,Proteomics,Biosynthesis of specialized proresolving mediators (SPMs),0.5007,0.8777425373134329,-0.796551608582791
2830,R-HSA-9033241,0.9936725349557534,Transcriptomics,Peroxisomal protein import,0.7466,0.8927570891697985,-0.7967525562874227
2831,R-HSA-1250196,0.9933540808292549,Transcriptomics,SHC1 events in ERBB2 signaling,0.6804,0.8786055923473142,-0.7975790716011109
2832,R-HSA-5357769,1.1496533670608045,Proteomics,Caspase activation via extrinsic apoptotic signalling pathway,0.5499,0.8777425373134329,-0.7984004585772467
2833,R-HSA-111471,0.9927448311242929,Transcriptomics,Apoptotic factor-mediated response,0.6569,0.8777425373134329,-0.7991603172786216
2834,R-HSA-1643713,0.9927252376532073,Transcriptomics,Signaling by EGFR in Cancer,0.7165,0.8854020979020979,-0.7992111701411001
2835,R-HSA-948021,1.147346412518785,Proteomics,Transport to the Golgi and subsequent modification,0.7196,0.8854020979020979,-0.8034335171124486
2836,R-HSA-5658623,1.147134023037249,Proteomics,FGFRL1 modulation of FGFR1 signaling,0.488,0.8777425373134329,-0.8038968850173472
2837,R-HSA-9687136,0.9907040824991439,Transcriptomics,Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.8008,0.902319257837492,-0.8044568728881215
2838,R-HSA-211728,0.9892552404621251,Transcriptomics,Regulation of PAK-2p34 activity by PS-GAP/RHG10,0.832,0.911421875,-0.8082171951168775
2839,R-HSA-9634597,0.9884429135119641,Transcriptomics,GPER1 signaling,0.811,0.9035918626827718,-0.8103255071410048
2840,R-HSA-9013409,0.9879777334550373,Transcriptomics,RHOJ GTPase cycle,0.8381,0.9132457496136012,-0.8115328346920714
2841,R-HSA-6811440,0.9879621032403432,Transcriptomics,Retrograde transport at the Trans-Golgi-Network,0.7211,0.8854020979020979,-0.8115734013254604
2842,R-HSA-2122947,0.9872079096790272,Transcriptomics,NOTCH1 Intracellular Domain Regulates Transcription,0.8701,0.9239406779661016,-0.8135308340482413
2843,R-HSA-9696270,1.141976219084213,Proteomics,RND2 GTPase cycle,0.5845,0.8777425373134329,-0.8151496118205388
2844,R-HSA-156584,1.917967586249569,Metabolomics,Cytosolic sulfonation of small molecules,0.8991,0.93868374032162,-0.8181086206125812
2845,R-HSA-8985947,0.985418631208095,Transcriptomics,Interleukin-9 signaling,0.7206,0.8854020979020979,-0.8181747244350258
2846,R-HSA-210744,0.9853463528889971,Transcriptomics,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,0.8502,0.9158818097876268,-0.8183623154649772
2847,R-HSA-1679131,1.1403088455916932,Proteomics,Trafficking and processing of endosomal TLR,0.5141,0.8777425373134329,-0.81878730308625
2848,R-HSA-6804116,0.9850139000546384,Transcriptomics,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,0.5994,0.8777425373134329,-0.8192251630019137
2849,R-HSA-199977,0.9849685521644699,Transcriptomics,ER to Golgi Anterograde Transport,0.7999,0.902319257837492,-0.8193428588411225
2850,R-HSA-9033500,0.9847734537222513,Transcriptomics,TYSND1 cleaves peroxisomal proteins,0.6184,0.8777425373134329,-0.8198492170156683
2851,R-HSA-9703465,0.9844442311594451,Transcriptomics,Signaling by FLT3 fusion proteins,0.7029,0.8854020979020979,-0.8207036807111555
2852,R-HSA-2173791,0.9834865658644499,Transcriptomics,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),0.7596,0.8969559367642113,-0.8231892036353029
2853,R-HSA-8876384,0.9827750591510603,Transcriptomics,Listeria monocytogenes entry into host cells,0.8056,0.902319257837492,-0.8250358469835131
2854,R-HSA-5696395,0.9824607380268752,Transcriptomics,Formation of Incision Complex in GG-NER,0.7788,0.9003598298985933,-0.8258516355098269
2855,R-HSA-418889,1.1368826201823723,Proteomics,Caspase activation via Dependence Receptors in the absence of ligand,0.7197,0.8854020979020979,-0.8262622631367473
2856,R-HSA-3270619,0.9819883215218297,Transcriptomics,IRF3-mediated induction of type I IFN,0.8155,0.9049619530754598,-0.8270777445263826
2857,R-HSA-9613829,0.9814479770294051,Transcriptomics,Chaperone Mediated Autophagy,0.7877,0.9008983992159426,-0.8284801537291353
2858,R-HSA-9603798,0.9804855464671374,Transcriptomics,Class I peroxisomal membrane protein import,0.632,0.8777425373134329,-0.8309780444200875
2859,R-HSA-73621,1.8856447630197124,Metabolomics,Pyrimidine catabolism,0.8058,0.902319257837492,-0.8337240785755079
2860,R-HSA-9623433,0.97882412678593,Transcriptomics,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,0.562,0.8777425373134329,-0.8352900903152991
2861,R-HSA-9660821,0.9779947803876716,Transcriptomics,ADORA2B mediated anti-inflammatory cytokines production,0.8428,0.9132457496136012,-0.8374425745868949
2862,R-HSA-196849,1.877917920196318,Metabolomics,Metabolism of water-soluble vitamins and cofactors,0.8493,0.9151939655172414,-0.8374569885517442
2863,R-HSA-9022699,1.131720175147058,Proteomics,MECP2 regulates neuronal receptors and channels,0.4649,0.8777425373134329,-0.8375251153404822
2864,R-HSA-8964038,1.1312927268720285,Proteomics,LDL clearance,0.4266,0.8777425373134329,-0.8384576747601886
2865,R-HSA-8964011,0.9773303697783604,Transcriptomics,HDL clearance,0.7689,0.9001672240802675,-0.8391669847844034
2866,R-HSA-190370,1.13091807418444,Proteomics,FGFR1b ligand binding and activation,0.4792,0.8777425373134329,-0.8392750506003528
2867,R-HSA-9694631,0.9769870316137147,Transcriptomics,Maturation of nucleoprotein,0.7544,0.8946156451066711,-0.8400580840895797
2868,R-HSA-445095,0.976956748163548,Transcriptomics,Interaction between L1 and Ankyrins,0.7705,0.9003598298985933,-0.8401366817061007
2869,R-HSA-8853884,0.9762970240865587,Transcriptomics,Transcriptional Regulation by VENTX,0.8148,0.9044719314938152,-0.8418489284853652
2870,R-HSA-204005,0.9758830501772743,Transcriptomics,COPII-mediated vesicle transport,0.7545,0.8946156451066711,-0.8429233556854555
2871,R-HSA-1614635,1.8652621937023166,Metabolomics,Sulfur amino acid metabolism,0.8665,0.9239406779661016,-0.8435710882902482
2872,R-HSA-400685,1.128709209101388,Proteomics,Sema4D in semaphorin signaling,0.6482,0.8777425373134329,-0.8440941083914236
2873,R-HSA-9614085,0.9732913606565585,Transcriptomics,FOXO-mediated transcription,0.7774,0.9003598298985933,-0.8496498223849134
2874,R-HSA-170834,0.9731533248728323,Transcriptomics,Signaling by TGF-beta Receptor Complex,0.8293,0.9110536218250236,-0.8500080802299006
2875,R-HSA-114452,0.9722946170188093,Transcriptomics,Activation of BH3-only proteins,0.7183,0.8854020979020979,-0.8522367691752701
2876,R-HSA-9682385,0.9713144301145515,Transcriptomics,FLT3 signaling in disease,0.7857,0.9003598298985933,-0.8547807446468819
2877,R-HSA-2408522,1.8419585349525427,Metabolomics,Selenoamino acid metabolism,0.8459,0.9134751773049644,-0.8548293036076945
2878,R-HSA-6807878,0.9711535456799537,Transcriptomics,COPI-mediated anterograde transport,0.8574,0.9202391904323828,-0.8551983038425854
2879,R-HSA-156580,1.8380702236478828,Metabolomics,Phase II - Conjugation of compounds,0.794,0.902319257837492,-0.856707783135702
2880,R-HSA-9637687,0.9705206087442503,Transcriptomics,Suppression of phagosomal maturation,0.739,0.8897836538461539,-0.8568410273196208
2881,R-HSA-5620971,1.1216079816456612,Proteomics,Pyroptosis,0.6082,0.8777425373134329,-0.8595867818730475
2882,R-HSA-5693548,0.9684976565070795,Transcriptomics,Sensing of DNA Double Strand Breaks,0.5874,0.8777425373134329,-0.8620913942131693
2883,R-HSA-110313,0.9684471087351364,Transcriptomics,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,0.738,0.8897836538461539,-0.8622225858169433
2884,R-HSA-9029569,0.9680020723353473,Transcriptomics,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.7943,0.902319257837492,-0.8633776325535607
2885,R-HSA-3000178,0.967465224648166,Transcriptomics,ECM proteoglycans,0.681,0.8786055923473142,-0.8647709661537633
2886,R-HSA-190377,1.1188525690293776,Proteomics,FGFR2b ligand binding and activation,0.5444,0.8777425373134329,-0.8655982366866521
2887,R-HSA-1368082,0.966870815804924,Transcriptomics,RORA activates gene expression,0.7743,0.9003598298985933,-0.8663136938832894
2888,R-HSA-9651496,0.9660868633185394,Transcriptomics,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),0.7548,0.8946156451066711,-0.8683483628710185
2889,R-HSA-9671793,0.9660868633185394,Transcriptomics,Diseases of hemostasis,0.7548,0.8946156451066711,-0.8683483628710185
2890,R-HSA-416550,1.1173169114898147,Proteomics,Sema4D mediated inhibition of cell attachment and migration,0.5251,0.8777425373134329,-0.8689485646388789
2891,R-HSA-5668914,1.8082211887708106,Metabolomics,Diseases of metabolism,0.8333,0.911421875,-0.8711281308275555
2892,R-HSA-382551,1.8071598000209488,Metabolomics,Transport of small molecules,0.8045,0.902319257837492,-0.8716408976514164
2893,R-HSA-194306,0.964170700915806,Transcriptomics,Neurophilin interactions with VEGF and VEGFR,0.4608,0.8777425373134329,-0.8733215676047319
2894,R-HSA-3214841,1.1151814436996519,Proteomics,PKMTs methylate histone lysines,0.4605,0.8777425373134329,-0.8736074923256462
2895,R-HSA-111461,0.963884452330574,Transcriptomics,Cytochrome c-mediated apoptotic response,0.7122,0.8854020979020979,-0.874064496709835
2896,R-HSA-3769402,0.9635962891499996,Transcriptomics,Deactivation of the beta-catenin transactivating complex,0.8535,0.9174600737100738,-0.8748123949525257
2897,R-HSA-2980767,0.9628503408940351,Transcriptomics,"Activation of NIMA Kinases NEK9, NEK6, NEK7",0.6337,0.8777425373134329,-0.8767484278234223
2898,R-HSA-354194,0.9628261992532228,Transcriptomics,GRB2:SOS provides linkage to MAPK signaling for Integrins ,0.7058,0.8854020979020979,-0.876811084998094
2899,R-HSA-1247673,0.9622527079445278,Transcriptomics,Erythrocytes take up oxygen and release carbon dioxide,0.7607,0.8969559367642113,-0.8782995233930219
2900,R-HSA-114508,1.1114168858703557,Proteomics,Effects of PIP2 hydrolysis,0.8475,0.9138170055452866,-0.881820588669285
2901,R-HSA-168927,0.9607172140189288,Transcriptomics,"TICAM1, RIP1-mediated IKK complex recruitment",0.8594,0.9205288902476306,-0.8822847417902119
2902,R-HSA-1660499,0.9601072512068528,Transcriptomics,Synthesis of PIPs at the plasma membrane,0.7678,0.9001672240802675,-0.8838678382647479
2903,R-HSA-200425,0.9591320757299934,Transcriptomics,Carnitine metabolism,0.5517,0.8777425373134329,-0.8863988070859713
2904,R-HSA-9706377,0.9588841211134147,Transcriptomics,FLT3 signaling by CBL mutants,0.7896,0.9014183240952072,-0.8870423480881098
2905,R-HSA-76005,1.10876596336522,Proteomics,Response to elevated platelet cytosolic Ca2+,0.7491,0.8945240532241556,-0.8876040785030087
2906,R-HSA-2132295,0.9586625546789477,Transcriptomics,MHC class II antigen presentation,0.8986,0.93868374032162,-0.8876174012460005
2907,R-HSA-5626467,0.958005954951594,Transcriptomics,RHO GTPases activate IQGAPs,0.8787,0.9285778985507248,-0.8893215390933834
2908,R-HSA-264870,0.9574476968414448,Transcriptomics,Caspase-mediated cleavage of cytoskeletal proteins,0.775,0.9003598298985933,-0.8907704412699774
2909,R-HSA-8876493,0.9560521894973611,Transcriptomics,InlA-mediated entry of Listeria monocytogenes into host cells,0.783,0.9003598298985933,-0.8943923387248219
2910,R-HSA-6809371,0.9548987444566902,Transcriptomics,Formation of the cornified envelope,0.8438,0.9132457496136012,-0.8973859880773821
2911,R-HSA-6805567,0.9548987444566902,Transcriptomics,Keratinization,0.8438,0.9132457496136012,-0.8973859880773821
2912,R-HSA-6807004,0.9536007658712565,Transcriptomics,Negative regulation of MET activity,0.8358,0.9123129675810474,-0.9007547595531867
2913,R-HSA-1855204,0.9531796976237259,Transcriptomics,Synthesis of IP3 and IP4 in the cytosol,0.8376,0.9132457496136012,-0.9018475993870384
2914,R-HSA-1236394,0.9531176639833168,Transcriptomics,Signaling by ERBB4,0.8092,0.9035918626827718,-0.9020086013948494
2915,R-HSA-177128,1.7404104560889424,Metabolomics,Conjugation of salicylate with glycine,0.9667,0.974776721405935,-0.9038881294854346
2916,R-HSA-1483257,1.7356157929366296,Metabolomics,Phospholipid metabolism,0.8564,0.9194478527607364,-0.9062044760610077
2917,R-HSA-5689877,0.9509959424605601,Transcriptomics,Josephin domain DUBs,0.7648,0.897887323943662,-0.9075153139289975
2918,R-HSA-8856688,0.9509431452645204,Transcriptomics,Golgi-to-ER retrograde transport,0.8628,0.922824427480916,-0.9076523436843548
2919,R-HSA-189200,0.9506244313406828,Transcriptomics,Cellular hexose transport,0.7741,0.9003598298985933,-0.9084795332756278
2920,R-HSA-425407,1.7293546197258898,Metabolomics,SLC-mediated transmembrane transport,0.812,0.9035918626827718,-0.9092293073505159
2921,R-HSA-381771,0.9500585318668026,Transcriptomics,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.7248,0.8857541899441341,-0.9099482678350224
2922,R-HSA-400508,0.9500585318668026,Transcriptomics,"Incretin synthesis, secretion, and inactivation",0.7248,0.8857541899441341,-0.9099482678350224
2923,R-HSA-9617629,0.949925548041248,Transcriptomics,Regulation of FOXO transcriptional activity by acetylation,0.7619,0.8969559367642113,-0.9102934138361192
2924,R-HSA-964975,1.726547153432999,Metabolomics,Vitamins B6 activation to pyridoxal phosphate,0.7463,0.8927033492822967,-0.910585620552714
2925,R-HSA-381753,1.722348359884766,Metabolomics,Olfactory Signaling Pathway,0.8642,0.923008849557522,-0.9126140969540846
2926,R-HSA-177135,1.7202022218783053,Metabolomics,Conjugation of benzoate with glycine,0.9043,0.9414187983343248,-0.9136509162809178
2927,R-HSA-1266695,0.9480831769382729,Transcriptomics,Interleukin-7 signaling,0.8331,0.911421875,-0.9150751007523753
2928,R-HSA-450385,0.9471830931948553,Transcriptomics,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,0.7429,0.8907673860911272,-0.9174111766127084
2929,R-HSA-3322077,0.946987571484213,Transcriptomics,Glycogen synthesis,0.801,0.902319257837492,-0.9179186333374217
2930,R-HSA-3785653,0.946987571484213,Transcriptomics,Myoclonic epilepsy of Lafora,0.801,0.902319257837492,-0.9179186333374217
2931,R-HSA-2173795,0.9468471955249865,Transcriptomics,Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.8549,0.9181190549248236,-0.9182829648700355
2932,R-HSA-5339562,0.9464813292225545,Transcriptomics,Uptake and actions of bacterial toxins,0.8134,0.9043519695044472,-0.919232533666796
2933,R-HSA-432722,1.0913882620503645,Proteomics,Golgi Associated Vesicle Biogenesis,0.8119,0.9035918626827718,-0.9255168272511322
2934,R-HSA-1237112,1.6955302046741338,Metabolomics,Methionine salvage pathway,0.9192,0.946513680494263,-0.9255701983551542
2935,R-HSA-9605308,0.9436693830116828,Transcriptomics,Diseases of Base Excision Repair,0.6721,0.8777425373134329,-0.9265306542159238
2936,R-HSA-6811434,0.9433527955879519,Transcriptomics,COPI-dependent Golgi-to-ER retrograde traffic,0.9018,0.9396546591247396,-0.9273523246923336
2937,R-HSA-209776,1.090372627103617,Proteomics,Metabolism of amine-derived hormones,0.4567,0.8777425373134329,-0.9277326273652093
2938,R-HSA-418889,0.9424315651944558,Transcriptomics,Caspase activation via Dependence Receptors in the absence of ligand,0.7078,0.8854020979020979,-0.9297432845333368
2939,R-HSA-5656169,0.9421798192710874,Transcriptomics,Termination of translesion DNA synthesis,0.7896,0.9014183240952072,-0.9303966654868524
2940,R-HSA-9619483,0.9411011117195623,Transcriptomics,Activation of AMPK downstream of NMDARs,0.8692,0.9239406779661016,-0.9331963412835825
2941,R-HSA-9694493,0.9409539970186475,Transcriptomics,Maturation of protein E,0.7956,0.902319257837492,-0.9335781625352391
2942,R-HSA-9683683,0.9409539970186475,Transcriptomics,Maturation of protein E,0.7956,0.902319257837492,-0.9335781625352391
2943,R-HSA-9700645,0.9409026888401718,Transcriptomics,ALK mutants bind TKIs,0.8596,0.9205288902476306,-0.9337113276968712
2944,R-HSA-450302,0.9407889785620434,Transcriptomics,activated TAK1 mediates p38 MAPK activation,0.8635,0.922824427480916,-0.9340064511648265
2945,R-HSA-76009,0.9401101600232306,Transcriptomics,Platelet Aggregation (Plug Formation),0.7514,0.8946156451066711,-0.9357682556787552
2946,R-HSA-446219,1.0863187273733255,Proteomics,Synthesis of substrates in N-glycan biosythesis,0.4236,0.8777425373134329,-0.9365769779004115
2947,R-HSA-446193,1.0863187273733255,Proteomics,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",0.4236,0.8777425373134329,-0.9365769779004115
2948,R-HSA-912694,1.0855711642547514,Proteomics,Regulation of IFNA/IFNB signaling,0.7331,0.8897836538461539,-0.9382079285177772
2949,R-HSA-2173789,0.9385657016794983,Transcriptomics,TGF-beta receptor signaling activates SMADs,0.852,0.9169741697416974,-0.9397767403119553
2950,R-HSA-201688,0.9383637938651366,Transcriptomics,WNT mediated activation of DVL,0.7272,0.8871383757406761,-0.9403007715197095
2951,R-HSA-420029,0.937807865631714,Transcriptomics,Tight junction interactions,0.7594,0.8969559367642113,-0.941743626738097
2952,R-HSA-69895,0.9377584001411826,Transcriptomics,Transcriptional  activation of  cell cycle inhibitor p21 ,0.5428,0.8777425373134329,-0.9418720093904835
2953,R-HSA-69560,0.9377584001411826,Transcriptomics,Transcriptional activation of p53 responsive genes  ,0.5428,0.8777425373134329,-0.9418720093904835
2954,R-HSA-9636383,0.9375904624778718,Transcriptomics,Prevention of phagosomal-lysosomal fusion,0.8249,0.9086347908147216,-0.9423078745243337
2955,R-HSA-1643685,1.6543344000078368,Metabolomics,Disease,0.8852,0.9297629762976296,-0.9454722765690797
2956,R-HSA-5205647,0.9362402500195938,Transcriptomics,Mitophagy,0.866,0.9239406779661016,-0.9458122137074054
2957,R-HSA-8964208,0.9352746227690084,Transcriptomics,Phenylalanine metabolism,0.5131,0.8777425373134329,-0.9483184010779349
2958,R-HSA-442720,0.9349524098795188,Transcriptomics,CREB1 phosphorylation through the activation of Adenylate Cyclase,0.6633,0.8777425373134329,-0.9491546718788793
2959,R-HSA-75108,1.0800980168532943,Proteomics,"Activation, myristolyation of BID and translocation to mitochondria",0.6509,0.8777425373134329,-0.9501486368159169
2960,R-HSA-140837,0.9342181774309848,Transcriptomics,Intrinsic Pathway of Fibrin Clot Formation,0.7498,0.8946156451066711,-0.9510602975625303
2961,R-HSA-8986944,0.9338036167921111,Transcriptomics,Transcriptional Regulation by MECP2,0.9111,0.9454356846473028,-0.952136247559627
2962,R-HSA-3000178,1.078719804354927,Proteomics,ECM proteoglycans,0.6711,0.8777425373134329,-0.9531554685726265
2963,R-HSA-2129379,0.9328344491938351,Transcriptomics,Molecules associated with elastic fibres,0.7982,0.902319257837492,-0.9546516235427027
2964,R-HSA-72200,0.9327509159148777,Transcriptomics,mRNA Editing: C to U Conversion,0.6507,0.8777425373134329,-0.954868425676875
2965,R-HSA-75094,0.9327509159148777,Transcriptomics,Formation of the Editosome,0.6507,0.8777425373134329,-0.954868425676875
2966,R-HSA-8936459,1.0779237426593449,Proteomics,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,0.5726,0.8777425373134329,-0.9548922280269285
2967,R-HSA-390450,0.9309080614552511,Transcriptomics,Folding of actin by CCT/TriC,0.7395,0.8897836538461539,-0.959651367096186
2968,R-HSA-9022692,0.9305394573647745,Transcriptomics,Regulation of MECP2 expression and activity,0.9218,0.9478995299647476,-0.9606080415435133
2969,R-HSA-2514859,0.9303541481047651,Transcriptomics,"Inactivation, recovery and regulation of the phototransduction cascade",0.6876,0.8802487198244331,-0.9610889928907295
2970,R-HSA-2672351,0.9302351128684027,Transcriptomics,Stimuli-sensing channels,0.8238,0.9086347908147216,-0.9613979367464862
2971,R-HSA-373753,1.0739917094587506,Proteomics,Nephrin family interactions,0.7733,0.9003598298985933,-0.9634707036320982
2972,R-HSA-210993,1.0738092059504296,Proteomics,Tie2 Signaling,0.7229,0.8854020979020979,-0.963868869622597
2973,R-HSA-2173782,1.0726348048150083,Proteomics,Binding and Uptake of Ligands by Scavenger Receptors,0.7082,0.8854020979020979,-0.9664310482657917
2974,R-HSA-3656253,0.9266587716290704,Transcriptomics,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",0.5122,0.8777425373134329,-0.9706799668893648
2975,R-HSA-3656237,0.9266587716290704,Transcriptomics,Defective EXT2 causes exostoses 2,0.5122,0.8777425373134329,-0.9706799668893648
2976,R-HSA-8955332,0.926253575110037,Transcriptomics,Carboxyterminal post-translational modifications of tubulin,0.8686,0.9239406779661016,-0.9717316132653016
2977,R-HSA-6806003,0.9258596522934653,Transcriptomics,Regulation of TP53 Expression and Degradation,0.8222,0.9077917981072556,-0.9727539998924984
2978,R-HSA-9008059,0.9256201876188804,Transcriptomics,Interleukin-37 signaling,0.9092,0.944272997032641,-0.9733755061132154
2979,R-HSA-193639,0.925494997471209,Transcriptomics,p75NTR signals via NF-kB,0.8998,0.93868374032162,-0.9737004244156129
2980,R-HSA-199920,0.9248253616605268,Transcriptomics,CREB phosphorylation,0.6201,0.8777425373134329,-0.9754383960921255
2981,R-HSA-73943,0.9226727981191349,Transcriptomics,Reversal of alkylation damage by DNA dioxygenases,0.8059,0.902319257837492,-0.9810251559504747
2982,R-HSA-9679504,0.9215184360812901,Transcriptomics,Translation of Replicase and Assembly of the Replication Transcription Complex,0.8455,0.9134751773049644,-0.9840211852759846
2983,R-HSA-1660661,1.573353709992205,Metabolomics,Sphingolipid de novo biosynthesis,0.9484,0.962804524361949,-0.9845948046896996
2984,R-HSA-2979096,0.9209735753935206,Transcriptomics,NOTCH2 Activation and Transmission of Signal to the Nucleus,0.8931,0.9342050209205022,-0.9854353158046727
2985,R-HSA-449836,1.063851709952401,Proteomics,Other interleukin signaling,0.6997,0.8854020979020979,-0.9855930342341145
2986,R-HSA-73856,1.0630504267999674,Proteomics,RNA Polymerase II Transcription Termination,0.566,0.8777425373134329,-0.9873411852860806
2987,R-HSA-83936,1.5638256944400686,Metabolomics,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.9216,0.9478995299647476,-0.9891978780433622
2988,R-HSA-8877330,1.0615818586717827,Proteomics,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),0.7167,0.8854020979020979,-0.9905451449729566
2989,R-HSA-9672396,1.061363956434165,Proteomics,Defective cofactor function of FVIIIa variant,0.4094,0.8777425373134329,-0.9910205399999956
2990,R-HSA-9673202,1.061363956434165,Proteomics,Defective F9 variant does not activate FX,0.4094,0.8777425373134329,-0.9910205399999956
2991,R-HSA-9672383,1.061363956434165,Proteomics,Defective factor IX causes thrombophilia,0.4094,0.8777425373134329,-0.9910205399999956
2992,R-HSA-209543,0.9168684080565935,Transcriptomics,p75NTR recruits signalling complexes,0.8899,0.9328092243186584,-0.9960898603273963
2993,R-HSA-880009,0.9165640497552517,Transcriptomics,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,0.7151,0.8854020979020979,-0.9968797913597653
2994,R-HSA-71288,1.5445440192570135,Metabolomics,Creatine metabolism,0.8806,0.9292557999397408,-0.9985130355138174
2995,R-HSA-674695,1.0570194031564664,Proteomics,RNA Polymerase II Pre-transcription Events,0.4397,0.8777425373134329,-1.000499006331985
2996,R-HSA-167172,1.0570194031564664,Proteomics,Transcription of the HIV genome,0.4397,0.8777425373134329,-1.000499006331985
2997,R-HSA-6804757,0.9148671099777551,Transcriptomics,Regulation of TP53 Degradation,0.8394,0.9132457496136012,-1.0012840260541913
2998,R-HSA-5674400,0.9147439467681123,Transcriptomics,Constitutive Signaling by AKT1 E17K in Cancer,0.8467,0.9135172626387176,-1.0016036836449784
2999,R-HSA-5578768,0.9144396852853603,Transcriptomics,Physiological factors,0.8053,0.902319257837492,-1.0023933633945397
3000,R-HSA-5210891,0.9132560135532596,Transcriptomics,Uptake and function of anthrax toxins,0.843,0.9132457496136012,-1.005465463052089
3001,R-HSA-1483191,0.9131845426968083,Transcriptomics,Synthesis of PC,0.9006,0.93868374032162,-1.0056509583948217
3002,R-HSA-9694614,1.0542512816767193,Proteomics,Attachment and Entry,0.7526,0.8946156451066711,-1.0065381879397515
3003,R-HSA-3371497,0.9126365363184591,Transcriptomics,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,0.8441,0.9132457496136012,-1.0070732532436422
3004,R-HSA-1963642,0.9123670362021609,Transcriptomics,PI3K events in ERBB2 signaling,0.8247,0.9086347908147216,-1.0077727134001502
3005,R-HSA-1963640,0.9123670362021609,Transcriptomics,GRB2 events in ERBB2 signaling,0.8247,0.9086347908147216,-1.0077727134001502
3006,R-HSA-9702518,0.9107535303351206,Transcriptomics,STAT5 activation downstream of FLT3 ITD mutants,0.8868,0.9306746626686656,-1.0119604038612469
3007,R-HSA-9703648,0.9107535303351206,Transcriptomics,Signaling by FLT3 ITD and TKD mutants,0.8868,0.9306746626686656,-1.0119604038612469
3008,R-HSA-936440,0.9105652006981042,Transcriptomics,Negative regulators of DDX58/IFIH1 signaling,0.8413,0.9132457496136012,-1.0124491942899563
3009,R-HSA-5689896,0.9101990829506216,Transcriptomics,Ovarian tumor domain proteases,0.8985,0.93868374032162,-1.0133994156867856
3010,R-HSA-5357956,0.910114989524081,Transcriptomics,TNFR1-induced NFkappaB signaling pathway,0.9124,0.9457008244994112,-1.0136176716270697
3011,R-HSA-174403,0.9083246899150784,Transcriptomics,Glutathione synthesis and recycling,0.6582,0.8777425373134329,-1.0182642122739147
3012,R-HSA-434316,1.502156030833135,Metabolomics,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,0.8964,0.9373767553032566,-1.018991068842128
3013,R-HSA-140877,0.9074788922594559,Transcriptomics,Formation of Fibrin Clot (Clotting Cascade),0.8029,0.902319257837492,-1.0204593941116888
3014,R-HSA-9014325,0.9074501427690276,Transcriptomics,"TICAM1,TRAF6-dependent induction of TAK1 complex",0.8352,0.9123129675810474,-1.0205340104916396
3015,R-HSA-9749641,0.9073940306885162,Transcriptomics,Aspirin ADME,0.8173,0.9059734513274336,-1.020679643692677
3016,R-HSA-2168880,1.0474863416210687,Proteomics,Scavenging of heme from plasma,0.5195,0.8777425373134329,-1.0212971867267053
3017,R-HSA-9696264,1.0472449200693372,Proteomics,RND3 GTPase cycle,0.6833,0.8788546255506609,-1.0218238935947392
3018,R-HSA-5221030,0.9068037490630941,Transcriptomics,"TET1,2,3 and TDG demethylate DNA",0.8764,0.9276534623525854,-1.0222116596478934
3019,R-HSA-1538133,1.045031405643845,Proteomics,G0 and Early G1,0.4826,0.8777425373134329,-1.026653094807462
3020,R-HSA-1362277,1.045031405643845,Proteomics,Transcription of E2F targets under negative control by DREAM complex,0.4826,0.8777425373134329,-1.026653094807462
3021,R-HSA-198203,0.9050278023831259,Transcriptomics,PI3K/AKT activation,0.8188,0.9059734513274336,-1.0268209487264401
3022,R-HSA-8956319,1.4854625000832713,Metabolomics,Nucleotide catabolism,0.952,0.9648812970469022,-1.0270558695503944
3023,R-HSA-2243919,0.9048749981134945,Transcriptomics,Crosslinking of collagen fibrils,0.5414,0.8777425373134329,-1.0272175366753418
3024,R-HSA-446353,0.9046886884822573,Transcriptomics,Cell-extracellular matrix interactions,0.8117,0.9035918626827718,-1.0277010843843897
3025,R-HSA-380615,0.9046870245485402,Transcriptomics,Serotonin clearance from the synaptic cleft,0.819,0.9059734513274336,-1.0277054029552093
3026,R-HSA-389960,0.9040080031250803,Transcriptomics,Formation of tubulin folding intermediates by CCT/TriC,0.8698,0.9239406779661016,-1.0294677340356158
3027,R-HSA-1614603,1.4783780833510958,Metabolomics,Cysteine formation from homocysteine,0.8664,0.9239406779661016,-1.0304784174784158
3028,R-HSA-174048,0.9032812503233493,Transcriptomics,APC/C:Cdc20 mediated degradation of Cyclin B,0.8802,0.9292557999397408,-1.0313539470563142
3029,R-HSA-196757,0.9024726149813662,Transcriptomics,Metabolism of folate and pterines,0.7929,0.902319257837492,-1.0334526778866768
3030,R-HSA-156711,0.9022282430078985,Transcriptomics,Polo-like kinase mediated events,0.819,0.9059734513274336,-1.0340869205028052
3031,R-HSA-175474,0.902078886083347,Transcriptomics,Assembly Of The HIV Virion,0.8854,0.9297629762976296,-1.034474561217983
3032,R-HSA-5467340,0.9008326864483618,Transcriptomics,AXIN missense mutants destabilize the destruction complex,0.7856,0.9003598298985933,-1.0377089456913553
3033,R-HSA-5358752,0.9008326864483618,Transcriptomics,CTNNB1 T41 mutants aren't phosphorylated,0.7856,0.9003598298985933,-1.0377089456913553
3034,R-HSA-5358751,0.9008326864483618,Transcriptomics,CTNNB1 S45 mutants aren't phosphorylated,0.7856,0.9003598298985933,-1.0377089456913553
3035,R-HSA-4839748,0.9008326864483618,Transcriptomics,Signaling by AMER1 mutants,0.7856,0.9003598298985933,-1.0377089456913553
3036,R-HSA-5467337,0.9008326864483618,Transcriptomics,APC truncation mutants have impaired AXIN binding,0.7856,0.9003598298985933,-1.0377089456913553
3037,R-HSA-5358749,0.9008326864483618,Transcriptomics,CTNNB1 S37 mutants aren't phosphorylated,0.7856,0.9003598298985933,-1.0377089456913553
3038,R-HSA-5358747,0.9008326864483618,Transcriptomics,CTNNB1 S33 mutants aren't phosphorylated,0.7856,0.9003598298985933,-1.0377089456913553
3039,R-HSA-5467348,0.9008326864483618,Transcriptomics,Truncations of AMER1 destabilize the destruction complex,0.7856,0.9003598298985933,-1.0377089456913553
3040,R-HSA-5339716,0.9008326864483618,Transcriptomics,Signaling by GSK3beta mutants,0.7856,0.9003598298985933,-1.0377089456913553
3041,R-HSA-4839735,0.9008326864483618,Transcriptomics,Signaling by AXIN mutants,0.7856,0.9003598298985933,-1.0377089456913553
3042,R-HSA-4839743,0.9008326864483618,Transcriptomics,Signaling by CTNNB1 phospho-site mutants,0.7856,0.9003598298985933,-1.0377089456913553
3043,R-HSA-4839744,0.9008326864483618,Transcriptomics,Signaling by APC mutants,0.7856,0.9003598298985933,-1.0377089456913553
3044,R-HSA-9013507,0.8998905679855308,Transcriptomics,NOTCH3 Activation and Transmission of Signal to the Nucleus,0.8973,0.9380376344086022,-1.0401541183929939
3045,R-HSA-428359,0.899211388114294,Transcriptomics,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,0.8003,0.902319257837492,-1.0419168607084988
3046,R-HSA-1251985,1.0369691091163469,Proteomics,Nuclear signaling by ERBB4,0.833,0.911421875,-1.0442425226058674
3047,R-HSA-6804116,1.036060711408047,Proteomics,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,0.5604,0.8777425373134329,-1.0462243643612383
3048,R-HSA-2197563,0.8968791444317284,Transcriptomics,NOTCH2 intracellular domain regulates transcription,0.9156,0.9457008244994112,-1.0479699621083398
3049,R-HSA-174824,0.8964459222459401,Transcriptomics,"Plasma lipoprotein assembly, remodeling, and clearance",0.9339,0.9540718038528896,-1.0490943462534619
3050,R-HSA-176974,0.8960714777708524,Transcriptomics,Unwinding of DNA,0.6718,0.8777425373134329,-1.050066178825358
3051,R-HSA-76061,1.0334159385246948,Proteomics,RNA Polymerase III Transcription Initiation From Type 1 Promoter,0.7376,0.8897836538461539,-1.0519944376295975
3052,R-HSA-749476,1.0334159385246948,Proteomics,RNA Polymerase III Abortive And Retractive Initiation,0.7376,0.8897836538461539,-1.0519944376295975
3053,R-HSA-76046,1.0334159385246948,Proteomics,RNA Polymerase III Transcription Initiation,0.7376,0.8897836538461539,-1.0519944376295975
3054,R-HSA-74158,1.0334159385246948,Proteomics,RNA Polymerase III Transcription,0.7376,0.8897836538461539,-1.0519944376295975
3055,R-HSA-76066,1.0334159385246948,Proteomics,RNA Polymerase III Transcription Initiation From Type 2 Promoter,0.7376,0.8897836538461539,-1.0519944376295975
3056,R-HSA-381676,1.0331017603435315,Proteomics,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,0.5391,0.8777425373134329,-1.0526798768731875
3057,R-HSA-163359,1.0331017603435315,Proteomics,Glucagon signaling in metabolic regulation,0.5391,0.8777425373134329,-1.0526798768731875
3058,R-HSA-5693554,0.8945741223976229,Transcriptomics,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),0.7805,0.9003598298985933,-1.0539524124867499
3059,R-HSA-9697154,0.894314024207363,Transcriptomics,Disorders of Nervous System Development,0.9176,0.9457008244994112,-1.0546274708999543
3060,R-HSA-9005891,0.894314024207363,Transcriptomics,Loss of function of MECP2 in Rett syndrome,0.9176,0.9457008244994112,-1.0546274708999543
3061,R-HSA-9005895,0.894314024207363,Transcriptomics,Pervasive developmental disorders,0.9176,0.9457008244994112,-1.0546274708999543
3062,R-HSA-9675151,0.894314024207363,Transcriptomics,Disorders of Developmental Biology,0.9176,0.9457008244994112,-1.0546274708999543
3063,R-HSA-198323,0.8932354398951963,Transcriptomics,AKT phosphorylates targets in the cytosol,0.9,0.93868374032162,-1.0574268268414573
3064,R-HSA-5205685,0.892028598411057,Transcriptomics,PINK1-PRKN Mediated Mitophagy,0.9159,0.9457008244994112,-1.060559061235161
3065,R-HSA-3781860,0.8911094715049794,Transcriptomics,Diseases associated with N-glycosylation of proteins,0.8877,0.931060833083608,-1.062944561688394
3066,R-HSA-164378,0.8907899841509122,Transcriptomics,PKA activation in glucagon signalling,0.7175,0.8854020979020979,-1.0637737586392069
3067,R-HSA-163615,0.8907899841509122,Transcriptomics,PKA activation,0.7175,0.8854020979020979,-1.0637737586392069
3068,R-HSA-1912420,0.8900845945558529,Transcriptomics,Pre-NOTCH Processing in Golgi,0.8672,0.9239406779661016,-1.0656045256286106
3069,R-HSA-9694676,0.8891995003435499,Transcriptomics,Translation of Replicase and Assembly of the Replication Transcription Complex,0.8824,0.9294011435449896,-1.067901697684658
3070,R-HSA-110312,0.8879050789800631,Transcriptomics,Translesion synthesis by REV1,0.8701,0.9239406779661016,-1.0712612367524996
3071,R-HSA-5655862,0.8879050789800631,Transcriptomics,Translesion synthesis by POLK,0.8701,0.9239406779661016,-1.0712612367524996
3072,R-HSA-5656121,0.8879050789800631,Transcriptomics,Translesion synthesis by POLI,0.8701,0.9239406779661016,-1.0712612367524996
3073,R-HSA-428890,1.0243456334926675,Proteomics,Role of ABL in ROBO-SLIT signaling,0.7491,0.8945240532241556,-1.0717830270130577
3074,R-HSA-9617828,0.8872438601586174,Transcriptomics,FOXO-mediated transcription of cell cycle genes,0.9271,0.9510111371629544,-1.0729773629890562
3075,R-HSA-113510,0.8863414737679898,Transcriptomics,E2F mediated regulation of DNA replication,0.8301,0.9110536218250236,-1.0753194151361531
3076,R-HSA-176417,0.8862907564850263,Transcriptomics,Phosphorylation of Emi1,0.7554,0.8948392554991539,-1.0754510466885494
3077,R-HSA-390522,0.885850598744439,Transcriptomics,Striated Muscle Contraction,0.8306,0.9113166144200626,-1.0765934313611358
3078,R-HSA-3656225,1.0217128175316348,Proteomics,Defective CHST6 causes MCDC1,0.6114,0.8777425373134329,-1.0775270139893647
3079,R-HSA-174490,0.8853199850321081,Transcriptomics,Membrane binding and targetting of GAG proteins,0.9141,0.9457008244994112,-1.077970585313313
3080,R-HSA-174495,0.8853199850321081,Transcriptomics,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",0.9141,0.9457008244994112,-1.077970585313313
3081,R-HSA-9615710,0.8838724617590035,Transcriptomics,Late endosomal microautophagy,0.9288,0.951639344262295,-1.0817274848243854
3082,R-HSA-75892,0.8837792059051878,Transcriptomics,Platelet Adhesion to exposed collagen,0.8447,0.9134751773049644,-1.0819695209132791
3083,R-HSA-2206281,0.8825933170215446,Transcriptomics,Mucopolysaccharidoses,0.933,0.9534306569343066,-1.085047374962278
3084,R-HSA-500792,1.0181390282551162,Proteomics,GPCR ligand binding,0.8079,0.9031140210795272,-1.0853239125816752
3085,R-HSA-372708,0.8812978874116736,Transcriptomics,p130Cas linkage to MAPK signaling for integrins,0.8195,0.9061749842072014,-1.0884095308311192
3086,R-HSA-190872,0.8807886752352593,Transcriptomics,Transport of connexons to the plasma membrane,0.8778,0.9281873111782476,-1.0897311392723432
3087,R-HSA-190861,0.8807886752352593,Transcriptomics,Gap junction assembly,0.8778,0.9281873111782476,-1.0897311392723432
3088,R-HSA-190840,0.8807886752352593,Transcriptomics,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,0.8778,0.9281873111782476,-1.0897311392723432
3089,R-HSA-452723,1.0158330301020468,Proteomics,Transcriptional regulation of pluripotent stem cells,0.8101,0.9035918626827718,-1.0903548845731328
3090,R-HSA-909733,0.8781756364666568,Transcriptomics,Interferon alpha/beta signaling,0.6949,0.8845385174418605,-1.096513015774488
3091,R-HSA-2979096,1.0128790574567017,Proteomics,NOTCH2 Activation and Transmission of Signal to the Nucleus,0.7768,0.9003598298985933,-1.0967995357201783
3092,R-HSA-432047,0.8762492288600238,Transcriptomics,Passive transport by Aquaporins,0.8785,0.9285778985507248,-1.1015128108934729
3093,R-HSA-937042,0.8758239777154626,Transcriptomics,IRAK2 mediated activation of TAK1 complex,0.8459,0.9134751773049644,-1.1026165070113654
3094,R-HSA-15869,1.3279498412580204,Metabolomics,Metabolism of nucleotides,0.9768,0.9829787234042554,-1.1031517070031869
3095,R-HSA-1181150,0.8752646702020164,Transcriptomics,Signaling by NODAL,0.9051,0.9416914387633768,-1.1040681328075426
3096,R-HSA-111448,0.875241053629164,Transcriptomics,Activation of NOXA and translocation to mitochondria,0.749,0.8945240532241556,-1.1041294272216984
3097,R-HSA-212676,1.0094150141590161,Proteomics,Dopamine Neurotransmitter Release Cycle,0.5396,0.8777425373134329,-1.1043570026611889
3098,R-HSA-3304351,0.8751204996337972,Transcriptomics,Signaling by TGF-beta Receptor Complex in Cancer,0.9143,0.9457008244994112,-1.1044423128620655
3099,R-HSA-3656534,0.8751204996337972,Transcriptomics,Loss of Function of TGFBR1 in Cancer,0.9143,0.9457008244994112,-1.1044423128620655
3100,R-HSA-437239,0.8747348082420892,Transcriptomics,Recycling pathway of L1,0.9266,0.9510111371629544,-1.1054433356627733
3101,R-HSA-8853884,1.00551127988591,Proteomics,Transcriptional Regulation by VENTX,0.5584,0.8777425373134329,-1.1128737387929801
3102,R-HSA-9673221,0.8710287789167459,Transcriptomics,Defective F9 activation,0.7787,0.9003598298985933,-1.1150619580497831
3103,R-HSA-68689,0.8707989636136908,Transcriptomics,CDC6 association with the ORC:origin complex,0.7647,0.897887323943662,-1.1156584203075766
3104,R-HSA-9646399,0.8704456317056318,Transcriptomics,Aggrephagy,0.9112,0.9454356846473028,-1.1165754573578937
3105,R-HSA-195399,0.8703748576669919,Transcriptomics,VEGF binds to VEGFR leading to receptor dimerization,0.5712,0.8777425373134329,-1.11675914418083
3106,R-HSA-194313,0.8703748576669919,Transcriptomics,VEGF ligand-receptor interactions,0.5712,0.8777425373134329,-1.11675914418083
3107,R-HSA-9029558,0.8701882931728058,Transcriptomics,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,0.8053,0.902319257837492,-1.1172433533607542
3108,R-HSA-5668541,1.0017067304017198,Proteomics,TNFR2 non-canonical NF-kB pathway,0.7971,0.902319257837492,-1.1211740845107767
3109,R-HSA-917729,0.8686581395446199,Transcriptomics,Endosomal Sorting Complex Required For Transport (ESCRT),0.9154,0.9457008244994112,-1.1212147115588629
3110,R-HSA-209560,0.8670004430923691,Transcriptomics,NF-kB is activated and signals survival,0.9127,0.9457008244994112,-1.125517094191793
3111,R-HSA-5693537,0.866464915795137,Transcriptomics,Resolution of D-Loop Structures,0.8008,0.902319257837492,-1.1269070008541033
3112,R-HSA-5693568,0.866464915795137,Transcriptomics,Resolution of D-loop Structures through Holliday Junction Intermediates,0.8008,0.902319257837492,-1.1269070008541033
3113,R-HSA-9704646,0.866249901380239,Transcriptomics,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,0.8025,0.902319257837492,-1.1274650489112312
3114,R-HSA-9704331,0.866249901380239,Transcriptomics,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,0.8025,0.902319257837492,-1.1274650489112312
3115,R-HSA-9701192,0.866249901380239,Transcriptomics,Defective HDR through Homologous Recombination (HRR) due to BRCA1 loss-of-function,0.8025,0.902319257837492,-1.1274650489112312
3116,R-HSA-9701193,0.866249901380239,Transcriptomics,Defective HDR through Homologous Recombination (HRR) due to PALB2 loss of function,0.8025,0.902319257837492,-1.1274650489112312
3117,R-HSA-9709603,0.866249901380239,Transcriptomics,Impaired BRCA2 binding to PALB2,0.8025,0.902319257837492,-1.1274650489112312
3118,R-HSA-5339700,0.8645345936342473,Transcriptomics,Signaling by TCF7L2 mutants,0.8177,0.9059734513274336,-1.1319169558007374
3119,R-HSA-9027277,0.9964627890129896,Proteomics,Erythropoietin activates Phospholipase C gamma (PLCG),0.9092,0.944272997032641,-1.1326147364542452
3120,R-HSA-451308,0.8615575182241397,Transcriptomics,Activation of Ca-permeable Kainate Receptor,0.709,0.8854020979020979,-1.139643652400696
3121,R-HSA-451306,0.8615575182241397,Transcriptomics,Ionotropic activity of kainate receptors,0.709,0.8854020979020979,-1.139643652400696
3122,R-HSA-110320,0.8614418194495705,Transcriptomics,Translesion Synthesis by POLH,0.9028,0.9404166666666668,-1.1399439368090278
3123,R-HSA-3000171,0.8608254070509268,Transcriptomics,Non-integrin membrane-ECM interactions,0.7833,0.9003598298985933,-1.1415437725298843
3124,R-HSA-9022537,0.8603636355116112,Transcriptomics,Loss of MECP2 binding ability to the NCoR/SMRT complex,0.9111,0.9454356846473028,-1.1427422536199747
3125,R-HSA-2691230,0.8590739648824508,Transcriptomics,Signaling by NOTCH1 HD Domain Mutants in Cancer,0.9243,0.9493544600938968,-1.1460894626397962
3126,R-HSA-2691232,0.8590739648824508,Transcriptomics,Constitutive Signaling by NOTCH1 HD Domain Mutants,0.9243,0.9493544600938968,-1.1460894626397962
3127,R-HSA-2980736,0.9900045673659986,Proteomics,Peptide hormone metabolism,0.723,0.8854020979020979,-1.146704570905062
3128,R-HSA-426117,0.857952469269647,Transcriptomics,Cation-coupled Chloride cotransporters,0.8183,0.9059734513274336,-1.1490001905000646
3129,R-HSA-83936,0.8575834771378147,Transcriptomics,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.6844,0.8789743589743589,-1.1499578720692851
3130,R-HSA-425397,1.228968274145276,Metabolomics,"Transport of vitamins, nucleosides, and related molecules",0.9419,0.9597234352256184,-1.1509706270697344
3131,R-HSA-210991,0.9847560969523824,Proteomics,Basigin interactions,0.8836,0.9297629762976296,-1.158155103774636
3132,R-HSA-8875791,0.9842408473228696,Proteomics,MET activates STAT3,0.7406,0.8898386543082732,-1.1592792184887946
3133,R-HSA-5693571,0.9842404806029684,Proteomics,Nonhomologous End-Joining (NHEJ),0.6548,0.8777425373134329,-1.1592800185577579
3134,R-HSA-8866652,0.8536014314897891,Transcriptomics,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,0.9435,0.9600581395348836,-1.1602928667640848
3135,R-HSA-181429,0.9833603775283751,Proteomics,Serotonin Neurotransmitter Release Cycle,0.5229,0.8777425373134329,-1.161200130207449
3136,R-HSA-210500,0.9833603775283751,Proteomics,Glutamate Neurotransmitter Release Cycle,0.5229,0.8777425373134329,-1.161200130207449
3137,R-HSA-181430,0.9833603775283751,Proteomics,Norepinephrine Neurotransmitter Release Cycle,0.5229,0.8777425373134329,-1.161200130207449
3138,R-HSA-5250971,0.9833603775283751,Proteomics,Toxicity of botulinum toxin type C (botC),0.5229,0.8777425373134329,-1.161200130207449
3139,R-HSA-168799,0.9833603775283751,Proteomics,Neurotoxicity of clostridium toxins,0.5229,0.8777425373134329,-1.161200130207449
3140,R-HSA-264642,0.9833603775283751,Proteomics,Acetylcholine Neurotransmitter Release Cycle,0.5229,0.8777425373134329,-1.161200130207449
3141,R-HSA-9772572,0.9820590330165009,Proteomics,Early SARS-CoV-2 Infection Events,0.769,0.9001672240802675,-1.164039259884011
3142,R-HSA-196849,0.9815164605330648,Proteomics,Metabolism of water-soluble vitamins and cofactors,0.5307,0.8777425373134329,-1.1652229845820854
3143,R-HSA-8964026,0.8513355357838036,Transcriptomics,Chylomicron clearance,0.6302,0.8777425373134329,-1.1661737687351459
3144,R-HSA-2151201,1.1828621116595066,Metabolomics,Transcriptional activation of mitochondrial biogenesis,0.9518,0.9648812970469022,-1.1732449450341182
3145,R-HSA-9753281,0.9775373035779906,Proteomics,Paracetamol ADME,0.5857,0.8777425373134329,-1.173904269588297
3146,R-HSA-211859,1.1792523062726592,Metabolomics,Biological oxidations,0.8845,0.9297629762976296,-1.17498887575056
3147,R-HSA-157858,0.8477708823545548,Transcriptomics,Gap junction trafficking and regulation,0.9285,0.951610541727672,-1.1754254643550472
3148,R-HSA-190828,0.8477708823545548,Transcriptomics,Gap junction trafficking,0.9285,0.951610541727672,-1.1754254643550472
3149,R-HSA-196854,0.9755523789802487,Proteomics,Metabolism of vitamins and cofactors,0.7127,0.8854020979020979,-1.178234758770651
3150,R-HSA-71032,0.8466708731561516,Transcriptomics,Propionyl-CoA catabolism,0.8318,0.911421875,-1.178280426410885
3151,R-HSA-69109,0.8450747232028846,Transcriptomics,Leading Strand Synthesis,0.8049,0.902319257837492,-1.1824230713620547
3152,R-HSA-69091,0.8450747232028846,Transcriptomics,Polymerase switching,0.8049,0.902319257837492,-1.1824230713620547
3153,R-HSA-9022535,0.8443161672085224,Transcriptomics,Loss of phosphorylation of MECP2 at T308,0.8991,0.93868374032162,-1.1843918263363549
3154,R-HSA-193048,0.8433152375980733,Transcriptomics,Androgen biosynthesis,0.606,0.8777425373134329,-1.18698963739334
3155,R-HSA-189445,0.8431959022434247,Transcriptomics,Metabolism of porphyrins,0.8638,0.9228632478632478,-1.1872993601756006
3156,R-HSA-2995383,0.967573381275237,Proteomics,Initiation of Nuclear Envelope (NE) Reformation,0.8451,0.9134751773049644,-1.1956424544014512
3157,R-HSA-199220,1.1304590807282204,Metabolomics,Vitamin B5 (pantothenate) metabolism,0.8812,0.9292557999397408,-1.1985613389895071
3158,R-HSA-196783,1.1304590807282204,Metabolomics,Coenzyme A biosynthesis,0.8812,0.9292557999397408,-1.1985613389895071
3159,R-HSA-9683610,0.8384056084924286,Transcriptomics,Maturation of nucleoprotein,0.8835,0.9297629762976296,-1.1997320806612692
3160,R-HSA-8939246,0.9598762665597402,Proteomics,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,0.9048,0.9416592328278324,-1.2124351688696557
3161,R-HSA-9632974,0.8334710113965539,Transcriptomics,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,0.7848,0.9003598298985933,-1.2125393258097836
3162,R-HSA-9031528,0.8334710113965539,Transcriptomics,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,0.7848,0.9003598298985933,-1.2125393258097836
3163,R-HSA-111931,0.8329320081998779,Transcriptomics,PKA-mediated phosphorylation of CREB,0.8016,0.902319257837492,-1.2139382538157668
3164,R-HSA-2022854,0.9570688022792158,Proteomics,Keratan sulfate biosynthesis,0.6565,0.8777425373134329,-1.218560184253357
3165,R-HSA-156587,1.0832185827133922,Metabolomics,Amino Acid conjugation,0.9802,0.9852670878805284,-1.221383665048478
3166,R-HSA-159424,1.083218582713392,Metabolomics,Conjugation of carboxylic acids,0.9802,0.9852670878805284,-1.221383665048478
3167,R-HSA-975110,0.8286412346837857,Transcriptomics,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,0.9314,0.9523517382413088,-1.2250745203091926
3168,R-HSA-114608,0.9520947114946636,Proteomics,Platelet degranulation ,0.8116,0.9035918626827718,-1.229412105963156
3169,R-HSA-9637628,0.8266914198799579,Transcriptomics,Modulation by Mtb of host immune system,0.9356,0.9549722951297754,-1.2301350664290982
3170,R-HSA-174577,0.826287378547427,Transcriptomics,Activation of C3 and C5,0.7627,0.8972941176470589,-1.2311837146358955
3171,R-HSA-392517,0.824700668252463,Transcriptomics,Rap1 signalling,0.8472,0.9137750385208012,-1.2353018599135035
3172,R-HSA-3134973,0.824195887366808,Transcriptomics,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,0.928,0.951610541727672,-1.236611967390013
3173,R-HSA-450321,0.8234986168187122,Transcriptomics,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.9169,0.9457008244994112,-1.2384216622183442
3174,R-HSA-1483213,0.8231002224127871,Transcriptomics,Synthesis of PE,0.8837,0.9297629762976296,-1.2394556544011597
3175,R-HSA-2132295,0.946925680311353,Proteomics,MHC class II antigen presentation,0.6424,0.8777425373134329,-1.2406893270969166
3176,R-HSA-69273,0.9431841099375229,Proteomics,Cyclin A/B1/B2 associated events during G2/M transition,0.6955,0.8845385174418605,-1.2488522719499957
3177,R-HSA-6798163,0.8193081235083072,Transcriptomics,Choline catabolism,0.5711,0.8777425373134329,-1.2492976616316362
3178,R-HSA-446388,0.8192283823502675,Transcriptomics,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,0.8713,0.9239406779661016,-1.249504621701445
3179,R-HSA-380108,0.9417217744321733,Proteomics,Chemokine receptors bind chemokines,0.7606,0.8969559367642113,-1.2520426339889832
3180,R-HSA-6787639,0.8173248161583504,Transcriptomics,GDP-fucose biosynthesis,0.8918,0.9333333333333332,-1.2544451342504204
3181,R-HSA-1234158,0.939635407219124,Proteomics,Regulation of gene expression by Hypoxia-inducible Factor,0.8078,0.9031140210795272,-1.2565944394614965
3182,R-HSA-350054,0.8152156700024304,Transcriptomics,Notch-HLH transcription pathway,0.9446,0.960796280151119,-1.2599192086982605
3183,R-HSA-5626467,0.9374398569959582,Proteomics,RHO GTPases activate IQGAPs,0.8595,0.9205288902476306,-1.2613844483623637
3184,R-HSA-1300645,0.8131233220232,Transcriptomics,Acrosome Reaction and Sperm:Oocyte Membrane Binding,0.7245,0.8857541899441341,-1.2653496851860784
3185,R-HSA-3134975,0.8130626600497588,Transcriptomics,Regulation of innate immune responses to cytosolic DNA,0.9453,0.960949753122277,-1.2655071271717078
3186,R-HSA-113501,0.8117811419889571,Transcriptomics,Inhibition of replication initiation of damaged DNA by RB1/E2F1,0.8328,0.911421875,-1.2688331770290824
3187,R-HSA-75893,0.8103672878926735,Transcriptomics,TNF signaling,0.9449,0.9608221963974432,-1.2725026916142697
3188,R-HSA-196741,0.9311740925585159,Proteomics,"Cobalamin (Cbl, vitamin B12) transport and metabolism",0.5084,0.8777425373134329,-1.275054400937081
3189,R-HSA-9758881,0.9311740925585159,Proteomics,Uptake of dietary cobalamins into enterocytes,0.5084,0.8777425373134329,-1.275054400937081
3190,R-HSA-389599,0.8089925834119274,Transcriptomics,Alpha-oxidation of phytanate,0.6364,0.8777425373134329,-1.2760705973519835
3191,R-HSA-69416,0.9285857298615366,Proteomics,Dimerization of procaspase-8,0.7638,0.8976830087306917,-1.2807014046933087
3192,R-HSA-5218900,0.9285857298615366,Proteomics,CASP8 activity is inhibited,0.7638,0.8976830087306917,-1.2807014046933087
3193,R-HSA-3371378,0.9285857298615366,Proteomics,Regulation by c-FLIP,0.7638,0.8976830087306917,-1.2807014046933087
3194,R-HSA-177539,0.8035745124318024,Transcriptomics,Autointegration results in viral DNA circles,0.7232,0.8854020979020979,-1.29013264982077
3195,R-HSA-175567,0.8035745124318024,Transcriptomics,Integration of viral DNA into host genomic DNA,0.7232,0.8854020979020979,-1.29013264982077
3196,R-HSA-166786,0.9241031374206026,Proteomics,Creation of C4 and C2 activators,0.6759,0.8786055923473142,-1.290481029620346
3197,R-HSA-180689,0.803072827805624,Transcriptomics,APOBEC3G mediated resistance to HIV-1 infection,0.8587,0.9205288902476306,-1.2914347212705506
3198,R-HSA-418594,0.9360056633855002,Metabolomics,G alpha (i) signalling events,0.9388,0.9571220506845324,-1.29250360209782
3199,R-HSA-8866427,0.8024186943018717,Transcriptomics,VLDLR internalisation and degradation,0.9185,0.9463497203414778,-1.2931324582852737
3200,R-HSA-9717189,0.9230308310694029,Metabolomics,Sensory perception of taste,0.9265,0.9510111371629544,-1.2987718648410598
3201,R-HSA-6803211,0.920142445974951,Proteomics,TP53 Regulates Transcription of Death Receptors and Ligands,0.6949,0.8845385174418605,-1.2991220286182665
3202,R-HSA-352230,0.9210332868340578,Metabolomics,Amino acid transport across the plasma membrane,0.9464,0.9617886178861788,-1.2997368971284406
3203,R-HSA-9757110,0.7993382308750179,Transcriptomics,Prednisone ADME,0.5748,0.8777425373134329,-1.3011274879730534
3204,R-HSA-9024446,0.9166354651366836,Proteomics,NR1H2 and NR1H3-mediated signaling,0.5312,0.8777425373134329,-1.3067731719413511
3205,R-HSA-167590,0.7969477953744879,Transcriptomics,Nef Mediated CD4 Down-regulation,0.9544,0.9661943319838056,-1.307331620321081
3206,R-HSA-8941237,0.7944626159351201,Transcriptomics,Invadopodia formation,0.6162,0.8777425373134329,-1.3137816509314095
3207,R-HSA-71288,0.7943774907475641,Transcriptomics,Creatine metabolism,0.6585,0.8777425373134329,-1.3140025847025283
3208,R-HSA-6814848,0.7939010837313528,Transcriptomics,Glycerophospholipid catabolism,0.7396,0.8897836538461539,-1.3152390506851697
3209,R-HSA-3928663,0.9127091006319081,Proteomics,EPHA-mediated growth cone collapse,0.8513,0.9166102737619196,-1.3153392802122907
3210,R-HSA-8852405,0.9125558889568715,Proteomics,Signaling by MST1,0.6712,0.8777425373134329,-1.3156735405172473
3211,R-HSA-3828062,0.7936938377721003,Transcriptomics,Glycogen storage disease type 0 (muscle GYS1),0.7233,0.8854020979020979,-1.3157769365053524
3212,R-HSA-3814836,0.7936938377721003,Transcriptomics,Glycogen storage disease type XV (GYG1),0.7233,0.8854020979020979,-1.3157769365053524
3213,R-HSA-9609646,0.9095471597314967,Proteomics,HCMV Infection,0.6935,0.8845385174418605,-1.322237653520804
3214,R-HSA-1474228,0.9089453281525605,Proteomics,Degradation of the extracellular matrix,0.758,0.8968897903989181,-1.3235506631661815
3215,R-HSA-5357905,0.7904653948057794,Transcriptomics,Regulation of TNFR1 signaling,0.9534,0.9655381944444444,-1.324156032045338
3216,R-HSA-447043,0.7903859627182572,Transcriptomics,Neurofascin interactions,0.9496,0.963641635256596,-1.3243621899540363
3217,R-HSA-9018683,0.7893207076707499,Transcriptomics,Biosynthesis of DPA-derived SPMs,0.8271,0.9091865577889446,-1.3271269511440682
3218,R-HSA-9025094,0.7893207076707499,Transcriptomics,Biosynthesis of DPAn-3 SPMs,0.8271,0.9091865577889446,-1.3271269511440682
3219,R-HSA-5368598,0.7882162176380025,Transcriptomics,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,0.7892,0.9014183240952072,-1.3299935427499587
3220,R-HSA-8963899,0.7855364651931563,Transcriptomics,Plasma lipoprotein remodeling,0.9207,0.9477794117647058,-1.3369485678171862
3221,R-HSA-5336415,0.7836243408038265,Transcriptomics,Uptake and function of diphtheria toxin,0.8079,0.9031140210795272,-1.3419112922975847
3222,R-HSA-444257,0.7786157017328876,Transcriptomics,RSK activation,0.8701,0.9239406779661016,-1.3549107058658307
3223,R-HSA-211897,0.7989349849407664,Metabolomics,Cytochrome P450 - arranged by substrate type,0.9589,0.9687103289094056,-1.3587237277960746
3224,R-HSA-6803204,0.8911170347849323,Proteomics,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,0.6803,0.8786055923473142,-1.362446463871244
3225,R-HSA-352230,0.7754000675547856,Transcriptomics,Amino acid transport across the plasma membrane,0.8912,0.9333333333333332,-1.3632565574980384
3226,R-HSA-189200,0.7891231520158474,Metabolomics,Cellular hexose transport,0.9896,0.992719977070794,-1.3634639159748352
3227,R-HSA-9029569,0.890275256137349,Proteomics,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.5406,0.8777425373134329,-1.3642829635203706
3228,R-HSA-9609690,0.8894982005010094,Proteomics,HCMV Early Events,0.706,0.8854020979020979,-1.3659782576545076
3229,R-HSA-9709957,0.7827722634952774,Metabolomics,Sensory Perception,0.9693,0.9761939010356732,-1.3665320895689226
3230,R-HSA-3000170,0.7720065656395686,Transcriptomics,Syndecan interactions,0.8893,0.9324595566207308,-1.372064046761239
3231,R-HSA-5682910,0.7706246615812933,Transcriptomics,LGI-ADAM interactions,0.6551,0.8777425373134329,-1.3756506382705753
3232,R-HSA-9609523,0.8832950730633531,Proteomics,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,0.6659,0.8777425373134329,-1.3795115557435598
3233,R-HSA-8850843,0.7682119854097017,Transcriptomics,Phosphate bond hydrolysis by NTPDase proteins,0.8686,0.9239406779661016,-1.3819124940195247
3234,R-HSA-389887,0.7669111190874486,Transcriptomics,Beta-oxidation of pristanoyl-CoA,0.8228,0.908167770419426,-1.3852887603226987
3235,R-HSA-389977,0.762706232182062,Transcriptomics,Post-chaperonin tubulin folding pathway,0.9546,0.9661943319838056,-1.3962021168486214
3236,R-HSA-5250913,0.8749543311344117,Proteomics,Positive epigenetic regulation of rRNA expression,0.5906,0.8777425373134329,-1.397708464954709
3237,R-HSA-212165,0.8749543311344117,Proteomics,Epigenetic regulation of gene expression,0.5906,0.8777425373134329,-1.397708464954709
3238,R-HSA-5663084,0.7138657445171186,Metabolomics,Diseases of carbohydrate metabolism,0.9633,0.972188581314879,-1.3998214728267913
3239,R-HSA-189085,0.7138657445171186,Metabolomics,Digestion of dietary carbohydrate,0.9633,0.972188581314879,-1.3998214728267913
3240,R-HSA-430116,0.7606831393325816,Transcriptomics,GP1b-IX-V activation signalling,0.8824,0.9294011435449896,-1.4014528486871263
3241,R-HSA-1660661,0.7599060623033344,Transcriptomics,Sphingolipid de novo biosynthesis,0.9508,0.9643002028397566,-1.4034696731247625
3242,R-HSA-4717374,0.7592046752792542,Transcriptomics,Defective DPM1 causes DPM1-CDG,0.8851,0.9297629762976296,-1.405290051848061
3243,R-HSA-162699,0.7592046752792542,Transcriptomics,Synthesis of dolichyl-phosphate mannose,0.8851,0.9297629762976296,-1.405290051848061
3244,R-HSA-4719360,0.7592046752792542,Transcriptomics,Defective DPM3 causes DPM3-CDG,0.8851,0.9297629762976296,-1.405290051848061
3245,R-HSA-4719377,0.7592046752792542,Transcriptomics,Defective DPM2 causes DPM2-CDG,0.8851,0.9297629762976296,-1.405290051848061
3246,R-HSA-9675126,0.7577322405605043,Transcriptomics,Diseases of mitotic cell cycle,0.9425,0.959775967413442,-1.4091116064839966
3247,R-HSA-211897,0.8675607043056406,Proteomics,Cytochrome P450 - arranged by substrate type,0.684,0.8788546255506609,-1.4138390630826072
3248,R-HSA-5661231,0.7545152176923758,Transcriptomics,Metallothioneins bind metals,0.8329,0.911421875,-1.4174610623200044
3249,R-HSA-1433617,0.8648420530168704,Proteomics,Regulation of signaling by NODAL,0.5202,0.8777425373134329,-1.4197703160934294
3250,R-HSA-446199,0.7513801433097025,Transcriptomics,Synthesis of Dolichyl-phosphate,0.7056,0.8854020979020979,-1.4255978291922766
3251,R-HSA-8979227,0.8608694719514259,Proteomics,Triglyceride metabolism,0.7995,0.902319257837492,-1.428437254550186
3252,R-HSA-163560,0.8608694719514259,Proteomics,Triglyceride catabolism,0.7995,0.902319257837492,-1.428437254550186
3253,R-HSA-9018896,0.859677473801997,Proteomics,Biosynthesis of E-series 18(S)-resolvins,0.5496,0.8777425373134329,-1.431037824414331
3254,R-HSA-9018676,0.859677473801997,Proteomics,Biosynthesis of D-series resolvins,0.5496,0.8777425373134329,-1.431037824414331
3255,R-HSA-9662360,0.8592585654281283,Proteomics,Sensory processing of sound by inner hair cells of the cochlea,0.6915,0.8829806639912441,-1.4319517524212184
3256,R-HSA-947581,0.7474410170184527,Transcriptomics,Molybdenum cofactor biosynthesis,0.8251,0.9086347908147216,-1.435821431059422
3257,R-HSA-113507,0.7473633957958612,Transcriptomics,E2F-enabled inhibition of pre-replication complex formation,0.9312,0.9523517382413088,-1.4360228890522717
3258,R-HSA-211945,0.6355699486026082,Metabolomics,Phase I - Functionalization of compounds,0.9636,0.972211011818968,-1.4376469035165083
3259,R-HSA-2046104,0.7420505506362703,Transcriptomics,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.71,0.8854020979020979,-1.4498118386003231
3260,R-HSA-2046106,0.7420505506362703,Transcriptomics,alpha-linolenic acid (ALA) metabolism,0.71,0.8854020979020979,-1.4498118386003231
3261,R-HSA-446343,0.7415890402755959,Transcriptomics,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,0.9385,0.9570949883449884,-1.4510096418278
3262,R-HSA-1250342,0.8497315387164016,Proteomics,PI3K events in ERBB4 signaling,0.6231,0.8777425373134329,-1.4527367667044124
3263,R-HSA-9659787,0.7409061601017123,Transcriptomics,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,0.9066,0.9424116424116424,-1.45278198790268
3264,R-HSA-9661069,0.7409061601017123,Transcriptomics,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.9066,0.9424116424116424,-1.45278198790268
3265,R-HSA-9668250,0.7403546520010882,Transcriptomics,Defective factor IX causes hemophilia B,0.8908,0.9331936545944328,-1.4542133711157066
3266,R-HSA-2142712,0.738872513064839,Transcriptomics,Synthesis of 12-eicosatetraenoic acid derivatives,0.9211,0.9478995299647476,-1.458060112061704
3267,R-HSA-168799,0.7385778466908874,Transcriptomics,Neurotoxicity of clostridium toxins,0.8815,0.9292921686746988,-1.4588248886817399
3268,R-HSA-173736,0.8452212980719708,Proteomics,Alternative complement activation,0.6528,0.8777425373134329,-1.4625767114271189
3269,R-HSA-211981,0.5773399097171892,Metabolomics,Xenobiotics,0.9945,0.9957379862700227,-1.465778379468613
3270,R-HSA-211957,0.5773399097171892,Metabolomics,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,0.9945,0.9957379862700227,-1.465778379468613
3271,R-HSA-5626978,0.7350749167951726,Transcriptomics,TNFR1-mediated ceramide production,0.6458,0.8777425373134329,-1.4679163871447016
3272,R-HSA-1483255,0.842569158354269,Proteomics,PI Metabolism,0.6609,0.8777425373134329,-1.4683628568407352
3273,R-HSA-1660499,0.842569158354269,Proteomics,Synthesis of PIPs at the plasma membrane,0.6609,0.8777425373134329,-1.4683628568407352
3274,R-HSA-6803207,0.8417736645133942,Proteomics,TP53 Regulates Transcription of Caspase Activators and Caspases,0.6796,0.8786055923473142,-1.4700983774123764
3275,R-HSA-9634635,0.7309482280035,Transcriptomics,Estrogen-stimulated signaling through PRKCZ,0.9157,0.9457008244994112,-1.4786267884155087
3276,R-HSA-1538133,0.7291648270952433,Transcriptomics,G0 and Early G1,0.8358,0.9123129675810474,-1.4832554241858373
3277,R-HSA-399721,0.7272094828577839,Transcriptomics,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.9593,0.9687103289094056,-1.4883303213886534
3278,R-HSA-399719,0.7272094828577839,Transcriptomics,Trafficking of AMPA receptors,0.9593,0.9687103289094056,-1.4883303213886534
3279,R-HSA-156590,0.8323443853906664,Proteomics,Glutathione conjugation,0.7767,0.9003598298985933,-1.490670136805565
3280,R-HSA-5619102,0.8321965772627631,Proteomics,SLC transporter disorders,0.7858,0.9003598298985933,-1.4909926082483984
3281,R-HSA-351906,0.8321004425457634,Proteomics,Apoptotic cleavage of cell adhesion  proteins,0.8514,0.9166102737619196,-1.4912023443524747
3282,R-HSA-5210891,0.8286840289322633,Proteomics,Uptake and function of anthrax toxins,0.5792,0.8777425373134329,-1.4986558981109095
3283,R-HSA-1483206,0.8285842749962729,Proteomics,Glycerophospholipid biosynthesis,0.6588,0.8777425373134329,-1.4988735302271095
3284,R-HSA-420092,0.8274110608651803,Proteomics,Glucagon-type ligand receptors,0.6602,0.8777425373134329,-1.501433119195406
3285,R-HSA-420499,0.5031660995302866,Metabolomics,Class C/3 (Metabotropic glutamate/pheromone receptors),0.9962,0.996969696969697,-1.5016124403328819
3286,R-HSA-9668328,0.7208057890933534,Transcriptomics,Sealing of the nuclear envelope (NE) by ESCRT-III,0.9679,0.9757056451612904,-1.5049504576031454
3287,R-HSA-9018679,0.8231516461256791,Proteomics,Biosynthesis of EPA-derived SPMs,0.5753,0.8777425373134329,-1.5107258396713135
3288,R-HSA-168276,0.8223669738679671,Proteomics,NS1 Mediated Effects on Host Pathways,0.7521,0.8946156451066711,-1.5124377509084361
3289,R-HSA-6809371,0.8217332780862928,Proteomics,Formation of the cornified envelope,0.6696,0.8777425373134329,-1.5138202783508214
3290,R-HSA-6805567,0.8217332780862928,Proteomics,Keratinization,0.6696,0.8777425373134329,-1.5138202783508214
3291,R-HSA-9687139,0.7157319642844072,Transcriptomics,Aberrant regulation of mitotic cell cycle due to RB1 defects,0.9575,0.9677302916546348,-1.5181190541281
3292,R-HSA-417973,0.71566156368798,Transcriptomics,Adenosine P1 receptors,0.6753,0.8786055923473142,-1.5183017717197347
3293,R-HSA-1980145,0.8189828047848275,Proteomics,Signaling by NOTCH2,0.863,0.922824427480916,-1.519820957113077
3294,R-HSA-8849473,0.8178281058258619,Proteomics,PTK6 Expression,0.8093,0.9035918626827718,-1.5223401517244817
3295,R-HSA-1592389,0.817124833721274,Proteomics,Activation of Matrix Metalloproteinases,0.8098,0.9035918626827718,-1.5238744731010387
3296,R-HSA-9673221,0.813773602565072,Proteomics,Defective F9 activation,0.6165,0.8777425373134329,-1.531185818975844
3297,R-HSA-4791275,0.8131694083854221,Proteomics,Signaling by WNT in cancer,0.7136,0.8854020979020979,-1.532503983082426
3298,R-HSA-1483166,0.8093992507761589,Proteomics,Synthesis of PA,0.6127,0.8777425373134329,-1.5407292964073034
3299,R-HSA-9665244,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to sapitinib,0.6697,0.8777425373134329,-1.541532588763989
3300,R-HSA-9652282,0.7067107923868878,Transcriptomics,Drug-mediated inhibition of ERBB2 signaling,0.6697,0.8777425373134329,-1.541532588763989
3301,R-HSA-9665737,0.7067107923868878,Transcriptomics,Drug resistance in ERBB2 TMD/JMD mutants,0.6697,0.8777425373134329,-1.541532588763989
3302,R-HSA-9665230,0.7067107923868878,Transcriptomics,Drug resistance in ERBB2 KD mutants,0.6697,0.8777425373134329,-1.541532588763989
3303,R-HSA-9665249,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to afatinib,0.6697,0.8777425373134329,-1.541532588763989
3304,R-HSA-9665233,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to trastuzumab,0.6697,0.8777425373134329,-1.541532588763989
3305,R-HSA-9665247,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to osimertinib,0.6697,0.8777425373134329,-1.541532588763989
3306,R-HSA-9665245,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to tesevatinib,0.6697,0.8777425373134329,-1.541532588763989
3307,R-HSA-9665246,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to neratinib,0.6697,0.8777425373134329,-1.541532588763989
3308,R-HSA-9665250,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to AEE788,0.6697,0.8777425373134329,-1.541532588763989
3309,R-HSA-9665251,0.7067107923868878,Transcriptomics,Resistance of ERBB2 KD mutants to lapatinib,0.6697,0.8777425373134329,-1.541532588763989
3310,R-HSA-8939247,0.8086580498925277,Proteomics,RUNX1 regulates transcription of genes involved in interleukin signaling,0.6356,0.8777425373134329,-1.5423463666034045
3311,R-HSA-427389,0.8075029789168163,Proteomics,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.63,0.8777425373134329,-1.5448663728398426
3312,R-HSA-2473224,0.8072744409983484,Proteomics,Antagonism of Activin by Follistatin,0.8411,0.9132457496136012,-1.5453649716202742
3313,R-HSA-182218,0.705067393431064,Transcriptomics,Nef Mediated CD8 Down-regulation,0.9695,0.9761939010356732,-1.5457978636983185
3314,R-HSA-9699150,0.7047488120651876,Transcriptomics,Defective DNA double strand break response due to BARD1 loss of function,0.7777,0.9003598298985933,-1.5466247092488778
3315,R-HSA-9663199,0.7047488120651876,Transcriptomics,Defective DNA double strand break response due to BRCA1 loss of function,0.7777,0.9003598298985933,-1.5466247092488778
3316,R-HSA-73933,0.8061152223011291,Proteomics,Resolution of Abasic Sites (AP sites),0.8096,0.9035918626827718,-1.547894026897236
3317,R-HSA-112126,0.7016341340760229,Transcriptomics,ALKBH3 mediated reversal of alkylation damage,0.956,0.9670520231213872,-1.5547085393551414
3318,R-HSA-1483257,0.8025238004491646,Proteomics,Phospholipid metabolism,0.7403,0.8897836538461539,-1.5557293942945138
3319,R-HSA-9717207,0.3553840855884634,Metabolomics,"Sensory perception of sweet, bitter, and umami (glutamate) taste",0.9964,0.996969696969697,-1.5730073123084698
3320,R-HSA-5625886,0.7943366682428286,Proteomics,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,0.7414,0.8904941660947152,-1.5735911747844997
3321,R-HSA-2162123,0.7940390284634707,Proteomics,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),0.6033,0.8777425373134329,-1.5742405323702808
3322,R-HSA-198933,0.7901771295962001,Proteomics,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.8433,0.9132457496136012,-1.582665996635818
3323,R-HSA-2500257,0.7901291356425408,Proteomics,Resolution of Sister Chromatid Cohesion,0.6419,0.8777425373134329,-1.5827707045412853
3324,R-HSA-9616222,0.7882136315013658,Proteomics,Transcriptional regulation of granulopoiesis,0.8015,0.902319257837492,-1.5869497398414418
3325,R-HSA-4641263,0.6886995543595099,Transcriptomics,Regulation of FZD by ubiquitination,0.9531,0.9655137481910276,-1.5882789261777803
3326,R-HSA-416993,0.6885527793611409,Transcriptomics,Trafficking of GluR2-containing AMPA receptors,0.947,0.9621190130624092,-1.5886598657660105
3327,R-HSA-418890,0.7866646423809773,Proteomics,Role of second messengers in netrin-1 signaling,0.5735,0.8777425373134329,-1.5903291531637702
3328,R-HSA-204626,0.6867985945228721,Transcriptomics,Hypusine synthesis from eIF5A-lysine,0.726,0.8862922915940007,-1.5932126741965706
3329,R-HSA-9027283,0.7829623681358512,Proteomics,Erythropoietin activates STAT5,0.9368,0.9559183673469388,-1.5984063660648875
3330,R-HSA-5669034,0.7824564838382522,Proteomics,TNFs bind their physiological receptors,0.8266,0.9091865577889446,-1.5995100485326081
3331,R-HSA-3359485,0.6790033009482668,Transcriptomics,Defective CD320 causes MMATC,0.7833,0.9003598298985933,-1.613444566258857
3332,R-HSA-77387,0.7694956890566508,Proteomics,Insulin receptor recycling,0.6705,0.8777425373134329,-1.627786478609743
3333,R-HSA-74713,0.7694956890566508,Proteomics,IRS activation,0.6705,0.8777425373134329,-1.627786478609743
3334,R-HSA-6804114,0.672275592028286,Transcriptomics,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,0.9552,0.9665221162185604,-1.630905650872649
3335,R-HSA-3296469,0.6706019796481733,Transcriptomics,Defects in cobalamin (B12) metabolism,0.9228,0.948546255506608,-1.635249341678452
3336,R-HSA-5660526,0.6688015205783363,Transcriptomics,Response to metal ions,0.8875,0.931060833083608,-1.6399222501731587
3337,R-HSA-9012546,0.7628723525967668,Proteomics,Interleukin-18 signaling,0.802,0.902319257837492,-1.6422365423165695
3338,R-HSA-428157,0.7626663610721621,Proteomics,Sphingolipid metabolism,0.6296,0.8777425373134329,-1.6426859518659156
3339,R-HSA-9014826,0.7598536684731703,Proteomics,Interleukin-36 pathway,0.6562,0.8777425373134329,-1.6488223738171965
3340,R-HSA-1221632,0.7570643675417656,Proteomics,Meiotic synapsis,0.7648,0.897887323943662,-1.6549077624125714
3341,R-HSA-447038,0.7557973415396275,Proteomics,NrCAM interactions,0.7401,0.8897836538461539,-1.6576720197562822
3342,R-HSA-5676594,0.7521373271712951,Proteomics,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,0.8414,0.9132457496136012,-1.6656570347273063
3343,R-HSA-139915,0.6581687366686054,Transcriptomics,Activation of PUMA and translocation to mitochondria,0.9429,0.9599040139616056,-1.6675185599624514
3344,R-HSA-9632697,0.6565389523419682,Transcriptomics,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,0.7918,0.902319257837492,-1.671748499510687
3345,R-HSA-9630791,0.6565389523419682,Transcriptomics,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,0.7918,0.902319257837492,-1.671748499510687
3346,R-HSA-3214847,0.7441304696784429,Proteomics,HATs acetylate histones,0.8047,0.902319257837492,-1.6831255117651198
3347,R-HSA-187015,0.7422013749893652,Proteomics,Activation of TRKA receptors,0.8588,0.9205288902476306,-1.6873341974211347
3348,R-HSA-177504,0.6437861556280449,Transcriptomics,Retrograde neurotrophin signalling,0.9689,0.9761514104778354,-1.7048470870287897
3349,R-HSA-211000,0.7317143878747887,Proteomics,Gene Silencing by RNA,0.82,0.9062203978528576,-1.7102135472497488
3350,R-HSA-2046105,0.6411439076314538,Transcriptomics,Linoleic acid (LA) metabolism,0.7454,0.8923563611491109,-1.7117047731129897
3351,R-HSA-1912408,0.7293049290078266,Proteomics,Pre-NOTCH Transcription and Translation,0.796,0.902319257837492,-1.715470238395889
3352,R-HSA-1912422,0.7293049290078266,Proteomics,Pre-NOTCH Expression and Processing,0.796,0.902319257837492,-1.715470238395889
3353,R-HSA-9025106,0.6390721050196286,Transcriptomics,Biosynthesis of DPAn-6 SPMs,0.9305,0.9519877228880445,-1.717081926188194
3354,R-HSA-196783,0.6385037238956561,Transcriptomics,Coenzyme A biosynthesis,0.8918,0.9333333333333332,-1.7185571016181374
3355,R-HSA-71403,0.6378823362103451,Transcriptomics,Citric acid cycle (TCA cycle),0.8824,0.9294011435449896,-1.7201698501897886
3356,R-HSA-3772470,0.6376136776436812,Transcriptomics,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,0.9643,0.9726368876080692,-1.7208671261897663
3357,R-HSA-6811440,0.7267103175661711,Proteomics,Retrograde transport at the Trans-Golgi-Network,0.9173,0.9457008244994112,-1.7211308749728569
3358,R-HSA-2299718,0.7252568274736844,Proteomics,Condensation of Prophase Chromosomes,0.7622,0.8970073974445191,-1.7243019390673484
3359,R-HSA-9660821,0.72177884541376,Proteomics,ADORA2B mediated anti-inflammatory cytokines production,0.8197,0.9061749842072014,-1.7318898160597829
3360,R-HSA-112311,0.630203707552655,Transcriptomics,Neurotransmitter clearance,0.9485,0.962804524361949,-1.740098950319495
3361,R-HSA-9018676,0.6268271336246957,Transcriptomics,Biosynthesis of D-series resolvins,0.7424,0.8907673860911272,-1.7488625047125392
3362,R-HSA-9610379,0.7118468843608031,Proteomics,HCMV Late Events,0.7778,0.9003598298985933,-1.7535582713493791
3363,R-HSA-167021,0.7105695884294394,Proteomics,PLC-gamma1 signalling,0.8238,0.9086347908147216,-1.756344934489998
3364,R-HSA-202433,0.7104990676336523,Proteomics,Generation of second messenger molecules,0.8145,0.9044257614213198,-1.7564987889707346
3365,R-HSA-187706,0.7078871297239853,Proteomics,Signalling to p38 via RIT and RIN,0.8715,0.9239406779661016,-1.76219722652129
3366,R-HSA-177504,0.7078871297239853,Proteomics,Retrograde neurotrophin signalling,0.8715,0.9239406779661016,-1.76219722652129
3367,R-HSA-187042,0.7078871297239853,Proteomics,TRKA activation by NGF,0.8715,0.9239406779661016,-1.76219722652129
3368,R-HSA-198203,0.7078871297239853,Proteomics,PI3K/AKT activation,0.8715,0.9239406779661016,-1.76219722652129
3369,R-HSA-159740,0.6211721166166141,Transcriptomics,Gamma-carboxylation of protein precursors,0.842,0.9132457496136012,-1.7635395265107456
3370,R-HSA-159763,0.6211721166166141,Transcriptomics,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,0.842,0.9132457496136012,-1.7635395265107456
3371,R-HSA-1500620,0.7060862974146133,Proteomics,Meiosis,0.7723,0.9003598298985933,-1.766126083488371
3372,R-HSA-1474165,0.7060862974146133,Proteomics,Reproduction,0.7723,0.9003598298985933,-1.766126083488371
3373,R-HSA-5362517,0.7044201588560398,Proteomics,Signaling by Retinoic Acid,0.7424,0.8907673860911272,-1.7697610805116397
3374,R-HSA-2465910,0.6150373151104561,Transcriptomics,MASTL Facilitates Mitotic Progression,0.8751,0.926732223903177,-1.7794617802024453
3375,R-HSA-5339717,0.6999124187586364,Proteomics,Signaling by LRP5 mutants ,0.8027,0.902319257837492,-1.7795955698171155
3376,R-HSA-447041,0.6148237245063767,Transcriptomics,CHL1 interactions,0.8908,0.9331936545944328,-1.7800161329033275
3377,R-HSA-141424,0.698777330890094,Proteomics,Amplification of signal from the kinetochores,0.6684,0.8777425373134329,-1.782071979118172
3378,R-HSA-69618,0.698777330890094,Proteomics,Mitotic Spindle Checkpoint,0.6684,0.8777425373134329,-1.782071979118172
3379,R-HSA-9648025,0.698777330890094,Proteomics,EML4 and NUDC in mitotic spindle formation,0.6684,0.8777425373134329,-1.782071979118172
3380,R-HSA-141444,0.698777330890094,Proteomics,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,0.6684,0.8777425373134329,-1.782071979118172
3381,R-HSA-9672393,0.6113054445021497,Transcriptomics,Defective F8 binding to von Willebrand factor,0.8122,0.9035918626827718,-1.7891474710125563
3382,R-HSA-9672391,0.6113054445021497,Transcriptomics,Defective F8 cleavage by thrombin,0.8122,0.9035918626827718,-1.7891474710125563
3383,R-HSA-447038,0.6085497690257162,Transcriptomics,NrCAM interactions,0.9522,0.9648812970469022,-1.7962995465905074
3384,R-HSA-446107,0.6071843965330761,Transcriptomics,Type I hemidesmosome assembly,0.9006,0.93868374032162,-1.7998432321017113
3385,R-HSA-2559586,0.690551171250456,Proteomics,DNA Damage/Telomere Stress Induced Senescence,0.8015,0.902319257837492,-1.8000189053501783
3386,R-HSA-416700,0.6888456757741875,Proteomics,Other semaphorin interactions,0.9168,0.9457008244994112,-1.803739766948113
3387,R-HSA-1362409,0.604657311668862,Transcriptomics,Mitochondrial iron-sulfur cluster biogenesis,0.9736,0.980040264595916,-1.8064020239824399
3388,R-HSA-2514853,0.6842555595706602,Proteomics,Condensation of Prometaphase Chromosomes,0.8247,0.9086347908147216,-1.8137539753405807
3389,R-HSA-73772,0.6719964980252879,Proteomics,RNA Polymerase I Promoter Escape,0.7383,0.8897836538461539,-1.8404994413741211
3390,R-HSA-5250941,0.6719964980252879,Proteomics,Negative epigenetic regulation of rRNA expression,0.7383,0.8897836538461539,-1.8404994413741211
3391,R-HSA-5250924,0.6719964980252879,Proteomics,B-WICH complex positively regulates rRNA expression,0.7383,0.8897836538461539,-1.8404994413741211
3392,R-HSA-427413,0.6719964980252879,Proteomics,NoRC negatively regulates rRNA expression,0.7383,0.8897836538461539,-1.8404994413741211
3393,R-HSA-427359,0.6719964980252879,Proteomics,SIRT1 negatively regulates rRNA expression,0.7383,0.8897836538461539,-1.8404994413741211
3394,R-HSA-6791312,0.6696282607544477,Proteomics,TP53 Regulates Transcription of Cell Cycle Genes,0.8361,0.9123129675810474,-1.8456661997962236
3395,R-HSA-1614635,0.6675850101052992,Proteomics,Sulfur amino acid metabolism,0.7518,0.8946156451066711,-1.8501239383133645
3396,R-HSA-1606341,0.5872428553597426,Transcriptomics,IRF3 mediated activation of type 1 IFN,0.8339,0.9117931896282412,-1.851599475110808
3397,R-HSA-3214858,0.6663332376686935,Proteomics,RMTs methylate histone arginines,0.8351,0.9123129675810474,-1.8528549171130917
3398,R-HSA-189451,0.5846517224270071,Transcriptomics,Heme biosynthesis,0.9436,0.9600581395348836,-1.8583244972427417
3399,R-HSA-1362300,0.5826553354252263,Transcriptomics,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,0.9785,0.9841235632183908,-1.8635059167682566
3400,R-HSA-3214815,0.6610276119203498,Proteomics,HDACs deacetylate histones,0.8141,0.9044257614213198,-1.8644301451771497
3401,R-HSA-3000171,0.6564403230454368,Proteomics,Non-integrin membrane-ECM interactions,0.9571,0.9676054303870596,-1.8744381852164247
3402,R-HSA-73854,0.650192820847016,Proteomics,RNA Polymerase I Promoter Clearance,0.7618,0.8969559367642113,-1.8880682952557537
3403,R-HSA-73864,0.650192820847016,Proteomics,RNA Polymerase I Transcription,0.7618,0.8969559367642113,-1.8880682952557537
3404,R-HSA-5617472,0.6494020222099876,Proteomics,Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.7787,0.9003598298985933,-1.889793572350394
3405,R-HSA-5619507,0.6494020222099876,Proteomics,Activation of HOX genes during differentiation,0.7787,0.9003598298985933,-1.889793572350394
3406,R-HSA-9710421,0.6383145972657776,Proteomics,Defective pyroptosis,0.7604,0.8969559367642113,-1.9139828910961458
3407,R-HSA-212300,0.6383145972657776,Proteomics,PRC2 methylates histones and DNA,0.7604,0.8969559367642113,-1.9139828910961458
3408,R-HSA-5334118,0.6383145972657776,Proteomics,DNA methylation,0.7604,0.8969559367642113,-1.9139828910961458
3409,R-HSA-3247509,0.6354013998841731,Proteomics,Chromatin modifying enzymes,0.8532,0.9174193548387096,-1.9203385832778295
3410,R-HSA-4839726,0.6354013998841731,Proteomics,Chromatin organization,0.8532,0.9174193548387096,-1.9203385832778295
3411,R-HSA-375280,0.5533136517959242,Transcriptomics,Amine ligand-binding receptors,0.8034,0.902319257837492,-1.939659273974416
3412,R-HSA-912446,0.6223706160066913,Proteomics,Meiotic recombination,0.7783,0.9003598298985933,-1.9487677078315893
3413,R-HSA-68616,0.615613493558319,Proteomics,Assembly of the ORC complex at the origin of replication,0.7858,0.9003598298985933,-1.963509651026714
3414,R-HSA-391908,0.5409479192473082,Transcriptomics,Prostanoid ligand receptors,0.9004,0.93868374032162,-1.9717532757974798
3415,R-HSA-5655291,0.6114352529844566,Proteomics,Signaling by FGFR4 in disease,0.842,0.9132457496136012,-1.9726252746765833
3416,R-HSA-8964572,0.5395017819280614,Transcriptomics,Lipid particle organization,0.8811,0.9292557999397408,-1.9755065782061998
3417,R-HSA-3000157,0.6067178216729697,Proteomics,Laminin interactions,0.7842,0.9003598298985933,-1.9829172451051484
3418,R-HSA-196819,0.5365887974470671,Transcriptomics,Vitamin B1 (thiamin) metabolism,0.8112,0.9035918626827718,-1.9830669333146442
3419,R-HSA-167590,0.6060714225923873,Proteomics,Nef Mediated CD4 Down-regulation,0.7975,0.902319257837492,-1.9843274872015637
3420,R-HSA-3772470,0.605040212692948,Proteomics,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,0.8464,0.9134751773049644,-1.9865772670266202
3421,R-HSA-1660662,0.6029658379788305,Proteomics,Glycosphingolipid metabolism,0.7374,0.8897836538461539,-1.991102908589959
3422,R-HSA-8963693,0.5322423085842095,Transcriptomics,Aspartate and asparagine metabolism,0.9085,0.944106294536817,-1.9943478033269988
3423,R-HSA-197264,0.5923473981696962,Proteomics,Nicotinamide salvaging,0.7768,0.9003598298985933,-2.0142690473839684
3424,R-HSA-201722,0.5908190765546907,Proteomics,Formation of the beta-catenin:TCF transactivating complex,0.8001,0.902319257837492,-2.0176033706265075
3425,R-HSA-73728,0.587125008413327,Proteomics,RNA Polymerase I Promoter Opening,0.8322,0.911421875,-2.02566268035709
3426,R-HSA-113510,0.5827725111153284,Proteomics,E2F mediated regulation of DNA replication,0.9321,0.9527891355140188,-2.0351584780748726
3427,R-HSA-5633008,0.5752452962189373,Proteomics,TP53 Regulates Transcription of Cell Death Genes,0.9034,0.9407616780720024,-2.0515805238891858
3428,R-HSA-73886,0.5707893161110005,Proteomics,Chromosome Maintenance,0.8299,0.9110536218250236,-2.061302088968361
3429,R-HSA-157579,0.5707893161110005,Proteomics,Telomere Maintenance,0.8299,0.9110536218250236,-2.061302088968361
3430,R-HSA-174577,0.5706511111859801,Proteomics,Activation of C3 and C5,0.8425,0.9132457496136012,-2.061603609204157
3431,R-HSA-71240,0.5656780947576857,Proteomics,Tryptophan catabolism,0.7293,0.8887708913649024,-2.0724531870021736
3432,R-HSA-2855086,0.565292987351447,Proteomics,Ficolins bind to repetitive carbohydrate structures on the target cell surface,0.8722,0.9239406779661016,-2.073293371792396
3433,R-HSA-8849470,0.5648656865748454,Proteomics,PTK6 Regulates Cell Cycle,0.8321,0.911421875,-2.074225609416329
3434,R-HSA-1306955,0.5576942873626309,Proteomics,GRB7 events in ERBB2 signaling,0.7864,0.9003598298985933,-2.08987137588331
3435,R-HSA-73927,0.5565588038591617,Proteomics,Depurination,0.8408,0.9132457496136012,-2.092348648336938
3436,R-HSA-9670095,0.5565588038591617,Proteomics,Inhibition of DNA recombination at telomere,0.8408,0.9132457496136012,-2.092348648336938
3437,R-HSA-110331,0.5565588038591617,Proteomics,Cleavage of the damaged purine,0.8408,0.9132457496136012,-2.092348648336938
3438,R-HSA-774815,0.5565588038591617,Proteomics,Nucleosome assembly,0.8408,0.9132457496136012,-2.092348648336938
3439,R-HSA-110330,0.5565588038591617,Proteomics,Recognition and association of DNA glycosylase with site containing an affected purine,0.8408,0.9132457496136012,-2.092348648336938
3440,R-HSA-171306,0.5565588038591617,Proteomics,Packaging Of Telomere Ends,0.8408,0.9132457496136012,-2.092348648336938
3441,R-HSA-606279,0.5565588038591617,Proteomics,Deposition of new CENPA-containing nucleosomes at the centromere,0.8408,0.9132457496136012,-2.092348648336938
3442,R-HSA-8847993,0.49278345150437414,Transcriptomics,ERBB2 Activates PTK6 Signaling,0.7967,0.902319257837492,-2.096759255788664
3443,R-HSA-6785631,0.49278345150437414,Transcriptomics,ERBB2 Regulates Cell Motility,0.7967,0.902319257837492,-2.096759255788664
3444,R-HSA-5579026,0.4893489212016838,Transcriptomics,Defective CYP11A1 causes AICSR,0.8603,0.9205288902476306,-2.1056732300609164
3445,R-HSA-2395516,0.4893489212016838,Transcriptomics,Electron transport from NADPH to Ferredoxin,0.8603,0.9205288902476306,-2.1056732300609164
3446,R-HSA-166663,0.5503597274707727,Proteomics,Initial triggering of complement,0.892,0.9333333333333332,-2.10587310829428
3447,R-HSA-3000471,0.5479945648019628,Proteomics,Scavenging by Class B Receptors,0.7455,0.8923563611491109,-2.111033158889371
3448,R-HSA-9022702,0.54353447839462,Proteomics,MECP2 regulates transcription of neuronal ligands,0.9772,0.9830985915492956,-2.1207636826389047
3449,R-HSA-69205,0.5418993055672914,Proteomics,G1/S-Specific Transcription,0.7837,0.9003598298985933,-2.124331122051002
3450,R-HSA-2428933,0.5390554183138517,Proteomics,SHC-related events triggered by IGF1R,0.9055,0.9418276374442792,-2.1305356010528063
3451,R-HSA-5578749,0.5339757385821045,Proteomics,Transcriptional regulation by small RNAs,0.8635,0.922824427480916,-2.1416178850615686
3452,R-HSA-444821,0.47147276542303374,Transcriptomics,Relaxin receptors,0.9003,0.93868374032162,-2.1520689752295743
3453,R-HSA-196843,0.47030799693734837,Transcriptomics,Vitamin B2 (riboflavin) metabolism,0.9902,0.9930372492836675,-2.1550920134326135
3454,R-HSA-419812,0.46916076121129185,Transcriptomics,Calcitonin-like ligand receptors,0.9244,0.9493544600938968,-2.158069547140284
3455,R-HSA-8849175,0.46757455734999925,Transcriptomics,Threonine catabolism,0.9683,0.9758278145695364,-2.1621863780207784
3456,R-HSA-6807878,0.507243923500142,Proteomics,COPI-mediated anterograde transport,0.9563,0.967075989598382,-2.1999384057346543
3457,R-HSA-6783984,0.45222201229143866,Transcriptomics,Glycine degradation,0.8809,0.9292557999397408,-2.202032348096628
3458,R-HSA-1442490,0.5036521678900879,Proteomics,Collagen degradation,0.9352,0.9548424737456244,-2.207774501288456
3459,R-HSA-73929,0.49918502570640283,Proteomics,"Base-Excision Repair, AP Site Formation",0.872,0.9239406779661016,-2.2175204185512545
3460,R-HSA-110329,0.49918502570640283,Proteomics,Cleavage of the damaged pyrimidine ,0.872,0.9239406779661016,-2.2175204185512545
3461,R-HSA-73928,0.49918502570640283,Proteomics,Depyrimidination,0.872,0.9239406779661016,-2.2175204185512545
3462,R-HSA-110328,0.49918502570640283,Proteomics,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,0.872,0.9239406779661016,-2.2175204185512545
3463,R-HSA-1963642,0.49716344362246256,Proteomics,PI3K events in ERBB2 signaling,0.9301,0.9518567251461988,-2.2219308829868822
3464,R-HSA-6785631,0.49716344362246256,Proteomics,ERBB2 Regulates Cell Motility,0.9301,0.9518567251461988,-2.2219308829868822
3465,R-HSA-1963640,0.49716344362246256,Proteomics,GRB2 events in ERBB2 signaling,0.9301,0.9518567251461988,-2.2219308829868822
3466,R-HSA-9659787,0.49704887341457554,Proteomics,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,0.9161,0.9457008244994112,-2.222180839608126
3467,R-HSA-9661069,0.49704887341457554,Proteomics,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.9161,0.9457008244994112,-2.222180839608126
3468,R-HSA-9675126,0.49704887341457554,Proteomics,Diseases of mitotic cell cycle,0.9161,0.9457008244994112,-2.222180839608126
3469,R-HSA-9687139,0.49704887341457554,Proteomics,Aberrant regulation of mitotic cell cycle due to RB1 defects,0.9161,0.9457008244994112,-2.222180839608126
3470,R-HSA-8847993,0.4964787980098268,Proteomics,ERBB2 Activates PTK6 Signaling,0.9192,0.946513680494263,-2.223424567141252
3471,R-HSA-73884,0.4959639333455836,Proteomics,Base Excision Repair,0.8791,0.9287201931783882,-2.2245478419807183
3472,R-HSA-6804114,0.4931259747245173,Proteomics,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,0.9219,0.9478995299647476,-2.230739386547437
3473,R-HSA-196807,0.4909322455996842,Proteomics,Nicotinate metabolism,0.9351,0.9548424737456244,-2.2355254223771666
3474,R-HSA-2022090,0.4902287430696949,Proteomics,Assembly of collagen fibrils and other multimeric structures,0.912,0.9457008244994112,-2.2370602464704055
3475,R-HSA-75157,0.4884531016897713,Proteomics,FasL/ CD95L signaling,0.9499,0.9636666666666666,-2.240934144650844
3476,R-HSA-1307965,0.4765220294862259,Proteomics,betaKlotho-mediated ligand binding,0.8042,0.902319257837492,-2.266964039776389
3477,R-HSA-166662,0.4764249531201086,Proteomics,Lectin pathway of complement activation,0.9294,0.9518567251461988,-2.267175830266472
3478,R-HSA-111457,0.4240575339714664,Transcriptomics,Release of apoptotic factors from the mitochondria,0.8187,0.9059734513274336,-2.275130388588212
3479,R-HSA-1483249,0.47158017532558816,Proteomics,Inositol phosphate metabolism,0.859,0.9205288902476306,-2.2777456311818045
3480,R-HSA-1855204,0.4715801753255882,Proteomics,Synthesis of IP3 and IP4 in the cytosol,0.859,0.9205288902476306,-2.2777456311818045
3481,R-HSA-8963693,0.41846537572108566,Proteomics,Aspartate and asparagine metabolism,0.8453,0.9134751773049644,-2.393625632554079
3482,R-HSA-2892247,0.3980649940066704,Proteomics,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",0.9407,0.9587798485730926,-2.4381329314361966
3483,R-HSA-140834,0.39259328372247293,Proteomics,Extrinsic Pathway of Fibrin Clot Formation,0.8654,0.9239406779661016,-2.450070504390679
3484,R-HSA-5633231,0.31281823092960914,Transcriptomics,Defective ALG14 causes ALG14-CMS,0.9271,0.9510111371629544,-2.5638406918869276
3485,R-HSA-1663150,0.3257516992720936,Proteomics,The activation of arylsulfatases,0.9114,0.9454356846473028,-2.5958980883316785
3486,R-HSA-435354,0.2895633039579583,Transcriptomics,Zinc transporters,0.9927,0.9946893787575152,-2.6241964909218103
3487,R-HSA-442380,0.2895633039579583,Transcriptomics,Zinc influx into cells by the SLC39 gene family,0.9927,0.9946893787575152,-2.6241964909218103
3488,R-HSA-1483152,0.27787619154402826,Transcriptomics,Hydrolysis of LPE,0.9424,0.959775967413442,-2.6545292031686887
3489,R-HSA-933542,0.2564714114813911,Proteomics,TRAF6 mediated NF-kB activation,0.9379,0.9567618770037888,-2.7470461657797127
3490,R-HSA-5578999,0.1964783140112527,Transcriptomics,Defective GCLC causes HAGGSD,0.992,0.994557433400172,-2.8657891200122574
3491,R-HSA-2029485,0.18341241738185193,Proteomics,Role of phospholipids in phagocytosis,0.9892,0.9926032110091744,-2.906438207160848
3492,R-HSA-1482925,0.14269314285443843,Proteomics,Acyl chain remodelling of PG,0.9838,0.9874677373100086,-2.9952750214432973
3493,R-HSA-1482801,0.14269314285443843,Proteomics,Acyl chain remodelling of PS,0.9838,0.9874677373100086,-2.9952750214432973
3494,R-HSA-1482922,0.14269314285443843,Proteomics,Acyl chain remodelling of PI,0.9838,0.9874677373100086,-2.9952750214432973
3495,R-HSA-1482839,0.14269314285443843,Proteomics,Acyl chain remodelling of PE,0.9838,0.9874677373100086,-2.9952750214432973
3496,R-HSA-1482788,0.14269314285443843,Proteomics,Acyl chain remodelling of PC,0.9838,0.9874677373100086,-2.9952750214432973
3497,R-HSA-70350,0.11761925589046533,Transcriptomics,Fructose catabolism,0.999,0.999,-3.0704597891491954
3498,R-HSA-6788467,0.1151680610369574,Transcriptomics,IL-6-type cytokine receptor ligand interactions,0.9974,0.9976850528722492,-3.0768216162215407
3499,R-HSA-444473,0.08649110169707387,Proteomics,Formyl peptide receptors bind formyl peptides and many other ligands,0.9946,0.9957379862700227,-3.1178904253407813
